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1 Abstract
The biotin-binding protein streptavidin (SAV) is applied in a large variety of methods due to its
extremely high aﬃnity to the vitamin biotin, ranging from protein puriﬁcation and use as a bioinsecti-
cide to tumor staining. However, common processes for the production and puriﬁcation of the protein
show a diverse range of serious deﬁciencies like low productivities and concentrations of product, the
application of the toxic and ﬂammable organic solvent methanol in heterologous production, and labile,
expensive gel materials used for aﬃnity chromatography of SAV. Hence, this project focused on the
development of advanced strategies for the production and puriﬁcation of the protein, targeting an
economical and sustainable supply of SAV for common applications.
Optimization of process conditions for the natural producer Streptomyces avidinii led to a highly
ecological bioreactor fed-batch process based on the constant feeding of glucose. Reproducibly yielding
39.2µM of SAV in 14 days (114 nMh−1), this strategy surpassed previously reported concentrations
for this host by the factor 12.7. Continuous cultivation indicated that even higher productivities can
be achieved at dilution rates in the range of 0.2 h−1. A systematic variation of the rotary frequency of
the stirrer revealed shear-sensitive properties of the streptomycete. Moreover, shake ﬂask studies led
to a selection of eﬃcient strategies for the control of morphology.
Heterologous expression of the SAV gene was analyzed applying three hosts: the Gram-negative
bacterium Escherichia coli and the yeasts Pichia pastoris and Hansenula polymorpha.
For E. coli, broad optimization of process conditions allowed a more holistic view of the production of
SAV by this biotechnological model bacterium. Application of the periplasmic 'leaky mutant' JW1667-
5 (∆lpp-752::kan), the constitutive β-lactamase promoter from E. coli, the bglA-leader peptide from
Bacillus amyloliquefaciens, and addition of the non-ionic surfactant Triton led to the secretion of more
than 90% of SAV to the medium. Bioreactor fed-batch fermentation at 30 °C resulted in 2.6±0.2µM
of highly bioactive SAV in 40 h (65.2 nMh−1), exceeding all reference concentrations for the soluble,
secretory production of full-length SAV by E. coli.
For P. pastoris, a new strategy for the methanol-free production of a shortened form of SAV based
on the constitutive GAP promoter was developed. This study demonstrates for the ﬁrst time that SAV
can be produced in a growth-associated manner by the biotin auxotrophic yeast, obviating the need for
an induction by methanol. Productivity was greatly enhanced by successive cooling and acidiﬁcation
throughout the cultivation. Model-based evaluation of the optimized conditions in the bioreactor
revealed that the majority of product accumulated in the late phase of fermentation at diminishing
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growth rates. This is atypical for GAP promoter-based production processes, since the activity of
PGAP is usually known to be positively correlated to the growth rate of the host. The ﬁnal fed-batch
process led to 4.2±0.1µM of SAV in 72 h (57.8 nMh−1). Compared to literature, the proportion of
biotin-blocked binding sites Qblocked was lowered from 20% to 0±2%.
The yeast H. polymorpha has not been used for the production of SAV prior to this project. Es-
tablishing this host for the production of SAV included genetic aspects, process development, and
up-scaling to the bioreactor. Like observed for E. coli, cultivation at 30 instead of 37 °C turned out
to be beneﬁcial, resembling typical conditions for the natural producer S. avidinii. Application of
the FMD promoter and a full-length SAV gene allowed the accumulation of SAV in the absence of
methanol ('derepression'). However, production was enhanced upon induction by the organic solvent.
A three-stage process, consisting of a batch phase and two phases of DO-stat feeding of glucose and
methanol, respectively, yielded 11.4±0.2µM of SAV in 216 h (52.5 nMh−1). These properties resemble
reference results reported for the methanol-based expression of a full-length SAV gene using P. pastoris.
Remarkably, Qblocked was as low as 1.1±3.8%.
In addition to these studies, a novel ﬂuorometric assay was developed for the rapid detection of biotin-
blocked binding sites of SAV based on the heat-based displacement of biotin from the binding pocket.
Model-based evaluation of association and dissociation courses led to conditions allowing the detection
of all biotin-blocked binding sites in a sample independent of the degree of biotin saturation. This new
strategy facilitates analysis of the bioactivity and host toxicity of SAV during heterologous production.
Furthermore, it may simplify the development of methods for the non-denaturing separation of SAV
and biotin by revealing changes of the overall concentration of SAV rather than the concentration of
biotin-free binding sites.
To demonstrate the latter feature, the assay was used for the development of methods for the par-
tial recovery of biotin-blocked binding sites of SAV by hydrogen peroxide treatment and UV radiation.
Incubation in the presence of hydrogen peroxide at elevated temperatures resulted in the recovery of up
to 30% of biotin-blocked binding sites of a completely biotin-saturated sample of SAV without major
eﬀects on the overall bioactivity of SAV.
Puriﬁcation of SAV was studied by aqueous two-phase extraction, thermal inactivation of contam-
inating proteins, diaﬁltration, dialysis, and ammonium sulfate precipitation. The eﬃciency of the
methods was assessed by SDS-PAGE analysis and determination of total protein. The results indicate
that for many applications the direct use of crude supernatants or SAV puriﬁed by these simple and
inexpensive procedures may be suﬃcient, whereas puriﬁcation by chromatography may be necessary if
high product purities are required.
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2 Introduction
The protein streptavidin (SAV) was ﬁrst isolated from supernatants of the ﬁlamentous soil bacteria
Streptomyces avidinii and S. lavendulae in the early 1960s (Stapley et al., 1963; Chaiet & Wolf, 1964).
As shown in Fig. 2.1, SAV naturally occurs in a homotetrameric structure.
(a) monomer (b) homotetramer
Fig. 2.1: Protein backbone structure of SAV and bound biotin according to the data of
Weber et al. (1989). Biotin is located inside of a highly stable β-barrel structure.[1]
The interaction of SAV and its binding partner biotin (vitamin H, MW: 244.3 Da) serves as a model
interaction in molecular biology and is used for numerous applications in this ﬁeld. SAV therefore has an
extraordinary value as a biotechnological product. Naturally, SAV is part of the antibiotic complex MSD-
235 (Stapley et al., 1963; Chaiet & Wolf, 1964), which may be the reason for its natural occurrence
(Tausig & Wolf, 1964; Bayer et al., 1995). This hypothesis is supported by toxic eﬀects observed in
animal dietary studies upon feeding of raw egg white, which contains the biotin-binding protein avidin
(Boas, 1924).
2.1 Binding of biotin to streptavidin (SAV)
To this date, the interaction of SAV and its binding partner biotin is one of the strongest known
non-covalent interactions in biological systems, characterized by a dissociation constant Kd in the
[1]Visual representation created in Jmol (www.jmol.org).
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range of 10−15M (Sano et al., 1996). As shown in Fig. 2.1, biotin is bound by SAV inside of a highly
stable β-barrel structure, which is part of the core sequence of the protein. The interaction is subject
to stabilization by hydrogen bonds and van der Waals forces (Weber et al., 1989). Fig. 2.2 shows
molecular interactions of biotin and the binding pocket of SAV.
Fig. 2.2: Schematic representation of the interaction of biotin and the binding pocket of
SAV according to Miyamoto & Kollman (1993). Amino acids marked by squares are
involved in the formation of hydrogen bonds, whereas ellipsoids indicate van der Waals
interactions. Trp120 belongs to the neighboring monomer of SAV in a dimer.
Generally, Fig. 2.2 indicates that the amino acids located in close proximity to the binding pocket
mainly interact with the heterocycles of the headgroup as well as the terminally carboxylated hydro-
carbon chain of biotin. Interestingly, the valerate group of biotin binds to a neighboring monomer of
SAV (interaction with Lys-121 and Trp-120), which causes a strong dimer stabilization (Miyamoto &
Kollman, 1993; Sano et al., 1995, 1996).
The stabilizing eﬀect of bound biotin on SAV has been studied in detail (Sano et al., 1996; González
et al., 1997, 1999; Katz, 1997). From the thermodynamical perspective, the interaction of SAV and
the vitamin is characterized by a total free energy of binding of 300 to 330 kJ per mol of tetrameric
SAV (Miyamoto & Kollman, 1993; Green, 1990). These aspects lead to a remarkable rupture force of
250 pN for the release of SAV-bound biotin (Grubmüller et al., 1996).
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2.2 Properties and applications of SAV
Applications of SAV range from molecular biology and medicine to the downstream processing of
various biomolecules. Searching the literature database Google Scholar[2] for articles containing the
term 'streptavidin' in their title yields 35,900 results.[3] The enormous popularity of the molecular
tool SAV is due to its extraordinary binding properties and its stability towards extrema of pH (Sano
& Cantor, 1995), temperature (González et al., 1999; Waner et al., 2004), organic solvents, and
denaturing agents (Sano & Cantor, 1990a; Kurzban et al., 1991). Expression of the SAV gene may lead
to shortened forms of the protein, termed 'core streptavidins', depending on the degree of proteolysis
on SAV (Bayer et al., 1989; Sano et al., 1995). Chain lengths range from the 159AA (16.5 kDa per
monomer) of the full-length mature protein down to 125 (residues 14-138, 13.1 kDa, Pähler et al.,
1987) or even 119AA (residues 15-133, 12.6 kDa, Sano et al., 1995). An analysis of Bayer et al. (1989)
revealed that these truncated forms of SAV are used for commercial preparations, too.
Core SAV oﬀers advantageous properties for applications due to an enhanced structural stability
and an improved accessibility of the binding site towards biotinylated macromolecules (Sano et al.,
1995). Furthermore, it is characterized by an increased proteolytic stability (Pähler et al., 1987; Bayer
et al., 1989). These aspects along with the potentially lower metabolic burden for the host cell due to
the shortened chain length of the protein make core SAV genes an interesting target for heterologous
expression. The amino acid sequence of SAV is shown below.
1 MRKIVVAAIA VSLTTVSITA SASADPSKDS KAQVSAAEAG ITGTWYNQLG
51 STFIVTAGAD GALTGTYESA VGNAESRYVL TGRYDSAPAT DGSGTALGWT
101 VAWKNNYRNA HSATTWSGQY VGGAEARINT QWLLTSGTTE ANAWKSTLVG
151 HDTFTKVKPS AASIDAAKKA GVNNGNPLDA VQQ
The blue sequence corresponds to the native secretion signal peptide of 24AA, which is cleaved oﬀ
during secretion. Thus, mature, full-length SAV contains 159 of the 183AA of the unprocessed protein
(UniProt No. P22629, www.uniprot.org). The green region represents a shortened core-SAV gene
(AA 13-139 of the native protein), which was applied in some of the studies of heterologous expression
during this thesis.
An in silico-analysis of the signal peptide[4] (Bagos et al., 2010) suggests with a high probability[5]
[2]scholar.google.com
[3]search performed 23rd of March, 2016
[4]http://www.compgen.org/tools/PRED-TAT/
[5]Reliability score: 0.996, see Fig. 8.1 on p. 180 in the supplements.
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that the protein is secreted via the Sec pathway (unfolded secretion, see p. 18ﬀ.).
Unlike the biotin-binding protein avidin from chicken egg white (Woolley & Longsworth, 1942) SAV
is not glycosylated (Livnah et al., 1993) and has a neutral isoelectric point, which ranges from 5 to 8
depending on the preparation (Dittmer et al., 1989). This reduces unspeciﬁc binding of contaminating
proteins (Wood & Warnke, 1981). The dissociation constant for the formation of the SAV-biotin
complex leads to a practically irreversible binding of biotin. These combined properties therefore allow
harsh washing conditions for its application (Rybak et al., 2004), e.g., in ELISA-based methods.
2.2.1 Ligands of SAV and resulting applications
Applications of SAV can be divided into (i) methods involving SAV as a coupling agent between
several biotinylated molecules and (ii) methods exploiting SAV itself, e.g., for the puriﬁcation of other
macromolecules.
However, biotin is not the only compound that can be applied for the use of SAV-based systems.
Table 2.1 provides an overview of various SAV-binding molecules described in literature. Based on their
chemical identity the molecules can be divided into four groups:
1. biotin and biotin derivatives
2. SAV-binding peptides
3. nucleic acid aptamers
4. chemically derived ligands
To further extend the range of potential applications of SAV, the protein has been engineered in
numerous studies. Muteins[6] showing a mono- (Qureshi et al., 2001; Wu & Wong, 2006; Demonte
et al., 2014) or dimeric (Sano et al., 1997) instead of the native homotetrameric structure (Fig. 2.1b)
have been designed and characterized. Variants with diﬀerent biotin-binding properties, e.g. for the
reversible binding of the vitamin (Qureshi et al., 2001), were also in the focus of interest.
Generally, the tetrameric structure of SAV allows its use as a crosslinking agent, which is exploited
in many applications, e.g., for immunochemical staining. Corresponding procedures typically involve
a biotinylated antibody which binds to the target molecule. By the binding of this antibody, SAV
links the target structure to a biotinylated detection marker, e.g., an enzyme catalyzing a colorimetric
reaction or a ﬂuorescent molecule. Depending on the quality of SAV used, up to three binding sites are
[6]A blend of the terms ’mutated’ and ’protein’.
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Tab. 2.1: Affinity constants Kd of various SAV-binding molecules.
designation type 1 Kd sequence reference 2
biotin B 1 fM - Sano et al. (1996)
B4F 3 B 0.14 nM - Aslan et al. (2005)
desthiobiotin B 0.01-2 nM - Green (1970)
diaminobiotin B 0.12µM - Germeroth et al. (2013)
iminobiotin, pH 11 4 B 0.035 nM - Fudem-Goldin & Orr (1990)
iminobiotin, pH 4 4 B <1mM - Fudem-Goldin & Orr (1990)
Strep-tag I 5 P 36µM WSHPQFEK IBA Lifesciences (2009)
Strep-tag II P 72µM WRHPQFGG IBA Lifesciences (2009)
Nano-tag9 P 17 nM DVEAWLGAR 6 Lamla & Erdmann (2004)
Nano-tag15 P 4nM DVEAWLGARVPLVET 6 Lamla & Erdmann (2004)
SBP-tag 7 P 2.5 nM MDEKTTGWRGGHVVEGLAG
ELEQLRARLEHHPQGQREP Keefe et al. (2001)
glycoluril C 2.5µM - Katz et al. (1996)
HABA 8 C 0.14mM - Weber et al. (1994)
RNA aptamer N 7nM 9 (113 bases) Tahiri-Alaoui (2002)
RNA aptamer N 70 nM UCAUGCAAGUGCGUAAGAU
AGUCGCGGGCCGGGGGCGU
AU Srisawat & Engelke (2001)
DNA aptamer N 69 nM (81 bases, ssDNA) Wang et al. (2009)
1 type of ligand: P = peptide ligand, B = biotin or biotin derivative, C = chemically derived ligand, N =
nucleic acid ligand
2 References refer to the given affinity constant, not the paper first describing the molecule.
3 biotin-4-fluorescein
4 The 2-imino residue of iminobiotin is subjected to a pH-dependent protonation/deprotonation, causing the
binding of SAV at pH 11 (unprotonated) and its release at pH 4 (protonated).
5 only for N-terminal fusion to the target protein
6 The initial methionine has to be formylated for binding to SAV (Perbandt et al., 2007).
7 Streptavidin-Binding Peptide
8 2-(4-hydroxyphenylazo)benzoic acid. HABA shows a drastically (up to 165fold) increased affinity for SAV
upon methylation at the 3’- and 5’-positions of the hydroxyphenyl-cycle (Weber et al., 1994). However, the
resulting derivatives are not commercially available.
9 Binding data in the presence of biotin suggest that the aptamer does not directly bind to the biotin binding
pocket of SAV.
available for the detection procedure, thus ideally resulting in a threefold signal ampliﬁcation. In the
presence of twofold biotinylated molecules, formation of complexes involving several molecules of SAV
may lead to an even stronger ampliﬁcation of the signal. A schematic representation of the procedure
is shown in Fig. 2.3.
This detection method is nearly universally applicable, depending on the availability of biotinylated
compounds or other SAV-binding ligands (see Table 2.1).
Among the most popular non biotin-related binding partners are the peptide tags Strep-tag I
(Schmidt & Skerra, 1993) and II (Schmidt et al., 1996), which are commonly used in the downstream
processing of proteins (Schmidt & Skerra, 2007). Both tags are characterized by dissociation constants
in the micromolar range (see Table 2.1, p. 7). In addition to these peptide tags, the biotin-derivative
2-iminobiotin is frequently applied for aﬃnity chromatography of SAV due to a pH-dependent binding
and release of the protein (Hofmann et al., 1980).
The numerous variants of SAV and potential ligands, as well as the extraordinary stability and
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Fig. 2.3: Scheme for immunostaining of an antigen by SAV, biotinylated antibodies and
detection markers. From left to right: targeting of the antigen, addition of SAV, and
fluorescence labelling. Washing steps are performed between every step to remove
unbound fractions of all binding partners. The SAV tetramer binding to the antibody
would allow a twofold signal amplification due to one biotin-blocked binding site (see
section 3.1, p. 28).[7]
speciﬁcity of SAV-based systems result in a nearly universal applicability of SAV as a molecular tool.
SAV can thus be referred to as the Swiss Army Knife of molecular biology. To illustrate this, Table 2.2
shows a selection of the highly diverse scope of applications for SAV. Recent developments in the ﬁeld
of SAV-biotin technology were summed up by Dundas et al. (2013).
2.3 Other biotin-binding proteins
The biotin-binding ability of SAV is shared by many other proteins. The most common protein
in this context is avidin, which was isolated from chicken egg white (Woolley & Longsworth, 1942).
However, due to a basic isoelectric point and glycosylation, this protein is prone to unspeciﬁc binding of
contaminating proteins. In respect to this disadvantage, engineering of charged groups on the protein
surface yielded a neutral,[8] unglycosylated variant of avidin termed 'NeutrAvidin' (Hiller et al., 1987),
[7]Figure created in PowerPoint (see Table 2.4, p. 24).
[8]Isoelectric point: 6.3 for commercial preparations according to Invitrogen. https://tools.
thermofisher.com/content/sfs/manuals/mp00887.pdf, revision 23/02/2009.
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Tab. 2.2: Selected applications of SAV.
application reference(s)
analysis of DNA-protein interactions Wu (2006)
containment of GMOs1 Szafranski et al. (1997); Kaplan et al. (1999)
crosslinking of polymer nanospheres Chen et al. (2005)
detection of cortisol Patzl (1990)
detection of nucleic acids Forster et al. (1985)
detection of pathogens Blake & Weimer (1997); Call et al. (2003); Lee et al. (2004)
drug targeting Muzykantov et al. (1999); Nguyen et al. (2013)
immobilization of antibodies Gretch et al. (1987)
preparation of ssDNA2 Wilson (2011)
purification of proteins Schmidt & Skerra (1993); Schmidt et al. (1996)
Keefe et al. (2001); Lamla & Erdmann (2004)
targeted precipitation of biotinylated proteins Navakouski et al. (2009)
thermoprecipitation of biotinylated biomolecules Malmstadt et al. (2003)
thermoprecipitation of polymers Fong et al. (1999)
tumor imaging Kalofonos et al. (1990); Diaz-Moralli et al. (2011)
use as an insecticide Morgan et al. (1993)
1 genetically modified organisms
2 single-stranded DNA
which shows properties comparable to those of SAV. Hertz & Sebrell (1942) demonstrated that the
egg white of amphibia like the wood frog Rana sylvatica and the pickerel frog R. palustris, as well as
of various bird species like duck, goose, and turkey also contains biotin-binding proteins.
More recently, a large variety of avidin-like proteins was isolated from a wide range of bacteria. Bayer
et al. (1995) isolated two comparable proteins from supernatants of strains of Streptomyces venezuelae.
The emerging ﬁeld of whole-genome sequencing led to the discovery of biotin-binding proteins in nu-
merous organisms. Two 'bradavidins', proteins serving the same function from the symbiotic, root
nodule-inhabiting bacterium Bradyrhizobium japonicum, were identiﬁed (Nordlund et al., 2005; Help-
polainen et al., 2008). All of these proteins occur in tetrameric form. Due to this feature, the discovery
of a biotin-binding natural dimer isolated from Rhizobium etli, accordingly termed 'rhizavidin', came
as a surprise (Helppolainen et al., 2007).
However, the host range for biotin-binding proteins is even more diverse than expected. Lately,
'xenavidin' was isolated from the frog Xenopus tropicalis (Määttä et al., 2009), 'zebavidin' was iden-
tiﬁed in the zebraﬁsh Danio rerio (Taskinen et al., 2013), and a family of 'lentiavidins', characterized
by low isoelectric points, was discovered in the shiitake mushroom Lentinula edodes (Takakura et al.,
2016).
Thus, the binding of biotin is a common feature of many diﬀerent proteins from a broad range of
organisms, demonstrating that the properties of SAV are not as unique as previously assumed, but
rather just one contribution to a large family of proteins.
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2.4 Homologous and heterologous production of SAV
Production of SAV is either performed by the closely related (Ochi, 1989) natural producers S. avidinii
and S. lavendulae or by heterologous expression in a variety of hosts.
2.4.1 Homologous production of SAV
Streptomycetes are Gram-positive, GC-rich (Woese, 1987) aerobic actinobacteria showing ﬁla-
mentous growth. Over two thirds of all microbial antibiotics are derived from strains of the genus
Streptomyces, emphasizing their vital importance for the production of pharmaceuticals (Bérdy, 2012).
The metabolic complexity of streptomycetes and the broad variety of products is reﬂected by typically
20-40 gene clusters for the formation of secondary metabolites and a remarkable genome size in the
range of 8-10Mb (Nett et al., 2009).
S. avidinii, one member of this genus, is commonly used for the production of SAV.
2.4.1.1 Morphology
Streptomycetes typically exhibit a complex life cycle. Grown on solid media, spores germinate and
give rise to vegetative hyphae, so-called substrate mycelia, reaching deep down into the substrate.
Upon substrate depletion, this step is followed by the formation of aerial hyphae growing into the
air. This coincides with the start of production of many antibiotics, which typically accumulate as
secondary metabolites. In the ﬁnal step of this developmental cycle, aerial hyphae diﬀerentiate into
spores (Flärdh & Buttner, 2009). The morphological development is visualized in Fig. 2.4a.
In liquid media, two major forms of hyphae can be observed: mycelial pellets of varying size (see
Fig. 2.4b) and dispersed ﬁlamentous growth. Liquid cultures often consist of a combination of both
morphologies. The morphological variety brings about numerous challenges on the level of cultivation.
The eﬀect of biomass on the viscosity of the culture broth strongly depends on the type of hyphae.
Pellets typically only have a weak impact on the rheology (ﬂow behavior) of the culture broth, whereas
ﬁlaments may drastically inﬂuence this parameter (Metz et al., 1979). Especially for increasing biomass
concentrations, ﬁlamentous suspensions tend to be highly viscous (Metz et al., 1979) and exhibit a
non-Newtonian rheology, which is characterized by a shear-dependent viscosity. In the latter case,
the viscosity therefore depends on the type of stirrer, the previous treatment of the broth, and the
stirring frequency in the bioreactor. The rheology of ﬁlamentous suspensions can often be described
as pseudoplastic[9] or shear-thinning[10] (Olsvik & Kristiansen, 1994). Thus, pellet growth may be
[9]Decreasing viscosity with increasing shear rate.
[10]Decreasing viscosity over time upon shearing.
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(a) Developmental cycle of streptomycetes grown
on solid media (Flärdh & Buttner, 2009).
(b) Pellet formation of Streptomyces avidinii in
submerged culture.
Fig. 2.4: Morphology of streptomycetes.
advantageous regarding the viscosity of the culture broth. Then again, this morphological appearance
may bring about nutrient limitation within the pellets (Nielsen, 1996), as shown in Fig. 2.5.
From the engineering point of view, the viscous eﬀects of high concentrations of ﬁlamentous biomass
cause separation of the reactor into diﬀerent zones, especially for large cultivation volumes. The regions
of the reactor close to the stirrer are typically less viscous and well aerated, but tend to overheat.
Contrarily, the regions bordering the reactor wall are oxygen-depleted and overcooled. Thus, it is
very diﬃcult to maintain optimal conditions for production throughout the whole fermenter (Braun &
Vecht-Lifshitz, 1991). Eﬀects of oxygen depletion for ﬁlamentous growth were, e.g., characterized by
Járai et al. (1969) for S. lavendulae. High stirring frequencies may minimize these eﬀects, but come at
the cost of high power consumption and potential damage of the ﬁlaments due to increased shearing
(Braun & Vecht-Lifshitz, 1991).
Product formation by ﬁlamentous organisms is strongly dependent on their morphology. Filamentous
growth was found to be preferable for the production of proteases by Aspergillus niger, whereas pellets
were beneﬁcial for glucoamylase production by the same host (Papagianni & Moo-Young, 2002). These
examples illustrate that control of the morphology is critical for optimal production.
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Fig. 2.5: Nutrient gradient within a pellet according to Wucherpfennig et al. (2010). The
blue line indicates the course of the concentration of nutrients like oxygen within the
pellet, whereas the red line is the limiting concentration. For pellets exceeding the
critical pellet radius rcrit, growth of the culture is limited by the given nutrient caused
by nutrient deprivation in the pellet.
2.4.1.2 Control of morphology
Pellet formation depends on a large variety of factors, including microbiological parameters like
inoculum size and the growth rate, as well as physicochemical properties like shear rate, the presence
of surface-active agents, pH, temperature, and the ionic strength of the medium (Metz & Kossen,
1977; Braun & Vecht-Lifshitz, 1991). Additionally, the availability of nutrients and oxygen plays a key
role in morphological development (Papagianni et al., 1999; Metz & Kossen, 1977). The complexity
of pellet formation is illustrated in Fig. 2.6.
In addition to a targeted modiﬁcation of the properties discussed in the previous paragraph, supple-
mentation of microparticles to the cultivation medium may also contribute to a more homogeneous
broth, as shown for the addition of talc- and aluminum oxide particles by Kaup et al. (2008). The
authors were able to reduce the pellet size of Streptomyces aureofaciens by a factor of 5.4 by the
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Fig. 2.6: Factors influencing the formation (a) and structure (b) of pellets. The figure was
adapted from Bailey (1986), based on the data of Metz & Kossen (1977).
addition of microparticles. Kaup et al. (2008) demonstrated that the eﬀect may increase the accumu-
lation of various products. Based on this ﬁnding, they established the term 'microparticle-enhanced
cultivation' (MPEC). The reduced pellet diameter was attributed to cell-particle-collisions, as well as
shear stress resulting from rotating particles in shake ﬂasks. By varying the size and concentration
of the microparticles, a precise regulation of the pellet diameter is possible, which may help to avoid
nutrient and oxygen depletion inside of large pellets (Nielsen, 1996). In the meantime, this eﬀect has
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been conﬁrmed for a large variety of ﬁlamentous organisms, as reviewed by Walisko et al. (2012).
2.4.1.3 Production of SAV by S. avidinii
S. avidinii is an aerobic, mesophile (temperature optimum: 28-30 °C) and neutrophile (optimum
of pH: 6.5) organism (Aldwin et al., 1990). The strain has been used for the production of SAV in
several batch studies in shake ﬂasks in either complex (Aldwin et al., 1990; Kolomiets & Zdor, 1998)
or synthetic media (Cazin Jr. et al., 1988).
However, to date no sophisticated strategies for fed-batch or continuous cultivation in the bioreactor
or for the control of morphology have been reported. This is detrimental for the eﬃcient production
of SAV due to the problems arising from the morphology discussed in section 2.4.1.1, strongly limiting
product concentrations and productivities reported in literature.
2.4.2 Heterologous production of SAV
SAV is a rather small protein (16.5 kDa per monomer), even for constructs based on the full-length
gene. Moreover, it does not contain disulﬁde bonds and is not glycosylated. These advantageous
properties and the numerous applications of the protein (section 2.2, p. 5ﬀ.) led to a wide range of
studies of heterologous expression of the SAV gene by a broad range of hosts.
Initially, heterologous expression of the SAV gene was carried out in the Gram-positive hosts
Streptomyces lividans (Meade & Jeﬀrey, 1986; Noda et al., 2015) and Bacillus subtilis (Nagarajan et al.,
1993; Wu & Wong, 2002; Wu et al., 2002), and the Gram-negative model bacterium Escherichia coli
(Sano & Cantor, 1990b; Thompson & Weber, 1993; Gallizia et al., 1998; Veiko et al., 1999; Wu &
Wong, 2006; Miksch et al., 2008; Chen et al., 2014). More recently, the yeast Pichia pastoris was
identiﬁed as a suitable host for the heterologous production of SAV (Casteluber et al., 2012; Nogueira
et al., 2014). A study applying Saccharomyces cerevisiae focused on secretion of SAV to the surface
of the yeast (Furukawa et al., 2006), but even optimized conditions yielded diminishing concentrations
of the protein using this strategy (Hong Lim et al., 2012).
In summary, the vast majority of studies was performed applying unicellular organisms for which
sophisticated process strategies are available. Important process parameters like the ﬁnal product
concentration and productivity of these publications are summarized in Table 7.4 (p. 167) in the
'Summary and Outlook'-part of this thesis.
In respect of the application as an insecticide, additional projects focused on expression of the SAV
gene in tissues of tobacco (Nicotiana tabacum) (Murray et al., 2002; Markwick et al., 2003) and
apple plants (Malus domestica) (Markwick et al., 2003). However, despite allowing relatively high
concentrations of SAV, these hosts are evidently not comparable to bacterial or yeast-based systems
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with regard to long generation times and complicated downstream processing and are therefore not
suited for industrial production processes.
The broad range of hosts successfully used for expression of the SAV gene experimentally conﬁrmed
the suitable theoretical properties for the heterologous production of SAV discussed above. However,
the biotin-binding ability of the protein leads to a signiﬁcant downside of corresponding processes.
2.4.3 Product toxicity for heterologous expression of the SAV gene
Understanding the function of biotin in the cellular metabolism is indispensable for the evaluation
of cytotoxic eﬀects of SAV.
2.4.3.1 Functions and metabolism of biotin
The vitamin biotin is an essential part of many biochemical pathways in pro- and eukaryotes. It serves
as a cofactor in carboxyl transfer reactions (Attwood & Wallace, 2002) and is involved in pathways
like fatty acid synthesis, gluconeogenesis and in the amino acid metabolism (Streit & Entcheva, 2003).
Unlike humans and animals, which require biotin in their diets, microbes, plants and fungi are typically
able to synthesize the vitamin by themselves (Streit & Entcheva, 2003).
Biotin metabolism and recycling leads to diﬀerent cellular intermediates and side products of the
vitamin. Fig. 2.7 outlines these aspects.
Biotin as well as its numerous intermediates show a diverse range of aﬃnities for the protein SAV,
leading to toxic eﬀects during heterologous production of the protein. Generally, information on the
aﬃnity of the degradation products of biotin to SAV is sparse. Furthermore, their cellular localization
is not characterized suﬃciently. Therefore, the following section mainly focuses on the toxic eﬀects
associated to free biotin and biotinylated proteins.
2.4.3.2 Host toxicity of SAV
Two main types of toxic eﬀects may occur upon expression of the SAV gene in heterologous hosts:
SAV may bind free biotin, causing biotin deprivation of the host. Alternatively, complex formation
of SAV and biotinylated proteins may - e.g., in the case of important enzymes - interfere with their
function, leading to secondary damage to the host. Generally, the toxic impact caused by the binding
of biotinylated proteins may vary depending on their host-dependent quantity (Fall et al., 1975).
Host toxicity for the production of SAV by E. coli
The binding of biotinylated proteins is of increased importance for the expression of core SAV genes,
as they improve the accessibility of the binding pocket of SAV towards biotinylated ligands (Sano
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Fig. 2.7: Metabolism, recycling and degradation of biotin according to Rucker et al. (2007).
et al., 1995). Wang et al. (2005) observed a copuriﬁcation of the biotin carboxyl carrier protein
(BCCP) during the soluble production and periplasmic secretion of core SAV by E. coli. As BCCP is
part of the acetyl-CoA carboxylase, an enzyme in fatty acid synthesis, toxic eﬀects can be assumed.
These ﬁndings are supported by the data of Miksch et al. (2008), who analyzed soluble expression
of a full-length SAV gene. Their study was based on secretion to the medium by a Sec signal peptide
(see section 2.4.3.3) and release into the medium by a bacteriocin release protein. A negative correlation
of the maximal optical density and maximal overall concentration of SAV can be deduced from the
data, emphasizing the toxic eﬀects of the protein.[11]
As decelerated growth was also observed for the cytoplasmic expression of SAV by
Sørensen et al. (2003b), toxic eﬀects in all cellular compartments are probable.
[11]OD600 of ∼21 for ∼0.7µM, OD of ∼14 for ∼1.8µM of SAV in shake flasks (Miksch et al., 2008).
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Host toxicity for the production of SAV by B. subtilis
Poor growth was also observed for the overexpression of a full-length SAV gene and secretion of the
protein to the medium by B. subtilis (Wu & Wong, 2002; Wu et al., 2002). This has been linked to
the reduced availability of biotinylated enzymes and biotin deﬁciency (Wu & Wong, 2002). For this
host, two enzymes are biotinylated and thus potentially aﬀected, namely the pyruvate carboxylase and
- like in E. coli - the biotin carboxyl carrier protein (Marini et al., 1995). Both enzymes are involved in
fatty acid synthesis.
Engineering of the producer strain to provide elevated levels of biotin was tested by (Wu & Wong,
2002) to alleviate the toxic eﬀects. However, this strategy came at the cost of decreased bioactivity
of SAV (approx. 20% of biotin-blocked binding sites).
Reduction of host toxicity by insoluble production and other methods
Generally, toxic eﬀects can be reduced by provoking the formation of biologically inactive inclusion
bodies (IB) via overexpression in the cytoplasm, like performed by Sano & Cantor (1990b), Thompson
& Weber (1993), and Chen et al. (2014). Similar aggregates may accumulate upon overexpression
and secretion to the periplasm, as summed up by Baneyx (1999). Miroux & Walker (1996) studied
this strategy for cytotoxic membrane proteins, suggesting that the choice of the host strain is of vital
importance for high product concentrations. Additionally, tightly regulated promoter systems are part
of the strategy of choice for many proteins as summed up by Hannig & Makrides (1998). By reducing
the toxic eﬀects to the host, these aspects may improve transformability of and plasmid stability in the
producer strain (Dumon-Seignovert et al., 2004).
However, as IB formation brings about the necessity of time-consuming solubilization and refolding
accompanied by the loss of product, soluble expression seems to be a favorable approach.
Host toxicity for the production of SAV by yeast
Concerning biotin deprivation of the host, additional problems may arise for the application of yeast-
based expression systems, since these organisms are typically biotin auxotrophic (Gasser et al., 2010).
In general, corresponding problems can be targeted by excessive supplementation of biotin.[12] However,
this strategy results in reduced yields of bioactive SAV. To prevent this problem in the context of avidin
production, Jungo et al. (2007b) studied the growth-promoting eﬀects of oleic acid and aspartic acid
for the cultivation of P. pastoris in biotin-free media, observing partial recovery from growth-limiting
eﬀects. Moreover, regarding the cultivation of yeast, studies of Zurek et al. (1996) using H. poly-
[12]See section 3.10 in the manuscript on the development of an assay for the detection of biotin-blocked
binding sites of SAV, p. 30ff., for an example.
Jakob M. Müller 17
2 - Introduction
morpha indicate that biotin-free complex media may be a suitable alternative to biotin-supplemented
synthetic media for an improved bioactivity of SAV.
Generally, secretory pathways are a key factor for the soluble expression of SAV, since most of the
toxic eﬀects are likely to be due to intracellular complex formation.
2.4.3.3 Secretory pathways
The toxic eﬀects resulting from the production of SAV depend on the cellular localization of SAV
and biotinylated proteins as discussed in the previous section. However, the type of secretion system
is also relevant for the eﬃcient transport of SAV to the periplasm or medium.
Bacterial secretion
The two most commonly used pathways for the secretion of proteins are the twin-arginine translo-
cation (Tat) and the general secretory (Sec) pathway. These pathways are widespread, existing in
bacteria, archaea, and eukarya alike. Secretion depends on N-terminal signal peptides, consisting of a
positively charged, polar 'n-region', an uncharged, hydrophobic 'h-region', and a second polar 'c-region'.
The signal peptide is recognized by the secretory machinery and cleaved oﬀ during secretion (Natale
et al., 2008). Both pathways are visualized in Fig. 2.8b.
Drawbacks and beneﬁts of secretion via Sec and Tat were summed up by Natale et al. (2008).
Generally, the Sec pathway is based on the secretion of unfolded proteins, whereas Tat translocates
folded proteins. In Gram-negative hosts like E. coli, secretion via these pathways leads to transport to
the periplasm, as illustrated in Fig. 2.8b. Since SAV is toxic to E. coli, the choice of the Sec pathway
seems advantageous, because the protein remains in an unfolded state during translocation. This may
temporarily prevent the binding of biotin or biotinylated compounds, which potentially minimizes toxic
eﬀects.
Both pathways are available in Gram-positive as well as -negative bacteria. However, Fig. 2.8a
clearly shows that transport of the protein of interest strongly depends on the surface structure of the
host. In Gram-negative bacteria, the outer membrane and the lipopolysaccharide layer complicate
secretion of proteins to the medium (indicated by the crossed out arrow in Fig. 2.8b), whereas this step
is much easier in Gram-positive hosts. This leads to a diﬀerent fraction of proteins in the respective
compartments. For E. coli, most of the secreted proteins are located in the periplasm, whereas for
streptomycetes and other Gram-positive bacteria secretion mostly leads to a release into the culture
medium (Morosoli et al., 1997).
Most studies on secretion by the genus Streptomyces focused on S. lividans, a host which is fre-
quently applied for the production of heterologous proteins. For this host, observations indicated that
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(a) Surface structure of Gram-positive and Gram-negative bacteria (Pugsley, 1993).
Arrows indicate pathways of cellular targeting.
(b) Visualization of the Sec and Tat pathway in Gram-negative bacteria
(translated from Sommer, 2008). Abbreviation: SP = signal peptide.
Fig. 2.8: Cell wall structure of Gram-positive and -negative bacteria (a) and visualization
of the two main secretory pathways (b) in Gram-negative bacteria.
the secretory eﬃciency is higher for homologous rather than heterologous secretion signal peptides
(Rowland et al., 1992) and for proteins of prokaryotic instead of eukaryotic origin (Anné et al., 2012).
Assuming that S. avidinii shows similar properties, a high secretory eﬃciency can be expected for the
homologous production of SAV. As discussed in section 2.2 (p. 5), the native secretion signal peptide
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for SAV from S. avidinii is most likely used for secretion via the Sec pathway. Thus, regulation of
toxicity in the native producer may involve the avoidance of folded SAV in the cytoplasm. Generally,
Anné et al. (2014) and Schaerlaekens et al. (2004) concluded that the overall secretory potential of
S. lividans can be considered excellent. This may also apply to S. avidinii , but stands in contrast to
E. coli .
Nevertheless, the utilization of secretory pathways for studies of heterologous expression based on
Gram-negative hosts like E. coli oﬀers advantages towards cytosolic targeting: the risk of proteolytic
degradation of the target protein is lowered towards cytoplasmic expression by periplasmic or extracellu-
lar targeting, typically with optimal results for the latter. However, the expression level of the gene has
to be ﬁne-tuned in order to avoid overloading of the export machinery. These aspects were reviewed
by Makrides (1996). Furthermore, the proportion of contaminating proteins is lower when the target
protein is transported to the periplasm, since this cellular fraction contains a fraction of only about
4% of the total protein of the cell (Nossal & Heppel, 1966). Thus, use of the secretory pathways
for periplasmic targeting seems favorable, even if the release of the target protein to the medium is
diﬃcult.
Consequently, Miksch et al. (2008) used a Sec-associated signal peptide for the secretion of SAV by
E. coli. The transfer of the target protein from the periplasm to the surrounding medium was based on
a bacteriocin release protein. Alternative approaches for the release of periplasmic SAV by E. coli may,
e.g., focus on the application of periplasmic 'leaky mutants', i.e., strains with a decreased stability of
the outer membrane.
Protein secretion in yeast
Due to a more complex cellular structure and various internal compartments, yeast-based expression
systems oﬀer a diﬀerent way of cellular targeting. As summarized by Delic et al. (2013), proteins are
secreted to the medium via co- or post-translational translocation to the lumen of the endpolasmic
reticulum (ER), where they are folded in the presence of enzymes and chaperones. This step is followed
by vesicular transport to the Golgi apparatus and medium via so-called COPII-vesicles. The process is
shown in Fig. 2.9.
Taking this into account, the contact of folded and thus bioactive secreted proteins and the cytoplasm
is minimized. This feature may be relevant for the expression of the SAV gene, since all four enzymes
involved in the synthesis of long fatty acids in the Saccharomyces cerevisiae are located in the cytoplasm
of the yeast (Schweizer et al., 1978). Among these enzymes is the acetyl CoA carboxylase, which -
like in bacteria - depends on a biocytin group (lysin-coupled biotin) for fatty acid synthesis. Assuming
that the localization of biotinylated proteins in other yeast strains is comparable, transport of bioactive
SAV to a diﬀerent compartment than these biotinylated enzymes may be advantageous.
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Fig. 2.9: Visualization of protein secretion in eukaryotes (Graf et al., 2009). Proteins are
either co- or post-translationally translocated from cytosol to ER.
2.5 Purification of SAV
A variety of methods has been applied for the puriﬁcation of SAV. The standard procedure for the iso-
lation of highly pure SAV is aﬃnity chromatography based on iminobiotin columns
(Hofmann et al., 1980). The biotin derivative iminobiotin allows the pH-dependent binding and release
of SAV and thus provides properties suited for a rapid puriﬁcation of the protein. However, correspond-
ing materials are costly and not very durable, leading to the necessity of replacement after a low number
of cycles of puriﬁcation and regeneration. Due to the strong aﬃnity of SAV towards iminobiotin (see
Table 2.1, p. 7), iminobiotin chromatography is superior to alternative chromatographic approaches.
Therefore, genes for the heterologous expression of SAV usually don't contain additional functional
sequences like the hexahistidine- (Hochuli et al., 1988) or the maltose binding protein (MBP)-tag
(di Guan et al., 1988) for downstream processing. However, hydrophobic interaction chromatography
has also successfully been applied for puriﬁcation of the protein by Schwidop et al. (1990).
Other, less costly methods include precipitation by ammonium sulfate and dialysis (Suter et al., 1988;
Nogueira, 2013), and various combinations of dialysis in urea or guanidinium-HCl and precipitation by
organic solvents like dimethyl ether, ethanol, and acetone, or direct precipitation by these solvents
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(Nogueira, 2013). Due to the strong heat stability of SAV, heat incubation of SAV-containing super-
natants and subsequent centrifugation has been used for the denaturing of contaminating proteins,
followed by their removal via centrifugation (Gallizia et al., 1998).
In respect to the heterologous production of SAV focusing on insoluble expression, Sørensen et al.
(2003a) studied the puriﬁcation of SAV via dialysis-based refolding and the accompanying removal of
low molecular weight contaminants.
2.5.1 Aqueous two-phase extraction
Up to this point, aqueous two-phase extraction of SAV has not been studied. This procedure is based
on the incompatibility of either a polymer towards another polymer (e.g., dextran and polyethylene
glycol, abbreviated PEG) or of a polymer towards a salt (e.g., PEG and phosphate salts). When
the concentration of both compounds exceeds a critical concentration, this incompatibility causes
separation of the system into two phases (Albertsson, 1986). The separation behavior is typically
depicted in the form of a binodal, which displays the concentrations necessary for phase separation, as
shown in Fig. 2.10.
This binodal curve is speciﬁc for a deﬁned composition of the system at a constant pH, temperature,
and concentration of supplements like sodium chloride. Generally, compositions characterized by high
concentrations of both polymer and salt, i.e., points in the upper right of Fig. 2.10, yield more stable
two-phase systems than compositions close to the binodal. Phase formation for the latter systems is
more susceptible towards changes of additional factors like pH and temperature.
Unlike methods based on organic extraction, aqueous two-phase systems (ATPS) can be used for
the puriﬁcation of proteins due to mild environmental conditions. Furthermore, the method is more
economical due to the redundancy of explosionproof devices as well as more ecological because of the
absence of organic solvents. The distribution of a protein in ATPS can be inﬂuenced by a variety of
factors, including the adjustment of the chain length of the polymer, the pH value used for extraction,
and the addition of supplements like sodium chloride (Albertsson, 1986). The extraction can further-
more be aﬀected by the temperature, the use of charged or hydrophobic polymer derivatives or the
coupling of aﬃnity ligands to the polymer (Diamond & Hsu, 1992).
2.6 Focus of this dissertation
The major part of the studies performed for this dissertation focused on the expression of the SAV
gene by a variety of host organisms. The natural producer S. avidinii (section 4, p. 60ﬀ.) and several
heterologous hosts (section 5, p. 91ﬀ.) were analyzed with respect to their productive properties.
Among other criteria, the hosts were selected based on diﬀerent secretory pathways due to the toxic
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Fig. 2.10: Phase diagram of an aqueous two-phase system (Kaul, 2000). The binodal
separates the one phase-region (bottom left) from the two-phase region (top right) of
the plot. As illustrated by the sketches, the tie-lines sum up two-phase systems in which
different phase ratios are achieved, but the concentrations of salt and polymer in the
top- and bottom phase are constant. These constant concentrations refer to the end
points of the tie-line, describing the composition of the top- (T) and bottom phase
(B), respectively. Cp is the critical point of the phase system, which is gathered by
extrapolation of the central points of the tie-lines.
properties of SAV and the secretory aspects discussed in the previous section. A summary of the hosts
studied throughout this thesis is shown in Table 2.3.
Accompanying experiments were conducted to yield a more complete picture of the production
process and to the process-dependent product quality by establishing a new method for the detection of
biotin-blocked binding sites of SAV (section 3 p. 28ﬀ.). Furthermore, studies targeting the replacement
of the current downstream processing procedure, namely iminobiotin aﬃnity chromatography, by a
cheaper and simpler method (section 6, p. 144ﬀ.), were performed.
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Tab. 2.3: Summary of the hosts studied in this thesis.
host class strain(s) secretion 1 remarks
E. coli Gammaproteobacteria JW1667-5 Sec (UF), LM, M Gram-negative
KRX Sec (UF), PP Gram-negative
H. polymorpha 2 Saccharomycetes ATCC 34438 VT (F), M yeast
ATCC 26012 (DL-1) VT (F), M yeast
P. pastoris 3 Saccharomycetes GS 115 VT (F), M yeast
X-33 VT (F), M yeast
S. avidinii 4 Actinobacteria CBS 730.72 Sec (UF) 5, M Gram-positive
1 type of secretory pathway (see section 2.4.3.3, p. 18ff. for details): Sec = general secretory pathway,
unfolded (UF); LM = periplasmic ’leaky mutant’ for secretion from periplasm to medium; VT = vesicular
transport via ER and Golgi apparatus to medium (folded (F) upon translocation to the ER). Targeting:
PP = periplasm, M = medium.
2 also known as Ogataea polymorpha
3 also known as Komagataella phaffii
4 natural producer
5 suggested by an in silico-analysis of the signal peptide (Fig. 8.1, p. 180)
2.7 Software
The software that has been used for this thesis is shown in Table 2.4.
Tab. 2.4: Software used for this thesis.
application software version reference / supplier 1
pellet analysis ImageJ 1.48v Schneider et al. (2012)
cloning work Clone Manager 9 Scientific & Educational
Software
design of experiments MODDE 10.1.0 Umetrics
flow chart creation Dia 0.97.2 The Free Software Foundation
image processing 2 PowerPoint 2010 14.0.7147.5001 Microsoft
image processing GIMP 2.8.0 www.gimp.org
literature management Zotero 3 4.0.26.4 Center for History and
New Media
modelling and simulation CellDesigner 4.3 Funahashi et al. (2008)
Scilab 5.5.0 Scilab Enterprises (2012)
parameter estimation COPASI 4.10.55 Hoops et al. (2006)
plotting: contour plots Ipython 2.7 Pérez & Granger (2007)
Spyder 2.3.0rc www.pythonhosted.org/spyder
Matplotlib 1.4.3 Hunter (2007)
plotting: other plots Gnumeric portable 1.12.17 www.gnumeric.org
text processing MikTeX (LaTeX implementation) 2.9 www.miktex.org
text processing TeXlipse (LaTeX editor) 1.5.0 texlipse.sourceforge.net
1 if available/specified; otherwise: URL
2 schematic representation of biochemical mechanisms
3 Mozilla Firefox plugin
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2.8 Abbreviations
The most important abbreviations and quantities used for this thesis are shown in Table 2.5 and
2.6. Abbreviations and quantities only applied in speciﬁc publications are not listed in the tables, but
deﬁned in the corresponding papers.
2.9 Structural remarks
Due to the modular structure of this thesis, the focus of this document was put on the research
articles published in various journals and the summary of main ﬁndings of additional experiments.
Additional methods and - in some instances - more detailed experimental descriptions are listed in the
supplementary material, whereas the main body only contains brief experimental remarks.
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Tab. 2.5: Important characteristic quantities and their dimensions used in this
thesis.
abbreviation quantity dimension
η dynamic viscosity mPa s a
µ, µmax (maximal) specific growth rate h−1
µset setpoint for µ for exponential feeding h−1
τ residence time (=1/D) h
cSAV , cSAV,app (apparent) concentration of SAV b nM
D dilution rate h−1
E − factor environmental factor -
Kd dissociation constant M
kdeg degradation constant min−1, h−1
kLa volumetric oxygen transfer coefficient h−1
KS Monod constant g L−1
L, Lspec (specific) power input W (WL−1)
Lg, Lspec,g aerated (specific) power input W (WL−1)
MW molecular weight kDa
n rotary frequency of the stirrer min−1
p volumetric productivity c nMh−1
pmax volumetric productivity from t0 to Pmax c nMh−1
pspec specific (DCW-related) productivity c nmol g−1
P , Pmax (maximal) concentration of product c nM, µM
Q air flow rate vvm
Qblocked, Qbl proportion of biotin-blocked binding sites of SAV -, %
QSAV proportion of detectable SAV -, %
rDO relative dissolved oxygen saturation %
s0S (substrate) saturation parameter (=S0/KS) -
sP/X process selectivity (product per biomass) nmol g−1
S, S0 (initial) concentration of substrate g L−1
t time h, min
YP/S yield coefficient of product per substrate -
YX/S yield coefficient of biomass (DCW) per substrate -
a 1mPa s = 10−3 Nm2 s = 1
g
sm
b Referring to the tetrameric concentration of SAV, if not stated otherwise.
c Referring to the extracellular, tetrameric concentration of SAV, if not stated
otherwise.
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Tab. 2.6: Abbreviations used in this thesis.
abbreviation term
AA amino acid(s)
AB antibiotic(s)
ATPE aqueous two-phase extraction(s)
ATPS aqueous two-phase system(s)
B4F biotin-4-fluorescein
BCCP biotin carboxyl carrier protein
BSA bovine serum albumin
DCW dry cell weight
DF diafiltration
DO dissolved oxygen
DoE Design of Experiments
DSP downstream processing
ELP elastin-like polypeptide(s)
ER endoplasmic reticulum
HPLC high performance liquid chromatography
IB inclusion body/bodies
LMW low molecular weight
MPEC microparticle-enhanced cultivation
MW, MWCO molecular weight (cut-off)
PEG polyethylene glycol
PTVA post-transformational vector amplification
RT room temperature
SAV streptavidin
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis
Sec general secretory pathway
Tat twin-arginine translocation pathway
UF ultrafiltration
UV ultraviolet
vvm volume per volume and minute
WCW wet cell weight
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3 Development of an assay for the
detection of biotin-blocked binding
sites of SAV
In addition to the development of methods for the production and puriﬁcation of SAV, an assay was
designed for the rapid detection of biotin-blocked binding sites of the protein.
3.1 Motivation
The quality of isolates of SAV may be quantiﬁed based on a selection of parameters. The chain
length of the protein varies depending on the host, the SAV gene used for expression, the presence
of proteases, and the downstream processing procedure (Bayer et al., 1989; Sano et al., 1995). The
molecular weight of SAV may therefore be valuable to diﬀerentiate between diﬀerent isolates. More-
over, the purity of the protein - which is mainly inﬂuenced by the expression host, contaminating host
proteins, the cultivation medium, and the method of puriﬁcation - may be used for this purpose. While
these two parameters can easily be assessed by standard laboratory techniques like SDS-PAGE analysis
or terminal sequencing of the protein, another property is less readily accessible.
The bioactivity of diﬀerent isolates of SAV varies depending on the proportion of bioactive binding
sites. As biotinylated proteins, biotin or derivatives of the vitamin (see Fig. 2.7, p. 16) may bind to
SAV during production, diﬀerent production processes lead to a varying ratio of bioavailable and biotin-
blocked binding sites. The biotin-free binding sites can easily be quantiﬁed by ﬂuorescence quenching
of biotin-4-ﬂuorescein (B4F) (Kada et al., 1999a,b). Fig. 3.1 depicts the procedure of this standard
assay.
Despite advantageous properties in terms of experimental eﬀort and expenditure of time, Kada's
method is limited to biotin-free binding sites. Thus, complex procedures have to be applied to determine
the proportion of blocked binding sites.
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Fig. 3.1: Standard fluorescence quenching assay for the detection of biotin-free binding sites
of SAV via biotin-4-fluorescein (B4F) according to Kada et al. (1999a,b).[1]
3.1.1 Goals of this study
To allow a simpler and more rapid measurement of biotin-blocked binding sites and therefore provide
the basis for an analysis of this parameter during fermentations, a part of this project focused on the
development of a corresponding assay.
3.2 Concept of the assay
The concept of the assay was based on results of Holmberg et al. (2005), who were able to dissociate
the SAV-biotin interaction by incubation of the binding partners at elevated temperatures in non-ionic,
aqueous solutions. As their studies were based on SAV coupled to magnetic beads and biotinylated
DNA, the applicability of the method to free SAV and biotin had to be conﬁrmed. Experiments of
this part of the thesis therefore focused on the heat-induced displacement of SAV-bound biotin by
biotin-4-ﬂuorescein, as shown in Fig. 3.2.
Based on this strategy, the model-based development of an assay was performed. Experiments
were carried out using a variety of supernatants of SAV producers, namely engineered clones of the
yeast P. pastoris, the Gram-negative bacterium E. coli, and the natural producer S. avidinii. The
supernatants did not only vary in the concentration of contaminating proteins (see Fig. 6.1, p. 145),
but also in the chain length of the SAV gene used for expression.
The optimization of assay conditions led to the successful, reproducible detection of the entire
biotin-blocked binding sites in the samples.
[1]Figure created in PowerPoint (see Table 2.4, p. 24).
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Fig. 3.2: Concept of a heat-based assay for the detection of biotin-blocked and biotin-free
binding sites of SAV via displacement of biotin by B4F.[2]
3.3 Manuscript
The corresponding research article was published in Engineering in Life Sciences (Müller et al., 2015)
(Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission) and is shown on the
following pages, including the accompanying supplementary material.
[2]Figure created in PowerPoint (see Table 2.4, p. 24).
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Model-based development of an assay for the
rapid detection of biotin-blocked binding sites
of streptavidin
The protein streptavidin (SAV) is applied in a large variety of molecular methods
due to an extraordinarily strong binding to the vitamin biotin (BIO). The protein
structure is homotetrameric, characterized by one binding site for BIO per subunit.
Therefore, one of the major criteria to determine the quality of SAV isolates is the
proportion of BIO-blocked binding sites per tetramer. A rapid analysis of BIO-
free binding sites is achieved by fluorescence quenching of biotin-4-fluorescein
(B4F). However, BIO-blocked binding sites can only be determined by costly and
laborious procedures such as ELISA-based methods or radioactive labeling. This
study describes the systematic, model-supported development of a method for the
quick and simple detection of BIO-blocked binding sites, based on a short-term heat
incubation of the sample in the presence of B4F. Kinetic modeling and parameter
estimation yielded dissociation constants of 1.22 ± 0.27 × 10−11 M for the complex
SAV–BIO and 5.16± 0.70× 10−13 M for SAV–B4F at 70°C, allowing a displacement
of SAV-boundBIOby B4F. Thismethod allows the rapidmonitoring of BIO-blocked
binding sites in fermentation processes, independent from the chain length of SAV
and the concentration of contaminating proteins, e.g. when optimizing the BIO
concentration in cultivation media.
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1 Introduction
Streptavidin (SAV) is a highly versatile molecular tool used for
a large variety of applications. The homotetrameric protein was
isolated from culture supernatants of Streptomyces avidinii and
Streptomyces lavendulae in the early 1960 s [1, 2]. The nearly
universal applicability of SAV is based on its ability to bind the
vitamin BIO with an extraordinary dissociation constant Kd of
up to 10−15 M [3], conveying a very high specificity when uti-
lized. Furthermore, SAVexhibits ahigh tolerance toward extreme
values of pH, temperature, and other environmental factors,
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especially upon BIO binding [4, 5]. This allows the application
of SAV-based methods even in very harsh conditions. Molecular
methods utilizing the SAV–BIO interaction include purification
procedures for various macromolecules, e.g. for proteins by the
Strep-tag technology [6], strategies for the containment of genet-
ically engineered microorganisms by induced inactivation [7],
numerous applications in molecular labeling, e.g. in the local-
ization of tumors [8], and drug targeting approaches [9]. Recent
discoveries suggest that the BIO-binding function of SAV and
avidin, a protein of similar function from chicken egg white, is
widely spread among a number of different proteins and species
[10–12] and therefore not as unique as previously assumed.
1.1 Chain length and bioactivity of SAV
Several publications demonstrated that the terminal regions of
SAV are not necessary for BIO binding [13, 14] and are even re-
ported to result in a decreased stability of the protein. Moreover,
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the binding of biotinylated macromolecules to SAV is facilitated
by the proteolytic removal of N- and C-terminal regions of the
protein [15]. Therefore, some systems focus on the expression
of N- and C-terminally truncated forms of the SAV gene. The
corresponding protein variants are commonly referred to as core
SAVs, typically ranging from 118 to 127 AA instead of the 159
AA of full-length mature SAV [15].
Apart from its chain length, SAV isolates can be characterized
based on their bioactivity. Due to its homotetrameric structure,
SAV is naturally capable of binding up to four molecules of BIO.
However, depending onhost, expression systemand the presence
of BIO and its derivatives in the medium, a fraction of the bind-
ing sites may be blocked by either of these compounds, which
compromises the use of SAV e.g. as a crosslinking agent. While
most SAV isolates from S. avidinii can typically be expected to
be almost BIO-free [16], expression by Bacillus subtilis brings
about proportions of BIO-blocked binding sites Qblocked in the
range of 0.2, representing a relative BIO saturation of the binding
sites of 20% [17, 18]. The production of SAV by the yeast Pichia
pastoris leads to comparable results [19]. Insoluble intracellular
productionof SAVbyEscherichia coli followedby resolubilization
causes degrees of BIO saturation of 0.025–0.25 [20]. Commercial
preparations of SAV are usually characterized by specific activi-
ties in terms of bound units of BIO per milligram of protein, not
containing information on the concentration of BIO-blocked
binding sites or incorporating potential variations of the chain
length of SAV. Due to the large experimental effort necessary for
the determination of BIO-blocked binding sites information on
this parameter is often sparse.
1.2 Determination of the active binding sites of SAV
Kada et al. published an assay for the rapid detection of SAV in
crude supernatants by static fluorescence quenching of biotin-
4-fluorescein (B4F) [21, 22]. However, the assay is limited to
binding sites, which are unblocked by BIO. To detect the blocked
binding sites complex, time-consuming methods have to be ap-
plied. Potential strategies are the denaturing of SAV followed
by measurements of released BIO, radioactive labeling of BIO
or immunological methods (ELISA) in combination with ac-
tive site determination by the quenching of B4F. However, these
methods are costly and very laborious and therefore not suitable
for a rapid monitoring of fermentation processes.
1.3 Motivation and theoretical concept of the assay
As our research group is currently screening a variety of heterol-
ogous expression systems for their potential to produce SAV, a
method for the rapid detection of BIO-blocked binding sites was
in the focus of interest. For an improved process performance, a
fine-tuned optimization of the BIO concentration in fermenta-
tion media is desirable to maximize bioactivity of SAV without
a major impact on cell growth. In this respect, the proportion of
BIO-blocked binding sites provides essential information. A cor-
responding assay should be able to quickly quantify the blocked
binding sites independent from the chain length of SAV and
concentration of contaminating host proteins.
Holmberg et al. discovered to their surprise that a short-term
incubation of biotinylated molecules at elevated temperatures
in a nonionic, aqueous solution allows their release from SAV-
coated magnetic beads [23]. Therefore, the goal of our studies
was to combine this heat incubation step and the fluorescence
quenching assay by Kada et al. [21, 22] in order to detect BIO-
blocked binding sites. In theory, the elution of the SAV–BIO
interaction should intermittently result in a fraction of unoccu-
pied binding sites, which may be bound by B4F, a fluorescence
derivative of BIO. Binding of B4F to SAV for its part should
then lead to fluorescence quenching as described by Kada and
coworkers. The key questions were if the elution of the SAV–
BIO interaction would also be broken if SAV and BIO are in
free suspension in an aqueous solution instead of being coupled
to other molecules, because the coupling of SAV to beads leads
to an increased dissociation constant and therefore a facilitated
elution of the SAV–BIO interaction [24], and if the dissociation
constants at elevated temperatures would allow a displacement
of BIO by B4F.
The association rates of the complexes SAV–BIO and SAV–
B4F differ only by a factor of 3.4 at 37°C with values of kon,B4F
of 2.0 ± 0.1 × 107 M−1 s−1 for B4F and a kon,bio of 6.7 ±
0.5 × 107 M−1 s−1 for BIO (Supporting Information of [25]),
which is achieved by the short ethylene diamine spacer between
BIO and fluorescein [17]. Furthermore, the dissociation rate of
the SAV–BIO complex koff,bio is known to increase exponentially
upon temperature [26]. The investigation of a competition of
B4F and BIO for the binding sites of SAV at elevated tempera-
tures therefore seemed worthy of a detailed investigation.
2 Materials and methods
2.1 Standard procedure for the measurement of SAV
by fluorescence quenching of B4F
SAV was quantified by the fluorescence quenching assay of Kada
et al. [21, 22] using a calibration curve of B4F (GERBU, Hei-
delberg, Germany) in concentrations equivalent to 0–600 nM
of tetrameric SAV. The calibration curve was gathered by a di-
lution of a 50 nM B4F solution in measurement buffer to final
volumes of 1 mL at concentrations of 1, 5, 10, 20, 30, 40, 45, and
49 nM, respectively. The measurement buffer was composed of
100 mM of NaCl, 1 mM of EDTA, and 50 mM of NaH2PO4.
The pH was adjusted to 7.5 by the addition of NaOH. Once
per week, working volumes of this buffer solution were freshly
supplemented with B4F and—to reduce unspecific binding to
the reaction tube—BSA (GERBU) in concentrations of 50 nM
and 0.1 g L−1, respectively. Three technical replicates of samples
of 20 μL were each added to 980 μL of measurement buffer
(dilution factor: 1:50), vortexed for 1 s and incubated at room
temperature (RT) for 30min, followed by fluorescencemeasure-
ment in disposable polystyrene semimicro cuvettes (BRAND,
Wertheim, Germany). Measurements were performed five-fold
in a RF-5301 PC fluorimeter (Shimadzu, Duisburg, Germany) at
excitation and emission wavelengths of 495 and 525 nm, respec-
tively. If not stated otherwise, all resulting molar concentrations
refer to tetrameric SAV. A table for the calculation of the SAV
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concentration based on the B4F calibration curve is attached in
the Supporting Information, Table S1.
2.2 Procedure for the detection of BIO-blocked
binding sites
The optimization procedure for the detection of blocked binding
sites resulted in the following method: samples of 20 μL were
mixed with 980 μL of measurement buffer including B4F and
BSA by vortexing for 1 s, followed by an incubation at 70°C
for 10 min in a standard laboratory heat block (VWR, Darm-
stadt, Germany) with water-filled wells to release SAV-bound
BIO, inverting three times and a final incubation step at RT for
30min. After the incubation, the fluorescence measurement was
performed applying the conditions described in Section 2.1. All
supernatants were analyzed in three replicates each, applying (i)
the normal assay procedure and (ii) the heat incubation pro-
cedure. For the heat assay, samples were diluted to tetrameric
concentrations of cSAV,HT  300 nM. A schematic representation
of the assay is shown later in Fig. 4.
After conversion of the fluorescence signals to SAV concentra-
tions according toSupporting Information,Table S1, the concen-
tration of BIO-blocked SAV cSAV,blocked was calculated according
to Eq. (1):
cSAV,blocked = cSAV,HT − cSAV,RT (1)
where cSAV,RT is the (tetrameric) concentration of SAV measured
in the standard assay at RT (free binding sites) and cSAV,HT is
the concentration measured after the heat incubation step (total
binding sites—blocked and unblocked).
2.3 Production of SAV by different expression hosts
Measurements for the development of the assay were performed
on supernatants from cultivations of different expression sys-
tems for the production of SAV. Supernatants for one part of
the studies were acquired from bioreactor cultivations of the
natural producer S. avidinii. Cultivation conditions were chosen
according to the bioreactor batch experiments onM3medium as
described previously [27]. Furthermore, SAV derived from het-
erologous expression systems produced by two different hosts
was analyzed in the experiments: core SAV (AA 13–139) se-
creted by a clone of the yeast P. pastoris GS115 (Invitrogen,
Germany) carrying a chromosomal expression cassette and full-
length SAV produced by an E. coli K-12 derivative transformed
with a plasmid-based expression vector (unpublished expression
systems).
2.3.1 Shake flask cultivation conditions
To demonstrate the application of the assay, a MutS (methanol
utilization slowphenotype) clone ofP. pastorisGS115 producing
and secreting core SAV (AA 13–139) under control of the alco-
hol oxidase 1 (AOX1) promoter was cultivated in baffled 500mL
shake flasks (Duran,Wertheim (Main), Germany) in three repli-
cates, each filled with 50 mL, at 30°C at a shaking frequency
of 160 min−1 and an eccentricity of 20 mm. The shake flasks
were inoculated with an overnight culture on YPDmedium [28]
(p. 30) to an optical density OD600 of 0.5 after one washing step
with sterile, demineralized water. Buffered MG medium (ad-
justed to pH 6.0) [28] (p. 57) with concentrations of BIO of 1
and 4 μM, respectively, was used. After the initial batch growth
phase, sterile methanol was added to final concentrations of 0.2
and 0.4% v/v in the morning and evening, respectively. Samples
of 1mLwere taken per sampling point and used for the determi-
nation of dry cell weight and substrate concentration according
to standard laboratory procedures (differential weighing, HPLC
analysis). The supernatants were used for the standard SAV as-
say (Section 2.1) and the determination of BIO-blocked binding
sites (Section 2.2).
2.4 Software for simulation, data analysis, and
evaluation
Parameter estimation for biochemical modeling was performed
using theparameter estimation toolboxofCOPASI (Universityof
Manchester/Universita¨t Heidelberg, UK/Germany, [29]), based
onmodels developed inCellDesigner (Systems Biology Institute,
Japan, [30]). The acquired parameters were used for simulations
in Scilab (Scilab Enterprises, France, [31]). A polynomial model
was developed in the design of experiments software MODDE
(Umetrics, Sweden). If not statedotherwise, all plotswere created
using the Python plotting library Matplotlib [32].
3 Results and discussion
The results are divided into a section discussing the scope of
SAV variants, which were used for the studies followed by steps
describing the development and validation of the final assay
procedure. Subsequently, the conditions used for the assay were
evaluated by polynomial and kinetic modeling. Finally, the assay
was tested in a shake flask cultivation of a SAV-producing clone
of P. pastoris.
3.1 Characterization of the supernatants used for the
experiments
The three different culture supernatants, namely samples from
S. avidinii, P. pastoris, and E. coli cultivations, varied drastically
concerning the proportion of contaminating proteins. While
SAV was the dominant protein in the supernatants of both
P. pastoris and S. avidinii, the supernatant of the E. coli pro-
ducer contained a large fraction of unspecific SDS-PAGE bands.
Furthermore, the SAV isolates varied in the chain length of SAV
with 139 AA (core SAV) for the P. pastoris construct and the full
159 AA for the E. coli and S. avidinii supernatants, which was
confirmed by SDS-PAGE analysis. Due to their variance in chain
length and contaminating proteins these supernatants were cho-
sen to represent typical extremes of supernatants used for the
assay.
3.2 Heat stability of SAV and estimation of the
heat-induced systematic error
First, an assay on the loss of activity of SAV samples at elevated
temperatureswas performed in order to find an appropriate time
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Figure 1. Development of a heat-based assay for the rapid quantification of biotin (BIO) blocked binding sites of streptavidin (SAV). Error
bars represent SDs from three replicates. (A) Loss of activity by heat incubation: denaturing studies on a supernatant containing SAV
derived from a bioreactor cultivation of Streptomyces avidinii on M3 medium incubated at elevated temperatures. The curves were acquired
by a fit to the first order denaturation model of Eq. (2). The degradation constants kdeg were 3.31 × 10−6, 1.24 × 10−5, 6.36 × 10−5, and
8.84 × 10−4 s−1 for 60, 65, 70, and 80°C, respectively. (B) Course of the degradation constant kdeg upon temperature, based on calculations
according to Arrhenius’ equation (Supporting Information, Eq. (S1)) with an activation energy Ea of 229 kJ mol−1 [34] and a preexponential
factor kdeg,0 of 6.5395 × 1030 s−1. (C) Condition variation to detect BIO-blocked binding sites of SAV. A supernatant containing BIO-blocked
binding sites was incubated at different temperatures for different periods of time either in the presence (+B4F) or absence (−B4F) of
biotin-4-fluorescein and fluorescence measurement buffer. A reference sample was incubated at room temperature. The second bar shows
a control sample with an excess of BIO (abbreviated BE for biotin excess).
and temperature range for the assay. An SAV-containing super-
natant from a cultivation of S. avidinii of a concentration of
5606± 11 nMwas diluted 10-fold by demineralized water. Sam-
ples of 1 mL were incubated in a reaction tube at 60, 65, 70, and
80°C for 180 min for an analysis of heat-induced denaturation
of SAV. Three samples of 20μL each were taken after 0, 5, 15, 30,
45, 60, 90, 120, and 180min of incubation at these temperatures,
followed by a measurement after 30 min of incubation at RT. To
quantify the results, the data sets were fit to the first-ordermodel
for an irreversible denaturation of SAV described in Eq. (2).
dcSAV
dt
= −kdeg cSAV (2)
where t is the time and kdeg is the reaction rate of the irreversible
denaturing step.
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Experimental results and the regression curves acquired by
parameter fits to Eq. (2) are shown in Fig. 1A. A meta-analysis
of the degradation constants was performed according to Arrhe-
nius [33] (see Section 2 of Supporting Information for details).
A corresponding plot is shown in Fig. 1B. The plot does not
incorporate denaturation of SAV at higher temperatures. Ac-
cording to the data, an incubation of SAV at temperatures above
70°C should be avoided in order to retain bioactivity of the pro-
tein. This result matches the data of Gonza´lez et al. [5], who
observed a melting point of 75°C for BIO-free SAV in a phos-
phate buffer. Themodel curves predict the loss of 50%of activity
after 182 and 13 min of incubation at 70 and 80°C, respectively.
For a short-time incubation of 10 min a proportion of 41.2%
of SAV lost its BIO-binding ability during incubation at 80°C,
whereas this proportion was only 3.7% at 70°C. Based on these
results, temperatures above 70°C were not included in the fol-
lowing experiments.
The results of the parameter estimation suggest that 49 nM of
monomeric, BIO-free SAV1 lose 3.7% of activity after 10 min
of incubation at 70°C. However, for measurements of BIO-
containing samples it has to be taken into account that the stabil-
ity of SAV increases in the presence of bound BIO [5]. Thus, the
loss of activity should be even lower in the conditions provided
by the assay. Considering the close structural relation of BIO
and B4F, B4F is likely to stabilize SAV at elevated temperatures
as well. This hypothesis seems to be confirmed by the results of
the control curve shown in Fig. 2A, which shows no decrease of
the SAV concentration for 15 min of incubation at 70°C. Taking
into account the dissociation constants of 1.4 × 10−10 M for the
B4F–SAV complex [35] and 1× 10−15 M for the complex of BIO
and SAV [3], the proportion of free and therefore less stabilized
SAV in the presence of both of these molecules can be consid-
ered diminishingly small. Therefore, the loss of activity through
heat-induced unfolding of SAV was neglected in the following
studies.
3.3 Screening for conditions for the detection of
BIO-blocked binding sites
In the next step, appropriate conditions for the determination
of blocked binding sites of SAV were in the focus. A volume
of 100 mL of a supernatant containing 3356 ± 65 nM of SAV
was saturated with a strong excess (approximately 191 μM) of
(+)-BIO (Fluka, Switzerland) and incubated at RT for 15min to
allow the binding of BIO to SAV.UnboundBIOwas removed by a
stepwisediafiltrationapplyinga5kDapolyethersulfonefiltration
module (Pellicon XL-50, Millipore, Germany). The sample was
diluted 10-fold for seven times, followed by a concentration step,
in which the volume was reduced to the initial 100 mL.
For the detection of BIO-blocked binding sites, samples of the
filtration retentate were incubated in a standard laboratory heat
block (VWR) at elevated temperatures, followed by fluorescence
measurement in the presence of B4F. Two temperatures (50 and
70°C) and three incubation times (1, 5, and 10 min) were ana-
lyzed. A volume of 980 μL of B4F containing assay buffer was
1the maximal detectable concentration for a measurement applying a
50 nM B4F-buffer.
either incubated in the heat block along with 20 μL of sample,
or the sample was added to room-tempered, B4F-supplemented
assay buffer directly after the heat incubation. A control sample
with an excess of free BIO (abbreviated BE for biotin excess) was
also measured to analyze the impact of a strong BIO surplus on
the assay. As shown in Fig. 1C, the detection of 533 ± 1 nM
of BIO-blocked SAV in a sample containing 3356 ± 65 nM of
BIO-saturated SAV was possible for a temperature of 70°C and
an incubation time of 5 min in the presence of B4F and mea-
surement buffer. This corresponds to a proportion of detectable
SAVQSAV of 0.16, whereQSAV = 1 represents 100% detectability.
The control sample incubated at RT allowed the detection of
46 ± 7 nM of SAV (QSAV = 0.01). Incubating only the sample
at elevated temperatures and mixing it with room tempered,
B4F-containing measurement buffer afterwards did not deliver
satisfying results. These results indicate that the heat incubation
caused displacement of BIO by B4F followed by fluorescence
quenching, thus allowing a partial detection of BIO-blocked
binding sites of SAV.
3.4 Analysis of BIO displacement
Two parameters were varied in the next step in order to improve
the low proportions of detectable SAV. The incubation time at
the elevated temperature (70°C) was altered to characterize the
course of the assay signal over time. Moreover, the incubation
time at RT after the heat incubation was changed to determine
whether the assay signal is stable or subject to variations due to
BIO-binding to B4F-blocked binding sites releasing B4F, once
the temperature is lowered from 70°C to RT. An E. coli super-
natant diluted to an SAV concentration of 596 nM was used for
the experiments to fit the maximal concentration range of the
assay. In contrast to the previous experiments this supernatant
was characterized by a large number of contaminating proteins
and a higher salt content.2 No changes in the assay signal were
observed when the incubation time at RT after the heat incuba-
tion was performed for 5, 15, 30, and 45 min, respectively (data
not shown). The results of the variation of the incubation time
at 70°C are shown in Fig. 2A.
The asymptotic course of the signal curve indicates robust
assay conditions for incubation periods 7.5 min. A BIO-free
control sample of SAV of 596 nM led to a constant assay signal
in the analyzed time interval, indicating that SAV is sufficiently
stable under these conditions. As SAV is further stabilized in the
presence of BIO [4,5], it is highly improbable that denaturation
took place in the partially and completely BIO-saturated SAV
samples. The proportions of detectable SAV QSAV of 0.89 ± 0.01
and 0.82 ± 0.04, respectively, were still lower than 1 for both
partially and completely BIO-blocked binding sites (Qblocked of
0.5 and1.0, respectively).However, these proportionswere larger
than the ones observed for the approximately 3.4 μM sample
(QSAV of 0.16) of the previous experiment.
In the next step, the general applicability of the displacement
of BIObyB4Fwas tested ondifferent fermentation supernatants.
2NaCl concentration of the undiluted E. coli-supernatant: 2.5 g L-1 vs.
approx. 0 g L-1 for the diafiltered supernatant.
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Figure 2. Variation of SAV concentration, biotin (BIO) saturation and time of heat incubation, and studies on the association and dissociation
of the complexes SAV–BIO and SAV–B4F. Error bars represent SDs from three replicates. (A) Variation of the incubation time at 70°C in
the heat assay for the detection of blocked binding sites of SAV. Samples characterized by different degrees of BIO saturation Qblocked were
analyzed, whereQblocked = 1 represents 100% of saturation of the available binding sites.QSAV is the proportion of detected SAV. The model
curves were acquired by parameter optimization for Eqs. (4a) and (4b) in COPASI (see Section 3.7). (B) Heat assay results for a 296 nM
SAV sample after an incubation at 70°C for 10 min. Degrees of BIO saturation vary from Qblocked = 0 (all binding sites are BIO-free) to
Qblocked = 1 (complete saturation). All concentrations were within a range of ±5% of the signal for the unsaturated SAV sample, as is
shown by the shaded gray area. (C) Kinetic data sets (symbols) and model curves (lines) for the parameter estimation based on BIO-free
SAV samples that were preincubated in measurement buffer for the formation of the SAV–B4F complex. All samples contained 605 ± 24
nM of tetrameric SAV. Curve A: ratio of BIO to monomeric SAV: 1.06:1; B: 2.11:1; C: 4.23:1; D: 80% of BIO-free, B4F-blocked SAV and 20%
of BIO-saturated SAV (ratio of total BIO—bound and unbound—to monomeric SAV: 1.06:1). (D) Comparison of model curve and kinetic
experimental data of one of the five data sets used for the estimation of the association rate of the SAV–B4F complex at 70°C. The initial
values for all species were chosen according to the data set. The kon,B4F and koff,B4F rates correspond to the results from the parameter
estimation with 1.60 × 108 M−1 s−1 and 8.27 × 10−4 s−1, respectively.
3.5 Variation of the culture supernatant
The supernatants were taken from cultivations on complex me-
dia without BIO supplementation, which according to our expe-
rience usually lead to low proportions of BIO-blocked binding
sites. This was achieved by expression systems that allow the se-
cretion of SAV into themedium. Fluorescencemeasurements on
these samples after an incubation at 70°C for 10 min resulted
in an unaltered fluorescence signal compared to the signal of a
similar assay at RT, indicating a negligible proportion of blocked
binding sites.3
3The hypothesis that small fractions of biotin-blocked binding sites can
be detected by this procedure is confirmed by the following optimiza-
tion procedure and by calculations based on the polynomial and the
biochemical model discussed in sections 3.6 and 3.7.
The supernatants were diluted by demineralized water to ad-
just the concentration of SAV to 1.2 μM. The samples were then
mixed with different volumes of an aqueous, 4.8 μM solution of
BIOdissolved ina50mMphosphatebuffer (pH7.5), to reachafi-
nal tetrameric SAV concentration of 600 nMwith degrees of BIO
saturationQblocked of 0, 0.25, 0.5, 0.75, and 1.0. All volumes were
adjusted to 1 mL by the addition of demineralized water. After
15 min of incubation at RT, six aliquots of 20 μL of each sample
were mixed with 980 μL of fluorescence measurement buffer.
Three aliquots were measured at RT in the standard assay to de-
termine the concentration of BIO-free binding sites, whereas the
other three were analyzed after 10min of incubation at 70°C and
30 min of incubation at RT to detect BIO-blocked binding sites.
The supernatants from the different expression hosts showed
a similar signal pattern in the assay, indicating that neither
the SAV chain length, nor the concentration of contaminating
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Table 1. Proportions of detectable SAVQSAV for three different cul-
ture supernatants, different degrees of biotin saturation Qblocked
and an incubation of the samples at 70°C for 10 min
Theoretical
Qblocked [-]
QSAV, E. coli [-] QSAV, S. avidinii [-] QSAV, P. pastoris [-]
0 1.01 ± 0.01 1.00 ± 0.02 1.00 ± 0.00
0.25 0.93 ± 0.00 0.92 ± 0.01 0.92 ± 0.01
0.5 0.89 ± 0.02 0.87 ± 0.01 0.87 ± 0.02
0.75 0.87 ± 0.01 0.85 ± 0.03 0.83 ± 0.01
1 0.82 ± 0.01 0.82 ± 0.01 0.80 ± 0.02
The Escherichia coli and Streptomyces avidinii supernatants contained
full-length streptavidin (SAV), whereas the Pichia pastoris supernatant
contained a core SAV consisting of AA 13–139 of full-length SAV. All
sampleswere diluted to a tetrameric SAV concentration of approximately
600 nMwith actual concentrations of 592 (E. coli), 593 (S. avidinii), and
604 nM (P. pastoris).
proteins has a major impact on the assay signal. Table 1 sums up
the results from the variation experiments of the SAV-containing
supernatants.
As was already observed in the kinetic measurements, the
maximal detectable SAV concentration was again dependent on
thedegreeofBIOsaturation.HigherproportionsofdetectedSAV
were achieved for lower degrees of BIO saturation. The relative
ratios of BIO, B4F, and available binding sites therefore had an
impact on the assay signal and were varied in the next optimiza-
tion step. Most of the following experiments were performed on
the E. coli supernatant, because an SDS-PAGE analysis of this
supernatant showed the largest proportion of contaminating
proteins, representing the potentially most difficult conditions
for the assay.
Additional experiments focused on the heat resistance of BIO,
B4F, and the SAV–B4F complex at 70°C, indicating a sufficient
stability of all of these compounds (Supporting Information,
Sections 7 and 8). Moreover, the impact of salt ions on the re-
sult of the assay was identified to be negligible for the conditions
tested (Supporting Information, Section 9). These results simpli-
fied the setup for the following experiments andmodeling steps.
3.6 Variation of the B4F to BIO ratio and polynomial
modeling
To provide a more favorable ratio of B4F toward BIO and SAV,
respectively, the BIO-supplemented SAV samples were diluted
two-fold for the next experiment. The heat incubation was per-
formed for 10 min at 70°C to reach the constant region of the
curves shown in Fig. 2A.
Figure 2B reveals that the problemof an only partial detection
of SAV can be eliminated by a stronger excess of B4F toward BIO
and SAV binding sites. A constant assay signal corresponding
to the total concentration of available binding sites in the sam-
ple was detected independent of the degree of BIO saturation
Qblocked. Thus, the SAV sample should be diluted in order to yield
valid results in the heat assay.
To determine the maximal concentration of BIO-saturated
SAV to be used for the assay while minimizing the proportion
of undetected binding sites, a systematic variation of the SAV
concentration at different degrees of BIO saturationQblocked was
performed. The E. coli supernatant was diluted to concentrations
from 300 to 600 nM in increments of 50 nM. The results were
imported into the design of experiments software MODDE and
evaluated by a partial least square fit to a polynomial model
leading to the contour plot shown in Fig. 3A.
The model consisted of the factors cSAV and Qblocked and their
linear interaction (cSAV × Qblocked), all of which were found to
be highly significant (p-values for a confidence level of 0.95:
1.1 × 10−10, 1.5 × 10−8, and 2.1 × 10−4). Model values of 0.855
and 0.811 for R2 and predicted R2, respectively, were achieved.
Model Eq. (3) allows the calculation of the detectable SAV con-
centration cSAV,det:4
cSAV,det = 1.0074 − 0.137 Q blocked − 1.117 × 10−5cSAV
−0.0006 Q blocked cSAV (3)
The plot in Fig. 3A, visualizing the results of Eq. (3) for typical
SAV concentrations and degrees of BIO saturation, can be used
to decide if a given sample should be diluted for valid results
of the assay or if the undiluted sample may be used for the
determination of blocked binding sites.
3.7 Kinetic modeling of the displacement of BIO by
B4F at 70°C
To further characterize the detection of BIO-blocked binding
sites and to provide biochemical insight into the displacement of
SAV-bound BIO by B4F at 70°C, the data set was analyzed by the
means of a competitive binding model using CellDesigner for
model creation, COPASI for parameter optimization and Scilab
for parameter variation, and simulation of various assay condi-
tions. The competition reaction can be described by a system
of the two differential Eqs. (4a) and (4b), each consisting of a
term for the association (on) and the dissociation (off) of the
respective complexes:
dcSAV−bio
dt
= cSAV cbio kon,bio − cSAV−bio koff,bio (4a)
dcSAV−B4F
dt
= cSAV cB4F kon,B4F − cSAV−B4F koff,B4F (4b)
where cSAV is the concentration of free SAV, cSAV-bio the con-
centration of the SAV–BIO complex, cSAV–B4F the concentration
of SAV–B4F complex, and cbio and cB4F the concentrations of
the unbound concentrations of BIO and B4F, respectively. The
net change of the complex concentration is determined by the
complex formation and dissociation rates kon and koff for both
complexes.
The equations are based on the assumption that an accurate
description of the system is achieved by a pseudo-first order re-
action model referring to monomeric concentrations instead of
the SAV tetramer. Four data sets were used for the parameter
estimation: the kinetic data set shown in the saturation curves in
Fig. 2A was used to determine koff,bio by providing conditions in
4exact coefficients in order of appearance: 1.00736, 0.137313, –1.11701
× 10–5 and –0.000558038. Please use the tetrameric concentration of
SAV in the sample for the calculation without taking into account the
dilution by measurement buffer.
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Figure 3. Contour plots for the proportion of detectable SAV QSAV in the heat assay at 70°C for an incubation for 10 min as a function of
the final monomeric SAV concentration after the dilution in the measurement buffer cSAV and the proportion of biotin-blocked binding sites
Qblocked. The plots are based on two different models. (A) Results of the model developed in MODDE. The data set was fit to the polynomial
model described in Eq. (3). (B) Plot of simulation results based on the ordinary differential equation system of Eqs. (4a) and (4b), applying
the parameters shown in Table 2 in the interval of 25–50 nM of monomeric SAV. (C) Plot of the ordinary differential equation simulation in
the complete interval of 0–50 nM of SAV. (D) Direct comparison of the polynomial model (MODDE) and the biochemical model presented
as the difference of the predicted concentrations of detectable SAV QSAV of the polynomial model QSAV,MODDE and the biochemical model
QSAV,kin,mod. Supporting Information, Fig. S2 contains two plots visualizing the deviations of both models toward the experimental data.
A final monomeric SAV concentration of 48 nM in the measurement buffer corresponds to a tetrameric concentration of 600 nM in the
sample used for the assay (dilution factor: 1:50 and conversion of tetrameric concentrations into monomers).
which BIO is displaced by B4F by an initially high concentration
of the BIO–SAV complex. This was achieved by incubating the
sample in measurement buffer at RT prior to the addition of
BIO. An additional set of kinetic measurements was included for
the calculation of the koff,B4F rate focusing on conditions charac-
terized by high initial concentrations of the SAV–B4F complex.
A selection of corresponding data sets is shown in Fig. 2C. Addi-
tionally, the data set of the concentration variation experiments
used for the fit of the polynomial model was taken into account.
Finally, kinetic binding measurements for the association of the
B4F–SAV complex were performed using the E. coli supernatant.
A corresponding data set is shown in Fig. 2D. All data sets were
completed by calculations based on the mass balances of SAV,
BIO, and B4F, from which the theoretical time courses for the
SAV–BIO complex and free BIO and B4F were reconstructed.
The calculations were performed assuming that the free SAV
concentration is negligible, which seems reasonable considering
the dissociation constants at RT and the full detectability of a
300 nM SAV sample at 70°C. Please refer to the Supporting In-
formation, Section 3.1 for a detailed description of the parameter
estimation. The results of the parameter estimation are shown in
Table 2.
The dissociation constants Kd,bio and Kd,B4F at 70°C derived
from the parameter optimization differ by a factor of 23.6 ±
6.1. In contrast to this ratio, usual dissociation constants for the
B4F–SAV complex at RT are in the range of 1.4 × 10−10 M [35],
whereas the constant for BIO is approximately 1 × 10−15 M [3],
leading to a factor in the range of 10−5. Therefore, unlike at RT,
the heat assay provides conditions favoring the formation of the
SAV–B4F complex instead of the complex of SAV and its natu-
ral ligand BIO. As the structures of B4F and BIO only vary in
the modification on the valeric acid side chain, the difference in
temperature dependence of the dissociation constants is likely to
be an effect of this side chain rather than the core structure of the
vitamin. Since the side chain is involved in dimer stabilization of
SAV [3], the reason for the elution of BIO at elevated tempera-
turesmay be associated to a decreased dimer stability, rather than
to an effect on a single SAV subunit. A comparison of the results
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Figure 4. Schematic display of the final assay procedure. Either di-
lute the supernatant to a tetrameric cSAV,HT 300nMoruse Fig. 3A
and B to choose an appropriate concentration. Equation (5) may
be used for the correction of the assay signal for cSAV,tetrameric >
300 nM.
Table 2. Parameter values and corresponding SDs acquired by the
final parameter optimization in COPASI based on the ordinary
differential equation system consisting of Eqs. (4a) and (4b) and
additional binding measurements for the association of the B4F–
SAV complex
Parameter Value CV [%]
kon,bio 4.46 ± 0.93 × 107 M−1 s−1 21.08
koff,bio 5.38 ± 0.32 × 10−3 s−1 5.94
kon,B4Fa) 1.60 ± 0.01 × 108 M−1 s−1 0.60
koff,B4F 8.27 ± 1.11 × 10−4 s−1 13.36
Kd,bio 1.22 ± 0.27 × 10−11 M 21.90
Kd,B4F 5.16 ± 0.70 × 10−13 M 13.37
QKd 23.60 ± 6.05 25.66
All values refer to a temperature of 70°C. The dissociation constants were
calculated according to Kd = koff /kon. The SDs are shown as absolute
and relative values (coefficient of variation, CV). Deviations for the
dissociation constantsKd and the ratio of the dissociation constantsQKd
= Kd,bio /Kd,B4F were calculated by Gaussian error propagation.
a) Parameter estimation based on binding measurements of only the
SAV–B4F complex.
to the data of Chivers et al. [25] and Deng et al. [26] suggests
that the results are feasible. A detailed analysis is performed in
the Supporting Information, Section 3.2.
Basedon thekinetic parameters inTable 2, theordinarydiffer-
ential equation system of Eqs. (4a) and (4b) was solved covering
the whole range of potential SAV concentrations in the assay (0–
50 nM of monomeric SAV) and proportions of blocked binding
sites Qblocked from 0 to 1 (0–100% of BIO saturation). The sys-
tem was solved by Scilab’s ordinary differential equation solver
using its order 4 adaptive Runge–Kutta algorithm. The results
are shown in Fig. 3B and C (Section 3.6). The results from the
solver correlate well with the experimental data (see Supporting
Information, Table S3 for a direct comparison), especially for
high concentrations of SAV.
3.8 Discussion of model accuracy and specification
of boundary conditions for the assay
According to the polynomial model, even very low concentra-
tions of SAV lead to errors in the quantification of detectable
SAV at high degrees of BIO saturation Qblocked. For a maximal
error of 5% theQblocked value should not exceed 0.5 for interme-
diate tetrameric SAV concentrations of approximately 440 nM
in the sample used for the measurement (see Fig. 3A in Section
3.6). This concentration corresponds to a final concentration of
35 nM of monomeric SAV in the measurement buffer. The pre-
diction matches the data, as can be seen in Supporting Informa-
tion, Table S4.
The biochemical model (Fig. 3B) deviates from the experi-
mental data in several cases when the product in the sample is
to be detected in its entirety (QSAV approaching 1). At a con-
centration of approximately 300 nM of tetrameric SAV in the
sample, the detection of all binding sites is possible indepen-
dent from the degree of BIO saturation (see Section 3.6, Fig. 2B).
Figure 3B clearly indicates the lack of fit of the biochemicalmodel
for intermediate concentrations of SAV (24 nM of monomeric
SAV in measurement buffer), with an increasing error for in-
creasing degrees of BIO saturation. At 100% of BIO saturation,
the predicted QSAV differs from the experimental data by 8.6%.
Figure 3D shows a plot of the differences for the modeled values
ofQSAV of both models, indicating that in the corresponding pa-
rameter area (upper left part of the plot) the polynomial model
developed in MODDE leads to more accurate results, because
this part of the plot showsnegative values,meaning that the poly-
nomial model leads to higher proportions of detectable SAV. We
therefore recommend the use of this model (Fig. 3A, Section
3.6) for an estimation of the detectable SAV concentration in
this parameter area (cSAV  300 nM, high Qblocked). However,
the polynomial model shows an increasing lack of fit for high
concentrations of SAV at low degrees of BIO saturation. The
comparative plot in Fig. 3D once again shows a negative de-
viation, meaning that higher QSAV values are predicted by the
polynomial model (MODDE). However, unlike for the upper
left area of the plot the biochemical model (Fig. 3B) predicts the
experimental data more accurately in the lower right area of the
plot and should therefore be used for corresponding analyses.
This can most easily be tracked by the two additional plots of
the differences of modeled and experimental data for bothmod-
els that are shown in Supporting Information, Fig. S1. Low/low
and high/high combinations of cSAV andQSAV along the diagonal
of Fig. 3D also show slightly negative values. The biochemi-
cal model reflects the experimental results more accurately in
this parameter area, as can be seen in Supporting Information,
Fig. S1.
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After characterizing the assay system and discussing the ac-
curacy of both models, we can now define practical boundary
conditions for the assay. For typical applications, a deviation
of 5% of measured and actual SAV should be sufficient. As
a consequence of both the biochemical and polynomial model
and their accuracy discussed above, we suggest using maximal
tetrameric SAV concentrations of 300 nM for the assay, corre-
sponding to a ratio of monomeric SAV after dilution to B4F of
approximately 1:2. This should provide favorable conditions for
a complete detection of BIO-blocked as well as free binding sites.
The practical measurements suggest that the actual error is next
to zero, indicated by concentrations of 296± 10 nM at complete
saturation vs. 297 ± 3 nM for a BIO-free sample (see Fig. 2B).
For a validationof this concentration range, the threedifferent
culture supernatants from cultivations of E. coli, P. pastoris, and
S. avidinii were once again analyzed in different concentrations
at complete BIO saturation. At 300 nM of SAV the detection of
all of the available binding sites was possible independent from
the chain length of SAV and the total protein concentration in
the sample. The results of this final validation step are shown
in the Supporting Information, Table S5. Moreover, the kinetic
accuracy of the biochemical model was validated for the three
supernatants. A plot of these experiments is shown in Support-
ing Information, Fig. S2. Both validation steps led to satisfying
results. The final, validated assay procedure is visualized in Fig. 4.
The following section describes a method for the mathematical
correction of the assay signal without dilution of the sample for
working concentrations of tetrameric SAV above 300 nM.
3.9 Mathematical correction of assay values for SAV
concentrations larger than 300 nM
Although the dilution of the sample for concentrations of cSAV >
300 nM is recommended, larger SAV concentrations measured
at high degrees of BIO saturation may be corrected by the use of
Eq. (5), if a dilution of the sample is not feasible.5
cSAV,corr = −134 nM + 0.117 cSAV,RT + 1.472 cSAV,HT
−0.001 cSAV,RT cSAV,HT (5)
where cSAV,corr is the corrected SAV concentration and cSAV,HT and
cSAV,RT are the SAV concentrations calculated from the measure-
ments at 70°C and RT, respectively. This equation is valid for
tetrameric SAV concentrations in the range of 300 nM cSAV 
600 nM.
Equation (5) was derived from a partial least square fit in
MODDE based on themeasurement values for cSAV,HT and cSAV,RT
and the theoretical concentration of SAV in the sample. The data
was taken from the concentration variation experiments. Sup-
porting Information, Table S6 shows exemplary results for SAV
concentrations corrected according to this procedure, including
the concentrations from the supernatant variation, which were
not used for the parameter optimization in MODDE, therefore
5exact coefficients in order of appearance: –133.96 (p = 0), 0.116972
(p = 1.46 × 10–8), 1.47184 (p = 3.09 × 10–27) and –0.000639386 (p =
0.003); model characterization: R2 = 0.98; predicted R2 = 0.976. Please
use the tetrameric concentrations of SAV in the sample prior to mixing
with measurement buffer for the calculation.
serving as an external control. Typical deviations of the theoret-
ical and the corrected calculated concentration for the external
validation are in the range of ±5%.
Additional simulations based on the kinetic model suggest,
that comparable improvements of the assay result for cSAV >
300 nM can be expected when the B4F concentration in the
assay buffer is doubled (Supporting Information, Section 10, Fig.
S3A). Minor improvements may also be achieved by prolonging
the incubation period at 70°C (Supporting Information, Fig.
S3B).
3.10 Monitoring of the production of SAV in shake
flasks
After optimizing and characterizing the assay procedure, it was
applied to a shakeflask cultivationof a cloneofP. pastoris express-
ing the core SAV gene under control of the methanol-inducible
alcohol oxidase 1 (AOX1) promoter (see Section 2.3.1 for experi-
mental details). A variation of the BIO concentration in buffered
MG medium was performed with BIO supplements of 1 (label
A) and 4 μM (label B), respectively. This did not influence the
growth behavior of P. pastoris (Fig. 5B). Figure 5A demonstrates
exemplarily that the standard assay by Kada et al. [21, 22] leads
to biased results for cultivations applyingmedia with high initial
concentrations of BIO. Production of SAV started directly after
induction at 24 h of cultivation. However, the standard assay
allowed the detection of SAV only after 48 and 73 h of cultiva-
tion for concentrations of BIO of 1 and 4 μM in the medium,
respectively. The heat-based results suggest that residual BIO
was present in the medium after the initial growth phase, which
subsequently was incorporated into the binding pockets of SAV
after induction. Therefore, the accumulation of free binding sites
was delayed by several hours. Overall, the volumetric productiv-
ities based on the heat assay amount to 4.2 (1 μM of BIO) and
6.7 nM h−1 (4 μM), as opposed to 2.8 and 1.9 nM h−1 (factors
1.5 and 3.5, respectively) based on the standard assay. Moreover,
the course of product formation starting from induction can be
described as linear, which is not reflected by the results from
the standard assay. Both cultivations suggest that prolonging the
induction period should lead to higher proportions of bioactive
binding sites. These findings clearly show that the standard as-
say leads to biased results concerning the productive properties
of the host, which can be avoided by an additional heat-based
analysis.
4 Concluding remarks
By a systematic optimization of conditions, we demonstrated
that BIO-blocked binding sites of SAV can be detected by a
combination of the fluorescence quenching assay established by
Kada et al. [21,22] and a prior incubation in a heat block at 70°C.
The elution studies of Holmberg and coworkers [23] are there-
fore partially applicable to free SAV and BIO. The proportion
of detectable binding sites depends on the ratio of B4F toward
BIO and the concentration of available binding sites of SAV, re-
spectively. If the dilution of the SAV-containing sample is strong
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Figure 5. Shake flask cultivation of a clone of Pichia pastoris secreting core SAV in biotin-supplemented bufferedMG-mediumupon induction
by methanol. The medium was supplemented with two concentrations of biotin: 1 μM (labeled A) and 4 μM (labeled B). Induction was
started after 24 h of cultivation according to Section 2.3.1. All cultivations were performed in three biological replicates. (A) Plot of the
SAV concentrations at room temperature and in the heat assay and corresponding proportion of biotin-blocked binding sites Qblocked. The
shaded area is a graphical representation of the biotin-blocked binding sites. (B) Course of the concentrations of dry cell weight X, methanol
cMeOH, and glycerol cGly.
enough (tetrameric cSAV < 300 nM)6, all of the binding sites in
the sample can be detected, independent of the chain length of
SAV, the total protein concentration in the sample, and the de-
gree of BIO saturation. This allows the application of the assay
for supernatants derived from a large variety of expression sys-
tems, which typically differ strongly in the chain length of SAV
due to variable N- and C-termini [13, 14] and their content of
contaminating proteins. Unlike for SAV, the assay procedure did
not lead to displacement of bound BIO by B4F when applied to
avidin (Supporting Information, Section 11).
Further studies provided insight into the kinetic parameters
during heat incubation. A model-based analysis revealed that
the dissociation constants for B4F and BIO at 70°C differ by a
factor of approximately 23.60 ± 6.05 with values of Kd of 1.22 ±
0.27 × 10−11 M for SAV–BIO and of 5.16 ± 0.70 × 10−13 M for
the SAV–B4F complex, thus favoring the association of the B4F–
SAV complex. At RT this factor is in the range of 10−5 [5, 35].
This is due to larger association as well as smaller dissociation
rates for the SAV–B4F complex toward the natural binding part-
ners SAV and BIO at 70°C (see Table 2). The change in affinity
causes a shift from the precise detection of free binding sites at
RT to conditions that allow a reliable detection of BIO-blocked
sites after a heat incubation step. The results indicate that B4F
– like BIO – seems to stabilize SAV at 70°C. Additional studies
(see Supporting Information) showed that neither the degrada-
tion of SAV, nor heat-induced damage on B4F and BIO at 70°C
harm the outcome of the assay. This is caused by the very low
proportion of free, more heat-susceptible SAV due to the small
dissociation constants for the SAV–BIOand SAV–B4F complexes
and the thermostability of BIO and its fluorescence derivative,
respectively. No change in complex formation of SAV and B4F
was observed for altered salt contents in the sample. Further-
more, the presence of free BIO did not cause a displacement of
B4F in time intervals of up to 45 min after the heat incubation
step, once the B4F–SAV complex was formed. These properties
6For the dilution of 20μL of sample by 980 μL of a 50 nM B4F solution.
allow a robust and reliable measurement of the blocked binding
sites. The assay was tested in a shake-flask cultivation, providing
insight into the fermentative properties of a clone of P. pastoris
producing core SAV and demonstrating its worth for a more
detailed analysis of SAV producers.
The final optimized assay, characterized by an incubation at
70°C for 10 min prior to the fluorescence measurement (see
Fig. 4), permits a rapid and reliable monitoring of BIO-blocked
binding sites throughout the fermentationofdifferent expression
hosts.Noadditional equipment ormaterial is required compared
to the assay of Kada et al. [21,22] except for a standard laboratory
heat block.
Practical application
The assay herein developed may be useful for various ap-
plications, particularly the monitoring and optimization
of SAV production. Unlike a standard assay, heat-based
measurement of total SAV reveals the actual start of SAV
biosynthesis and the unbiased fermentative properties of
a producer, rather than the accumulation of free binding
sites. Combined with measurements of BIO-blocked, cyto-
plasmic SAV after cell disruption, this information may be
used to optimize the BIO concentration in media and to
monitor strategies to reduce host toxicity by SAV, which
is a central problem in heterologous production of the
protein. In downstream processing, the assay may deter-
mine whether the proportion of BIO-blocked SAV is high
enough to render its denaturing, diafiltration and refold-
ing economically feasible. Furthermore, it may be useful to
monitor the effectiveness of nondenaturing methods for
the separation of BIO and SAV by quantifying the degrada-
tion of BIO-blocked sites.
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Nomenclature
Qblocked [-] Degree of biotin saturation of SAV
QSAV [-] Detectable proportion of SAV
cSAV [nM] SAV concentration
cSAV,HT and
cSAV,RT
[nM] SAV concentration calculated from
measurements at high temperature
and room temperature,
respectively
cSAV,det and
cSAV,corr
[nM] Detectable and corrected
concentration of SAV
cSAV,blocked [nM] Concentration of biotin-blocked SAV
cB4F and
cSAV–B4F
[nM] Concentration of B4F and its
complex with SAV
cbio and
cSAV–bio
[nM] Concentration of biotin and its
complex with SAV
cGly and cMeOH [g L−1] Concentration of glycerol and
methanol, respectively
Kd,bio and
Kd,B4F
[M] Dissociation constants of biotin and
B4F for the binding of SAV,
respectively
kon and koff [s−1] and
[M−1 s−1]
Reaction constants for the
association and dissociation of a
complex, respectively
kdeg [s−1] Degradation constant for the
irreversible denaturation of SAV
QKd [-] Ratio of the dissociation constants of
the complexes SAV–biotin and
SAV–B4F
X [g L−1] Dry cell weight concentration
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1. Calculation of the SAV concentration based on a B4F calibration curve 
 
SAV concentrations were calculated according to Table S1. 
Table S1 Calculation of the SAV concentration based on a B4F calibration curve. The fluorescence 
signals for different B4F concentrations (left row) were correlated to theoretical concentrations of 
quenched B4F, calculated from the concentration difference to the concentration in the measurement 
buffer of 49 nM. This maximal concentration results from the mixture of 980 µL of 50 nM B4F in 
measurement buffer with 20 µL of sample, therefore 50fold diluting the sample. This dilution factor was 
used for the conversion of cB4F,quenched in cSAV,monomeric. 
cB4F [nM] cB4F,quenched [nM] cSAV,monomeric [nM] cSAV,tetrameric [nM] 
49 0 0 0 
45 4 200 50 
40 9 450 112.5 
30 19 950 237.5 
20 29 1450 362.5 
10 39 1950 487.5 
5 44 2200 550 
1 48 2400 600 
 
2. Estimation of the degradation constant of streptavidin according to Arrhenius 
Based on the degradation reaction constants from the parameter fits the temperature-
dependency of the irreversible denaturing step of SAV can be modeled according to 
Arrhenius [33] as described in equation (S1). 
 
 
𝒌𝒅𝒆𝒈 = 𝒌𝒅𝒆𝒈,𝟎 𝐞𝐱𝐩 (−
𝑬𝒂,𝒅𝒆𝒈
𝑹𝑻
) (S1) 
   
where kdeg,0 is the pre-exponential factor, Ea,deg the activation energy for the denaturing step, 
R the universal gas constant and T the temperature in K. 
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An activation energy for the unfolding of SAV of about 229±16 kJ mol-1 has been reported 
[34]. Applying this activation energy, a parameter fit to the degradation rates acquired from 
the curves in Fig. 1 A resulted in an estimated kdeg,0 of 6.5395 × 10
30 s-1. The model curve for 
these parameters is shown in Fig. 1 B in the main document. 
 
3. Parameter estimation for kinetic modelling 
 
3.1 Steps of the parameter estimation 
First parameter estimations were performed based on studies without detailed binding 
studies. Using the model described by equations (4a) and (4b), a parameter optimization 
based on the differential evolution algorithm of COPASI1 led to the parameters shown in the 
supplements in Table S2. The values for the dissociation rates of both complexes 
determined by parameter estimation were characterized by small deviations. However, no 
accurate determination of the association rates was achieved. As long as the ratio of the 
dissociation constants Kd was not altered, they could be changed by several orders of 
magnitude without influencing the accuracy of the model. 
Table S2 shows the results of the first iteration of the parameter estimation. The resulting 
dissociation rate for the SAV-B4F complex was used for the estimation of kon,B4F. 
Table S2 Parameter values and corresponding standard deviations for the first iteration of the 
parameter optimization for the heat incubation at 70 °C for 10 min acquired with COPASI and the ODE 
system consisting of equations (4a) and (4b). The standard deviations are shown as absolute and 
relative values (coefficient of variation). 
Parameter value coeff. of variation [%] 
kon,bio 6.94±84.0 × 10
8
  M
-1
 s
-1 
1210.42 
koff,bio 5.37±0.15 × 10
-3
 s
-1 
2.86 
kon,B4F 2.55±30.9 × 10
9
 M
-1
 s
-1 
1211.96 
koff,B4F 8.33±0.54 × 10
-4
 s
-1 
6.50 
 
To achieve a more reliable quantification of the association rates, additional kinetic 
experiments were performed in order to yield more reliable association rates. 
An E. coli supernatant containing 1.21 µM of SAV was diluted onefold by demineralized 
water, resulting in a tetrameric concentration of 605 nM. A volume of 20 µL of the resulting, 
room-tempered solution was placed in a fluorescence measurement cuvette. Measurement 
buffer including B4F and BSA was tempered to 70 °C in a heat block. A kinetic measurement 
with scanning intervals of 0.1 s was started and 980 µL of the preheated measurement buffer 
were added directly into the cuvette. The fluorescence emission at 525 nm was measured for 
60 s. This procedure was performed fivefold. 
Two additional measurements were performed for calibration: to determine the maximal 
fluorescence at 70 °C, preheated measurement buffer supplemented with 20 µL of water 
instead of the sample was analyzed. The minimal fluorescence was determined at 70 °C for 
2 min by mixing 20 µL of the sample with 980 µL of measurement buffer. These maximal and 
                                                          
1
 parameters: 2000 generations, population size: 10. 
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minimal values were used for the calibration of the kinetic data, representing 0 (no 
quenching) and 600 nM (maximal quenching) of tetrameric SAV in the undiluted sample, 
corresponding to 0 and approx. 48 nM of monomeric SAV diluted by measurement buffer, 
respectively. 
The kinetic measurements were evaluated with a simple model representing complex 
formation and dissociation of the SAV-B4F complex according to equation (4b) in 
CellDesigner. The koff,B4F rate of 8.33±0.54 × 10
-4 s-1 from the first iteration of the parameter 
estimation (Table S2) was used as a constant parameter for the estimation of the kon,B4F rate 
in COPASI based on the CellDesigner model and the five kinetic measurements. The mass 
balances of B4F and SAV were used for the calculation of the free species of these 
compounds in addition to the measured B4F-SAV concentrations. 
The parameter estimation led to a kon,B4F rate of 1.60 × 10
8 s-1 characterized by  a drastically 
reduced coefficient of variation of 0.6 % as opposed to 1211.96 % for the first iteration of the 
estimation. The new value of the association rate for the SAV-B4F complex kon,B4F was 
reimported as a constant into the model consisting of equations (4a) and (4b) to recalculate 
the kon,bio rate and both dissociation rates. The complete results of this second parameter 
estimation are shown in Table 2 in the main document. 
 
3.2 Comparison of results of parameter estimation and literature data 
An Arrhenius-based estimation of the koff,bio rate of the SAV-biotin complex according to the 
data of Deng et al. [26] with activation parameters Ea of 31.7 kcal mol
-1 (activation energy) 
and A of 1018.2 s-1 (pre-exponential factor) leads to a koff,bio rate of 1.03 × 10
-2 s-1 at 70 °C. The 
parameter optimization resulted in a value of 5.38±0.32 × 10-3 s-1, differing by a factor of 1.91. 
As the data of Deng and coworkers only covers temperatures from 15.3 to 44.8 °C an 
extrapolation to 70 °C is necessary. This is error-prone due to typically very large pre-
exponential factors (A). Thus, the result of the parameter estimation seems feasible. 
Interestingly, the estimation suggests that the dissociation of the SAV-B4F complex at 70 °C 
is more than one order of magnitude slower than the dissociation of the SAV-biotin complex. 
Along with the 3.6fold higher association rate this results in conditions favoring the formation 
of the SAV-B4F complex, ultimately providing the conditions necessary for the assay. 
Another interesting insight is provided in comparison to the data of Chivers et al. [25] who 
measured a kon,B4F rate of 2.0±0.1 × 10
7 M-1 s-1 for the association of the B4F-SAV complex at 
37 °C. Surprisingly, the value from the parameter estimation of 1.60±0.01 × 108 M-1 s-1 at 
70 °C (factor 8) suggests that an increase in temperature improves the association of this 
complex. Opposed to that, the association rate of the SAV-biotin complex determined at 
elevated temperatures (4.46±0.93 × 107 M-1 s-1) is slightly lower (factor 1.5), but in the same 
order of magnitude as the value of Chivers and coworkers at 37 °C (6.7±0.5 × 107 M-1 s-1). 
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4. Comparison of experimental data and model prediction 
 
4.1 ODE-based model 
To provide brief insight into the accuracy of the results from the ODE-based model 
(equations (4a) and (4b), Fig. 3 B) in comparison to the experimental results, Table S3 
shows a summary of simulated and experimental data. 
Table S3 Comparison of experimental data (exp) and simulated (sim) proportions of detectable SAV 
QSAV for different degrees of biotin saturation Qblocked and different initial SAV concentrations cSAV. The 
abbreviations SB and SB4F refer to the complexes of SAV and biotin and SAV and B4F, respectively. 
The B4F concentration was kept constant at 49 nM for all experiments. Simulation and experimental 
data are based on an incubation at 70 °C for 10 min and refer to the actual, monomeric concentration 
of SAV in the assay buffer. 48 nM of monomeric SAV in measurement buffer correspond to 600 nM of 
tetrameric SAV in the initial sample. 
cSAV 
[nM] 
Qblocked  
[-] 
 cSB,sim 
[nM] 
cSB4F,sim 
[nM] 
QSAV, sim 
 [-] 
cSB,exp 
[nM] 
cSB4F,exp 
[nM] 
QSAV,exp 
[-] 
46.4 0.04 0.6 45.7 0.98 0.0 46.4 1.00 
46.4 0.31 3.5 42.8 0.92 3.7 42.7 0.92 
46.4 0.57 5.5 40.9 0.88 5.0 41.4 0.89 
46.4 0.81 7.1 39.3 0.85 6.2 40.2 0.87 
46.4 0.98 8.1 38.3 0.82 7.9 38.5 0.83 
45.1 0.07 0.9 44.1 0.98 0.0 45.1 1.00 
45.1 0.35 3.4 41.7 0.92 3.7 41.4 0.92 
45.1 0.61 5.2 39.9 0.88 5.9 39.2 0.87 
45.1 0.83 6.6 38.5 0.85 7.3 37.9 0.84 
45.1 0.97 7.5 37.6 0.83 8.5 36.6 0.81 
40.4 0.11 0.7 39.6 0.98 0.0 40.4 1.00 
40.4 0.35 2.3 38.1 0.94 2.8 37.6 0.93 
40.4 0.59 3.6 36.7 0.91 2.8 37.5 0.93 
40.4 0.81 4.8 35.5 0.88 4.1 36.2 0.90 
40.4 0.96 5.6 34.8 0.86 5.5 34.9 0.86 
37.0 0.08 0.4 36.6 0.99 0.0 37.0 1.00 
37.0 0.36 1.8 35.3 0.95 1.6 35.4 0.96 
37.0 0.60 2.9 34.1 0.92 1.2 35.9 0.97 
37.0 0.83 3.9 33.1 0.89 2.7 34.4 0.93 
37.0 0.98 4.6 32.4 0.87 3.9 33.2 0.90 
34.1 0.11 0.4 33.6 0.99 0.0 34.1 1.00 
34.1 0.38 1.5 32.6 0.96 2.0 32.1 0.94 
34.1 0.61 2.4 31.7 0.93 1.8 32.3 0.95 
34.1 0.83 3.3 30.8 0.90 2.1 32.0 0.94 
34.1 0.97 3.8 30.3 0.89 4.1 30.0 0.88 
28.7 0.13 0.3 28.4 0.99 0.0 28.7 1.00 
28.7 0.36 0.9 27.8 0.97 -0.2 28.9 1.01 
28.7 0.61 1.6 27.1 0.94 2.1 26.6 0.93 
28.7 0.82 2.2 26.5 0.92 1.0 27.7 0.97 
28.7 0.97 2.7 26.0 0.91 2.8 25.9 0.90 
23.6 0.05 0.1 23.5 1.00 0.0 23.6 1.00 
23.6 0.36 0.6 22.9 0.97 0.5 23.1 0.98 
23.6 0.61 1.1 22.4 0.95 1.2 22.4 0.95 
23.6 0.82 1.5 22.0 0.93 -0.8 24.3 1.03 
23.6 0.99 1.9 21.7 0.92 0.3 23.3 0.99 
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4.2 Polynomial model 
A comparison of the model prediction of the polynomial model and the experimental data is 
shown in Table S4, summing up the predicted and experimental error of the measured SAV 
concentration for different concentrations of SAV in the sample at complete (Qblocked = 1) and 
50 % of the maximal biotin saturation (Qblocked = 0.5). In addition to the theoretical Qblocked 
values (first row in the table), the table also contains calculated values for this parameter 
(fourth row, values in brackets). These refer to the concentration of SAV measured in the 
heat assay (70 °C, 10 min) prior to the saturation with biotin, corresponding to the total 
concentration of binding sites, and the free binding sites after the saturation procedure 
determined by a measurement at room temperature. The calculated Qblocked value is equal to 
the difference of the free and total concentration of binding sites divided by the total 
concentration of binding sites. 
Table S4 Summary of the results of the optimization and prediction routines of MODDE. The table 
shows the maximal SAV concentrations cSAV,max which may be used in the heat assay for a desired 
maximal deviation dcSAV of the actual SAV concentration in the sample. The predictions are compared 
to experimental results. The experimental data is divided into the actual SAV concentration and biotin 
saturation along with a prediction range and predicted value for dcSAV for this actual concentration. 
Qblocked 
[-] 
cSAV,max 
[nM] 
desired 
dcSAV [%] 
actual cSAV 
(Qblocked) [nM] / [-] 
observed 
dcSAV [%] 
 
predicted dcSAV-
range for actual cSAV 
(average value) [%] 
1 285 -1 295 (0.99) -1.1 0.7 ... -5.3 (-2.3) 
1 341 -5 359 (0.97) -9.9 -3.7 ... -7.9 (-5.8) 
1 434 -10 426 (0.97) -12.0 -8.0 ... -10.9 (-9.5) 
1 600 -20 580 (0.98) -17.0 -16.0 ... -20.3 (-18.2) 
0.5 296 -1 295 (0.61) -4.9 
a) 
0.4 ... -3.0 (-1.3) 
0.5 434 -5 426 (0.61) -5.2 -5.0 ... -6.7 (-5.9) 
0.5 600 -10 580 (0.58) -10.7 -9.4 ... -12.0 (-10.7) 
 
a)
 This value is certainly too large. The deviation for this cSAV was smaller for higher degrees of biotin 
saturation (Qblocked = 0.82: dcSAV = +3.3 % (data not shown); Qblocked = 0.99: dcSAV = -1.1 % (see first 
row)). It is therefore likely that this dcSAV is caused by measurement problems due to the device or the 
experimental procedure. 
 
4.3 Comparison of polynomial and ODE-based model 
A graphical comparison of model and simulated data for both the polynomial and the 
biochemical model is shown in Fig. S1. 
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Fig. S1 Plots of the deviations of the proportion of detectable SAV QSAV from the polynomial model 
(QSAV,PN) created by MODDE (A) and the biochemical model (QSAV,BC) acquired by parameter 
optimization for equations (4a) and (4b) (B) from the experimental data QSAV,exp. Negative values 
represent model values larger than the experimental data and vice versa. Please note that the color 
coding differs in the two plots. Spots differing from their surroundings and occuring in both plots are 
likely to result from measurement problems. The dark blue spot in the upper left of both plots serves 
as an example. The plots were created with Minitab 17. 
 
5. Validation of the selected concentration range for the assay 
 
Table S5 sums up the results of the final experimental validation of the assay procedure 
(section 3.11). 
  
Jakob M. Müller 49
Engineering in Life Sciences  J.M. Müller et al. 
 7 
Table S5 Results of the final validation of the selected range of acceptable SAV for the assay. 
Supernatants from three different organisms were analyzed in different concentrations at complete 
biotin saturation. The concentrations of the supernatants were 1242±67, 1196±27 and 1227±49 nM of 
tetrameric SAV prior to the dilution for the assay. These concentrations were used as a reference point 
for the calculation of the detectable proportion of SAV QSAV. The highlighted rows show that a 
concentration of approximately 300 nM in the sample should allow the detection of all of the available 
binding sites, independent from the degree of biotin saturation Qblocked and the supernatant - and thus, 
the total protein concentration and the chain length of SAV. 
supernatant cSAV [nM] cSAV,RT [nM] Qblocked [-] cSAV,HT [nM] QSAV [-] 
E. coli 621 10±10 0.98 476±10 0.77±0.02 
 466 11±6 0.98 424±6 0.91±0.01 
 311 6±6 0.98 305±6 0.98±0.02 
P. pastoris 598 56±2 0.91 484±0 0.81±0.00 
 449 49±2 0.89 412±5 0.92±0.01 
 299 26±2 0.91 303±6 1.01±0.02 
S. avidinii 614 26±3 0.96 486±2 0.79±0.00 
 460 21±7 0.96 417±6 0.91±0.01 
 307 9±5 0.97 302±3 0.99±0.01 
 
 
 
Fig. S2 Kinetic measurements on the three culture supernatants of E. coli, P. pastoris and S. avidinii 
incubated at 70 °C. The model curve was calculated for the average initial conditions for the three 
samples. The S. avidinii-curve shows slightly improved assay results for incubation times > 10 min, as 
is suggested by the biochemical model (Fig. S3). 
 
6. Validation of equation (5) for the correction of the calculated SAV concentration 
 
Equation (5) was validated by comparison of calculated data and expected concentrations 
according to Table S6. Two data sets were used for the calculations: The data set from the 
concentration variation leading to equation (5) and the data set from the supernatant 
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variation. The latter was not used for the calculation of equation (5) and therefore serves as 
an external control. 
Table S6 Comparison of SAV concentrations corrected according to equation (5) based on the 
deviation dcSAV of the theoretical SAV concentration cSAV,theo and the calculated corrected 
concentration cSAV,corr. The sample-row shows the origin of the sample, which was either part of the 
concentration variation experiment (c-var) or used for the supernatant-variation (sup-var; external 
validation). The organisms used for the production are abbreviated eco (Escherichia coli), ppa 
(Pichia pastoris) and str (Streptomyces avidinii). The concentrations refer to tetrameric SAV in the 
initial sample. 
Qblocked [-] cSAV,RT [nM] cSAV,HT [nM] cSAV,theo [nM] cSAV,corr [nM] dcSAV [nM] sample 
0.04 559 580 580 578 -2 c-var, eco 
0.57 247 518 580 576 -5  
0.98 11 482 580 573 -7  
0.11 451 505 505 516 11  
0.59 209 469 505 518 14  
0.96 21 436 505 505 0  
0.11 377 426 426 434 8  
0.61 166 404 426 437 11  
0.97 14 375 426 416 -10  
0.01 587 592 592 584 -8 sup-var, eco 
0.25 441 547 592 569 -23  
0.56 260 520 592 576 -16  
0.81 113 511 592 594 2  
0.98 13 484 592 576 -16  
0.00 592 593 593 584 -9 sup-var, ppa 
0.23 459 546 593 563 -30  
0.51 289 516 593 564 -29  
0.75 146 505 593 580 -14  
0.91 52 485 593 570 -24  
0.00 606 604 604 592 -12 sup-var, str 
0.22 473 557 604 573 -31  
0.49 310 529 604 576 -28  
0.77 139 505 604 581 -23  
0.95 30 486 604 575 -29  
 
7. Analysis of biotin and B4F stability during heat incubation 
 
In addition to the stability of SAV and B4F during heat incubation (see section 3.2) biotin has 
to provide similar properties. A 4.8 µM biotin solution in 50 mM NaH2PO4 (pH 7.5) was 
incubated at 70 °C for up to 30 min to analyze the heat stability of the vitamin. After 0, 2.5, 5, 
7.5, 10, 15, 20, 25 and 30 min, 500 µL of the vitamin solution were mixed with a culture 
supernatant containing 1.2 µM of tetrameric SAV. The following fluorescence measurements 
resulted in an unaltered binding of SAV for all of the samples (data not shown), indicating 
that biotin was not degraded. Due to the heat stability of the vitamin the ratio of biotin 
towards B4F and SAV can be assumed to be constant during the assay. 
To rule out the effect of heat-induced degradation of the detection marker B4F in the assay, 
1 mL of sample buffer was incubated at 70 °C for 5 min. The fluorescence emission signal at 
525 nm was 261±1 for a sample incubated at room temperature as opposed to a signal of 
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262±2 for the heat-incubated buffer. A loss of fluorescence on B4F in the relevant period of 
time can therefore be ruled out. Furthermore, a subsequent binding test with the heat-
incubated B4F-solution in the presence of SAV from a culture supernatant revealed that the 
quenching ability of B4F remained unaltered. 
 
8. Analysis of the stability of the SAV-B4F-complex 
 
In an additional experiment 20 µL of a 1.2 µM biotin solution were added at room 
temperature to a previously heat-incubated solution containing the usual 980 µL of 
measurement buffer and 20 µL of culture supernatant containing approximately 300 nM of 
tetrameric SAV. After vortexing, the sample was incubated at room temperature for 15 min. 
This did not lead to an increased fluorescence assay signal compared to a control sample to 
which water was added instead of biotin (data not shown). Additionally considering the 
results of section 3.4 (incubation at RT after the heat assay) the fluorescence signal in the 
presence of free biotin can be assumed to be stable in the relevant time interval. 
 
9. Impact of additional parameters on the outcome of the assay 
 
In the following section, two additional parameters are analyzed, which should be considered 
when working with the assay. 
Fluorescence signals were larger than the maximal fluorescence emission of the calibration 
curve in several cases, when measurements were performed on samples with a strong 
excess of biotin towards SAV binding sites, resulting in large concentrations of free biotin. 
Results acquired for these conditions should therefore be treated with care. During a typical 
fermentation course the SAV concentration surpasses the biotin concentration already early 
in the cultivation process. Hence, this problem usually disappears in the course of cultivation. 
In an additional variation, the impact of salt ions on the result of the assay was analyzed. 
Holmberg et al. observed a reduced elution efficiency of the SAV-biotin interaction for 
increasing salt concentrations in the eluent for an incubation at 70 °C for one second [23]. 
This extremely short incubation time was achieved by robot-assisted experiments, a 
mechanical separation of SAV-coated magnetic beads and by tempering the buffer solution 
to the corresponding temperature prior to the experiments. To analyze the influence of this 
factor a NaCl-free measurement buffer was tested in comparison to the unaltered buffer 
containing 100 mM of NaCl. This change resulted in a 3 % lower overall fluorescence 
emission and did not improve the proportion of detectable blocked binding sites. A partially 
biotin-saturated (Qblocked = 0.85), 580 nM tetrameric SAV sample allowed the detection of 
460±6 nM of SAV for the NaCl-free and 459±8 for the NaCl-supplemented measurement 
buffer for an incubation at 70 °C for 5 min. Thus, the elution mechanism does not seem to 
depend strongly on sodium and chloride ions at 70 °C for prolonged incubation times (5 min 
vs. 1 s). Since the sample is diluted 50fold by measurement buffer prior to the fluorescence 
analysis in the standard measurement procedure, the impact of the salt content of the 
sample can be assumed to be negligible for the assay result, allowing a broad range of 
cultivation media without altering the outcome of the assay. 
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10. Simulation of increased B4F concentrations and increased incubation time 
 
Two alternative strategies for the detection of biotin-blocked binding sites in concentrations 
> 300 nM were analyzed by simulation based on the biochemical model: doubling the B4F 
concentration in the assay buffer and increasing the incubation time at 70 °C. Results for 
these variations are shown in Fig. S3 A and B, respectively. 
 
Fig. S3 Simulation-based evaluation of methods for improved assay results. A Plot for a variation of 
the SAV concentration cSAV and the proportion of blocked binding sites Qblocked for a twofold 
concentrated B4F solution (100 instead of 50 nM). B Variation of the incubation time at 70 °C t70 °C at 
various SAV concentrations for Qblocked = 1.0. The black, dashed line represents the standard assay 
conditions of 10 min of incubation at 70 °C.. 
The variation of the concentration of B4F in the assay buffer (Fig. S3, A) suggests that an 
increased concentration of B4F should lead to similar results as a twofold dilution of the 
sample. Therefore, doubling the B4F concentration may be a suitable strategy for the 
detection of SAV in concentrations > 300 nM if the increased fluorescence intensity is below 
the maximal detectable fluorescence emission of the fluorimeter, which was the case in our 
experiments. The model suggests errors < 5 % for concentrations of SAV of 600 nM 
(tetrameric, corresponding to 48 nM of monomeric SAV in the plot) for degrees of biotin 
saturation Qblocked ≤ 0.7. 
The incubation time at 70 °C seems to be increasingly important for decreased SAV 
concentrations according to the biochemical model (Fig. S3, B). An expanded incubation 
time for low SAV concentrations and complete biotin saturation may result in slightly more 
adequate2 results according to the simulation. The time course acquired for the S. avidinii 
sample in the final kinetic validation step (Fig. S2) supports this hypothesis. 
 
11. Application of the assay to other biotin-binding proteins 
Based on the high temperature stability of avidin from chicken egg white [5] and its 
detectability by B4F quenching [16] an additional study was performed on partially and 
completely biotin-blocked samples of this protein (Sigma, Germany). Neither measurements 
                                                          
2
 improving the accuracy of the measurement by about 2.5 % for monomeric SAV concentrations of < 30 nM. 
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at 70 °C, nor at 84 °C resulted in a displacement of biotin by B4F (data not shown). This is 
likely to be an effect of the very different AA sequences of avidin and SAV, showing a 
sequence identity of only 32 % according to a BLAST analysis. However, the assay may be 
suitable for more homologous biotin-binding proteins. Among many others, a sequence 
homology search for the full length sequence of SAV (159 AA) revealed hypothetical proteins 
from S. violaceus, S. flavotricini, and S. lavendulae showing 99, 96 and 96 % of sequence 
identity3, respectively. Therefore, these proteins are suitable candidates for a further 
analysis. 
 
                                                          
3
 Sequence IDs: UniProtKB Q53532.1 (S. violaceus) and NCBI reference sequences WP_030030699.1 
(S. flavotricini) and WP_030744339.1 (S. lavendulae). 
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3.4 Potential applications for the assay
The assay herein described is not only a useful tool to evaluate the quality of SAV as a commercial
product in the end of a fermentation process.
When cultivating strains of biotin auxotrophic hosts like P. pastoris for the inducible production
of SAV, the assay may be used to determine the optimal point of time for induction to minimize
the residual concentration of free biotin after the growth phase and thus improve bioactivity of the
product. Vice versa, the method may be used to identify potential biotin-limiting eﬀects in the culture
accompanying SAV production, which should be detectable by increased proportions of biotin-free SAV
without the necessity of an additional method of measurement for the vitamin.
Optimizing the concentration of biotin in the medium to achieve maximal bioactivity without a
major impact on growth has been tested for the production of core SAV by P. pastoris (section 5.3,
p. 116ﬀ.).
For a better understanding of SAV-induced host toxicity, intracellular measurements of biotin-blocked
binding sites may prove beneﬁcial. This strategy could provide insight into the intracellular biotin de-
privation of the host, allowing the detection of potential bottlenecks for the secretion eﬃciency of
SAV. Corresponding measurements have been performed for the expression of the SAV gene by E. coli
(section 5.2, p. 93ﬀ.).
In addition to these applications, the assay has been used in a study on the recovery of biotin-blocked
binding sites of SAV, as discussed in the following section.
3.5 Recovery of biotin-blocked binding sites of SAV
The assay was applied for the evaluation of methods for the non-denaturing removal of biotin from
the binding pocket of SAV. In this context, it permits the detection the overall concentration (blocked
and free binding sites) of the protein in a sample, which - combined with the regular assay of Kada et al.
(1999a,b) - in turn allows quantiﬁcation of the degradation of biotin-blocked SAV. A short summary
of the corresponding experiments is given below.
3.5.1 Motivation
As only biotin-free binding sites of SAV are available for applications of the protein, methods for the
recovery of biotin-blocked binding sites of SAV are desirable. For this purpose, SAV can be denatured,
washed via diaﬁltration for the removal of biotin, and refolded, but this method is costly, cumbersome,
and leads to loss of product. Thus, methods for the non-denaturing removal of biotin were in the focus
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of interest.
Biotin is sensitive to oxidative stress and ultraviolet radiation.[3] Oxidative treatment leads to
oxidation at its probably most susceptible site, the sulfur atom of the head group of the vitamin, as
shown in Fig. 2.7 (p. 16). Oxidative degradation - as can be expected in the presence of hydrogen
peroxide - leads to biotin sulfoxide and biotin sulfone for the one- and twofold oxidation of the sulfur
atom, respectively.
The high stability of SAV towards various environmental factors (see section 2.2, p. 5) suggests that
SAV may be more resistant towards these factors than the vitamin. Thus, supernatants containing
biotin-blocked SAV were treated with UV radiation and/or hydrogen peroxide.
To partially dissociate the SAV-biotin-complex both methods were combined with incubation at
elevated temperatures (Holmberg et al., 2005). For the choice of incubation temperature and duration,
the thermal inactivation of SAV was simulated in Scilab based on the ﬁrst order kinetics and the
degradation parameters of Müller et al. (2015) (see Fig. 1 in the corresponding publication; section 3,
p. 28ﬀ.). The simulations led to the degradation curves shown in Fig. 3.3.
Fig. 3.3: Simulation of the heat-induced degradation of SAV depicted in the form of a
plot of the relative residual protein activity actres and active concentration of SAV
cSAV,res over the incubation time tinc. Simulation parameters: cSAV,0 = 1000 nM, kdeg,0
= 6.5395×1030 s−1, EA 229 kJmol−1, R = 8.314 Jmol−1K−1 (Müller et al., 2015).
[3]Product information sheet “Biotin in Cell Culture” by Sigma-Aldrich;
http://www.sigmaaldrich.com/life-science/cell-culture/learning-center/media-expert/biotin.html
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3.5.2 Brief summary of the results
Fig. 3.4 shows results of studies for the non-denaturing removal of biotin from the binding pocket of
SAV from S. avidinii by hydrogen peroxide treatment at 60 °C. A detailed description of the experimental
procedure is given in section 8.1.1 (p. 173) in the supplementary material.
The experimental results indicate that treatment of biotin-blocked SAV by hydrogen peroxide results
in a partial recovery of blocked binding sites. The eﬀect of hydrogen peroxide on the recovery of biotin-
blocked binding sites in the initial period of incubation was found to be concentration-dependent, as
shown in Fig. 8.2 (supplementary material, p. 180).
As shown in Fig. 8.4b (p. 182 in the supplements), treatment by UV radiation also resulted in
the recovery of blocked binding sites. On the one hand, UV treatment of SAV caused a decrease of
biological activity of the protein on the long term, while hydrogen peroxide seemed to bring about
only minor damage to SAV. On the other hand, UV radiation allowed an increase of biotin-free binding
sites of SAV at room temperature, whereas elevated temperatures were necessary for the hydrogen
peroxide-based degradation of biotin. This may be due to protective eﬀects of the binding pocket
towards elements of oxidative stress (see Fig. 2.1, p. 3), which in turn may be reduced or neutralized
by a partial dissociation of the SAV-biotin interaction (Holmberg et al., 2005). UV radiation, however,
may more easily target biotin located directly in the binding site.
Generally, both methods led to maximal proportions of recovered binding sites in the range of 30%
(Fig. 3.4a). This ﬁnal proportion was nearly independent of the incubation period and concentration of
H2O2. Moreover, a systematic variation of the degree of biotin saturation of a supernatant showed that
blocked binding sites were only recovered for completely biotin-saturated samples (data not shown).
If the degree of saturation was lower than 70%, no positive eﬀect of hydrogen peroxide was observed.
These results may indicate a 'biochemical inequality' of the binding sites of SAV due to potential
cooperative eﬀects between two or more binding sites of the tetrameric protein.
Several experiments focused on alternative approaches to destabilize SAV. However, incubation at
higher temperatures and pH values[4] did not bring about beneﬁcial properties. Using cycles of UV or
hydrogen peroxide treatment and incubation on ice did also not improve the results (data not shown).
The same applied for the recovery of binding sites by combining the physical and chemical degradation
of biotin via a combination of UV radiation and treatment by hydrogen peroxide, as shown in Fig. 8.4b
(supplements). Neither supplementation of the supernatant with the denaturing agent urea, nor the
addition of bovine serum albumin (BSA) (Fig. 3.4a) or UV-absorbing, aromatic amino acids (data not
shown) as protective agents towards the damaging eﬀects of the UV treatment increased the recovery
of binding sites.
However, as shown in Fig. 3.4b, the addition of BSA reduced damage on biotin-free binding sites for
[4]E.g., to deprotonate the carboxyl group of biotin.
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(a) Detection of free binding sites. (b) Degradation of SAV.
Fig. 3.4: Results of studies for the non-denaturing degradation of SAV-bound biotin by hydrogen peroxide
at 60 °C (n=3). An initial concentration of approx. 600 nM of biotin-saturated, tetrameric SAV was
used for the studies. (a) Measurement of biotin-free binding sites in the assay at room temperature.
(b) Results of measurements of the degradation of SAV. Labels for subfigure (a) indicate the concentration of
hydrogen peroxide and of additional agents. The labels for subfigure (b) show the degree of biotin saturation Qbl and
the concentration of hydrogen peroxide and supporting agents. Concentrations of the oxidizing agent are given in
% (w/w). Where indicated (HT), measurement of SAV was performed in the heat-based-assay (10min, 70 °C).
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samples with low proportions of blocked binding sites. Thus, this strategy may prevent the degradation
of recovered binding sites in future studies. Furthermore, supplementation of urea was found to speed
up the recovery of binding sites (Fig. 3.4a), but at the same time resulted in an increased degradation
of SAV (Fig. 3.4b).
Two main conclusions can be drawn from the results. Firstly, the studies show that a non-denaturing
recovery of biotin-blocked binding sites of SAV is possible. Similar observations were made for the
recovery of binding sites of immobilized SAV (see supplementary material, Fig. 8.3, p. 181). Secondly,
the experiments provide insight into the stability of SAV towards oxidation. Here, the ﬁndings indicate
that the binding of biotin does not only cause a higher thermotolerance of SAV (González et al., 1999),
but also improves the resistance of the binding pocket or the whole protein towards oxidizing agents
at elevated temperatures (see Fig. 3.4b).
If the degree of recovery can be increased, this procedure may lead to a method for the recycling of
free or immobilized SAV for future applications. Moreover, an eﬃcient method for the removal of SAV-
bound biotin would massively simplify handling of the toxic properties of the protein. In this context, it
would permit a non-denaturing recovery of biotin-blocked binding sites resulting from supplementation
of cultivation media by an excess of biotin after fermentation. Potential strategies to achieve this goal
may, e.g., include the application of an optical bandpass ﬁlter for the absorption wavelength of biotin,
which may protect SAV while at the same time allowing a more targeted, UV-based degradation of
biotin.
Jakob M. Müller 59
4 Production of SAV by Streptomyces
avidinii
The following chapter sums up studies performed for the production of SAV by the native producer
S. avidinii.
4.1 Motivation
To this date, S. avidinii, the native producer of SAV, has not been studied in a detailed manner.
Therefore, the kinetic of product formation by the host in varying production media, cultivation condi-
tions, and modes of operation is characterized either poorly or not at all. This lack of knowledge limits
the ﬁnal product concentration in current production processes. Furthermore, insuﬃcient characteri-
zation of the complex morphology of the ﬁlamentous bacterium poses problems to its cultivation.
4.1.1 Goals of this study
Hence, the primary goal of this study was to establish methods for a reproducible cultivation of
S. avidinii yielding high concentrations of SAV. In literature, processes are commonly performed batch-
wise in shake ﬂasks (Cazin Jr. et al., 1988; Kolomiets & Zdor, 1998). Thus, the development of fed-
batch processes in the bioreactor seemed highly promising for an improved production. Morphological
aspects were less important in bioreactor cultivations due to stronger shearing of the mycelia by the
stirrer and were therefore only analyzed in side projects in smaller scales (see section 4.4, p. 80ﬀ.).
4.2 Manuscript
The results of fed-batch development were published in a research article in the Journal of Biotech-
nology (Müller et al., 2013) (with permission from Elsevier, Copyright 2013), as shown on the following
pages. The studies also focused on the eﬀect of power input on SAV production. However, theoretical
calculations (see section 4.3, p. 71) indicated that the original results for this parameter were inaccu-
rate due to an insuﬃcient experimental design. Thus, a Corrigendum for the article was submitted for
publication in 2016 (with permission from Elsevier, Copyright 2016), containing corrected values for
this parameter (Müller et al., 2016b). The Corrigendum was based on considerations and calculations
described in section 4.3 (pp. 71ﬀ.).
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a  b  s  t  r  a  c  t
Streptavidin  is  a  tetrameric  protein  with  an  extremely  high  afﬁnity  to  biotin  and  different  biotin-like
peptide-tags.  This  characteristic  causes  its  widespread  use  in  biotechnology.  Streptavidin  is  produced
by  the  fermentation  of  wild  type  Streptomyces  avidinii  or  by recombinant  Streptomyces  lavendulae,
Escherichia  coli,  and Bacillus  subtilis  strains.  However,  little  is  known  about  the inﬂuence  of power  input
and  oxygen  supply  as  well  as  feeding  strategies  on  the  production  of  streptavidin  by  S.  avidinii.  This paper
provides  a systematic  analysis  of  the  effect  of  rotary  frequency  of  the  stirrer,  leading  to  a  plateau-like
streptavidin  formation  behaviour  between  400  and  700  min−1. This  plateau  was  characterized  by  speciﬁc
power  inputs  between  79  and  107  W  L−1 and  corresponding  maximal  product  concentrations  of  6.90  M
in  6  days.  Lower  as  well  as  higher  rotary  frequencies  were  not  beneﬁcial.  Subsequently,  a linear  fed-batch
procedure  could  be established  reproducibly  yielding  39.20  M streptavidin  in  14  days,  characterized  by
a constant  productivity  of 114  nM  h−1.  Fed-batch  procedures  based  on  dissolved  oxygen  were less  efﬁ-
cient.  The  linear  feeding  strategy  presented  in  this  paper  led  to  the  highest  streptavidin  concentration
ever  reported  and  exceeded  the  maximal  product  level  given  in  the  literature  drastically  by  a  factor
of  8.5.
© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Streptavidin (SAV) was found in 1963 in the culture super-
natants of Streptomyces avidinii and Streptomyces lavendulae (Chaiet
and Wolf, 1964; Stapley et al., 1963). Like avidin from chicken
egg white, SAV binds biotin with a dissociation constant (Kd) of
up to 10−15 M.  Each subunit of the tetrameric protein can bind
one molecule of biotin. In contrast to avidin, SAV is not glycosy-
lated and has an isoelectrical point near neutral pH (about 6.1).
After cleavage of the signal peptide native SAV has a molecular
mass of 65962.8 Da (4 times 16490.7 Da) and consists of four chains
of 159 amino acids. Depending on the degree of proteolysis dif-
ferent molecular species can be found with the lowest molecular
mass at 50.4 kDa (Bayer et al., 1989; Sano et al., 1995). The diges-
tion down to a so-called “core streptavidin” consisting of 118 to
127 amino acids per subunit does not affect the binding proper-
ties to biotin or the isoelectric point of the protein, but leads to an
increased solubility (Kopetzki et al., 1996; Pähler et al., 1987; Sano
et al., 1995). In contrast to native SAV, core streptavidin interacts
with the carboxyl carrier protein, which can reduce its number of
Abbreviation: SAV, streptavidin.
∗ Corresponding author.
E-mail address: jrisse@uni-bielefeld.de (J.M. Risse).
available biotin-binding sites (Wang et al., 2005). Core streptavidin
is commercially available in different molecular masses (Bayer
et al., 1989). The monomers re-assemble autonomously even under
slightly denaturing conditions (Warner et al., 2004). By changing
amino acid residues, monomeric forms of SAV were constructed.
These monomers showed signiﬁcantly reduced binding constants
(Howarth et al., 2006; Qureshi and Wong, 2002; Wu  and Wong,
2005, 2006).
SAV is used for the detection, localization, quantiﬁcation, and
isolation of various macromolecules like DNA and proteins. For
this purpose biotin or SAV itself are bound to the molecule of
interest. The application of SAV was  enhanced by the identiﬁca-
tion of several short peptide sequences with high afﬁnity to the
tetrameric protein. Strep-tag I®, Strep-tag II®, and Nano-tag are
catchwords in this ﬁeld of interest (Dumelin et al., 2006; Lamla
and Erdmann, 2004; Skerra, 2003; Skerra and Schmidt, 1999).
Molecules tagged with these peptides can be separated by SAV,
which is immobilized on resins like agarose. Depending on the
peptide sequence and length, dissociation constants of up to 4 nM
are described. In the widespread Strep-tag II® technology a dis-
sociation constant of about 1 M is reported, although a SAV
variant called streptactin is used, which had been modiﬁed in
position 44–47 (Schlapschy and Skerra, 2010; Skerra, 2003). In
comparison to the often-used His6-tag technology the associa-
tion constant (Ka) in Strep-tag II® technology is about three times
0168-1656/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.jbiotec.2012.10.021
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higher (Dorn et al., 1998; IBA GmbH, 2003). The construction of
proteins both fused with a His6- and a Strep-tag, resulting in so-
called “double-tagged” proteins, is a popular technique to yield
proteins of extremely high purity in order to investigate their
properties, e.g. for the analysis of unknown open reading frames
(IBA GmbH, 2003).
1.1. Survey on the production of streptavidin
Although SAV is of great use in biology, medical science, and
biotechnology only little has been published about its production
by microorganisms. Cultivations are mostly performed in shake
ﬂasks (Cazin et al., 1988; Meade and Jeffrey, 1986; Stapley et al.,
1963; Thompson and Weber, 1993; Wu and Wong, 2002, 2006).
No data are available on the inﬂuence of shear stress and oxygen
supply on SAV formation. Furthermore, techniques like fed-batch
fermentation are not discussed in the literature. Besides the native
producers S. avidinii and S. lavendulae three recombinant microor-
ganisms are mentioned for the production of SAV: S. lividans,
Bacillus subtilis,  and Escherichia coli.  While Gram-positive bacteria
are able to secrete the product into the medium, SAV remains in
the cyto- or periplasmatic space, when produced in E. coli (Gallizia
et al., 1998; Sano and Cantor, 1990; Wu  and Wong, 2006; Veiko
et al., 1999).
Media optimization led to maximal SAV concentrations of up
to 170 mg  L−1 by the cultivation of wild type S. avidinii (Kolomiets
et al., 1998). As shown in Table 1 a maximal productivity of approx-
imately 82 nM h−1 can be calculated from the data given in the
literature assuming a molecular mass of the product of 54 kDa
derived from their SDS-PAGE analysis. A maximal concentration of
up to 250 mg  L−1 was reported for the cultivation of a recombinant
S. lividans strain (Meade and Jeffrey, 1986). So far, no higher con-
centration during cultivation has been observed. However, details
about the productivity of this process were not speciﬁed.
By using a recombinant B. subtilis for the production of SAV Wu
et al. (2002) reached a maximal productivity up to 109 nM h−1,
but the SAV concentration was limited to 94 mg  L−1 (Wu et al.,
2002). The maximal molar concentrations of SAV during E. coli
cultivations were similar to the ones obtained with B. subtilis,  but
productivities were much higher. Productivities up to 340 nM h−1
have been described in the literature (see Table 1). Although the
productivities for E. coli refer to the time of induction, the values
for the whole process were minored only insigniﬁcantly, because
the induction was applied already at low cell densities, i.e. an
OD600 of about 1 (Gallizia et al., 1998; Sano and Cantor, 1990;
Wu and Wong, 2006). Intracellular accumulation of SAV produced
by Gram-negative recombinant microorganisms in some cases has
been associated with the formation of inclusion bodies. In order
to express high levels of SAV in E. coli a synthetic core strepta-
vidin with optimized codon usage was  constructed (Thompson and
Weber, 1993). Although the expression level was ten-fold higher
in comparison to the corresponding native gene, the maximal
concentration was only 3 mg  L−1. In order to overcome these draw-
backs an E. coli strain with a bacteriocine release protein-mediated
secretion of SAV into the medium was  constructed by Miksch
et al. (2008).  They observed a maximal SAV concentration up
to 2.12 M.
1.2. Goals and experimental setup
The primary goal of our research is the development of a fed-
batch strategy for the production of streptavidin by the natural
producer S. avidinii.  For a rational process design this strategy is
developed on the basis of studies on shear stress resistance and
oxygen demand of the organism. This is realized by a systematic
variation of the rotary frequency of the stirrer. Along with results
of shake ﬂask based medium optimization efforts we want to obtain
a long-term stable and highly productive process.
2. Material and methods
2.1. Strain
S. avidinii (DSMZ 40526; CBS 730.72) was  ordered from CBS
(Centraalbureau voor Schimmelcultures, Utrecht, Netherlands)
and DSMZ (Deutsche Sammlung von Mikroorganismen und Zell-
kulturen GmbH, Braunschweig, Germany). In order to avoid a
non-producing fraction of cells a selection of producer cells was
performed by picking colonies from HM agar plates (4.0 g L−1 yeast
extract, 10.0 g L−1 malt extract, 4.4 g L−1 d-glucose monohydrate,
pH 7.2) for which 15 g L−1 agar were used for solidiﬁcation. Each
colony was used for the inoculation of 30 mL  M3  medium (0.7 g L−1
yeast extract, 1.3 g L−1 casein hydrolysate, 10.0 g L−1 soy peptone,
10.0 g L−1 d-glucose monohydrate, 6.0 g L−1 NaCl, pH 7.0) in 300 mL
bafﬂed shake ﬂasks. Cultivation conditions are described in Section
2.3.  The best performing culture determined by SAV measurement
(see Section 2.4) was used for strain maintenance.
2.2. Strain maintenance
Strain maintenance was based on cultures of S. avidinii incu-
bated for 48 h in M3  medium followed by the addition of glycerol
Table 1
Microorganisms reported for the production of streptavidin (SAV). The molecular mass of the tetramer M is given more or less accurately by the literature. The maximal
productivities are estimated from literature data. cSAV,max: maximal SAV concentration, pmax: maximal productivity, and n.sp.: not speciﬁed.
Organism cSAV,max [mg  L−1] M [kDa] cSAV,max [M] pmax [nM h−1] Reference
S. avidinii 53 72 0.74 10.3 Aldwin et al. (1990)
S.  avidinii 145 70 2.07 10.4 (8.6 c) Cazin et al. (1988) and Suter et al. (1988)
S.  avidinii 170 58 d 2.93d 82.0 d(48.0 c, d) Kolomiets et al. (1998)
S.  lavendulae 201 n.sp. n.sp. n.sp. Zhang et al. (2007)
S.  lividans a 250 54 d 4.63 d n.sp. Meade and Jeffrey (1986)
B.  subtilis a 50 66.0 d (80 d) 0.76 d (0.63 d) 37.0 d (31.5 d) Wu and Wong (2002)
B.  subtilis a 94 66.0 d (80 d) 1.42 d (1.18 d) 109.2 d (90.8 d) Wu et al. (2002)
E.  coli a 65 64 1.02 340.0 b Sano and Cantor (1990)
E.  coli a 70 65.7 1.07 267.5 b Gallizia et al. (1998)
E.  coli a 70 16.6 e 1.05 843.0 b, e Wu and Wong (2006)
E.  coli a 127 60 d 2.12 265.0 Miksch et al. (2008)
a Recombinant microorganism.
b Productivity after induction by IPTG.
c Productivity referring to the maximal SAV concentration.
d M not clearly given.
e Monomeric SAV
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to a ﬁnal concentration of 13% (v/v), aliquotation in volumes of 1 mL,
shock-freezing and ﬁnally storage at −80 ◦C.
2.3. Cultivation
S. avidinii was cultivated in 100 mL  M3  medium in a 1 L baf-
ﬂed shake ﬂask inoculated with 1 mL  of a freshly thawed glycerol
stock. Cultivation was performed on a rotary shaker at a frequency
of 150 min−1, an amplitude of 2.5 cm,  and at 28 ◦C.
Fermentation experiments were carried out in a LAB bioreac-
tor (MBR, Wetzikon, Switzerland) with a total volume of 7 L and
a working volume of 5 L. The diameters of the fermenter and the
stirrer were 150 and 70 mm,  respectively. The bioreactor fulﬁlled
the criteria of the DECHEMA reference stirred tank reactor (Rehm,
1982), except from the stirrer installation. Instead of three six-
bladed Rushton turbines only two were used, which were placed in
a distance of 125 mm and 250 mm from the bottom, respectively.
Power input to the stirrer was achieved by magnetic coupling. The
bioreactor was  inoculated with 250 mL  of a 48 h old shake ﬂask cul-
ture in order to obtain comparable inoculation cell densities. For the
preparatory and main cultivation M3 medium was  used, however
the d-glucose monohydrate supplement for the bioreactor cultiva-
tion was increased to 30 g L−1. For shake ﬂask and fed-batch studies
medium variations were used as described in Table 3. For the lat-
ter a 400 g L−1 d-glucose monohydrate feed solution in two-fold
demineralized water was applied. Fermentations were controlled
at pH 7 by the automatic addition of 2 M NaOH and 20% (v/v)
H3PO4. The air ﬂow rate was set to 5 NL min−1. Antifoam (PE 8100,
BASF, Germany) was added automatically when required. For the
batch-studies the dissolved oxygen concentration was not actively
controlled. All cultivations were performed at a constant over-
pressure of 0.5 bar and 30 ◦C. For the fed-batch studies the rotary
frequency of the stirrer was set to 350 min−1.
Volumetric oxygen transfer coefﬁcients kLa were determined
in water for different rotary frequencies. Therefore, the values
were not the exact kLa values for the crude fermentation broth,
but relative values to compare the fermentations among each
other. Furthermore, they only represent the oxygen transfer in
the beginning of the fermentation, because the mycelial growth
of streptomycetes can be expected to reduce the transfer rate in
the cultivation course due to the increasing viscosity of the culture
broth (Járai et al., 1969).
For determination of the power input by the two Rushton
impellers into the bioreactor the motor current was  measured
by a system from Trainings Systeme, which was  composed of
a power quality analyzer (40 302) and an energy measuring
adapter (40 303). The motor efﬁciency was estimated to be 90%
(Wolf, 2000).
2.4. Analysis
Measurement of the SAV concentration was performed by ﬂuo-
rescence quenching as described by Kada et al. (1999a, 1999b).  An
assay mixture with a volume of 980 L containing 50 nM biotin-4-
ﬂuorescein (Sigma–Aldrich), 0.1 g L−1 bovine serum albumin (BSA),
100 mM NaCl, 1 mM  EDTA, and 50 mM NaH2PO4 (pH 7.5) was ﬁlled
in 1 mL  polypropylene assay tubes. Precoating of the tubes with BSA
was omitted, since it had no inﬂuence on the results when BSA was
added to the assay mixture instead. A sample volume of 20 L was
added to the assay mixture. After 2 s of vortexing and incubation
for 30 min  at 25 ◦C the samples were transferred into disposable
plastic cuvettes and ﬂuorescence was determined at 495 nm (exci-
tation)/525 nm (emission) by a ﬂuorimeter (Shimadzu RF-5301 PC).
For the determination of streptavidin in culture supernatants sam-
ples were diluted to a ﬁnal concentration of 0–600 nM (tetrameric
form). For quantiﬁcation a calibration curve was  generated using
different biotin-4-ﬂuorescein concentrations.
Because of its mycelial growth the determination of dry S. avi-
dinii biomass was performed by suction ﬁltration (paper ﬁlter,
∅110 mm MACHEREY-NAGEL MN  615) of 10 mL culture washed
once with 10 mL  tap water. After drying the ﬁlter at 50 ◦C to
constancy of weight, the dry mass was measured by differential
weighing. Microscopic analysis (10 L of sample, 200-fold mag-
niﬁcation) of the culture broth was  performed every 24 h to rule
out the effect of contaminations and, infrequently, of the ﬁltration
permeate to track mycelial fragmentation.
Glucose concentration was quantiﬁed utilizing ion-exchange
HPLC, which was  equipped with a Marathon Basic autosampler
(Spark Holland) and an Irica 871 pump. A Nucleogel Ion 300OA
(300 mm × 7.8 mm)  column (MACHEREY-NAGEL) was used. The
running buffer was  composed of 2.5 mM sulphuric acid. The sam-
ple tray of the autosampler was  tempered to 4 ◦C. Each sample
was diluted ﬁve-fold with two-fold demineralized water and after-
wards mixed with an equal volume of running buffer. d-Glucose
monohydrate solutions of 0.5, 5 and 10 g L−1, respectively, diluted
with an equal amount of running buffer, were used as references.
All samples and standards, each consisting of 1 mL  volume, were
ﬁnally supplemented with 5 L of 4 mM sodium azide in order
to inhibit microbial growth. These samples were injected on the
column with a volume of 20 L, followed by isocratic elution at a
constant ﬂow rate of 0.5 mL  min−1. The column was  tempered to
70 ◦C. An RI detector (Irica ERC-7515 A, Erma CR. Inc.) was used for
quantiﬁcation.
3. Results and discussion
Medium optimization for the batch production of SAV by S. avi-
dinii was already described by Kolomiets et al. (1998).  Therefore,
we initially focused on the optimization of bioprocess engineering
by the systematic variation of the rotary frequency of the stirrer in
the bioreactor. In order to identify an adequate basic medium com-
position for a fed-batch procedure shake ﬂask cultivations were
performed. The most promising medium variations were used for
further batch experiments in the bioreactor. Finally, the combined
results were integrated in the rational development of a fed-batch
strategy.
3.1. Selection of streptavidin producing S. avidinii cells
Genetic instability is widespread within the mycelial growing
genus Streptomyces (Birch et al., 1991). So, most of the analyzed
S. avidinii cells obtained from DSMZ and CBS lost their ability to
produce SAV. After the selection of SAV producing cells from CBS a
glycerol stock was  prepared.
3.2. Impact of rotary frequency on streptavidin production
The impact of shear stress on SAV production was analyzed in
the MBR-bioreactor. Corresponding results of measurements of the
oxygen transfer coefﬁcients and power inputs are shown in Table 2.
Cultivation of S. avidinii in M3  medium with an initial d-glucose
monohydrate concentration of 30 g L−1 each under the rotary fre-
quencies given in Table 2 led to the data set presented in Fig. 1.
Rotary frequencies of the stirrer below 400 min−1 resulted in
relatively low maximal streptavidin concentrations. This was  most
likely due to insufﬁciently low oxygen transfer rates indicated by
drops in the relative dissolved oxygen saturation curves and low
kLa-values as shown in Table 2. Very high frequencies between 1100
and 1500 min−1 seem to have a negative impact on SAV formation.
In this context the increased mycelial fragmentation observed by
microscopic analysis could be relevant.
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Table  2
Measured values for speciﬁc power input Lspec and volumetric oxygen transfer coef-
ﬁcient kLa for different rotary frequencies of the stirrer n. All measurements were
performed using the following conditions: 1.5 bar static pressure, 30 ◦C and an air
ﬂow rate of 5 NL min−1 in 5 L of demineralized water.
n [min−1] Lspec [W L−1] kLa [h−1]
200 54.8 18.6
300 67.5 39.9
350 72.7 55.5 (66.2 a)
400 79.1 75.6
500 88.1 90.4
700 106.6 95.0
900 119.7 109.5
1100 143.4 133.3
1300 161.1 161.9
1500 177.6 181.3
a For an air ﬂow rate of 10 NL min−1
A product formation plateau between 400 and 700 min−1, cor-
responding to a speciﬁc power input between 79 and 107 W L−1,
respectively, was observed, characterized by maximal SAV con-
centrations of 6.93 ± 0.07 M.  Applying a frequency of 900 min−1,
which corresponds to 120 W L−1, already resulted in a slight
decrease of the maximum product concentration to 6.58 M.
This suggests that on the one hand an increase of oxygen sup-
ply improves SAV formation whereas on the other hand mycelial
fragmentation induced by high shear stress affects this process.
Exemplarily, Fig. 2 shows the fermentation at a rotary frequency
of 700 min−1.
The course of the mycelial dry mass was representative for all
fermentations with rotary frequencies above 350 min−1. After a
strong increase in the beginning of the cultivation it reached its
climax after two days. Afterwards a nearly instantaneous concen-
tration decline could be observed. Similar observations were made
by Torres-Bacete et al. (2005) for the cultivation of S. lavendu-
lae in shake ﬂasks. To show that this concentration decline was
not an effect of biomass degradation we determined the over-
all cell dry mass concentration by centrifugation in order to take
into account small mycelial fragments as well. The latter did not
show a signiﬁcant decrease after correlating with the mycelial
dry mass concentration during the ﬁrst two days of cultivation.
Table 3
Results of the shake ﬂask medium optimization. 300 mL  bafﬂed shake ﬂasks (degree
of  ﬁlling: 10%) were used on a rotary shaker with an eccentricity of 2.5 cm and a fre-
quency of 150 min−1. All experiments were carried out for 144 h in three biological
replica, applying a d-glucose monohydrate concentration of 10 g L−1. Abbreviations:
cSAV,max: maximal streptavidin concentration; Xmax: maximal mycelial dry mass con-
centration; pmax: productivity until cSAV,max; process selectivity SSAV/X: cSAV,max Xmax−1 .
The media used are abbreviated with M3  (standard M3  medium); SP3 (M3  medium
with three times the amount of soy peptone); CH3 (M3 medium with three times
the  amount of casein hydrolysate and yeast extract) and 2 N/0.5 N (M3  medium with
twice/half the amount of soy peptone; casein hydrolysate and yeast extract).
Label cSAV,max [M] Xmax [g L−1] pmax [nM h−1] SSAV/X [nmol g−1]
M3 1.77 ± 0.09 5.0 ± 0.2 12.3 ± 0.6 354
SP3  1.71 ± 0.40 7.4 ± 0.0 11.9 ± 2.8 231
CH3  1.14 ± 0.07 5.8 ± 0.2 7.9 ± 0.5 195
2  N 3.37 ± 0.78 4.9 ± 0.3 23.4 ± 5.4 693
0.5  N 0.68 ± 0.22 3.0 ± 0.1 4.7 ± 1.5 226
Moreover, short mycelial fragments in the permeate of suction ﬁl-
tration were detected after the initial growth period, suggesting
that the mycelium is rather fragmented than completely degraded.
This effect was apparently correlated with the limitation of glu-
cose after 56 h of cultivation as shown in Fig. 2. Glucose limitation
and mycelial fragmentation, however, did not seem to affect the
accumulation of streptavidin in the fermentation supernatant, the
rate of which remained approximately linear in the evaluated time
period for all rotary frequencies. The observed productivities from
cultivation start to the maximal SAV concentration cSAV,max were
very similar to those reported by Kolomiets et al. (1998).
3.3. Shake ﬂask cultivation of S. avidinii
After the optimization of bioprocess engineering, medium
variation was carried out to further improve the maximal SAV con-
centration. These experiments were performed in 300 mL  bafﬂed
glass shake ﬂasks (Schott Duran). The results are shown in Table 3.
As was  already observed in the bioreactor batch experiments
(see Table 2), the data show no direct correlation between biomass
and SAV formation.
Neither higher eccentricities with corresponding higher oxygen
transfer rates, nor an increase in glucose content of the medium
Fig. 1. Productivity p (referring to cSAV,max), maximal mycelial dry mass Xmax , and maximal SAV concentration cSAV,max of fermentations of S. avidinii at different rotary
frequencies of the stirrer in a period of 6 days on M3  medium supplied with 30 g L−1 of d-glucose monohydrate at 30 ◦C, pH 7, 1.5 bar static pressure and at an air ﬂow rate
of  5 NL min−1.
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Fig. 2. Batch fermentation with a constant rotary frequency of the stirrer of 700 min−1, 30 ◦C, pH 7, 1,5 bar static pressure and an air ﬂow rate of 5 NL min−1 on M3 medium
with  30 g L−1 of d-glucose monohydrate.
resulted in higher productivities or improved maximal product
concentrations (data not shown). Moreover, decreasing the level of
nitrogen-containing compounds in the medium (0.5 N-variation)
was tested, assuming an improved oxygen supply for the cells rel-
ative to the lower mycelial concentrations. However, this did not
lead to a better performance.
The 2N-variation of the M3 medium seemed to be suitable for
a higher productivity, selectivity (SSAV/X; ratio of maximal product
concentration and maximal mycelial dry mass concentration), and
product concentration, whereas the SP3-variation yielded a high
mycelial dry mass concentration, suggesting its use in pre-cultures
for fermentations. Therefore, both of these variations were used for
subsequent fed-batch studies.
3.4. Fed-batch production of streptavidin
Two approaches for the fed-batch production of SAV were eval-
uated: A feed strategy dependent on the relative dissolved oxygen
signal, characterized by the initiation of feeding above a relative
dissolved oxygen saturation of 60%, and a linear feed proﬁle with a
constant glucose mass ﬂow into the fermentation vessel.
Based on the shake ﬂask experiments (see Section 3.3) and the
glucose-limitation occurring in all batch processes after approxi-
mately two days, conditions were selected as follows: 2 N and SP3
medium were chosen as basic media, whereas 1 L of a 400 g L−1
d-glucose monohydrate solution in two-fold demineralized water
was used as feed solution. To prevent mycelial fragmentation and
to ensure the long-term stability necessary for fed-batch processes,
the rotary frequency of the stirrer was chosen as low as 350 min−1.
All other default values like pH, temperature, and the initial ﬁlling
volume of 5 L were carried over from the rotary frequency variation
experiments (see Section 3.2).
First fed-batch fermentations were controlled by an on-off sys-
tem using the dissolved oxygen signal to initiate the glucose feed.
An exemplary process (see Table 4, FB 2 N, 60% #1) with a feed ini-
tiation above a setpoint of 60% is shown in Fig. 3. Glucose mass ﬂow
into the vessel began after 38 h and amounted to 2.3 g h−1 on aver-
age during the whole feed phase. For this process a maximal SAV
concentration of 12.70 M after 216 h was observed.
The oxygen-controlled processes were characterized by linear
glucose feed proﬁles and SAV concentrations above the values
reached for batch fermentation, as shown in Table 4. However,
towards the end of cultivation the oxygen concentration exceeded
the setpoint permanently, supposedly due to a reduced metabolic
activity of the cells and a corresponding decreased oxygen demand.
This resulted in a feed of the entire remaining feed solution accom-
panied by an unregulated increase in glucose concentration (see
Fig. 3 after 120 h). In order not to intensify this problem higher air
ﬂow rates were not applied, although the variation experiments
on the rotary frequency of the stirrer suggested that higher oxy-
gen transfer rates are beneﬁcial for the productivity. Raising the
setpoint to 70% did prevent uncontrolled feeding, but lowered the
maximal SAV concentration to 9.04 M after 232 h (see Table 4,
FB 2 N, 70%). As a consequence of these results the feed proﬁles
observed in the oxygen-controlled fermentations were used to
develop a linear fed-batch process. In detail the average glucose
ﬂow rate in the feed interval of the oxygen-controlled processes
was used to estimate the glucose demand of the culture. In the case
of Fig. 3, for example, this demand was calculated in the interval
between the initiation of feeding and the permanent transgression
of the oxygen setpoint. An exemplary fermentation course apply-
ing this strategy is shown in Fig. 4. Here, the linear feed proﬁle
permitted to set the air ﬂow rate to 2 vvm (10 NL min−1). A max-
imal product concentration of 40.41 M was reached after 336 h
(see Table 4, FB 2 N, lin #2).
As can be concluded from Fig. 4 the linear feed strategy as well
as the improved oxygen supply by a doubled air ﬂow rate resulted
in higher product concentrations as well as productivities than the
comparable processes with oxygen-controlled feed. SAV accumula-
tion remained linear even after 300 h of cultivation time, suggesting
a sufﬁciently high genetic stability of the organism and low or no
product inhibition. Table 4 shows a summary of all fed-batch as well
as several reference batch processes. In contrast to the 2 N medium
the M3  and SP3 medium generated less promising results.
The change of strategy from an oxygen-controlled to a linear
feed proﬁle along with the increased oxygen supply provided the
basis for the reproducible accumulation of 19.25 ± 0.86 M (n = 3;
FB 2 N, lin#1-3) SAV in 7 days. Compared to the 11.43 ± 1.27 M
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Table  4
Overview on all fed-batch processes. If not declared otherwise, air ﬂow was  set to 5 NL min−1. 2 N, M3  and SP3 symbolize the basic medium composition as described in Table 3
The  percentages indicate the relative dissolved oxygen saturation-setpoint for the oxygen-controlled fed-batch processes. The linear processes are entitled “lin”. Reference
batch  processes are labelled “B”, fed-batches “FB”. For all fed-batches 1 L of a 400 g L−1 d-glucose monohydrate feed solution was  used. Further abbreviations: cSAV,max:
maximal SAV concentration, tmax: cultivation time when reaching cSAV,max , tfeed: cultivation time when feed was initiated, Xmax: maximal mycelial dry mass concentration
pmax: productivity until cSAV,max , process selectivity SSAV/X: cSAV,max Xmax−1 , pfeed: average productivity in feed phase, m˙Glc: glucose mass ﬂow rate into the vessel during
feed  phase.
Label cSAV,max [M] tmax (tfeed) [h] Xmax [g L−1] pmax [nM h−1] SSAV/X [nmol g−1] pfeed [nM h−1] m˙Glc [g h−1]
B M3 5.57 136 (–) 8.2 41.0 679 – –
B  2 N 4.40 128 (–) 9.6 34.4 458 – –
B  SP3 3.12 88 a (–) 9.4 35.4 333 – –
FB  2 N, 60% #1 12.70 216 (34) 16.1 58.8 788 63.6 2.7
FB  2 N, 60% #2 10.15 184 (70) 16.0 55.2 634 80.2 2.0
FB  2 N, 60% #3 11.44 144 (38) 10.8 79.4 1062 54.9 2.3
FB  2 N, 70% 9.04 232 (52) 14.1 38.9 641 22.2 2.8
FB  M3, 60% 6.04 128 (50) 6.7 47.1 897 16.2 1.6
FB  SP3, 60% 6.99 152 (57) 15.1 46.0 464 34.9 1.1
FB  2 N, lin #1 b 18.54 184 (49) 19.8 100.8 936 100.1 1.8
FB  2 N, lin #2 b 40.41 336 (48) 23.8 120.3 1698 123.2 1.7
FB  2 N, lin #3 b 38.00 336 (37) 25.2 113.8 1507 101.5 1.7
a The streptavidin concentration showed a logarithmic course and didn’t increase after this time period until the process was  aborted after 168 h.
b Air ﬂow rate: 10 NL min−1.
(n = 3) obtained on average in 8 days for the processes with a feed
based on the oxygen signal (see Table 4, FB 2 N, 60% #1-3), the maxi-
mal  product concentration was increased by the factor 1.7. After 14
days of cultivation the concentration of SAV even reached 39.20 M
(n = 2) for the linear feed processes (see Table 4, FB 2 N, lin #2 and
#3). The characteristic mean productivity of 64 nM h−1 (n = 3) in the
oxygen-controlled processes was improved by a factor of 1.8, cor-
responding to 114 nM h−1 (n = 3). Furthermore, the new strategy
showed a more favourable process selectivity. Although the selec-
tivities of the single processes varied signiﬁcantly, the observed
overall tendency to a higher product to mycelial dry mass-ratio for
the linear feed proﬁles is beneﬁcial. Unlike for many other biotech-
nological processes the results reveal no indication for a strong
positive correlation between biomass and product formation as
shown in Table 3 and Table 4. The maximal mycelial dry mass
concentration for the linear processes was increased compared
to the oxygen-controlled processes. However, this was partially
due to the longer cultivation time for the former. By using the
feed data from the oxygen-controlled processes to develop a linear
feed proﬁle, the use of which allowed decoupling of the improved
oxygen input achieved through the doubled air ﬂow rate and glu-
cose feed. This permits an independent adjustment of these process
variables, which is very challenging for oxygen-controlled pro-
cesses. In case of a suboptimal choice of feed control parameters in
oxygen-controlled processes a strong oxygen signal ﬂuctuation can
occur, whereas linear feed strategies have the potential of providing
a more stable environment for the cells.
The reference processes for the fed-batch experiments show
that neither simple modiﬁcation of the basic medium nor the
implementation of the glucose feed solution alone are sufﬁcient
for a strong increase in productivity, but only the combination of
both leads to high product yields. This suggests that the inferior
product formation in the rotary frequency batch experiments was
caused by insufﬁcient carbon as well as nitrogen supply.
To sum up the process which led to the development of the
linear fed-batch strategy, ﬁve main aspects have to be considered:
Fig. 3. Fed-batch cultivation with an oxygen-controlled feed of a 400 g L−1 d-glucose monohydrate solution on 2 N medium supplemented with 30 g L−1 d-glucose monohy-
drate  above a feed-setpoint of 60% relative dissolved oxygen saturation and an air ﬂow rate of 5 NL min−1.
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Fig. 4. Fed-batch fermentation of S. avidinii based on a linear feed of a 400 g L−1 d-glucose monohydrate concentrate on 2 N medium supplemented with 30 g L−1 d-glucose
monohydrate. The air ﬂow rate was set to 10 NL min−1. Glucose mass ﬂow into the vessel was initiated after 48 h and amounted to a feed rate of 1.7 g h−1 on average.
1) The observation of glucose limitation accompanied by mycelial
instability at rotary frequencies above 350 min−1 resulted in
the decision to use a glucose concentrate as feed solution. 2)
Mycelial fragmentation was determined to be a main drawback at
high rotary frequencies of the stirrer. Hence, a low frequency of
350 min−1 was chosen in order to guarantee long-term stability
of the mycelium during fed-batch experiments. 3) The shake
ﬂask medium variation experiments resulted in two  potentially
beneﬁcial modiﬁcations of the M3  standard medium, 2 N and SP3.
These were therefore used in subsequent fed-batch experiments,
where the 2 N modiﬁcation turned out to be suitable. 4) Control
problems in the oxygen-controlled fed-batch processes could be
avoided efﬁciently by the development of a linear feed proﬁle. 5)
Oxygen supply seemed to be a second important parameter for
SAV production by S. avidinii. To provide sufﬁcient oxygen supply
during the fermentation without an alteration in power input, the
air ﬂow rate was doubled in the linear fed-batch fermentations.
4. Conclusions
In this paper the inﬂuence of stirrer induced shear stress on the
production of streptavidin (SAV) was examined using the natural
producer S. avidinii. In 6 day-fermentations maximal concentra-
tions of 6.93 ± 0.07 M were achieved for rotary frequencies of
the stirrer between 400 and 700 min−1, correlated with a spe-
ciﬁc power input of 79 and 107 W L−1, respectively. Both higher
and lower frequencies affected the product formation. The former
suggested shear stress induced damage on the mycelium for an
immoderately high power input. The latter caused insufﬁcient oxy-
gen supply. This clearly indicated the importance of an appropriate
choice of this process variable for the fermentation of S. avidinii.
Based on these results feed studies with a 400 g L−1 d-glucose
monohydrate concentrate on 2 N medium resulted in the develop-
ment of a linear fed-batch process reproducibly yielding 39.20 M
(n = 2) of streptavidin in 14 days. This product concentration by
far exceeds all maximal concentrations reported in literature for
SAV production. Furthermore, it outperformed the highest maxi-
mal  productivity of 82 nM h−1 described for S. avidinii by Kolomiets
et al. (1998) (see Table 1) by the factor 1.4 with a linear productivity
of 114 nM h−1 (n = 3) during the whole process.
Compared to processes in rapidly growing recombinant bacte-
ria like E. coli,  production of streptavidin by S. avidinii shows lower
productivities. The productivity for heterologous SAV production
in E. coli described by Sano and Cantor (1990) of approximately
340 nM h−1 (see Table 1), is still much higher than the one obtained
by the linear fed-batch strategy presented here. However, the pro-
ductivity is limited to a short time interval due to product toxicity,
causing a maximal concentration of only 1.02 M of SAV. In con-
trast to recombinant SAV expression no product inhibition even for
concentrations as high as 40 M was  observed using S. avidinii (see
Fig. 4). Furthermore, in the recombinant process the product accu-
mulated in the cytoplasm partly as inclusion bodies, causing the
necessity of refolding accompanied by poor product recovery. In
addition, considering the down time necessary for process prepa-
ration and shut-down, the productivity of the whole process has to
be corrected to lower values. To avoid these drawbacks, long-term
processes with constant productivities are desirable due to low
down times relative to their process length. The process strategy
described here implements the idea of a long-term stable produc-
tivity and at the same time outbalances all absolute productivities
described for SAV production by S. avidinii to date.
This paper for the ﬁrst time provides a protocol for a com-
plex process strategy for SAV production by S. avidinii. Therefore,
upcoming studies can now be realized much more rationally, allow-
ing targeted process optimization. In particular, the application
of different feed media and higher oxygen transfer rates as well
as experiments with varied feed proﬁles are now in the focus of
interest. Furthermore, the high stability of the organism observed
during linear fed-batch cultivation can be exploited by the appli-
cation of long-term process strategies like continuous cultivation
and repetitive fermentation.
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The authors regret mistakes in the original version of the article.
Power input
Measurements of the speciﬁc power input Lspec with the original experimental setup brought about incorrect results. Theoretical
calculations according to Briel and Wittig (1998) based on the given bioreactor system yielded drastically lower values for this parameter.
This suggested that measuring Lspec only for the ﬁnal ﬁlling volume of 5 L resulted in an overestimation of power input due to load-
dependent effects of mechanic friction, heat dissipation, and electrical loss of power (Briel and Wittig, 1998). The motor efﬁciency typically
increases upon load of the motor until it reaches its optimum in the range of 50–100% of the rated load (McCoy et al., 1993). The maximal
power of the given motor (80G-4, Elektromotoren Brienz AG, Brienz, Switzerland) was 1.5 kW,  but the motor was  operated at a much lower
load (see Table 2 in the original paper). Thus, the efﬁciency of the motor was probably lower than the maximal rated efﬁciency of 77%
(information of the supplier), leading to a large contribution of factors like friction for operation in the lower range of frequencies, which
falsiﬁed the results. Therefore, the measurements were repeated with a new experimental design for a differential calculation of power
input.
Table 2
Volumetric oxygen transfer coefﬁcient kLa and corrected values for the speciﬁc power input Lspec for different rotary frequencies of the stirrer n for the bioreactor described in
section 3.2. Measurements of the kLa were performed applying 1.5 bar static pressure, 30 ◦C and an air ﬂow rate of 5 NL min−1 (1 vvm) in 5 L of demineralized water, whereas
only  n and the air ﬂow rate were controlled for the estimation of power input.
n [min−1] Lspec [W L−1]a kLa [h−1]
200 0.1b 18.6
300 0.2b 39.9
350 0.4b 55.5 (66.2c)
400  0.5b 75.6
500 1.0 90.4
700 2.3 95.0
900 4.5 109.5
1100 7.6 133.3
1300 11.9 161.9
1500 17.4 181.3
a Acquired from ﬁtting to a power function (see Fig. 5); the values refer to aerated conditions.
b Experimental value close to lower detection limit.
c For an air ﬂow rate of 10 NL min−1.
All measurements of Lspec were performed without regulation of pH, temperature or pressure to minimize interfering factors.1 Firstly,
power input (a) was measured for a ﬁlling volume of 1 L, for which both stirrers were surrounded by air, whereas the bottom part of the
DOI of original article: http://dx.doi.org/10.1016/j.jbiotec.2012.10.021.
∗ Corresponding author.
E-mail address: jri@fermtech.techfak.uni-bielefeld.de (J.M. Risse).
1 No effect of the slight increase of temperature on power input during the measurements (+3 ◦C) was observed.
http://dx.doi.org/10.1016/j.jbiotec.2016.03.048
0168-1656/© 2012 Elsevier B.V. All rights reserved.
Jakob M. Müller 69
J.M. Müller et al. / Journal of Biotechnology 226 (2016) 76–77 77
Fig. 5. Results of the power input measurements of two identical bioreactors (R1 and R2) as speciﬁed in section 3.2. The plot shows the course of speciﬁc power input
Lspec over the rotary frequency of the stirrer n. Data for measurements in aerated conditions (1 vvm) are labelled “+A”. Experimental data and results from the ﬁt to the
two-parameter power function Lspec = na × b (power ﬁt) are shown (parameters: without aeration: a = 2.23, b = 2 × 10−6; aerated: a = 2.66, b = 6.22 × 10−8).
stirrer shaft including the magnetic coupling was  submerged in water. This conﬁguration was used for the evaluation of load-dependent,
friction-related effects. Secondly, measurements for a volume of 5 L (b), for which both stirrers were submerged in the liquid, were used
for estimation of the overall power input. Calculation of the speciﬁc power input was  then based on subtraction of (a) from (b), relating
to the ﬁlling volume of 5 L,2 and assuming that 90% of the energy was dissipated in the ﬂuid (Wolf, 2000). Two  identical bioreactors were
analyzed in this way. All measurements were performed in aerated and unaerated conditions. The course of the speciﬁc power input Lspec
was ﬁt to a power function to allow more accurate predictions for low values of n. Resulting values are shown in the corrected version of
Table 2 of the original paper and the additional Fig. 5.
The new values for Lspec are in the expected range for lab scale bioreactors and follow the typical course over the frequency of the
stirrer (Hortsch and Weuster-Botz, 2010). The corrected values also apply to the streptavidin formation plateau (abstract, p. 328, p. 331)
mentioned in the paper. The plateau observed for rotary frequencies of the stirrer between 400 and 700 min−1 is therefore correlated to a
range of Lspec between 0.5 and 2.3 W L−1.
The given method does, however, not allow quantiﬁcation of the volume-dependent change of slippage of the motor and the corre-
sponding loss of energy, which may  lead to lower values of Lspec for increasing frequencies of the stirrer. Slippage of electrical motors is
typically proportional to the motor load (McCoy et al., 1993), reaching a maximal value of 6.7% for the given motor (information of the
supplier). This maximal error would only apply in the worst case, i.e. when slippage is negligible for the low ﬁlling volume whereas it
reaches its maximal value for the working volume of 5 L, and for operation at full motor load (which was  not the case).
Strategy of feeding
An imprecise term was used for the strategy of feeding in the original article (‘linear fed-batch’; abstract, pp. 328–331). The correct term
is ‘constant feeding’, as the feed rate was kept constant over time.
The authors would like to apologise for any inconvenience caused.
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4.3 Theoretical analysis of the accuracy of the power
input measurements
A comparison of measured values for the speciﬁc power input Lspec and literature data suggested
that this parameter was not quantiﬁed accurately in the original manuscript. For typical reactors on
the laboratory scale, power input can be estimated to be in the range of 100-500W (van't Riet &
Tramper, 1991, p. 315). Related to a typical reactor volume of 5 L, this would yield a speciﬁc power
input of 20-100WL−1. Speciﬁc power input has been reported to be <44WL−1 for bioreactors with
a working volume of 50 L (Menkel, 1992, p. 128).
However, the power input measurements performed for this study yielded surprisingly high values
of Lspec in the range of 54.8 to 177.6WL
−1 in the variation interval of the stirring frequency from
200 to 1500min−1 (Müller et al., 2013). Moreover, the course of power input for increasing stirring
frequencies did not resemble a power function as expected (refer, e.g., to Hortsch & Weuster-Botz,
2010).
The discrepancy of literature values and experimental data indicated problems for the measurement
of Lspec by motor current and amperage as performed in the original paper. Generally, the method is
error-prone, because varying proportions of the measured current may be released not in the form of
motion but friction-induced heat (GVC-Fachausschuss 'Mischvorgänge', 1998).
Theoretical calculations according to the following sections were performed for an estimate of realistic
values of Lspec for the given bioreactor. Correlations and equations for this purpose were obtained
from GVC-Fachausschuss 'Mischvorgänge' (1998) (p. 44ﬀ.).
4.3.1 Dimensions of the MBR bioreactor.
The characteristic dimensions of the 5 L MBR bioreactor used in Müller et al. (2013) are shown in
Table 4.1.
4.3.2 Reynolds number and power equation
In general, the deﬁnition of the Reynolds number of mixing ReM is
ReM =
n · d2 · ρ
η
(4.1)
where n is the stirring frequency, d the diameter of the stirrer, and ρ and η the density and dynamic
viscosity of the ﬂuid, respectively.
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Tab. 4.1: Dimensions of the 5 L MBR bioreactor.
dimension/ratio value
stirrer type 6-bladed Rushton turbine
number of turbulence promoters 4
d/D1 70mm/150mm = 0,47
H/D2 300mm/150mm = 2
w3 15mm
installation height of the stirrer 125mm and 250mm
working volume 5L
1 ratio of stirrer diameter d and bioreactor diameter D
2 ratio of height H to diameter of the bioreactor D (assuming a
working volume of 5 L)
3 blade with of the stirrer
The power input L can be calculated from the power equation:
L = Ne · ρ · n3 · d5 (4.2)
where Ne is the Newton number and d is the diameter of the stirrer.
4.3.3 Performance characteristics of different stirrers
The Newton number Ne which was used for the following calculations was derived from Fig. 4.1.
The Newton number for Rushton turbines and vessels with turbulence promoters (curve gs, 'Scheiben-
rührer' = Rushton turbine) converges towards a constant value of 5 upon transition from an ordered
laminar to a turbulent ﬂow regime. This feature can be utilized for the calculation of L by equation 4.2.
4.3.4 System-based modifications
Several modiﬁcations of Ne apply due to the conﬁguration of the bioreactor, as discussed in the
following sections.
4.3.4.1 Impact of the ratio d/D
An increase of the ratio of stirrer- to bioreactor diameter d/D from 0.2 to 0.5 is correlated to a
decrease of the Newton number by approx. 20% (GVC-Fachausschuss 'Mischvorgänge', 1998). The
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Fig. 4.1: Plot of Newton number versus Reynolds number for different types of stirrers
according to Zlokarnik (1999) (p. 35).
reference system with a Rushton turbine depicted in Fig. 4.1 (Ne = 5) was characterized by a ratio
d/D of 0.3. In the system used for this study, this ratio was 0.47 (see Table 4.1). The diﬀerence
of the d/D ratio of the reference system and the applied reactor thus amounts to 0.47-0.3 = 0.17,
corresponding to approx. 50% of the interval 0.2 to 0.5. The Newton number used for the following
calculations was therefore reduced by 10% assuming a linear decrease of Ne in the given interval. This
yielded a value of Ne=4.5.
4.3.4.2 Heigth of filling
For a ratio of height of ﬁlling to diameter of the bioreactor (H/D) ≥ 0.8 the Newton number can
be considered constant (GVC-Fachausschuss 'Mischvorgänge', 1998). This condition was fulﬁlled by
the given system.
4.3.4.3 Systems with multiple stirrers
If several stirrers are installed in a bioreactor, the distance between the stirrers on the stirrer axis
is of central importance for the calculation of the overall power input. This distance should 1.2fold
exceed the diameter of the stirrer to assume an additive behavior of the power input by each stirrer
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(GVC-Fachausschuss 'Mischvorgänge', 1998).
This distance was 125mm in the present case (see Table 4.1, p. 72), corresponding to 1.8 times the
stirrer diameter (70mm). Thus, calculation of power input by the two Rushton turbines was calculated
by simple addition of the input by each stirrer.
4.3.5 Calculation of flow regime and power input
Estimations of the dynamic viscosity at the maximal biomass concentration of the cultivations by a
falling ball viscometer[1] yielded values in the range of 7.3mPa s.[2] Calculations based on the previous
paragraphs brought about the theoretical values for the power input L for various conﬁgurations of
the system given in Fig. 4.2. All conﬁgurations yielded Reynolds numbers larger than 100 (limit of the
Reynolds number for turbulent ﬂow in systems with turbulence promoters) as shown in Table 8.3 in the
supplementary material (p. 184). Therefore, turbulent ﬂow in the reactor can be assumed. However,
in the case of the biomass suspension, ReM was in the transition zone from partially developed to a
fully turbulent ﬂow (ReM > 10
3 or 104, Doran, 1995). This type of ﬂow regime may - as shown in
Fig. 4.1 - result in slightly lower actual values of Ne for low rotary frequencies of the stirrer.
4.3.6 Estimation of aerated power input
Generally, power input can be assumed to be lower in aerated than in unaerated conditions. To
calculate the eﬀect of aeration on power input a correlation of Hughmark (1980) was used. The ratio
of aerated Lg to unaerated power input L was estimated according to Eq. 4.3.
Lg
L
= 0.1
(
Q
n · V
)−0.25( n2 · d4
g · w · V 0.67
)−0.2
(4.3)
where Q is the volumetric gas ﬂow rate, V is the volume of liquid in the bioreactor, g is the gravita-
tional acceleration, and w is the blade width of the stirrer.
Based on the characteristic proportions of the bioreactor of Table 4.1 and the experimental volumetric
ﬂow rate of 1 vvm, the correlation yields factors for the decrease of L by aeration for diﬀerent rotary
frequencies of the stirrer.
[1]See section 8.1.2.1, p. 174 in the supplements for a detailed description of the method.
[2]This estimate is based on the assumption that the flow behavior of the fluid is close to Newtonian, which
may be feasible considering the low dry cell weight concentrations.
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4.3.7 Comparison of experimental and theoretical values
Based on these theoretical calculations, a new experimental setup was designed, which led to the
values presented in the Corrigendum of the article (see p. 69). Fig. 4.2 shows a comparison of calculated
values and experimental data acquired for the new experimental design.
Fig. 4.2: Comparison of theoretical and experimental values of the specific power input
Lspec for the new experimental design for the given bioreactor configuration for stirring
in water. Aerated conditions are labelled “+A”. The figure is an extended version of the
plot used in the Corrigendum (Müller et al., 2016b).
4.3.8 Load-dependent efficiency of electric motors - an error analysis
The motor applied in the study was a 3-phase current motor of the type DAS 80G-4 (Elektromotoren
Brienz AG, Brienz, Switzerland), operating at a frequency of 50Hz and a current of 400V. It was
characterized by a power of 1.5 kW and a rated maximal rotary frequency of 1400min−1 (operation
above this frequency was possible).
Electric motors are usually designed to run at 50-100% of their rated load with a maximal eﬃciency
at about 75% load (McCoy et al., 1993). Generally, motor eﬃciency for electric motors rises upon
increasing load and dimension of the motor. Moreover, the relative eﬃciency of smaller motors shows
a stronger dependency on load. Both aspects are illustrated in Fig. 4.3.
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Fig. 4.3: Relative efficiency of electric motors versus load (McCoy et al., 1993). Please note
that the load does not only depend on the frequency of the stirrer, but also on the flow
resistance arising from the stirred liquid.
The category for the motor used is 1.5-5 hp.[3] Its eﬃciency can thus be considered to be strongly
dependent on motor load. It was operated in a frequency range of 200 to 1500min−1, leading to a
maximal power consumption of the whole system in the range of 0.48 kW.[4] This corresponds to only
32% of the maximal power of 1.5 kW.
It therefore seems reasonable to assume that the motor was operated in underloaded conditions
even for intermediate rotary frequencies of the stirrer, resulting in a strong contribution of factors like
friction. The proportional inﬂuence of these factors on the overall power consumption can be expected
to be successively smaller for increasing frequencies of the stirrer. This leads to a non-linear deviation
of experimental data and actual power input, which explains the atypical linear course of Lspec over
n observed in the original paper. The diﬀerential method of measurement used for the Corrigendum
should circumvent this error, as friction-related eﬀects were analyzed and compensated by a separate
measurement for a low ﬁlling volume.
[3]hp = horsepower, 1 hp ≈ 735.5W.
[4]This includes power used for the console of the bioreactor and for control of the stirring frequency.
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4.3.8.1 Limitations of the differential method of measurement
As discussed in the Corrigendum, the optimized method is not able to quantify eﬀects of volume-
dependent changes of slippage on power input despite eliminating friction-related eﬀects from the
outcome of the measurement. A comparison of the rotary frequency of the rotor and the stator of the
motor may illustrate this feature.
The rated maximal rotation frequency n of the rotor according to the supplier is 1400min−1. The
rotation of the stator - the so-called synchronous speed ns - can be calculated according to equation 4.4.
ns =
f
p
(4.4)
where f is the frequency of the motor supply and p - always given in integer numbers - is the number
of magnetic poles .
For the given motor, f equals 50Hz and p equals 2. Thus, the synchronous speed is 25 s−1 or
1500min−1. From this information, slippage s of the motor can be calculated according to equation 4.5.
s = ns − n
ns
(4.5)
This leads to the maximal slippage of the motor of 6.7% (as speciﬁed by the supplier), which
corresponds to the maximal error arising from this factor. However, the actual rotary frequencies
measured for both bioreactors for the working volume of 5 L at a setpoint of 1500min−1 were 1445
and 1489min−1, respectively. These results suggest that the actual maximal error is lower, i.e., in
the range of 0.7 to 3.7%. Moreover, even these smaller errors would only apply assuming no slippage
for the measurement at a low ﬁlling volume and maximal contribution of this factor for the working
volume of 5 L, which seems unlikely.
4.3.9 Correlation of kLa and Lspec
Literature oﬀers many correlations of the volumetric oxygen transfer coeﬃcient kLa and the aerated
speciﬁc power input Lspec,g, typically resembling the form of equation 4.6.
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kLa = k
(
Lg
V
)x
vs
y (4.6)
where vs is the superﬁcial air velocity [m s
−1] and k, x, and y are the speciﬁc parameters of the equation.
In a study of van't Riet (1983) the parameters k, x, and y were estimated to be 0.026, 0.4, and 0.5,
respectively. These parameters were acquired by comparing literature values from diﬀerent publications
for water-based measurements. The parameters were found to be within a range of ±40% of these
values.
In addition to this absolute description of kLa and Lspec,g, van't Riet (1983) also proposed a relative
correlation of the two parameters, as shown in equation 4.7.
kLa ∝
(
Lg
V
)z
(4.7)
where Lg is the aerated power input and the model parameter z is 0.5 for coalescing, aqueous systems.
The experimental values of aerated speciﬁc power input Lspec,g and kLa were compared to theoretical
courses acquired from these equations as shown in Fig. 4.4. The superﬁcial air velocity vs was calculated
according to equation 4.8.
vs =
Q
A
(4.8)
where Q is the gas ﬂow rate [m3 s−1] and A is the cross-sectional area of the fermenter (0.018m2).
Fig. 4.4a shows that the data set of Müller et al. (2013) and the corrected values of Lspec,g published
in the Corrigendum lie within a range of±40% of the model curve based on the parameters of van't Riet
(1983). Generally, a comparison to the study of van't Riet (1983) suggests that the kLa values achieved
for the given bioreactor are relatively low. Parameter estimation of the parameters of equation 4.6
led to the parameter set depicted in the caption of Fig. 4.4a, yielding a more accurate ﬁt. The ﬁtted
curve suggests a limited eﬀect of an increase of Lspec,g beyond 5WL
−1, corresponding to a stirring
frequency of about 900min−1. Fig. 4.4b indicates similar eﬀects: the increase of kLa over Lspec can
more accurately be described by applying an exponent in the range of 0.3 (parameter estimation) for
equation 4.7 rather than 0.5 as suggested by van't Riet (1983).
The kLa can be taken as a measure for diﬀerent aspects of mass and heat transfer in the vessel.
This leads to the conclusion that increased values of Lspec are not only detrimental for cultivations
of S. avidinii from a biological perspective due to the fragmentation of mycelia (Müller et al., 2013).
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(a) Quantitative evaluation based on equa-
tion 4.6. Modelling according to van’t Riet
(1983) with confidence intervals of ±20 and
±40% . Parameter fitting yielded the pa-
rameters k=0.046, x=0.306, y=0.418 for the
experimental data.
(b) Relative correlation of aerated specific power
input and kLa based on equation 4.7. Param-
eter estimation yielded a value of 0.296≈0.3
for z.
Fig. 4.4: Comparison of experimental and theoretical values of Lspec,g and kLa based on
van’t Riet (1983).
They also drastically increase power consumption with only slight beneﬁts for homogenization of the
broth and improved oxygen supply. This decreased eﬃciency, visualized in Fig. 4.4a, has already been
described, e.g., by Winkler (1990).
4.3.10 Power input and streptomycetes in literature
Since the publication of the paper, the impact of power input on the morphology of streptomycetes
has been studied by Gamboa-Suasnavart et al. (2013). The authors analyzed the production of a
protein from Mycobacterium tuberculosis by S. lividans. They investigated the correlation of pellet
diameter and theoretical power input and found a decreasing pellet diameter dp from approx. 0.35
to 0.1mm for increasing stirring frequencies of up to 400min−1, followed by only minor changes of
dp for higher frequencies. The speciﬁc power input of the study was in the range of 0.15-9.4WL
−1
for frequencies of the stirrer between 250 and 999min−1 in a 1.5 L bioreactors with two turbulence
promoters and a volumetric air ﬂow rate of 0.5 Lmin−1 (0.33 vvm). The authors successfully used this
data for purposes of up-scaling to achieve a comparable morphology in shake ﬂasks and bioreactors.
In the study by Müller et al. (2013) applying S. avidinii, macroscopic pellets were only observed
in the initial growth phase, whereas the culture shifted to ﬁlamentous growth later in the process.
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However, microscopic analysis may contribute to improved scalability of the results for this organism,
too.
4.4 Summary of additional experiments applying
S. avidinii
Supplementing experiments focused on the impact of additional factors on the production of SAV.
These experiments included the evaluation of strategies for the control of morphology, a design of
experiments (DoE)-approach for the optimization of the growth medium, and studies of continuous
cultivation. Furthermore, genetic engineering of S. avidinii was analyzed. Results are brieﬂy summed
up in the following sections.
4.4.1 Control of the morphology of S. avidinii
Pellet formation posed problems to the reproducibility of shake ﬂask cultivations of S. avidinii
especially for a low inoculum size and the application of highly concentrated media, as exempliﬁed in
Fig. 4.5. Hence, strategies for the control of morphology of S. avidinii were evaluated to minimize
corresponding complications.
Fig. 4.5: Formation of small pellets in a shake flask culture of S. avidinii. The pellets shown
here are relatively small compared to further experiments.
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4.4.1.1 Control of morphology by the addition of microparticles
Kaup et al. (2008) analyzed the impact of the supplementation of microparticles to cultivation media
on a variety of ﬁlamentous organisms, revealing positive eﬀects on their morphology by a reduction
of the pellet diameter and an improved metabolite production. The method was called 'microparticle-
enhanced cultivation' (MPEC). As morphological problems remained an issue in shake ﬂask cultivations
throughout this thesis, this method was tested in several experiments.
Generally, particles and the remaining media compounds were always prepared and sterilized sepa-
rately. The experiments indicated that the addition of talc powder (hydrous magnesium silicate) and
aluminum oxide to the cultivation medium contributes to a more homogeneous culture broth when
highly concentrated media are applied. These media typically led to a strong pellet formation in the
absence of particles. The impact of talc particles on the morphology in the bioreactor seemed to be
smaller, which is most likely due to strong shearing by the blades of the stirrer in this system. However,
the production of SAV was increased by a factor of 1.6 in this cultivation system towards a reference
culture, as illustrated in Fig. 4.6.
Fig. 4.6: Microparticle-enhanced cultivation of S. avidinii in the presence of talc particles
in the bioreactor. Fermentation courses for cultivation at 30 °C at a stirring frequency
of 350min−1 in talc-supplemented (M3T5) and talc-free (M3) M3 medium are shown.
Abbreviations: X = conc. of dry cell weight, P = conc. of SAV, S = conc. of glucose.
The ’deg’-labels refer to regression curves acquired by a fit of X to equation 4.9.
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The courses of the dry cell weight (DCW) concentration X shown in Fig. 4.6 were evaluated based
on the ﬁrst order degradation model of equation 4.9
− dX
dt
= kdeg ·X (4.9)
where kdeg is the characteristic constant of degradation.
Parameter estimation yielded degradation constants of 0.00284 h−1 for the talc-free and
0.00946 h−1 (factor 3.3) for the talc-supplemented culture, indicating less stable ﬁlaments for the
microparticle-supplemented system. This may be due to the collision of particles and mycelia, as
discussed by Kaup et al. (2008). Interestingly, like observed for the un-supplemented cultures analyzed
in Müller et al. (2013), the feeding of glucose prevented the degradation of biomass for a talc-based
fed-batch process and seemed to stabilize the mycelia (data not shown). This could be the result of
morphological changes upon substrate depletion of the culture, as suggested by the growth-dependent
viscosity of the culture broth (see Fig. 8.5, p. 183).
Hence, advantageous properties regarding the production of SAV were achieved by the addition of
talc particles. However, additional studies in shake ﬂasks suggested that particle supplementation may
also improve the tolerance of S. avidinii towards ﬂuctuations of the cultivation temperature. Cultiva-
tion at 25 instead of 30 °C brought about problems of reproducibility for talc-free cultures, whereas
supplementation of talc speeded up the initial growth phase and resulted in a more homogeneous
growth among diﬀerent replicates (data not shown).
Additional MPEC-based experiments were performed in cooperation with the DECHEMA Research
Institute (Research Group 'Biochemical Engineering', Dr. Dirk Holtmann, Felicitas Vernen) to study
the impact of talc particles on the pellet size in unbaed shake ﬂasks. The morphology of the pellets
was evaluated via a USB microscope and the image analysis software ImageJ (see Table 2.4, p. 24)
as described in the supplements (section 8.1.2.2, p. 175). This analysis yielded a lower median of the
pellet diameter for talc-supplemented cultures especially in the early stage of cultivation, as shown in
Fig. 4.7.
Overall, a step-wise reduction of the pellet area was observed throughout the cultivation for both
the talc-supplemented and the reference culture. However, the course of the median of the pellet area
of S. avidinii indicates that talc has a major impact on the morphology of S. avidinii in the ﬁrst days
of cultivation. This impact is becoming successively smaller throughout the cultivation.
Reduction of the pellet diameter in the early stage of cultivation was also possible by the addition
of small glass beads (0.25 to 0.5mm) to the shake ﬂasks. However, unlike for the supplementation of
talc, this did not improve the ﬁnal concentration of product (results in publication).
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Fig. 4.7: Median value of the pellet area of S. avidinii over time for the cultivation in
unbaﬄed shake flasks (y-axis scaled logarithmically). M3 = reference culture, M3T5
= talc-supplemented culture. Please refer to Fig. 4.8 for the impact of talc on the
production of SAV. Number of analyzed pellets after 48, 72, and 96 h, respectively: M3:
211, 1096, 1282; M3T5: 608, 2236, 1599.
4.4.1.2 Control of morphology by further methods
Further strategies were evaluated for the control of the morphology of S. avidinii in shake ﬂasks and
microplates. Fig. 4.8 shows a brief summary of results from various shake ﬂask studies. Cultivation
conditions were chosen to provoke pellet formation by the application of shake ﬂasks without baes,
a low shaking frequency of 120min−1, and a low inoculum size.
The eﬀects of oxygen limitation on the morphology of ﬁlamentous fungi was studied by Hockenhull
(1980). This study indicated that upon ageing of the culture - and accompanying lower concentrations
of dissolved oxygen due to increased oxygen consumption of in the culture broth - a switch from pellets
to ﬁlamentous growth can be observed. Therefore, one of the conﬁgurations shown in Fig. 4.8 was
based on an artiﬁcial limitation of oxygen early in the culture based on sealing of shake ﬂasks via a
sterile sealing ﬁlm. This led to increased product concentrations for media typically resulting in strong
pellet formation, but was detrimental to media which are optimized for S. avidinii. The latter may
partially be due to the limitation of the DCW concentration to 2.78±0.04 g L−1 by the enclosed air
volume. This could be avoided by removing the ﬁlm after the initial growth phase in future experiments.
Co-sterilization of glucose and other compounds of M3 led to an increase of productivity. This
may be due to potentially beneﬁcial eﬀects of Maillard products on the morphology of S. avidinii.
These arise from the reaction of glucose and peptides in the complex compounds of M3 medium. The
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Fig. 4.8: Summary of shake flask studies on control of the morphology of S. avidinii (n≥3).
The plot shows concentrations of DCW X and SAV P after 6 days of cultivation at 28 °C.
If not indicated otherwise, experiments were performed in unbaﬄed 300mL shake flasks
with a filling volume of 30mL using an inoculum of 60µL per flask (inoc. + = 300µL
per flask). Designations refer to the medium used (M3, SP3, M3.2), the addition of talc
powder (M3T5), cycles and time of co-sterilization of glucose and other compounds of
M3 (coster.), and sealing of the flasks by an oxygen-impermeable sealing film. M3 and
SP3 medium were composed as described in Müller et al. (2013), whereas the optimized
M3.2 medium resulted from the optimization procedure discussed in section 4.4.2.
hypothesis is supported by the results from continuous cultivation of S. avidinii (see section 4.4.3).
Surprisingly, an increased inoculum size and the application of baed shake ﬂasks did not improve the
production of SAV. However, the volume percentage of 1% (v/v) used for high inoculation was still
rather low, meaning that a further increase may actually improve growth and production. Moreover,
inoculation was always performed by a mycelial glycerol stock instead of a spore suspension.
In summary, the results emphasize the impact of morphology on the formation of SAV in shake
ﬂasks, since strongly diﬀering concentrations of the protein were achieved for identical concentrations
of DCW in several cases. Generally, ﬁlamentous growth was essential for high product concentrations.
The adequacy of the method of morphological control depends on the cultivation system used. This
was, e.g., the case for the improved performance upon talc-supplementation of media in shake ﬂasks,
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whereas this strategy did not yield improvements for its application in squared v-bottom microplates
due to sedimentation. Opposed to this result, supplementation of shake ﬂask cultures of S. avidinii by
3mm-glass beads showed no eﬀect, whereas it reduced pellet formation in microplates as discussed in
the next section.
4.4.2 Medium optimization
The experiments performed up to this point led to remarkable concentrations of SAV in several
cases, but yielded rather limited concentrations of biomass. Thus, the major compounds of the M3
growth medium, namely yeast extract, soy peptone, casein hydrolysate, and glucose, were varied in a
DoE-approach designed in the software MODDE (Umetrics) to optimize the process outcome.
Cultivations were performed in MOPS[5]-buﬀered media in 24-well deepwell microplates in the pres-
ence of 6 glass beads (∅ 3mm) per well to minimize pellet formation based on a method for S. coelicolor
published by Sohoni et al. (2012). A detailed description of the method is given in the supplements
(section 8.1.2.3, p. 175).
The results indicate that the concentration of soy peptone in the standard medium may inhibit a
rapid formation of biomass and product. Optimized production media therefore contained elevated
concentrations of yeast extract and lower proportions of soy peptone.
Subsequent experiments in shake ﬂasks based on pulse-wise feeding of additional substrates (glu-
cose, yeast extract, meat extract) resulted in 7.3±0.1µM of SAV and a concentration of DCW of
15.5±0.6 g L−1 in 144 h, strongly surpassing the results for 2N medium described in Müller et al.
(2013) (3.37±0.78µM of SAV, 4.9±0.3 g L−1 of DCW). Among other suitable compositions, the op-
timization resulted in the medium shown to the right in Fig. 4.8 (M3.2), consisting of (per L) 5 g of
NaCl, 2 g of soy peptone, 3.75 g of yeast extract, 2 g of casein hydrolysate, and 15 g of glucose.
These results now have to be transferred to the bioreactor scale in order to analyze, whether the
improved performance also applies for this system.
Additional fed-batch fermentations in the bioreactor based on glycerol brought about lower con-
centrations of SAV than the glucose-based processes. These results were contrary to previous shake
ﬂask cultivations, in which glycerol yielded comparable or slightly advantageous results. Thus, glucose
seems to be a more suitable carbon source for the production of SAV by S. avidinii in the bioreactor.
[5]3-(N -morpholino)propanesulfonic acid
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4.4.3 Continuous cultivation
Since detailed knowledge on the properties of S. avidinii regarding biochemical engineering is sparse,
the organism was cultivated in chemostat operation using M3 medium to characterize the growth
rate-dependent production of SAV by the organism. Please refer to section 8.1.2.4 (p. 176) in the
supplementary material for a detailed description of the experimental setup.
Brieﬂy, experiments were performed in the same bioreactor as the fed-batch studies of Müller et al.
(2013) in M3 medium. All ingredients of this complex medium were sterilized simultaneously for 45min
(see Fig. 4.8 for results of this variation in shake ﬂasks), and two peristaltic pumps were used to adjust
the dilution rate of the culture. The fermenter was operated for 5-10 residence times τ [6] at each
dilution rate D to achieve steady state conditions (µ = D). The results are shown in Fig. 4.9.
Fig. 4.9: Continuous cultivation of S. avidinii in the bioreactor at 30 °C, pH 7.0, and a
stirring frequency of 500min−1 at different dilution rates D. The plot shows the residual
substrate concentration S, the volumetric productivity p, and the DCW concentration
X. Model curves were derived by a fit to a Monod-like growth model and the three-term,
biomass-based model of productivity used in Müller et al. (2016c) based on a modified
Luedeking-Piret equation (Luedeking & Piret, 1959).
For the model-based evaluation of the data, the Monod constant KS was set to a constant value
of approximately 8.6 g L−1 (equal to the inﬂow concentration of substrate) based on an estimated
[6]Times, in which the working volume is replaced once. Residence time τ = 1/D.
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saturation parameter s0S
[7] of 1.0 for the parameter ﬁt. This adjustment was performed to account
for the linear decrease of X over D, indicating a low aﬃnity of S. avidinii for the substrate glucose.
The course is therefore only a rough estimate. Detailed batch studies would be more suitable for a
more precise determination of KS due to a larger number of data points.
Parameter estimation brought about a yield coeﬃcient YX/S of biomass per substrate in the range
of 0.71 and a maximal speciﬁc growth rate µmax of 0.53 h
−1, matching the data of several neutrophile
streptomycetes analyzed by Flowers & Williams (1977) (µmax between 0.56 and 0.64 h
−1).
These results indicate that S. avidinii is capable of growing much faster than suggested by all
previous experiments. Cells were not washed out until the setpoint for the ﬂow rate was adjusted to
0.6 h−1.
Surprisingly, the culture formed small pellets at very high dilution rates, whereas for low rates
ﬁlamentous growth was observed. This is seemingly contradictory to the lower surface to volume-ratio
of pellets towards ﬁlaments, as nutrient limitation may occur for the former (see Fig. 2.5 p. 12) with
a corresponding impact on the growth rate.
Very high volumetric productivities were achieved at intermediate dilution rates of 0.2 to 0.3−1,
reaching an experimental maximum of 221±32 nMh−1 at a DCW concentration of only 4.0±0.5 g L−1
for D = 0.195 h−1 and a maximum of the model-based regression curve of 190 nMh−1 for D =
0.22 h−1 (see Fig. 4.9).
Due to the mode of operation, even low dilution rates resulted in low concentrations of SAV
(2.4±0.3µM of SAV for D = 0.058 h−1). Chemostat operation for the production of SAV would
therefore require the processing of very large volumes. Exponential feeding using a setpoint for µ
(µset) in the range of these growth rates could thus be a more suitable alternative to further improve
SAV production by S. avidinii. Slightly lower growth rates (e.g., µset = 0.1 h
−1) may allow prolonged
processes at a constant µset, while reducing the volumetric productivity to an only small extent. The
speciﬁc (biomass-related) productivity was even higher for very high dilution rates in the range of µmax,
but corresponding values of µset will be diﬃcult to implement due to constraints imposed by factors
like oxygen input.
Alternatively, further optimization may focus on cell retention or the cultivation of immobilized
biomass of S. avidinii in continuous cultivation to achieve higher cell densities at high ﬂow rates.
4.4.4 Analysis of the effect of oxygen supply
As the results of Müller et al. (2013) suggested a positive impact of high concentrations of oxygen
on the formation of SAV, additional fermentations focused on aeration by concentrated oxygen. These
[7]s0S = S0/KS , where S0 is the inflow concentration of substrate.
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studies indicate, however, that aeration by pure oxygen is as harmful as oxygen depletion (data not
shown), which may be due to oxidative damage to the cells. Another potential explanation of this
phenomenon is described by Wongwicharn et al. (1999), who observed that a lower concentration
of oxygen in the culture resulted in prolonged ﬁlaments, whereas more aggregates occurred for an
increased oxygen saturation for the cultivation of Aspergillus niger. Thus, the detrimental eﬀects of
high concentrations of oxygen observed here may be also be the result of undesired morphological
changes, negatively eﬀecting the formation of SAV. This hypothesis is supported by the improvements
of product formation for the cultivation in sealed shake ﬂasks (Fig. 4.8, p. 84). Therefore, control of
the oxygen saturation at intermediate setpoints - as performed for the studies of continuous cultivation
- is a more suitable method than supplying pure oxygen at high volumetric ﬂow rates not only from
the economical, but also from the biological perspective.
4.4.5 Determination of mycelial growth by viscosity measurements
The analytical methods for several bioreactor studies included measurements of the dynamic vis-
cosity η according to section 8.1.2.1 (p. 174ﬀ. in the supplementary material). The viscosity usually
increased for growing mycelia and dropped to a biomass-dependent base value for a stationary culture.
This behavior is common for ﬁlamentous organisms, since the viscosity of corresponding fermentation
broths is typically correlated to the growth rate and concentration of biomass of the culture (Olsvik
& Kristiansen, 1994). An example for corresponding measurements is shown in the supplementary
material, Fig. 8.5 (p. 183). The overall course roughly resembled the concentration of carbon dioxide
in the exhaust air, but was more sensitive towards small changes of the DCW concentration. It may
therefore be a useful parameter for a sensitive determination of the decelerated and stationary growth
phase of a cultivation or an at-line analysis of the eﬀect of diﬀerent feeding strategies on growth.
4.4.6 Genetic engineering of S. avidinii
A ﬁnal set of experiments targeted the genetic modiﬁcation of S. avidinii to determine if genetic
optimization of the host may serve as a tool for further optimization of SAV production. For this pur-
pose, a collaboration with the research group 'Microbial Genomics and Biotechnology' at the CeBiTec
at Bielefeld University (Prof. Dr. Jörn Kalinowski, Tetiana Gren) was established.
Sporulation of S. avidinii was successfully induced on oatmeal agar (40 g L−1 of oatmeal, 20 g L−1
of agar, pH 8.0). An analysis of the antibiotic (AB) resistances of the organism on oatmeal agar
plates revealed that the strain is sensitive to apramycin and resistant to nalidixic acid. This would
allow the killing of vector transferring strains of E. coli by the latter and selection of transformants
of S. avidinii by the former antibiotic. A summary of the AB resistance tests is shown in Table 4.2.
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Transformation by the standard broad host range vector pSET152 (NCBI ID 173260) conferring resis-
tance to apramycin applying an E. coli helper strain yielded colonies after selection by the antibiotic.
In conclusion, S. avidinii seems to fulﬁll the basic requirements for genetic engineering. However, due
to time restrictions no subsequent experiments were performed.
These preliminary results may be useful for future attempts to integrate additional copies of the
SAV expression cassette into the genome of S. avidinii.
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Tab. 4.2: Analysis of antibiotic resistances of
S. avidinii by Oxoid™Antimicrobial Suscep-
tibility Discs (Thermo Scientific).
antibiotic mass [µg] a AB resistance
ampicillin 25 +
bacitracin 10 units - b
ceftazidime 30 +
chloramphenicol 10 -
colistin sulfate 10 +
cycloserine 200mgL−1 c +
gentamicin 10 -
kanamycin 30 -
lincomycin 15 -
nalidixic acid d 30 +
norfloxacin 5 +
phosphomycin d 50µgmL−1 e +
polymyxin B 300 units +
rifampicin 30 -
spectinomycin 10 -
streptomycin 10 -
sulphonamide 300 +
tetracyclin 30 -
trimethoprim 5 +
vancomycin 5 -
a mass of AB per disc
b weak inhibition zone, partially overgrown
c analyzed in liquid culture
d suitable for the killing of E. coli helper strains
e supplied in liquid form (100µL)
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5.1 Motivation
Heterologous production of proteins oﬀers a large variety of advantages over conventional expression
systems. Only 0.1-10% of all microorganisms are estimated to be cultivable in laboratory conditions
(Zeyaullah et al., 2009). However, many of the strains not belonging to this minority host a diverse
range of metabolic properties which are of interest, e.g., for medical or biotechnological purposes.
Heterologous expression based on metagenomics oﬀers a way of making some of the corresponding
pathways or gene products available for corresponding purposes (Zeyaullah et al., 2009). Moreover,
heterologous studies may maximize product concentration and minimize process time based on estab-
lished process strategies (Lee, 1996) and a large number of host/vector-combinations suited for the
production of a highly diverse range of proteins (Abelson et al., 1990). Exploiting these properties,
product concentrations ranging from hundreds of milligrams to several grams per liter can be obtained
(Cos et al., 2006; Georgiou & Segatori, 2005), often surpassing the concentrations achieved by cultiva-
tion of the native host. However, in the case of SAV, product toxicity complicates common strategies
of gene expression (see section 2.4.3, p. 15ﬀ.). As these aspects are often host-speciﬁc, several hosts
were optimized for the production of this protein throughout this thesis.
5.1.1 Strategies of heterologous expression used for this project
Three promising hosts were selected for heterologous expression of the SAV gene. The entero-
bacterium E. coli was chosen representing Gram-negative hosts as it is the most frequently used
prokaryotic expression system (Chen, 2012; Hannig & Makrides, 1998; Hockney, 1994) and has already
been used for expression of the SAV gene in multiple studies (Sano & Cantor, 1990b; Gallizia et al.,
1998; Miksch et al., 2008).
As discussed in section 2.4.3.3 (p. 20ﬀ.), yeasts generally oﬀer a more elaborate compartmenta-
lization and a highly eﬃcient secretory pathway. Moreover, these eukaryotes are typically capable
of rapidly growing to high cell densities in simple, deﬁned media. Advantageous properties for post-
translational processing are not relevant for SAV, but may prove beneﬁcial for other target proteins
(Abelson et al., 1990). Due to these attributes, two yeast-based expression systems were applied.
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Firstly, experiments focused on the methylotrophic yeast P. pastoris (Macauley-Patrick et al., 2005;
Cregg et al., 2000), which is becoming increasingly popular in the last decade and has already been
identiﬁed as a suitable host for the production of SAV (Casteluber et al., 2012; Nogueira et al.,
2014). However, for P. pastoris only methanol-based processes have been applied, which - among
other downsides - increases process cost due to safety regulations for the ﬂammable and toxic organic
solvent. This will be discussed in detail in section 5.3 (p. 116).
Secondly, a novel expression system was constructed applying the yeast Hansenula polymorpha,
which in many aspects of growth, metabolism, and production of heterologous proteins resembles
P. pastoris (Gellissen, 2000).
5.1.2 Experimental remarks
During the ﬁnal stages of evaluation of the cultivations performed for this thesis theoretical consi-
derations and measurements of the kLa for diﬀerent experimental setups indicated that the choice of
the gas ﬂow rate for the cultivations of H. polymorpha and E. coli in the Sixfors bioreactor system
(Infors HT, Bottmingen, Switzerland) was not always optimal. For a fraction of experiments, very high
volumetric ﬂow rates of 5 or 3 vvm, respectively, were applied. Eﬀects of evaporation were avoided by
pre-saturation of the inﬂowing air by water vapor. However, dynamic measurements of the volumetric
oxygen transfer coeﬃcient kLa according to Bandyopadhyay et al. (1967) resulted in no improvements
for this parameter for these ﬂow rates towards lower setpoints. The results are consistent with literature,
as can be seen in Fig. 5.1.
Fig. 5.1: Qualitative dependency of volumetric oxygen transfer coefficient kLa and volumetric
air flow rate according to Stanbury et al. (1995) (Fig. 9.12).
According to Stanbury et al. (1995), air ﬂow rates larger than 1.5 vvm typically don't improve the
kLa. Additionally, power input may decrease in these conditions (see equation 4.3 in section 4.3.6,
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p. 74), which may in turn negatively contribute to the overall process, e.g., by decreasing heat transfer.
Thus, lower volumetric ﬂow rates should be applied especially for further experiments in larger scales.
5.2 Production of SAV by Escherichia coli
E. coli is a Gram-negative model bacterium and a biotechnological workhorse. Due to relatively
simple and well-established procedures of genetic and biochemical engineering, the organism is em-
ployed for a large variety of biotechnological production processes (Sørensen & Mortensen, 2005). It
has particularly been shown to be highly suited for the production of short proteins in the range of
100-200AA, which applies to SAV monomers. Corresponding proteins typically simplify recombinant
production as direct expression often leads to a soluble product without the necessity of fusion partners
(Abelson et al., 1990). In addition to these protein-speciﬁc properties, progress has been made for
the secretion of heterologous proteins by E. coli despite an unfavorable structure of the cell wall (see
Fig. 2.8a, p. 19) (Mergulhao et al., 2005; Ni & Chen, 2009). Secretion has been - and to some degree
still is - a major bottleneck, especially when the target protein produced is not secreted by its native
host (Abelson et al., 1990).
Heterologous production of SAV has been tested in many studies applying E. coli. Due to the natural
properties of the host, overexpression of the SAV gene often led to intracellular, inactive inclusion bodies
(Sano & Cantor, 1990b; Thompson & Weber, 1993; Chen et al., 2014), partially overcoming its toxicity.
Only Miksch et al. (2008) achieved soluble extracellular accumulation of the protein by the use of the
general secretory pathway (Sec) and a bacteriocin release protein.
5.2.1 Goals of this study
The goal of this study was to get a more holistic view of the productive properties of E. coli regarding
the soluble and secretory production of SAV. For this purpose, a novel expression system was established
based on the periplasmic 'leaky mutant' JW1667-5 (∆lpp::kan). This mutant is commercially available
from the Coli Genetic Stock Center (Keio Knockout Collection, Yale University, USA). A combined
analysis of various genetic, biochemical, and technical factors was performed.
5.2.2 Manuscript
The results were published in the Journal of Biotechnology (Müller et al., 2016c) (with permission
from Elsevier, Copyright 2016). Paper and accompanying supplementary material are shown below.
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a  b  s  t  r  a  c  t
Due  to its  various  applications  the  protein  streptavidin  is a highly  interesting  target  for  heterologous  pro-
duction.  This  study  focuses  on  different  Escherichia  coli-based  constructs  targeting  a high-level  expression
and  secretion  of  streptavidin  to the  medium.  The  effect  of  various  promoters,  variants  of the  target  gene,
leader  sequences  and  host  strains  on  expression  and  secretion  into  the  culture  broth  was  analyzed.  Consti-
tutive  production  of full-length  streptavidin  fused  with  the  leader  sequence  of the  bglA  gene  from  Bacillus
amyloliquefaciens  by  the periplasmic  ‘leaky  mutant’  E. coli JW1667-5  (lpp-752:kan)  at 30 ◦C  generated
the  highest  yield  of  the  conditions  tested,  surpassing  the extracellular  concentration  of  a conventional
T7-based  expression  system.  Supplementation  of  the  medium  by  the  non-ionic  surfactants  Triton® X-100
and X-45  led  to an improved  secretion  of the protein  to the  culture  supernatant.  Tetrameric  concentra-
tions  of  streptavidin  of  2790  ± 166  nM  were  reached  in  shake  ﬂasks  at  a productivity  of  49.6 nM  h−1.
Optimization  of  conditions  led  to a successful  transfer  to the  bioreactor,  yielding  a  maximal  concen-
tration  of  2608  ±  169 nM  and  a productivity  of  65.2  nM  h−1 in fed-batch  operation.  The  proportion  of
biotin-blocked  binding  sites  of  8.3  ±  4.3%  indicated  a  highly  bioactive  product.
©  2016  Elsevier  B.V.  All  rights  reserved.
1. Introduction
The homotetrameric protein streptavidin (SAV) binds one
molecule of the vitamin biotin per monomer characterized by a
dissociation constant Kd of 4 × 10−14 M (Green, 1990) to 10−15 M
(Bayer and Wilchek, 1990). Being one of the strongest noncova-
lent biological interactions the biotin-binding ability of SAV can be
used in a large variety of applications. Among them are the recov-
ery of biotinylated (Rösli et al., 2008) or peptide-tagged (Skerra and
Schmidt, 1999) proteins, the localization and detection of various
proteins (Zwart and Lewis, 2008), and strategies for drug target-
ing (Muzykantov et al., 1999). Due to its biotin-binding properties
SAV is known to be toxic to bacteria (Chaiet and Wolf, 1964). This
antibiotic effect probably is the reason for its natural occurrence
but complicates its heterologous production using Escherichia coli,
especially for strategies based on intracellular expression.
In contrast to avidin from chicken egg white SAV has no sulfur-
containing amino acids (Argaran˜a et al., 1986), a lower isoelectric
point (Chaiet and Wolf, 1964), and is not glycosylated which offers
Abbreviations: SAV, streptavidin; vvm, volume per volume and minute.
∗ Corresponding author.
E-mail address: jmu@fermtech.techfak.uni-bielefeld.de (J.M. Müller).
1 Both authors contributed equally.
advantages concerning applications of SAV due to less nonspeciﬁc
interactions with substances other than biotin (Bayer and Wilchek,
1990).
The native SAV gene codes for 159 amino acids (16.5 kDa
per monomer). However, various N- and C-terminally shortened
species naturally occur due to limited proteolysis (Bayer et al.,
1989; Sano et al., 1995). The so-called ‘core streptavidins’, small-
est forms of SAV still maintaining the biotin-binding properties of
full-length SAV, consist of 118-127 amino acids and show increased
solubility (Pähler et al., 1987; Sano et al., 1995). Lacking the non-
functional termini, core SAV may  exhibit advantageous properties
in production by reducing the metabolic burden for the host as well
as for applications due to an improved accessibility of the binding
site for biotinylated macromolecules.
Various expression systems for the heterologous production of
SAV are described in literature. Most of them are based on the
biotechnological model bacterium E. coli (Sano and Cantor, 1990;
Miksch et al., 2008; Gallizia et al., 1998; Wu  and Wong, 2006;
Chen et al., 2014). These systems usually lead to the intracellular
accumulation of the protein and inclusion body formation. Oth-
ers report soluble intracellular SAV partly overcoming its toxicity.
Only Miksch et al. (2008) achieved extracellular accumulation of
the protein in its active form. In regard to the necessity of cell dis-
ruption, additional puriﬁcation steps and possibly renaturation for
http://dx.doi.org/10.1016/j.jbiotec.2016.01.032
0168-1656/© 2016 Elsevier B.V. All rights reserved.
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intracellular products the secretion of bioactive SAV to the medium
is desirable. Other studies focus on production of SAV by Pichia
pastoris (Casteluber et al., 2012; Nogueira et al., 2014) and Bacil-
lus subtilis (Wu  et al., 2002; Wu and Wong, 2002). Homologous
production has been reported using the natural producers Strepto-
myces avidinii (Kolomiets and Zdor, 1998; Müller et al., 2013) and
Streptomyces lavendulae.
Using inducible expression systems the metabolic burden is
reduced during bacterial growth, which commonly leads to higher
growth rates compared to constitutive systems. This difference
is even more pronounced if the target protein is toxic (Baneyx,
1999). Approaches based on the inducible T7 expression system
are well-established and frequently used for heterologous protein
production by E. coli. A typical, commercial system consists of E. coli
KRX, a strain characterized by low basal expression (Hartnett et al.,
2006), and plasmids from the pET-series (Novagen, Madison, Wis-
consin, USA). Uncoupling of growth and production can also be
achieved by the use of stationary phase promoters.
However, for the production of SAV Miksch et al. (2008) obtained
best results using a constitutive promoter (PbglA). Secretion to
the culture broth was achieved by the phoA signal sequence for
periplasmic localization of the target protein and a gene coding
for a bacteriocin release protein (BRP) driven by the stationary
phase promoter Pstat52 (Miksch et al., 2005) in order to perme-
abilize the outer membrane in the stationary growth phase. This
active disruption of the outer membrane may  be avoided by the
use of periplasmic ‘leaky mutants’. The K12-derived E. coli strain
JW1667-5 (lpp-752:kan) was created by a single knockout of the
murein lipoprotein gene lpp, affecting the integrity of its cell enve-
lope (Baba et al., 2006; DiRienzo et al., 1978). For similar strains
lacking the lpp gene, Ni et al. (2007) describe enhanced permeabil-
ity of the outer membrane, but no signiﬁcant change in cell growth,
carbon metabolism or fatty acid composition compared to the wild
type. The strain of Ni et al. (2007) has already been used for the pro-
duction and secretion of a maltose binding protein, a xylanase and a
cellulase (Shin and Chen, 2008). Thus, the system seems promising
for secreting small proteins like SAV to the cultivation medium.
Transport of target proteins to the periplasm has several advan-
tages compared to intracellular localization, e.g., reduced protease
activity (Choi and Lee, 2004). In E. coli, this can be achieved by
using signal peptides for the general secretory pathway (Sec). In
the case of toxic proteins like SAV this pathway is advantageous
because the protein remains (partially) unfolded during transport
(Pugsley, 1993), reducing the concentration of bioactive intracel-
lular product. However, secretion efﬁciency strongly depends on
target protein, signal sequence, and host strain (Choi and Lee,
2004). For the secretion of SAV Miksch et al. (2008) used the signal
sequences of the phoA gene for the alkaline phosphatase from E. coli
and of the bglA gene for the -glucanase from Bacillus amylolique-
faciens.  The application of the phoA signal sequence led to secretion
efﬁciencies of almost 100%.
1.1. Performance of selected expression systems
Müller et al. (2013) used the natural producer S. avidinii for
production, yielding 39.2 M of extracellular, tetrameric SAV in
14 days (114 nM h−1) in a fed-batch process. However, due to the
complex morphology and sensitivity of the organism and long cul-
tivation times an efﬁcient heterologous expression system for the
SAV gene is desirable.
Miksch et al. (2008) reported a maximal concentration of 1.6 M
of extracellular SAV in 8 h (200 nM h−1) using E. coli in a stirred
tank bioreactor. Recently, heterologous expression systems were
published based on the yeast P. pastoris and complex methanol-
based fermentation processes (Nogueira et al., 2014; Casteluber
et al., 2012). Nogueira et al. (2014) reached a ﬁnal extracellular
SAV concentration of 11 M in 164 h (67 nM h−1) in the bioreactor.
Casteluber et al. reported even higher concentrations in the range
of 71 M in spinner ﬂasks.1
1.2. Goals of this study
The system of Miksch et al. (2008) as mentioned above led to
remarkable productivities in short cultivation periods. However,
maximal biomass concentrations were low (<10 g L−1, OD600 < 25).
Furthermore, the system contained an -Cm transposon (Miksch
et al., 1997) to avoid uncontrolled expression of the bacteriocin
release protein-encoding gene, causing serious problems in the
genetic stability of the producer strains. To achieve higher dry cell
weight (DCW) concentrations and a more stable expression over
longer periods of time, this study focused on an a novel secretion
strategy avoiding an active disruption of the outer membrane of
E. coli based on the application of the periplasmic ‘leaky mutant’
JW1667-5. Comparable deletion mutants have not been used for
the production of SAV before.
On the genetic level, several promoters, leader peptides, and
a variety of SAV genes differing in chain length and codon usage
were applied. One of the research questions in this context was if
shortened genes (core SAV) can be used for SAV production by E.
coli. Based on an optimized genetic conﬁguration, the performance
of the new construct was compared to a conventional producer
strain (E. coli KRX).
So far, none of the studies performed targeting expression of
the SAV gene by E. coli contained detailed investigations on the
optimization of process conditions. Corresponding experiments
where therefore integrated in the work plan applying various cul-
ture conditions and cultivation parameters (medium, temperature,
supplements) in batch and fed-batch operation. Thus, factors on all
major levels of the development of recombinant production pro-
cesses were part of this study to get a more holistic view of E. coli’s
potential for the production and secretion of SAV.
2. Materials and methods
2.1. Bacterial strains and plasmids
The strain E. coli KRX (Promega, Fitchburg, Wisconsin, USA) was
used for cloning work and as a host for heterologous gene expres-
sion based on the T7 system. The K12 BW25113-derived strain
E. coli JW1667-5, purchased from the Coli Genetic Stock Center
(CGSC, Keio Knockout Collection, Yale University, New Haven, Con-
necticut, USA), was used as a second expression host. S. avidinii (CBS
730.72; DSM 40526) was ordered from CBS (Centraalbureau voor
Schimmelcultures, Utrecht, Netherlands).
The plasmids constructed during this project are given in
Table 1, which contains information on designations and features.
The pET24a vector backbone was  purchased from Novagen (Madi-
son, Wisconsin, USA) and used in combination with E. coli KRX
(plasmids 7–10). For plasmids 1–6 the pEL vector backbone was
used, constructed and generously provided by Maurice Telaar of
Bielefeld University (Germany). Both backbones are shown in Fig.
S2 (Supplementary material).
2.2. Plasmid construction and veriﬁcation of cloning steps
The plasmids used in this project were constructed as described
by Gibson et al. (2009) using the isothermal reaction protocol (50 ◦C,
1 h) and a master mix  purchased from NEB (Ipswich, Massachusetts,
1 Assuming a molecular weight of the core SAV of 56 kDa per tetramer.
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Table  1
Features and designations of plasmids used in this study.
Plasmid number E. coli strain Plasmid backbonea Promoterb Signal peptidec SAV gened Type of secretione
1 JW1667-5f pEL Pbla bglA nat LM
2  JW1667-5 pEL Pbla bglA CO LM
3  JW1667-5 pEL Pbla phoA nat LM
4  JW1667-5 pEL Pbla phoA CO LM
5  JW1667-5 pEL Pstat69 bglA nat LM
6  JW1667-5 pEL Pstat69 bglA CO LM
7  KRX pET24a PT7 bglA nat BRP
8  KRX pET24a PT7 bglA CO BRP
9  KRX pET24a PT7 bglA nat + natSPh BRP
10  KRX pET24a PT7 bglA CO, coreSAVg BRP
a The antibiotic resistance marker used for selection was  tetracycline for the pEL-based vectors and kanamycin for the pET24a-based vectors.
b Promoter for the expression of the SAV gene: Pbla = -lactamase (bla) promoter from E. coli; PT7 = T7 promoter; Pstat69 = stationary phase promoter 69 (Miksch et al., 2005).
c Secretion signal peptide: bglA-SP = -glucanase (bglA) secretion signal peptide from B. amyloliquefaciens,  phoA-SP = alkaline phosphatase (phoA) secretion signal peptide
from  E. coli.
d SAV gene variant: nat = native SAV gene from S. avidinii, CO = codon-optimized gene.
e Method of secretion to the medium: LM = leaky mutant (JW1667-5), BRP = Co-expression of the optimized LppBRP gene (Miksch et al., 2008) under control of the stationary
phase  promoter Pstat52 (Miksch et al., 2005) for secretion of SAV.
f Native SAV gene and native secretion signal peptide in addition to the bglA leader.
g Codons 13–139 of the codon-optimized SAV gene (core SAV).
h Also used for E. coli KRX for the analysis of host strain-dependent secretory differences.
USA). The fragments for the assembly reaction were ampliﬁed by
PCR based on primers with homologous overlaps of up to 30 base
pairs (bp) and puriﬁed by clean-up from agarose gels. A volume
of 3 L of the Gibson Assembly mixture was used to transform
E. coli by electroporation using standard laboratory procedures
(Sambrook, 1989). Relevant plasmid sequences were conﬁrmed
by sequencing at Bielefeld University (IIT Biotech GmbH, Bielefeld,
Germany). A detailed description of the cloning strategy and primer
combinations is given in section S1 in the supplementary material
(Tables S1–S4). Glycerol stocks (20% (v/v)) of the cultures were used
for storage at −80 ◦C.
2.3. Media and supplements for cultivation
HSG medium was used as standard cultivation medium for E. coli
containing glycerol (14.9 g L−1), soy peptone (13.5 g L−1), yeast
extract (7.0 g L−1), NaCl (2.5 g L−1), K2HPO4 (2.3 g L−1), KH2PO4
(1.5 g L−1), and MgSO4·7H2O (0.249 g L−1). The pH was set to 7.4
using 6 N NaOH.
SGA medium (Selvamani et al., 2014) was used as a supplement
and prepared as a ﬁvefold concentrated stock solution. Final con-
centrations of onefold concentrated SGA-medium were: glycerol
(30 g L−1) K2HPO4 (13.53 g L−1), KH2PO4 (6.62 g L−1), citric acid
(1.7 g L−1), EDTA (0.0084 g L−1), MgSO4 (0.585 g L−1), FeCl3·6H2O
(0.0108 g L−1), ZnSO4·7H2O (0.00276 g L−1), MnSO4·H2O
(0.0037 g L−1), CoSO4·7H2O (0.00112 g L−1), CuCl2 (0.00034 g L−1),
H3Bo3 (0.002 g L−1), Na2MoO4·2H2O (0.005 g L−1), and (NH4)2SO4
(10 g L−1).
Substances for supporting secretion of proteins localized in
the periplasmic space were Triton® X-100, X-114, and X-45
(Sigma–Aldrich Chemie GmbH, Seelze, Germany) and glycine,
each supplemented as 200 g L−1 stock solutions or added drop-
wise directly from an undiluted solution (bioreactor experiments).
Isopropyl -D-1-thiogalactopyrano-side (IPTG, 100 mM stock solu-
tion) and rhamnose (200 g L−1 stock solution) were used to induce
transcription of the target gene in E. coli KRX carrying derivatives of
the pET24-based plasmid (plasmids 7–10, Table 1). The antibiotics
kanamycin (50 mg  L−1) and tetracycline (25 mg  L−1) were used to
achieve segregational stability of plasmids.
2.4. Ampliﬁcation of SAV gene and leader peptides
The SAV gene variants were either ampliﬁed from the genome
of S. avidinii or from a codon-optimized gene, which was
commercially synthesized by GeneArt® Gene Synthesis (Life Tech-
nologies, Carlsbad, California, USA; GenBank accession number:
KT344129). The bglA and phoA leader peptides were ampliﬁed from
constructs of Miksch et al. (2008).
2.5. Shake ﬂask and microplate cultivation
Cultivations were carried out in 24-squared well deepwell
plates (Axygen® 24 Well Clear V-Bottom, Corning, New York, USA)
or in shake ﬂasks inoculated to an optical density OD600 of 0.1. The
cultivation volume for microplates was  3 mL.  Plates were sealed by
sterile sealing ﬁlms (BREATHsealTM, Greiner Bio-One International
GmbH, Kremsmuenster, Austria) and incubated at 26, 30 or 37 ◦C
on a rotary shaker (KS 4000 ic control, IKA-Werke GmbH & Co.,
KG, Staufen im Breisgau, Germany) using a frequency of 200 min−1
(shaking diameter: 20 mm).  For shake ﬂask cultivations, 500 mL
bafﬂed glass ﬂasks (DURAN® bafﬂed ﬂask with membrane screw
cap, Schott AG, Mainz, Germany) were ﬁlled with 50 mL  of medium.
The cultures were incubated at 30 ◦C on a rotary shaker (LS-X, Küh-
ner AG, Birsfelden, Switzerland) using a frequency of 150 min−1
(shaking diameter: 50 mm).
2.6. Fermentations in the bioreactor
Fermentations in the bioreactor were performed in a Sixfors fer-
mentation system (Infors HT, Infors AG, Bottmingen, Switzerland)
with unbafﬂed glass vessels. Three six-bladed rushton turbines,
one three-bladed propeller stirrer and one mechanic foam dis-
ruptor were equally distributed on 14.5 cm of the stirrer axis. The
aspect ratio of the reactor was  2.77:1 and the ratio of stirrer to
reactor diameter 0.4. Cultivation was  performed at a stirring fre-
quency of 1000 min−1, 30 ◦C and pH 7.0, controlled by the automatic
addition of 20% (v/v) H3PO4 and 25% (w/w)  NH3. The initial fermen-
tation volume of 400 mL  of HSG medium and variations thereof
was adjusted to an optical density OD600 of 0.5 by an overnight
culture grown in HSG medium. The vessels were aerated with air
saturated by water vapor at a ﬂow rate of 5 vvm (2 NL min−1) or 1.2
vvm (0.48 NL min−1). For fed-batch cultivations, a 870 g L−1 glycerol
solution was  fed at a constant rate of 0.98 mL h−1 after 20 h of cul-
tivation. Samples were automatically taken in intervals of 6 or 8 h,
cooled to 4 ◦C, and processed in intervals of 24 h. To avoid excessive
foaming, media supplemented with the surfactant Triton® X-45 (9
drops per 400 mL  ≈ 0.65 g L−1) contained an additional supplement
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(46 drops per 400 mL  ≈ 4.13 g L−1) of the antifoam agent Pluronic®
PE 8100 (BASF, Ludwigshafen, Germany).
2.7. Determination of substrate (S) and biomass
The concentration of glycerol (S) was measured by ion-exchange
HPLC as described previously (Müller et al., 2013).
For measurement of the optical density OD600 at 600 nm (Bio-
Photometer plus, Eppendorf AG, Hamburg, Germany) samples of
cultures were diluted by a solution of NaCl (9 g L−1) if required, i.e.,
if the optical density was higher than 0.8. The dry cell weight con-
centration X was determined by differential weighing after drying
for 48 h at 60 ◦C using cell pellets acquired from 1 mL of culture
volume washed twice in an aqueous NaCl solution (9 g L−1).
2.8. Determination of the concentration (P) and the proportion of
biotin-blocked binding sites of SAV (Qblocked)
The concentration of soluble SAV was determined by ﬂuores-
cence quenching of biotin-4-ﬂuorescein as described by Kada et al.
(1999a,b). The assay was performed in ﬁnal volumes of 1 mL  as
speciﬁed elsewhere (Müller et al., 2013). Overall binding sites of
SAV were quantiﬁed via heat-based displacement of biotin by B4F
(Müller et al., 2015) by incubating the samples at 70 ◦C for 10 min
prior to the ﬂuorescence measurement. Samples were diluted to
overall SAV concentrations ≤300 nM of tetrameric SAV to allow full
detectability of the binding sites. The biotin-blocked sites were cal-
culated from the difference of the room temperature- (free binding
sites) and the heat-based measurement (overall binding sites) and
scaled from 0 to 1.2
2.9. Fractional cell disruption
In order to separate medium, periplasmic and cytoplasmic cell
fractions, the culture broth was treated by centrifugation followed
by osmotic shock and sonication (Khosla and Bailey, 1989) as
described by Miksch et al. (2008).
3. Results
3.1. Optimization of culture conditions using 24-well-plates
3.1.1. Effect of temperature (E. coli JW1667-5)
E. coli JW1667-5 carrying different plasmids (Table 1) was cul-
tivated at 26 ◦C, 30 ◦C and 37 ◦C in microplates for 48 h. The results
are shown in Fig. 1A and B.
Generally, at a cultivation temperature of 37 ◦C product con-
centrations (Fig. 1A, white bars) were relatively low. Only minor
differences were observed for different plasmids. In contrast to
that at lower temperatures of 26 ◦C (black bars) and especially at
30 ◦C (grey bars) plasmids 1 and 2 led to higher product concen-
trations compared to those achieved with plasmids 3–6. At 30 ◦C,
the signal peptide of the bglA gene from B. amyloliquefaciens (plas-
mids 1 and 2, Table 1) caused improved results compared to the
phoA signal peptide (plasmids 3 and 4) for the secretion of SAV. The
codon-optimized SAV gene (plasmids 2, 4 and 6) did not improve
production toward the native gene (plasmids 1, 3 and 5). Plasmids 1
and 2 providing the constitutive -lactamase promoter from E. coli
Pbla led to a higher extracellular product concentration than plas-
mids 5 and 6 for which SAV gene expression was controlled by the
2 Qblocked = 0: all binding sites are biotin-free; Qblocked = 1: binding sites are com-
pletely biotin-blocked.
strong stationary phase promoter Pstat69. Best results were achieved
for plasmid 1 at 30 ◦C (OD600 of 6.0 ± 0.3, 377 ± 9 nM of SAV in 48 h).
3.1.2. Effects of media supplements (E. coli JW1667-5)
Media supplements were tested in 24-well plates at 30 ◦C to
increase the extracellular product concentration. Triton® X-100
(Yang et al., 1998), glycine (Miksch et al., 2008; Yang et al., 1998),
and ZnSO4 (Beshay et al., 2007; Baneyx et al., 1991) were applied to
cultures of E. coli JW1667-5 carrying either plasmid 1 or plasmid 2
(Table 1) and compared to unsupplemented HSG medium. Triton®
X-100 supplementation (1 g L−1) of the strain carrying plasmid 1 led
to a 2.5 fold higher extracellular product concentration after 24 h
(730 ± 17 nM vs. 292 ± 48 nM)  compared to the reference culture
without decreasing the optical density of the culture (5.94 ± 0.25 vs.
5.58 ± 0.02). Combining this concentration of Triton® with 5 g L−1 of
glycine caused even higher product concentrations (891 ± 92 nM),
but also a strong decrease of the optical density (2.45 ± 0.07). The
addition of glycine alone resulted in lower optical densities and
unimproved SAV concentrations. Application of plasmid 2 gener-
ally brought about lower product concentrations. Detailed results
are shown in Fig. S1 in the Supplementary material. When com-
pared to the initial conditions (unsupplemented HSG medium,
37 ◦C), Triton® X-100 supplementation at 30 ◦C led to a 6.3 fold
increase of the extracellular product concentration and a 12.7 fold
increase of productivity. Thus, the following experiments were
performed based on plasmid 1, cultivation at 30 ◦C, and Triton®
supplementation.
3.1.3. Host-dependent efﬁciency of product secretion: E. coli
JW1667-5 vs. E. coli KRX
To calculate the efﬁciency of product secretion to the culture
medium, cytoplasmic, periplasmic, and extracellular SAV concen-
trations were measured and compared. Based on the results of the
previous sections, E. coli JW1667-5 carrying plasmid 1 (Table 1) was
cultivated in microplates in 3 mL  of HSG medium supplemented
with 1 g L−1 of Triton® X-100. Samples were taken after 12, 24 and
48 h of cultivation. Periplasmic and cytoplasmic product concen-
trations were acquired by fractional cell disruption of cell pellets
after 48 h of cultivation. A culture of E. coli KRX carrying plasmid 1
was treated similarly in order to compare the performance of the
mutant JW1667-5 to an established production strain. Results are
shown in Fig. 1C and D.
Cultivation of the strain KRX carrying plasmid 1 led to an OD600
of 10.0 ± 0.3 and an extracellular concentration of SAV of 439 ± 38
nM (Fig. 1C) after 48 h of cultivation. The strain JW1667-5 grew
faster in the beginning of the cultivation and reached its ﬁnal
OD600 of 5.9 ± 0.10 already after 24 h of cultivation. The extracellu-
lar product concentration reached its maximum of 779 ± 24.7 nM
after 24 h. In the culture of E. coli KRX carrying plasmid 1 containing
no active secretion system (neither BRP, nor periplasmic knock-
out) 439 ± 38 nM of SAV (35%) were located in the supernatant,
543 ± 116 nM (43%) in the periplasmic fraction, and 277 ± 37 nM
(22%) in the cytoplasm of the cells (Fig. 1D). In total the culture
produced about 1259 nM soluble tetrameric SAV corresponding
to a process selectivity SP/X of 126 nM per OD600 unit. The strain
JW1667-5 carrying the same plasmid secreted more than 95% of
the 783 nM of soluble SAV produced to the medium, leading to a
selectivity of 137 nM per OD600 unit.
In conclusion, E. coli KRX led to higher overall product con-
centrations, but accumulated the majority of bioactive product in
cytoplasm and periplasm due to the lack of a periplasmic secretion
system. Regarding downstream processing the strain JW1667-5
therefore is beneﬁcial.
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Fig. 1. Cultivation of E. coli JW1667-5 carrying variants of the pEL plasmid (Table 1) in 24-well plates in HSG medium at different cultivation temperatures. Designations
refer  to promoter, secretion signal peptide and target gene variant of the SAV expression cassette. Concentrations of tetrameric SAV in the culture supernatant P (A) and
corresponding optical densities at 600 nm OD600 (B) 48 h post inoculation are shown. For plasmid 1, a comparison of the host strain was  performed. (C, D) Comparison of
E.  coli JW1667-5 and E. coli KRX both carrying plasmid 1 in a 24-well deepwell plate in 3 mL  of HSG medium supplemented by 1 g L−1 Triton® X-100 at 30 ◦C. (C) Optical
density OD600 and extracellular concentration of extracellular tetrameric SAV P after 12, 24 and 48 h of cultivation. (D) Concentration of tetrameric SAV P in different fractions
(extracellular, periplasmic space and cytoplasmic) after 48 h of cultivation.
3.1.4. BRP-mediated secretion of SAV by E. coli KRX and
expression of a core SAV gene
For an active secretion of SAV by E. coli KRX, BRP-based
secretion of the protein was analyzed by using plasmids 7–10
(Table 1). Screening in 24-well plates led to optimized cultiva-
tion conditions allowing the accumulation of soluble extracellular
SAV. Using HSG medium supplemented with 1 g L−1 of rham-
nose and 0.01 mM of IPTG for induction of expression, and 1 g L−1
of Triton® X-100 for improved secretion yielded a maximum of
550 nM of extracellular tetrameric SAV after 48 h of cultivation
at 30 ◦C (data not shown), slightly surpassing the concentra-
tion of the KRX-based experiments applying plasmid 1 (Fig. 1C).
Again, the native SAV gene (plasmid 7) led to higher produc-
tivities than the codon-optimized gene (plasmid 8). Remarkably,
a codon-optimized core SAV gene (AA 13–139, plasmid 10) led
to no detectable SAV, even upon Triton®-supplementation of the
medium.
3.1.5. Evaluation of additional constructs
Two additional concepts were evaluated regarding their poten-
tial to reduce the toxicity of SAV to the host: a construct expressing
the full-length SAV gene including its native secretion signal pep-
tide (plasmid 9) and a co-expression-based construct (plasmid
11, Fig. S2(B) in the supplements) for the simultaneous expres-
sion of the SAV-binding Nanotag 15 (Lamla and Erdmann, 2004)
under control of the strong, constitutive CP25 promoter (Jensen
and Hammer, 1998). However, neither of the constructs led to
improved SAV production (see Supplementary material, Section S3
for details).
3.2. Shake ﬂask cultivations
The following experiments were based on E. coli JW1667-5 car-
rying plasmid 1. After optimization of culture conditions in 24-well
plates, the next steps of process development were batch and fed-
batch cultivations in bafﬂed 500 mL  shake ﬂasks using a culture
volume of 60 mL  (Fig. 2). Different media were tested for this pur-
pose, which were supplemented with Triton® X-100 due to the
favorable effects on cell mass and product concentration (Section
3.1.2).
Firstly, the positive effect of Triton® X-100 on the SAV con-
centration described before was reproduced for cultivation in
shake ﬂasks. After 27 h of cultivation 863 ± 3 nM of tetrameric
extracellular SAV was measured in Triton®-supplemented culture
(productivity p = 32.0 nM h−1, medium composition (b) in Fig. 2)
compared to 484 ± 56 nM (p = 17.9 nM h−1, medium composition
(a)) in Triton®-free HSG medium. A drawback was the decrease
of the DCW concentration after 12 h of cultivation upon Triton®
supplementation.
Secondly, an SGA supplement in the basic medium increased
both the optical density and product concentration. After the batch
phase of the cultivation at 36.5 h a maximum of 1778 ± 31 nM
of extracellular tetrameric SAV was  achieved in the culture with
48 mL  of HSG and 12 mL  of ﬁvefold concentrated SGA medium,
corresponding to a productivity p of 48.7 nM h−1. A reduced SGA
supplement (6 mL)  led to 1587 ± 21 nM after 36.5 h of cultivation
(p = 43.5 nM h−1).
Thirdly, adding 10% (v/v) of ﬁvefold concentrated SGA
medium after 37.8 h of cultivation to the culture grown in
the 48 mL  HSG/12 mL  SGA-combination (medium composition (d),
Fig. 2) resulted in a further boost of the extracellular prod-
uct concentration. This fed-batch strategy led to a maximum
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Fig. 2. Cultivation of E. coli JW1667-5 carrying plasmid 1 (Table 1) at 30 ◦C in three replicates in shake ﬂasks using different cultivation media. Labels refer to the basic
medium composition. (A) Plot of the dry cell weight concentration X over the cultivation time t. (B) Plot of the extracellular tetrameric SAV concentration P. All cultures were
supplemented two times with 10% (v/v) of ﬁvefold concentrated SGA medium indicated by the grey, shaded areas. Biomass measurements were performed onefold due to
small cultivation volumes.
of 2790 ± 166 nM of tetrameric extracellular SAV after 56.3 h
(p = 49.6 nM h−1).
3.3. Transfer to the bioreactor
The non-ionic surfactant Triton® X-100 caused excessive foam-
ing in the initial bioreactor experiments. To avoid this problem,
foaming of the surfactant was titrated by an antifoam agent
(Pluronic® PE 8100) in shake ﬂask experiments. A detailed anal-
ysis led to the conclusion that shorter-length variants of Triton®
like Triton® X-45 are more suitable for bioreactor cultivations (see
Section S3 in Supplementary material for an elaborate discussion).
Combining Triton® X-45 and Pluronic® PE 8100 in the bioreactor
resulted in negligible amounts of foam on the gas–liquid inter-
face even for high volumetric ﬂow rates due to low foam stability.
The properties were particularly advantageous for high rotary fre-
quencies of the stirrer, resulting in a rapid disruption of emerging
foam, an essential feature for an efﬁcient control of pH and feeding
during fermentation. Therefore, Triton® X-45 was used for the sub-
sequent studies in the bioreactor. The concentration of surfactant
was reduced from 1 g L−1 to 0.65 g L−1, because shake ﬂask stud-
ies indicated that this concentration is sufﬁcient for an efﬁcient
secretion.
3.4. Bioreactor fermentation
Various batch and fed-batch strategies were evaluated in biore-
actor experiments. The preparation of concentrated SGA medium
regularly resulted in precipitates, which cause abrasive effects on
the stirrer in the bioreactor. This factor, the complex preparation
procedure and composition of SGA medium, and occasional, inex-
plicable intermediary lag phases for combinations of HSG and SGA
medium led to the decision not to apply SGA-based media in the
bioreactor. Variations of HSG medium were used instead. Feeding
of 870 g L−1 glycerol was applied for fed-batch studies. Fig. 3 shows
a selection of batch fermentations.
Fig. 3D shows that twofold concentrated HSG medium was
most suitable for an increased production of SAV. A higher C/N-
ratio (Fig. 3B and C) led to improved SAV formation for an
initial glycerol concentration of 40 g L−1, but yielded worse results
and residual glycerol in the end of cultivation for an additional
increase to 80 g L−1. A maximal SAV concentration of 1570 ± 77 nM
was reached for the cultivation using twofold concentrated HSG
medium after 36 h of cultivation (Fig. 3D), corresponding to
a productivity of 43.6 nM h−1 as opposed to 944 ± 34 nM after
42 h (22.5 nM h−1) in the reference culture (Fig. 3A). Using a
threefold concentrate of HSG medium did not result in further
improvements (see Supplementary material, Fig. S3). The pro-
portion of biotin-blocked binding sites measured by heat-based
ﬂuorescence quenching of B4F was in the range of 5–10% for all
of the cultivations (data not shown), indicating a high bioactivity
of the product. Glycerol depletion after 24 h suggested the applica-
tion of a glycerol feeding after the initial growth phase for improved
product concentrations.
Thus, feeding of glycerol was applied to twofold concentrated
HSG medium, leading to the fermentation course shown in Fig. 4.
To ensure scalability of the process the air ﬂow rate was  reduced
from 5 to 1.2 vvm. The constant fed-batch process led to an SAV
concentration of 2607 ± 169 nM after 40 h of cultivation, corre-
sponding to a productivity of 65.2 nM h−1. The heat-based assay for
the determination of total binding sites of SAV yielded a proportion
of biotin-blocked binding sites of 8.3 ± 4.3% in the interval 40–56 h.
The process additionally led to the highest speciﬁc productivity
pspec (3.8 nmol g−1 h−1) of this study.
Table 2 sums up the results of the bioreactor and shake ﬂask
experiments, highlighting maximal values for both the batch and
the fed-batch studies.
3.5. Analysis of product toxicity and secretion efﬁciency in the
bioreactor
Cell fractions of different bioreactor cultivations were analyzed
by fractional cell disruption and determination of the proportion
of biotin-blocked binding sites Qblocked (Section 2.8). Fig. 5A sums
up the results. The sum of the concentration of SAV in all of the
fractions was  set to 100%. Like for the shake ﬂask cultivations,
the majority of SAV (91 ± 5%) accumulated as extracellular product
facilitating the puriﬁcation of the protein without cell disruption
and emphasizing the secretory potential of the strain. The propor-
tion of biotin-blocked SAV was  approximately 3.3 fold higher in the
cytoplasmic fraction than in the other fractions, independent from
the time of sampling.
3.6. Summary of the results
Several factors on the level of cultivation conditions and the
genetic composition of the producer strain were analyzed in this
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Fig. 3. Batch cultivations of E. coli JW1667-5 carrying plasmid 1 (Table 1) in the bioreactor using different cultivation media supplemented by Triton® X-45 (0.65 g L−1). (A)
standard HSG medium (reference), (B) HSG with 40 g L−1 of glycerol, (C) HSG with 80 g L−1 of glycerol, (D): twofold concentrated HSG medium. Abbreviations: rDO = relative
dissolved oxygen saturation, X = dry cell weight concentration, S = substrate concentration (glycerol), P = extracellular SAV concentration, t = cultivation time. Due to technical
problems no signal of the oxygen electrode is available for the reference cultivation (A) after 15 h onwards.
Fig. 4. Fed-batch cultivation of E. coli JW1667-5 carrying plasmid 1 (Table 1) in the bioreactor in twofold concentrated HSG medium supplemented by Triton® X-45 (0.65 g L−1).
A  870 g L−1 glycerol solution was used for feeding. Abbreviations: rDO = relative dissolved oxygen saturation, X = dry cell weight concentration, S = substrate concentration
(glycerol), P = product concentration (SAV), Vfed = fed volume (feed solution), t = cultivation time. Glycerol was  added to the culture medium after 20 h at a constant ﬂow rate
of  0.98 mL  h−1 (on an initial cultivation volume of 400 mL).
study in respect to their potential to improve SAV production by
the E. coli leaky mutant JW1667-5.
The characterization of various producer strains resulted in the
following optimal genetic conﬁguration of the producer strain:
maximal extracellular product concentrations were achieved for
(i) a native full-length SAV gene (ii) under control of the relatively
weak constitutive promoter of the bla gene (iii) fused to the bglA
signal peptide. The leader peptide was  of increased importance
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Table 2
Summary of the production processes using E. coli JW1667-5 carrying plasmid 1 (Table 1) in the bioreactor. Maximal bioreactor values for the batch and fed-batch experiments
or  shake ﬂask cultivations are printed in bold face.
Mediuma Cultiv. modeb Xmax [g L−1]c Pmax [nM]c pSAV,max [nM h−1]d sP/X [nmol g−1]e pspec [nmol g−1 h−1]f
HSG B 9.40 ± 0.35 (16 h) 944 ± 34 (42 h) 22.5 100 2.4
HSG  cGly: 40 g L−1 B 16.28 ± 0.31 (20 h) 1337 ± 18 (42 h) 31.8 82 2.0
HSG  cGly: 80 g L−1 B 16.34 ± 0.24 (42 h) 875 ± 20 (42 h) 20.8 54 1.3
2x  HSG B 19.08 ± 2.98 (12 h) 1570 ± 77 (36 h) 43.6 82 2.3
3x  HSG B 30.78 ± 0.55 (36 h) 311 ± 3 (36 h) 8.6 10 0.3
2x  HSG FB 17.17 ± 0.31 (40 h) 2608 ± 169 (40 h) 65.2 152 3.8
HSG/SGA FB SF 15.80 (56 h) 2791 ± 166 (56 h) 49.8 177 3.2
a Batch medium for the cultivation; cGly refers to the initial glycerol concentration (14.9 g L−1 for onefold concentrated HSG medium, if not speciﬁed otherwise). All
bioreactor-based processes were performed applying a Triton® X-45 supplement of 0.65 g L−1. For shake ﬂask results (FB SF), 1 g L−1 of Triton® X-100 was applied.
b Cultivation mode: B = batch, FB = fed-batch. For the fed-batch process a 870 g L−1 glycerol concentrate was  fed at a constant feed rate of 0.98 mL h−1 after 20 h. FB SF refers
to  the shake ﬂask fed-batch cultivation of Fig. 3, medium composition (d) (HSG/SGA medium combination with feeding of 5x SGA concentrate).
c Maximal dry cell weight (X) or product concentration (P). The number in brackets refers to the cultivation time at which the maximum was  reached.
d Productivity in the time interval from start of cultivation to the maximal product concentration.
e Process selectivity sP/X = Pmax/Xmax.
f Speciﬁc productivity pspec = pSAV,max/Xmax.
t
Fig. 5. Cellular localization of SAV upon optimization (A) and summary of the results of the optimization procedure (B). (A) Evaluation of the fractional localization of SAV
and  the proportion of biotin-blocked SAV Qblocked acquired by fractional cell disruption of E. coli JW1667-5 carrying plasmid 1 (Table 1) cultivated in the bioreactor. The
bars  represent average values of three cultivations and three time points (n = 3 × 3). (B) Relative improvement of the maximal extracellular product concentration caused by
selected parameters in comparison to a reference cultivation procedure. Error bars were derived from gaussian error propagation. The parameters of optimization (labels)
refer  to: (a) surfactant: HSG + 1 g L−1 Triton® X-100 (optimized) vs. HSG (microplate, reference), (b) temperature: 30 ◦C vs. 37 ◦C (microplate), (c) promoter: Pbla vs. Pstat69
(microplate), (d) leader peptide: bglA-natSAV vs. phoA-natSAV (microplate), (e) host strain: E. coli JW1667-5 vs. KRX (microplate), (f) medium: 2x HSG vs. HSG  (bioreactor),
and  (g) cultivation mode: fed-batch (glycerol feed) vs. batch (bioreactor).
for a cultivation temperature of 30 ◦C, indicating interactions of
these two factors. Finally, (iv) the host used for SAV production had
a strong impact on the accumulation of extracellular SAV, lead-
ing to improved results for the E. coli leaky mutant JW1667-5 in
comparison to E. coli KRX. Codon-optimization of the SAV gene did
not improve SAV production, whereas no free binding sites were
detectable in the supernatant for the application of a core SAV gene.
The native, full-length SAV gene from S. avidinii thus seems to be
the most suitable for heterologous expression by E. coli.
On the level of process optimization, two key factors were iden-
tiﬁed. Supplementation of the medium by Triton® X-100 led to a
nearly complete (95%) secretion of SAV from the periplasm to the
medium by the leaky mutant JW1667-5 containing plasmid 1. The
portion of secreted SAV was much lower (35%) for the established
producer strain E. coli KRX in the presence of the detergent, which
emphasizes the inherent properties of the knockout mutant used in
this study. The cultivation temperature was of equal importance in
the optimization procedure. Lowering it from 37 to 30 ◦C not only
improved SAV production but also increased the optical density of
the culture. These results indicate reduced host toxicity, which has
been a central issue for expression of the SAV gene by E. coli.
Up-scaling of the process to the bioreactor resulted in foam-
ing issues due to the detergent Triton® X-100. Foam formation
was efﬁciently avoided by using the lower chain-length variant
Triton® X-45 in combination with addition of antifoam agent with-
out negatively affecting product secretion. In the presence of both
supplements (Triton® and antifoam agent), the producer strain was
successfully employed for bioreactor fermentation.
4. Discussion
This study shows that E. coli JW1667-5 is a suitable strain for
the preparative heterologous production of SAV. The impact of the
single parameters optimized throughout this study on the maximal
extracellular concentration of SAV produced by this strain is shown
in Fig. 5B. The addition of surfactants to the medium, the optimiza-
tion of cultivation temperature, and the choice of promoter and
leader peptide had a major effect (factor larger 2) on the product
concentration. All of these factors contribute to a more efﬁcient
secretion of unfolded product (Sec pathway) and thus potentially
reduce the toxicity of SAV for the host. The improved results for the
bglA signal peptide are in in contrast to the ﬁndings of Miksch et al.
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(2008), who reported improved results for the phoA signal peptide
for a different vector backbone and E. coli BL21(DE3). Generally,
the codon-usage of the SAV gene had an only minor impact on the
product concentration, which may  be due to the relatively weak
promoter. The lack of active streptavidin in the core SAV-based con-
struct may  be an effect of binding of core SAV to the biotin carboxyl
carrier protein (Wang et al., 2005), which potentially reduces the
proportion of bioavailable binding sites.
Combinations of optimized conditions for the genetic param-
eters allowed the development of more sophisticated process
strategies. In this context, direct optimization of the biomass
concentration (3x HSG) turned out to be inefﬁcient, whereas a
well-balanced process (mediocre biomass concentration) led to
an improved product concentration, process selectivity, and spe-
ciﬁc productivity. Overall, the optimization procedure improved
the productivity and the extracellular product concentration by
factors of 31.5 ± 5.3 and 26.3 ± 4.4, respectively (E. coli JW1667-5
carrying the Pbla-phoA-natSAV construct in HSG medium at 37 ◦C
in a batch process in the microplate vs. the same strain carry-
ing Pbla-bglA-natSAV in Triton®-supplemented 2x HSG medium at
30 ◦C in a fed-batch process in the bioreactor). In general, Triton®-
supported cultivation may  be a useful tool for future expression
studies applying E. coli periplasmic leaky mutants, since secretion
efﬁciency is strongly protein-dependent for lpp-knockout strains
(Shin and Chen, 2008).
To our best knowledge, the product concentrations achieved in
this study are the highest concentrations for the soluble, extracel-
lular production of SAV by E. coli reported to date. The maximal
extracellular product concentration of 2608 ± 169 nM in the biore-
actor after 40 h of cultivation (Fig. 4) surpasses the reference
bioreactor concentration of 1600 nM given in literature (Miksch
et al., 2008) by a factor of 1.63. The maximal concentration
of 2790 ± 166 nM achieved in shake ﬂask fed-batch experiments
(Fig. 2(d)) corresponds to an increase toward the reference value
of 1715 nM (Miksch et al., 2008) by a factor of 1.63, emphasizing
the potential of the construct. However, the data of Miksch et al.
(2008) is based on batch experiments, whereas the results of this
study refer to fed-batch cultivations.
P. pastoris seems to offer advantageous properties for the pro-
duction of streptavidin, since the studies of Casteluber et al. (2012)
(71 M)  and Nogueira et al. (2014) (11 M)  led to signiﬁcantly
higher product concentrations. However, both of these publica-
tions were based on the ﬂammable and highly toxic organic solvent
methanol, causing strong heat evolution, and oxygen demand, as
well as increased cost for transport and storage on the indus-
trial scale. The functionality of Casteluber’s process has only been
demonstrated for spinner ﬂasks aerated through a porous stone at
an air ﬂow rates of 4 vvm. This system is not characterized regarding
technical properties like power input and oxygen transfer, drasti-
cally complicating scale-up. Furthermore, the process was  based
on a washing step between growth and production, preventing
a single-vessel fermentation and bearing the risk of contamina-
tion. Thus, a direct comparison of the bioreactor data of this study
is only possible toward Nogueira’s process, which was also per-
formed in a standard bioreactor. Their product concentration was
4.2 fold higher, but the process led to a higher proportion of biotin-
blocked binding sites (20% vs. 8.3 ± 4.3% in this study). Due to
comparable productivities (67 vs. 65 nM h−1), Nogueira’s process
was much longer (overall 10 vs. 3 days). The productivity in this
study was achieved for a drastically lower dry cell weight concen-
tration of 17.2 ± 0.3 g L−1 instead of the surprisingly high 235 g L−1
in Nogueira’s process (for the given medium, DCW concentrations
are typically in the range of <160 g L−1 for the medium applied; Jahic
et al., 2002), resulting in a 3.3 fold improved process selectivity (47
(P. pastoris) vs. 152 nmol g−1 (E. coli)). This corresponds to a more
efﬁcient conversion of the substrates to the actual product. From
the engineering point of view, the process described here was  per-
formed in conditions of poor oxygen supply by the use of un-bafﬂed
vessels and aeration with regular air, whereas Nogueira’s process
was dependent on supplementation with pure oxygen. Overall, the
choice of host and process may  therefore primarily depend on the
properties of the available fermentation system (oxygen supply,
cooling, safety properties) rather than the productive properties of
the host.
Heat-based evaluation of the overall binding sites of SAV indi-
cates that the extracellular product in the supernatant of the leaky
mutant was highly bioactive. Although only small proportions of
SAV were located in the cytoplasm for optimized culture condi-
tions (see Fig. 5A), the high proportion of biotin-blocked binding
sites in this compartment (3.3 fold increased toward medium and
periplasm) suggests that toxic effects on the host observed for the
expression of the SAV gene by E. coli may  primarily be the result
of cytoplasmic biotin binding. However, further investigations are
necessary, e.g., to determine whether leakage of folded, biotin-
blocked SAV from the cytoplasm to other cellular fractions takes
place throughout cultivation.
To further enhance the systems’ productivity the promoter may
be exchanged as Pbla is known to be relatively weak (Liang et al.,
1999). Optimization may  also be performed on the host strain, e.g.,
by the knockout of protease genes, supported by the higher overall
concentration of SAV in E. coli KRX.
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S1 – plasmid construction 
 
The plasmids used for this study were created mainly by the isothermal assembly reaction 
described by Gibson et al. (2009). Primers used for the amplification of the fragments are 
shown in the following tables. Short descriptions of the cloning strategy are given below the 
tables. Gene sequences refer to coding sequences (CDS). 
 
Tab. S1 Primers used for the construction of plasmids 7 to 10 (Tab. 1 in the main document). Primer pairs consisted of one 
forward (fwd) and one reverse (rev) primer. 
primer 
designation 
sequence (orientation: 5`3`) remark 
primer 1 
(fwd) 
CCCCATCGGTGATGTCGGCGATATAGGC Linearization of 
pET24a for insertion 
of LppBRP 
expression cassette 
primer 2 
(rev) 
AAGATCGGGCTCGCCACTTCGGGCTCATG 
primer 3 
(fwd) 
GCCTATATCGCCGACATCACCGATGGGGAATTC
GAGCTCGCTCTTGTCAAATTC 
Amplification of Pstat52 
from plasmid p616 
(Miksch et al. 2008) primer 4 
(rev) 
CGCGCCCAGTACCAGTTTAGTAGCTTTCATAACT
CGATCCTTATAAAATGAAAAG 
primer 5 
(fwd) 
ATGAAAGCTACTAAACTGGTACTGGGCGCGGTA
ATCCTGGGTTCTACTCTGCTGGC 
Amplification of 
LppBRP CDS from 
plasmid pBADLpp- 
BRPmalE, (Sommer 
et al. 2009) 
primer 6 
(rev) 
CATGAGCCCGAAGTGGCGAGCCCGATCTTAGAG
TTTGTAGAAACGCAAAAAGGCCATCC 
primer 7 
(fwd) 
ATGTATATCTCCTTCTTAAAGTTAAACAAAATTAT
TTCTAGAGGGGAATTGTTATC 
Linearization of 
pET24a for insertion 
of SAV CDS and 
secretion signal 
peptide 
primer 8 
(rev) 
ACCACCACCACCACCACTGAGATCCGGCTGCTA
ACAAAG 
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Tab. S1 (continued) Primers used for the construction of plasmids 7 to 10 (Tab. 1 in the main document). Primer pairs 
consisted of one forward (fwd) and one reverse (rev) primer. 
primer 
designation 
sequence (orientation: 5`3`) remark 
primer 9 
(fwd) 
TTGTGTGGGATCACTTCTAGTGTTTCGGCCGAC
CCCTCCAAGGACTCGAAGGCCCAGGTC 
Amplification of native 
SAV CDS from the 
genome of S. avidinii primer 10 
(rev) 
GCCGGATCTCAGTGGTGGTGGTGGTGGTTTATT
ACTGCTGAACGGCGTCGAGCGGGTTGC 
primer 11 
(fwd) 
TTATACCAAGTGCCAGTGATGCCAGCTTCAGCG
GCCGAAACACTAGAAGTGATC 
Amplification of bglA 
secretion signal 
sequence from 
plasmid p545 (Miksch 
et al. 2008) 
primer 12 
(rev) 
CTTTAAGAAGGAGATATACATATGAAACGAGTGT
TGCTAATTCTTGTCACCGG 
primer 13 
(fwd) 
GGCCGAAACACTAGAAGTGATCCC Linearization of 
plasmid 7 (Tab. 1) for 
exchanging SAV CDS primer 14 
(rev) 
ACCACCACCACCACCACTGAGATCC 
primer 15 
(fwd) 
GTGTGGGATCACTTCTAGTGTTTCGGCCCGCAA
GATCGTCGTTGCAGCCATCG 
Amplification of native 
SAV CDS including 
the native secretion 
signal  peptide from 
S. avidinii genome 
primer 10 
(rev) (see 
also above) 
GCCGGATCTCAGTGGTGGTGGTGGTGGTTTATT
ACTGCTGAACGGCGTCGAGCGGGTTGC 
primer 16 
(fwd) 
GCCGGATCTCAGTGGTGGTGGTGGTGGTTTATT
AGGACGCGGCAGATGGTTTCACTTTAG 
Amplification of the 
codon-optimized core 
SAV gene from a 
vector synthesized by 
GeneArt 
primer 17 
(rev) 
GCTGAAGCTGGCATCACTGGCACTTGGTATAAC
CAGCTGGGTTCCACGTTCATTG 
primer 18 
(fwd) 
GTGTGGGATCACTTCTAGTGTTTCGGCCGATCC
GTCCAAGGATTCTAAAGCGCAGGTATCTG 
Amplification of the 
codon-optimized full 
length SAV gene from 
a vector synthesized 
by GeneArt 
primer 19 
(rev) 
GATCTCAGTGGTGGTGGTGGTGGTTTATCACTG
CTGTACCGCGTCCAGCGGATTACCGTTG 
 
Primers 1 to 19 (Tab. S1) were used to amplify fragments for plasmids 7 to 10 (Tab. 1). The 
general cloning strategy was to first introduce the LppBRP exression cassette inte the pET24 
backbone. Primers 1 to 6 (Tab. 6) were used for this step. For construction of plasmid 7 
(Tab. 1) the native SAV CDS and the bglA secretion signal were amplified as well as the 
plasmid backbone carrying the LppBRP expression cassette. Primers 7 to 12 were used for 
this second step. Starting from plasmid 7 (Tab. 1) plasmids 8 to 10 were constructed by 
introducing different variants of the SAV gene into the vector. For this purpose, primer 10 and 
primers 13 to 19 were used. 
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Tab. S2 Primers used for the construction of plasmid 1 to 6 (Tab. 1). Primer pairs consisted of one forward (fwd) and one 
reverse (rev) primer. 
primer 
designation 
sequence (orientation: 5`3`) remark 
primer 20 
(fwd) 
ACTCTTCCTTTTTCAATATTATTGAAGCATTTATC Linearization of 
plasmid backbone 
used for plasmids 1 
and 2 (Tab. 1) 
primer 21 
(rev) 
ATCCGGCTGCTAACAAAGCCCGAAAG 
primer 22 
(fwd) 
GGGCCTTCGAGTCCTTGGAGGGGTCGGCCGAA
ACACTAGAAGTGATCCCACACAAAC 
Amplification of bglA 
secretion signal 
sequence from 
plasmid p545 (Miksch 
et al. 2008) 
primer 23 
(rev) 
CAATAATATTGAAAAAGGAAGAGTATGAAACGAG
TGTTGCTAATTCTTGTCACCGGATTG 
primer 9 
(fwd) (see 
also Tab. S1) 
TTGTGTGGGATCACTTCTAGTGTTTCGGCCGAC
CCCTCCAAGGACTCGAAGGCCCAGGTC 
Amplification of native 
SAV CDS from the 
genome of S. avidinii 
primer 24 
(rev) 
CTTTCGGGCTTTGTTAGCAGCCGGATTTATTACT
GCTGAACGGCGTCGAGCGGGTTG 
primer 25 
(fwd) 
CGGTAAGAGTGCCAGTGCAATAGTGCTTTGTTTC
ACACTCTTCCTTTTTCAATATTATTGAAGCATTTA
TC 
Linearization of 
plasmid 1 (Tab. 1) 
with deletion of bglA 
secretion signal 
sequence and 
introducing phoA 
secretion signal 
peptide using primer 
extensions 
primer 26 
(rev) 
TTACTGTTTACCCCTGTGACAAAAGCCGACCCCT
CCAAGGACTCGAAGGCCCAGGTCTC 
primer 27 
(rev) 
TTACTGTTTACCCCTGTGACAAAAGCCATGGATC
CGTCCAAGGATTCTAAAGC 
primer 28 
(fwd) 
CAATACAGTATAGAACAAATTTGCAAATTTGGCA
AGATGAATGTATTTAGAAAAATAAACAAATAGGG
GTTCCGCGCACATTTC 
Linearization of 
plasmid 1 (Tab. 1) 
with deletion 
promoter Pbla and 
introducing promoter 
Pstat69 using primer 
extensions 
primer 29 
(rev) 
AAGGAAGAGTATGAAACGAGTGTTGCTAATTCTT
GTCACCGGATTG 
primer 16 
(see also 
Tab. S1) 
GCCGGATCTCAGTGGTGGTGGTGGTGGTTTATT
AGGACGCGGCAGATGGTTTCACTTTAG 
Amplification of the 
codon-optimized CDS 
coding for SAV 
primer 30 
(rev) 
CTTTCGGGCTTTGTTAGCAGCCGGATTTATCACT
GCTGTACCGCGTCCAGCGGATTACC 
primer 31 
(fwd) 
TGTATTTAGAAAAATAAACAAATAGGGGTTCCGC
GCACATTTCC 
Linearization of 
plasmid backbone 
used for plasmids 5 
and 6 (Tab. 1) 
primer 21 
(rev) (see 
also above) 
ATCCGGCTGCTAACAAAGCCCGAAAG 
 
Plasmids 1 to 6 (Tab. 1) were constructed starting with a different plasmid than before 
carrying the Pbla promoter as well as a tetracycline resistance marker. Primers used for this 
second set of plasmids are listed in Tab. S2. Cloning work started with plasmids 1 and 2 
(Tab.1). Primers 20 and 21 were used for linearization of the backbone. In a first step primer 
9 and primers 22 to 24 were used in order to introduce a native CDS coding for full-length 
SAV and the bglA secretion signal (plasmid 1, Tab. 1). For plasmid 2 (Tab. 1) primers 16 and 
30 (Tab. S1 and S2) were used to amplify the condon-optimized SAV gene. 
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For construction of Plasmids 3 and 4 (Tab. 1) the bglA secretion signal sequence was 
exchanged by phoA. Therefore primers 28 and 29 were used before phosphorylation and 
self-ligation of the linearized plasmid (T4 polynucleotide kinase and T4 DNA ligase, Life 
Technologies GmbH, Darmstadt, Germany). 
 
For introducing the Pstat69 promoter (Miksch et al. 2005) instead of the Pbla promoter primers 
28 and 29 were used resulting in plasmids 5 and 6 (Tab. 1) depending on which Plasmid was 
used for linearization (plasmid 1 oder 2, Tab. 1). 
 
Tab. S3 Primers used for the construction of plasmid 11 (Fig. S2). Primer pairs consisted of one forward (fwd) and one 
reverse (rev) primer. 
primer 
designation 
sequence (orientation: 5`3`) remark 
primer 31 
(fwd) 
AGAAGGAGATATACATATGGACGTCGAAGCCTG
GCTTGGTGCGCGTGTACCGCTGGTGGAAACCTA
ATAGTGCTCCAGGTACCCAAAAAACCCCTCAAG
A 
Linearization of 
plasmid 1 (Tab. 1) for 
introduction of 
promoter CP25 and 
Nanotag 15 CDS 
using primer 
extensions 
primer 32 
(rev) 
TAAAAACAGTACTATGTGATTATACCAGCCCCCT
CACTACATGTCAAGAATAAACTGCCAAAGCAAGA
CTGGCCTCATGGGCCTTC 
 
Primers 31 and 32 (Tab. S3) were used for linearization of plasmid 1 (Tab. 1). Promoter 
CP25 and Nanotag 15-CDS were introduced using primer extensions. After phosphorylation 
the linearized plasmid was ligated. The resulting plasmid was plasmid 11 (Fig. S2). 
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S2 – effect of various media supplements on product concentration and biomass 
 
Different supplements were tested to compare their effect on the formation of streptavidin 
and biomass. Results are shown in Fig. S1. 
 
 
Fig. S1 Effect of permeabilizing compounds glycine, Triton® X-100 and ZnSO4 on extracellular product concentrations. E. coli 
JW1667-5 carrying variants of a plasmid either containing the native (plasmid 1, Tab. 1) or the codon-optimized (plasmid 2) 
SAV gene was cultivated in 24-well plates in 3 mL of HSG medium supplemented by different permeabilizing substances at 
30 °C. Reference cultures without supplements are designated ‘HSG’. The cultures were harvested 24 h post inoculation. 
The bars show the extracellular concentration of biotin-free, tetrameric SAV P and the optical density at 600 nm OD600. The 
number in parenthesis indicates the plasmid used. 
 
In an additional experiment, glycine was supplemented to HSG medium in concentrations of 
1 to 10 g L-1, which did also not improve the streptavidin productivity (data not shown). 
 
 
S3 – additional plasmid variants 
 
Two additional concepts were tested for their potential to reduce the toxicity of streptavidin to 
the host E. coli JW1667-5: a construct expressing the full-length native streptavidin gene 
including its native secretion signal peptide and a co-expression-based construct for the 
simultaneous expression of the streptavidin-binding Nanotag 15 (Lamla and Erdmann 2004) 
under control of the strong constitutive promoter CP25 (Jensen and Hammer 1998). Both 
constructs were evaluated due to their potential ability to block fractions of the free binding 
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sites in the cytoplasm by either the native signal peptide or the streptavidin-binding peptide 
tag, thus potentially reducing the availability of the sites for biotin. The corresponding plasmid 
maps are shown in Fig. S2. 
 
 
 
Fig. S2 Additional plasmid variants constructed and used for E. coli KRX (plasmid 9, A) and E. coli JW1667-5 (plasmid 11, B). 
The vectors contained either a kanamycin resistance gene (KanR, pET24) or a tetracycline (TetR, pEL). Origins of replication 
were either pBR322- (pET24) or pUC-based (pEL). Promoters are designated by P, terminators by T. Further relevant 
features: Pbla = bla promoter, PT7 = T7 promoter, bglA-SP = bglA secretion signal peptide from B. amyloliquefaciens, natSAV 
= native streptavidin gene from S. avidinii, TT7 = T7 transcription terminator, TrrnB = E. coli rrnB transcription terminator 
(Brosius et al. 1981), Pstat69 = stationary phase promoter 69 (Miksch et al. 2005), natSP = native SAV secretion signal peptide 
from S. avidinii, co-expression of peptide tag: PCP25 = CP25 promoter (Jensen and Hammer, 1998), Nanotag 15 = CDS for 
Nanotag 15 (Lamla and Erdmann 2004), co-expression of BRP gene: Pstat52 = stationary phase promoter 52 (Miksch et al. 
2005), LppBRP = optimized bacteriocin release protein (Miksch et al. 2008). 
The plasmid variant based on the native signal peptide and SAV gene yielded 131 ± 7 nM in 
an expression study with E. coli KRX (24-well plate, 30 °C, 48 h of cultivation, HSG medium 
supplemented with 1 g L-1 of rhamnose, 0.01 mM of IPTG and 1 g L-1 of Triton® X-100) as 
opposed to 550 nM in the reference cultivation (see main document). 
 
Co-expression of the Nanotag 15 led to reduced concentrations of SAV (100 ± 19 nM vs. 
377  ± 9  nM after 48 h of cultivation) in 24-well plates at 30 °C in the absence of the 
surfactant when compared to the reference vector (plasmid 1 in the main document). 
Supplementation by Triton® X-100 led to an even more pronounced difference. 
 
 
S3 – variation of surfactants in shake flasks for the scale-up to bioreactors 
 
Due to excessive foaming in early bioreactor experiments, shake flask experiments were 
performed to analyze, whether titration of the foaming effect of the surfactant by an antifoam 
agent (Pluronic PE 8100) was possible and if this strategy had an impact on product 
secretion. 
 
To analyze the impact of the choice of surfactant on the performance of Escherichia coli 
JW1667-5 carrying plasmid pEL-Pbla-bglASP-natSAV (plasmid 1, Tab. 1 in the main 
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document), different surfactants were supplemented in a concentration of approximately 
0.5 g L-1 to cultures of the strain in HSG medium in the presence of 25 mg L-1 of tetracycline. 
Cultivation was performed in 300 mL unbaffled shake flasks filled with 30 mL of medium at 
28 °C and a shaking frequency of 150 min-1 (shaking diameter: 5 cm). The flasks were 
directly inoculated from a glycerol stock with a volume fraction of 0.1 % (v/v) (30 µL). 
Antifoam agent was supplied to shake flasks as indicated in the caption of Fig. S3. The 
concentration of necessary antifoam agent was derived from bioreactor experiments at high 
volumetric flow rates. Samples were taken after 20 and 46 h, respectively. Results are shown 
in Fig. S3. 
 
 
Fig. S3 Cultivation of E. coli JW1667-5 carrying plasmid 1 (Tab. 1) in unbaffled shake flasks at 28 °C in HSG medium in the 
presence of various surfactants. Abbreviations: Ref = reference culture (no surfactant), AF = antifoam agent (Pluronic
®
 PE 
8100), dps = drops of antifoam agent per 60 mL of medium. Cultivations were performed in duplicates. Each sample was 
analyzed twice (n = 2x2), resulting in standard deviations calculated from four measurements. 
Studies applying Triton X-100 caused the necessity of large amounts of the antifoam agent. 
Foam formation for 5 drops of surfactant was successfully avoided by the addition of 54 
drops of Pluronic. Moreover, the properties of foam formation and stability of Triton X-100 
were not optimal. Thus, a selection of Triton variants was screened for less stable foam and 
reduced foam formation. Triton contains a hydrophilic polyethylene oxide chain, which 
differs in length for different commercial agents. Triton X-100 is characterized by an average 
chain length of 9.5. According to the supplier information, shorter chain lengths should result 
in a decrease of both foam formation and stability. The two surfactants Triton X-114 
(average chain length: 7.5) and Triton X-45 (average chain length: 5) showed improved 
properties in this respect. Triton X-45 showed the additional advantage that foam was 
rapidly mechanically disrupted by the impact of the foam disruptor in the bioreactor. Both 
surfactants needed less antifoam agent for reduced foaming. For Triton X-45, 12 drops of 
antifoam agent were sufficient per 5 drops of the surfactant when mixed in 300 mL of 
medium in the bioreactor. 
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Triton® X-45 was chosen for the following studies in the bioreactor, since the smallest 
amount of antifoam agent was necessary to prevent foam formation and the extracellular 
product concentration was among the highest in the experiment. 
Combinations of Triton® and antifoam agent were found to result in higher apparent biomass 
concentrations and a higher turbidity already in the beginning of cultivation. Furthermore, the 
initial biomass concentrations of fermentations in a bioreactor in the presence of both 
compounds were higher than expected when compared to the optical density of the 
inoculum. This effect is most likely due to insoluble aggregates formed by the two 
supplements, rather than to an actual increase of the biomass concentration. 
 
S4 – Additional batch fermentation 
 
S4.1 Batch experiments 
 
Additional fermentations in the bioreactor were performed to characterize the performance of 
Escherichia coli JW1667-5 carrying plasmid 1 (Tab. 1). As the twofold concentrated HSG 
medium resulted in an improved performance of the strain, a threefold concentrate with 
twofold concentrated salts (sodium chloride, potassium phosphate and magnesium sulfate) 
was tested. The corresponding plot is shown in Fig. S4. 
 
Fig. S4 Batch cultivation of E. coli JW1667-5 carrying plasmid 1 (Tab. 1) in 3fold concentrated HSG medium (twofold 
concentrated salts) in the bioreactor at 30 °C. Abbreviations: X = dry cell weight concentration, S = substrate concentration 
(glycerol), P = extracellular streptavidin concentration, t = cultivation time. 
 
Fig. S4 shows that the 3fold concentrate results in an improved biomass production, but at 
the same time causes a decreased SAV concentration. Therefore, this medium was not used 
for further experiments. 
 
Additional references 
 
Brosius J, Ullrich A, Raker MA, Gray A, Dull TJ, Gutell RR, Noller HF (1981) Construction and fine mapping of 
recombinant plasmids containing the rrnB ribosomal RNA operon of E. coli. Plasmid 6:112-118 
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5.2.5 Additional information: coexpression of inhibitors
As described in the article, the production of SAV by E. coli typically leads to toxic eﬀects on the
host. Thus, parts of the experiments focused on the coexpression of potential inhibitors of toxicity.
For this purpose, one of the constructs allowed the cytoplasmic coexpression of the Nano-tag15 (Lamla
& Erdmann, 2004) under control of the synthetic, strong, and constitutive promoter CP25 (Jensen &
Hammer, 1998). This strategy was performed to prevent cytoplasmic biotin from binding to folded
SAV in this cellular compartment by the competition of peptide tag and vitamin for the binding
pocket of SAV (and ideally displacement of SAV-bound biotin). The inhibitor was chosen based on
the favorable aﬃnity for SAV and the low molecular weight of the peptide analogue towards potential
nucleic acid-based inhibitors (see Table 2.1, p. 7).
To investigate on a theoretical basis whether this is a promising strategy, the concept was analyzed
by modelling.
5.2.5.1 Modelling of the competition: model development
The model was based on the assumption that during competition for the binding pocket of SAV
the species of free SAV and the complexes SAV-biotin, and SAV-inhibitor approach a steady state, in
which all corresponding concentrations are constant. This assumption leads to the consequence that
the respective association and dissociation terms have to level out. The change of concentrations of
the complexes SAV-biotin cSB and SAV-inhibitor cSI can thus be described by the following diﬀerential
equations:
dcSB
dt
= cSAV · cB · kb+ − cSB · kb− ≈ 0 (5.1)
dcSI
dt
= cSAV · cI · ki+ − cSI · ki− ≈ 0 (5.2)
where cSAV is the concentration of free SAV and ki+ and ki− are the rate constants for the associa-
tion and dissociation for the binding and release of the inhibitor to SAV, respectively. Corresponding
constants can be deﬁned for biotin (kb+/−).
Generally, association and dissociation of the SAV-inhibitor complex are characterized by equa-
tion 5.3.
SAV + I ki+− ===−
ki−
SI (5.3)
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where SAV , I, and SI are the species of free SAV and inhibitor and SAV-inhibitor-complex, respec-
tively.
Association and dissociation of the SAV-biotin complex can be depicted in a similar manner. In
a steady state, both equations reach an equilibrium characterized by the corresponding dissociation
constants Kd,i and Kd,b, exemplarily shown for the SAV-inhibitor-complex:
Kd,i =
ki−
ki+
= cSAV · cI
cSI
(5.4)
as a ratio of the rate constants or the concentrations of dissociated and associated species.
The steady states of equations 5.1 and 5.2 may be combined with equation 5.4 and the analogous
dissociation constant for the SAV-biotin-complex Kd,b to yield:
dcSB
dt
= cSAV · cB − cSB ·Kd,b ≈ 0 (5.5)
dcSI
dt
= cSAV · cI − cSI ·Kd,i ≈ 0 (5.6)
where the new expressions are gathered via division of equations 5.1 and 5.2 by the rate constants ki+
and kb+ for the formation of the respective complexes.
In addition to this equilibrium, the mass balances for all species have to be fulﬁlled in the steady
state. These balances are given in equations 5.7, 5.8 und 5.9.
nSAV,0 = nSAV + nSI + nSB (5.7)
nB,0 = nB + nSB (5.8)
nI,0 = nI + nSI (5.9)
where nSAV,0, nB,0, and nI,0 are the overall (molar) amounts of SAV, biotin, and inhibitor, respec-
tively, completed by the amounts of free and complex-bound species of these compounds in steady
state conditions.
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By combining these mass balances and equations 5.5 and 5.6 and assuming volume constancy,[1]
a system of diﬀerential equations is acquired with the two unknown complex concentrations cSI and
cSB:
dcSB
dt
= (cSAV,0 − cSI − cSB) · (cB,0 − cSB)− cSB ·Kd,b ≈ 0 (5.10)
dcSI
dt
= (cSAV,0 − cSI − cSB) · (cI,0 − cSI)− cSI ·Kd,i ≈ 0 (5.11)
Equations 5.10 and 5.11 can now be used for calculations of the steady state concentrations of both
complexes for varying concentrations of biotin, SAV, and inhibitor as well as for diﬀerent dissociation
constants.
5.2.5.2 Modelling of the competition: results of the simulation
Simulation of the competition of biotin and the Nano-tag15 (Kd,i ≈ 4 nM, Lamla & Erdmann, 2004;
see Table 2.1, p. 7) for the binding pocket of SAV was based on an intracellular concentration of
biotin of 10 nM (data for E. coli K12, Prakash & Eisenberg, 1979) and a monomeric intracellular
concentration of SAV of 50 nM, roughly based on the results of Miksch et al. (2008).
Three diﬀerent scenarios for the dissociation constant of the SAV-biotin-complex were evaluated
based on literature: Kd,b = 10
−12M (Chivers et al., 2010, 'best case'), Kd,b = 2.5×10−13M
(Reznik et al., 1998, 'medium case'), and Kd,b = 10
−15M (Sano et al., 1996, 'worst case'). Re-
sults for the simulation are shown in Fig. 5.2.
Generally speaking, the model suggests that a quantitative displacement of biotin by the pep-
tide tag is only probable for the two scenarios based on the data of Chivers et al. (2010) and
Reznik et al. (1998). In these scenarios, cytoplasmic concentrations in the range of 1 g L−1 of inhibitor
would suﬃce for the displacement of a majority of intracellular biotin. Based on Sano's scenario,
however, the necessary concentration of inhibitor would be in the range of 10 to 100 g L−1.
In addition to these problems, the strategy bears the risk of a leakage of inhibitor to the medium.
This would cause blocked binding sites due to the peptide tag. Thus, the result that no improvements
were visible for the coexpression of the peptide tag may either be due to insuﬃcient intracellular
concentrations of inhibitor or to blocking of secreted SAV. Therefore, this concept has to be rethought
in detail for further investigations. Potential strategies to avoid leakage of the inhibitor may, e.g., involve
fusion of the peptide tag to a protein or use of the larger SBP-tag (Keefe et al., 2001) (see Table 2.1,
7) to achieve properties favoring retention of the inhibitor in the cytoplasm.
[1]allowing direct conversion of the mass balances to concentrations
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Fig. 5.2: Simulation of the competition of biotin and Nano-tag15 for the binding pocket
of SAV based on equations 5.10 and 5.11. Parameters: cSAV,0 = 50nM (monomeric),
cB,0 = 10 nM (Prakash & Eisenberg, 1979), worst case: Kd,b = 10−15 (Sano et al., 1996),
medium case: Kd,b = 2,5×10−13 (Reznik et al., 1998), best case: Kd,b = 10−12 M (Chivers
et al., 2010). Abbreviations of the species concentrations: cSAV,free: concentration of
biotin-free SAV, cSI : concentration of SAV-inhibitor-complex, cSB: concentration of
SAV-biotin-complex. The course of the concentration of free SAV was identical for all
scenarios.
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5.3 Production of SAV by Pichia pastoris
More than 600 genes have successfully been heterologously expressed by the yeast P. pastoris by
the end of 2007 (Zhang et al., 2009). The organism can thus be considered one of the key hosts
for eukaryotic heterologous protein production. The popularity of P. pastoris is derived from various
extraordinary properties like facile growth to DCW concentrations of up to 160 g L−1 in fed-batch
operation in synthetic media (Jahic et al., 2002), the availability of the tightly regulated and very
strong methanol-inducible AOX1 promoter (Ellis et al., 1985), a high secretion eﬃciency for heterol-
ogous proteins (Cregg et al., 2000), and a low number of contaminating extracellular host proteins
(Cregg et al., 1993). The host is also capable of performing various posttranslational modiﬁcations
on the target protein (Cregg et al., 2000). Typical extracellular concentrations of heterologous pro-
teins range from several hundred milligrams to some grams per liter of supernatant, emphasizing the
remarkable potential of this host (Cos et al., 2006; Macauley-Patrick et al., 2005; Cereghino et al.,
2002).
Unlike E. coli, P. pastoris naturally requires the supplementation of biotin to the cultivation medium,
potentially complicating the heterologous production of biotin-binding proteins. Only recently,
Gasser et al. (2010) created biotin prototrophic strains of P. pastoris by genetic engineering. De-
spite this fact, production of SAV by this host was successfully established by Nogueira et al. (2014)
and Casteluber et al. (2012), applying common biotin auxotrophic producer strains. The general suit-
ability for the production of biotin-binding proteins was furthermore demonstrated by the successful
expression of avidin genes (Zocchi et al., 2003; Jungo et al., 2007a).
5.3.1 Goals of this study
The heterologous production processes of Nogueira et al. (2014) and Casteluber et al. (2012) were
dependent on the ﬂammable and toxic organic solvent methanol for induction (Zhang et al., 2009).
As corresponding processes cause problems of heat evolution (Niu et al., 2013) and oxygen demand
(Khatri & Hoﬀmann, 2006) on the industrial level, the goal of this study was to establish a methanol-
free production system for SAV based on this yeast.
5.3.2 Manuscript
The results were accepted for publication in Biotechnology Progress (Müller et al., 2016a) (Copyright
Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.). The revised manuscript used
for submission and the supporting information are shown hereinafter.
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Streptavidin is a homotetrameric protein binding the vitamin biotin and peptide analogues
with an extremely high affinity, which leads to a large variety of applications. The biotin-
auxotrophic yeast Pichia pastoris has recently been identified as a suitable host for the
expression of the streptavidin gene, allowing both high product concentrations and produc-
tivities. However, so far only methanol-based expression systems have been applied, bringing
about increased oxygen demand, strong heat evolution and high requirements for process
safety, causing increased cost. Moreover, common methanol-based processes lead to large
proportions of biotin-blocked binding sites of streptavidin due to biotin-supplemented media.
Targeting these problems, this paper provides strategies for the methanol-free production of
highly bioactive core streptavidin by P. pastoris under control of the constitutive GAP pro-
moter. Complex were superior to synthetic production media regarding the proportion of
biotin-blocked streptavidin. The optimized, easily scalable fed-batch process led to a tetra-
meric product concentration of up to 4.166 0.11 mM of biotin-free streptavidin and a pro-
ductivity of 57.8 nM h21 based on constant glucose feeding and a successive shift of
temperature and pH throughout the cultivation, surpassing the concentration in un-optimized
conditions by a factor of 3.4. Parameter estimation indicates that the optimized conditions
caused a strongly increased accumulation of product at diminishing specific growth rates (l
 D< 0.01 h21), supporting the strategy of feeding. VC 2016 American Institute of Chemical
Engineers Biotechnol. Prog., 32:855–864, 2016
Keywords: continuous shift of temperature and pH, biotin-free streptavidin, bioreactor fed-
batch process optimization, proteolysis, parameter estimation
Introduction
The homotetrameric protein streptavidin (SAV) is used as
a tool for various molecular applications. Originally isolated
from culture supernatants of Streptomyces avidinii and Strep-
tomyces lavendulae in the 1960s,1,2 its nearly universal
applicability results from extraordinary binding properties for
the vitamin biotin. The SAV-biotin interaction is characte-
rized by a dissociation constant Kd in the range of 10
215 M
and a remarkable biochemical stability in respect to extremes
of pH, temperature, and other factors.3–5 The interaction
therefore provides useful properties for the purification and
detection of various macromolecules, e.g. for affinity chro-
matography of proteins by the peptide-based Strep-tagVR
technology.6 The biotin-binding ability of SAV is shared by
several proteins from various species like variants produced
by Streptomyces venezuelae,7 avidin from chicken egg white
or bradavidin from Bradyrhizobium japonicum.8
Natural SAV contains a core sequence essential for biotin-
binding9,10 surrounded by C- and N-terminal regions that are
reported to reduce the stability of the protein and may
decrease the accessibility of the binding pocket for biotiny-
lated macromolecules.11 Thus, truncated forms of SAV, typi-
cally containing 118 to 127 amino acids (AA) instead of the
159 AA of mature full-length SAV, are commonly used for
Additional Supporting Information may be found in the online ver-
sion of this article.
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heterologous expression. These are referred to as “core
streptavidins.”
Sano and Cantor12 were the first to publish a heterologous
expression system for the SAV gene in Escherichia coli.
Since then, multiple studies were based on this host.13–17
The production of SAV by Bacillus subtilis has also been
studied extensively.18–20 Due to limited secretory efficiency
and/or cytoplasmic expression, these hosts commonly suffer
from intracellular binding of biotin by SAV. As this vitamin
is an important cofactor involved in carboxylation reactions
in the central metabolism of pro- and eukaryotes,21,22 biotin
deprivation strongly limits growth and therefore the accumu-
lation of SAV in most heterologous producers.
Although Pichia pastoris is known to be a suitable host
for the expression of the biotin-binding protein avidin since
the early 2000s,23 the SAV gene has only recently been
expressed in this yeast. Publications on the expression of
both core24 and full-length SAV25 in P. pastoris resulted in
remarkable concentrations of up to 4 g L21 (71 mM)* and
0.65 g L21 (11 mM) of SAV, respectively. Comparable prod-
uct concentrations have so far only been reported for the
secretion of the protein by the natural producer S. avidinii,26
documenting the outstanding properties of P. pastoris as a
host for heterologous protein production. However, both
studies were based on the methanol-inducible alcohol oxi-
dase 1 (AOX1, abbreviated AOX hereinafter) promoter. This
causes high requirements for process management and safety
due to the flammable and toxic properties of the organic sol-
vent,27 leading to increased cost. Furthermore, for the culti-
vation of Mut1 (methanol utilization plus) strains containing
an intact AOX1 gene, the use of methanol is accompanied by
a strong increase in heat evolution28,29 and oxygen demand,
leading to challenges in fermentation processes.30,31 Finally,
methanol brings about specific by-products like formalde-
hyde and hydrogen peroxide.32 Thus, production systems
designed for a methanol-free expression of the gene of inter-
est are desirable.
One of the major drawbacks for the expression of the
SAV gene by P. pastoris is caused by the biotin auxotrophy
of the commonly used wild type strains. Only recently engi-
neered, biotin-prototrophic strains have been designed.33 For
that reason, fermentations typically rely on biotin supple-
mentation of the media, resulting in a decreased yield of bio-
active SAV due to biotin-blocked binding sites. Typical
proportions of bioactive binding sites are in the range of 3.2
free binding sites per tetramer of SAV.25
Biotin-deficiency of the yeast Saccharomyces cerevisiae
results in a reduced content of DNA, RNA and total pro-
tein,34 and AA depletion.35 These effects can partly be com-
pensated by supplementation of media with aspartic acid,
oleic acid or Tween 80 as a source of fatty acids.36,37
A commonly used, strong promoter for the methanol-
independent gene expression by P. pastoris is the
glyceraldehyde-3-phosphate (GAP) dehydrogenase promoter
(PGAP) from the central carbon metabolism.
38 Operational
strategies for this promoter were recently reviewed.39
Although constitutive, the expression level of PGAP depends
on the specific growth rate of the host40 and the carbon
source, showing stronger expression for glucose and glycerol
than for methanol.27,38,41 Fructose was identified as another
promising candidate.42
This study addressed the two major challenges of SAV pro-
duction by P. pastoris: The dependency on methanol when
using the AOX promoter accompanied by the solvent-associ-
ated problems discussed above and the high proportion of
inactive SAV due to its production in biotin-supplemented
media. These problems were targeted by a PGAP-based expres-
sion system and a step-wise optimization approach of culture
conditions for increased concentrations of bioactive SAV.
Materials and Methods
Strains, vector construction, and transformation in E. coli
E. coli DH5aTM (Invitrogen/Life Technologies, Darmstadt,
Germany) was used for vector manipulation and amplifica-
tion. Expression of the SAV gene was performed by the
P. pastoris strain X-33 (Life Technologies). The expression
vector was constructed using the pUC-based pPpT4_GAP_aS
vector backbone (Pichia Pool/TU Graz, Graz, Austria),43
designed for the constitutive, secretory expression of the
gene of interest in P. pastoris by use of the GAP promoter
and the a-mating factor secretion signal from S. cerevisiae.
Further elements include the AOX terminator after the gene
of interest and a Zeocin
TM
-resistance gene for selection of
transformants of P. pastoris and E. coli, respectively.
The vector backbone was linearized by PCR and joined to
a core SAV gene (AA 13-139), which was amplified from
the genome of S. avidinii CBS 730.32 (Centraalbureau voor
Schimmelcultures, Utrecht, Netherlands), by isothermal
assembly at 508C for 1 h, as described by Gibson et al.44
The Gibson Assembly Mastermix was purchased from NEB
(New England Biolabs, Frankfurt/Main, Germany).
The construct was used for electroporation of E. coli
DH5a
TM
cells, which were prepared according to standard lab-
oratory procedures.45 Transformants were plated on selective
LB agar (5 g L21 yeast extract, 10 g L21 tryptone, 10 g L21
NaCl, 15 g L21 agar) supplemented with 100 mg L21 of Zeo-
cin
TM
(Invivogen, Toulouse, France). The plates were incubated
overnight at 378C. Clones were characterized by plasmid iso-
lation, restriction analysis, and DNA sequencing (Sequencing
Core Facility, Bielefeld University, Bielefeld, Germany). Posi-
tive clones were cultivated overnight in 300 mL shake flasks
with 30 mL of LB medium supplemented with Zeocin
TM
to a
final concentration of 50 mg L21 for plasmid isolation for the
transformation of Pichia pastoris.
Transformation of P. pastoris and clone characterization
Competent P. pastoris X-33 cells were prepared, trans-
formed and plated according to Lin-Cereghino et al.46 For
transformation, approximately 4 mg of plasmid DNA were
linearized via overnight digestion by BamHI, purified by
PCR clean-up, and concentrated by a vacuum concentrator
(SpeedVac
TM
, Thermo Fisher Scientific, Waltham, USA).
Screening for producers was performed in 24 well v-bottom
deepwell microplates (Axygen Scientific, Schwerte,
Germany).
Bioreactor fermentation
Bioreactor experiments were performed in a sixfold fer-
mentation system in unbaffled vessels (Sixfors, Infors HT,
*Homotetrameric concentration, calculation based on a molecular weight
of 56 kDa.
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Bottmingen, Switzerland) with a maximal volume of
500 mL and an initial filling volume of 400 mL. Three rush-
ton impellers, one propeller impeller and one mechanical
foam disruptor were installed in the vessels from bottom to
top. Cells were cultivated at 308C, 1000 min21 and an air
flow rate of 0.48 NL min21 (1.2 vvm). The input air was
pre-saturated by water vapor. The pH value was controlled
by the automatic addition of 20% (w/w) H3PO4 and 25% (w/
w) NH3. The latter also served as nitrogen source. One drop
per 100 mL of antifoam agent (Pluronic 8100, BASF, Lud-
wigshafen, Germany) was supplemented to the medium.
Automatic sampling was performed by fraction collectors,
instantly cooling the samples to 48C. The bioreactors were
inoculated to reach an OD600 of 0.2 or 0.5 by an overnight
shake flask culture in Zeocin
TM
-free YPD medium.
First cultivations were performed in synthetic basal salt
medium (BSM)47 supplemented with the PTM1 trace salt
solution. BSM composition was 26.7 mL L21 of 85% (w/w)
H3PO4, 0.93 g L
21 CaSO4, 18.2 g L
21 K2SO4, 14.9 g L
21
MgSO4  7 H2O, 4.13 g L21 KOH, and 40.0 g L21 glycerol
or glucose. Glucose and the PTM1 solution were sterilized
separately by autoclaving and sterile filtration, respectively.
A volume of 4.35 mL of PTM1 was added per L of BSM
medium. This solution contained 6.0 g L21 CuSO4  5 H2O,
0.08 g L21 NaI, 3.0 g L21 MnSO4  H2O, 0.2 g L21
Na2MoO4  2 H2O, 0.02 g L21 H3BO3, 0.5 g L21 CoCl2,
20.0 g L21 ZnCl2, 65.0 g L
21 FeSO4  7 H2O, 0.2 g L21
biotin and 5.0 mL L21 98% (w/w) H2SO4. BSM-based proc-
esses usually were performed at pH 5.0.
Two complex media (YPD and MGY) were tested in fur-
ther experiments at pH 6.0. YPD composition was (per L)
20 g soy peptone (UD Chemie, W€orrstadt, Germany), 10 g
yeast extract (Ohly, Hamburg, Germany), 20 g glucose, pH
7.0. MGY medium47 was additionally supplemented with
13.4 g L21 of yeast nitrogen base without AA and with
ammonium sulfate (YNB, Difco, BD, Heidelberg, Germany),
which was sterile-filtered as a 10x concentrate and supple-
mented after sterilization. Glucose was sterilized separately.
Feed solutions were either based on concentrates of the
medium or glucose and were supplemented with 2 mL per
100 mL of a biotin-free PTM1 solution in the latter case.
For the final fed-batch process strategy based on MGY
medium, feeding of an aqueous 500 g L21 solution of glu-
cose was initiated after 20 h of cultivation at a constant flow
rate of 2 mL h21 (approx. 5 mL L21 h21 based on the initial
cultivation volume). The setpoints of pH and temperature
were successively shifted throughout the cultivation from 6.0
to 4.0 and 308C to 248C, respectively.
Analytical methods: Biomass, product and substrate
The dry cell weight (DCW) concentration X was deter-
mined by differential weighing of cell pellets in pre-dried
and pre-weighed 1.5 mL reaction tubes acquired from 1 mL
of culture washed twice in demineralized water (centrifuga-
tion at 13,000 min21 for 10 min). Pellets were dried at 508C
until constancy of weight was reached (typically after 48 h).
SAV was quantified by the fluorescence quenching assay
developed by Kada et al.48,49 using a calibration curve of
biotin-4-fluorescein (B4F, GERBU Biotechnik, Heidelberg,
Germany) in concentrations equivalent to 0-600 nM of tetra-
meric SAV. The measurement buffer consisted of 100 mM
NaCl, 1 mM EDTA and 50 mM NaH2PO4 adjusted to pH
7.5. Prior to measurements, the buffer was supplemented
with 0.1 g L21 bovine serum albumin (BSA, GERBU Bio-
technik) and 50 nM of B4F. Samples of 20 mL were added
to 980 mL of this solution, vortexed and incubated at RT for
30 min, followed by fluorescence measurement in a RF-5301
PC fluorimeter (Shimadzu Deutschland, Duisburg, Germany;
excitation: 495 nm, emission: 525 nm) in disposable semi-
micro PS cuvettes (BRAND, Wertheim, Germany).
HPLC analysis of glycerol and glucose was performed as
described elsewhere.26 Where indicated, glucose was ana-
lyzed by an enzyme-based kit (ENZYTEC
TM
D-Glucose/D-
Fructose, R-Biopharm, Darmstadt, Germany).
Quantification of biotin-blocked binding sites
The quantification of biotin-blocked binding sites was per-
formed by the displacement of SAV-bound biotin by B4F
via heat incubation as described previously.50 SAV-
containing supernatants were diluted to tetrameric
concentrations 300 nM. Samples of 20 mL were mixed
with 980 mL of measurement buffer with BSA and B4F and
vortexed for 1 s. The solution was incubated at 708C for
10 min in a laboratory heat block (VWR International,
Darmstadt, Germany) with water-filled wells to allow bind-
ing of B4F to biotin-blocked binding sites. After heat incu-
bation the solution was inverted threefold, incubated at RT
for 30 min and analyzed by fluorescence quenching as
described above. The proportion of biotin-blocked streptavi-
din Qblocked [-] in the sample was calculated by Eq. (1):
Qblocked5
Pblocked
PHT
5
PHT2PRT
PHT
(1)
where Pblocked [nM of tetrameric SAV] is the concentration
of biotin-blocked binding sites, PHT [nM] is the SAV con-
centration measured after heat incubation at 708C (overall
streptavidin), and PRT [nM] is the SAV concentration meas-
ured at room temperature (biotin-free binding sites of SAV).
Quantitative analysis of fermentation courses: Modelling
For a quantitative analysis, the fermentation courses were
evaluated on the basis of a four-parameter logistic growth
model as described in Eq. (2):51
X tð Þ5 a2d
11 tc
 b1d (2)
where X [g L21] is the DCW concentration, t [h] is the time
and a (minimal asymptote), b (slope), c (inflection point),
and d (maximal asymptote) represent the specific parameters.
Where indicated, this model was also applied to describe the
degradation of biomass.
Based on the resulting regression curve for X, calculations
of the specific growth rate l [h21] were performed according
to Eq. (3):
l5
1
X
dX
dt
1D  1
X
dX
dt
1
F
V
(3)
where D [h21], which was only part of the calculations for
fed-batch processes, is the dilution rate, corresponding to
the ratio of the feed rate F [mL h21] and momentary cultiva-
tion volume V [mL]. The flow rate for sampling (approx.
1.7 mL h21) was considered for the volume balance of the fer-
menter. Maximal specific growth rates lmax were determined
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for X> 2 g L21 on the one hand to minimize errors for very
small biomass concentrations and on the other hand to calculate
‘macroscopic’ growth rates. The lag phase was determined in
the interval from inoculation to the cultivation time where l
surpassed 0.01 h21.
The courses of l and X were used for the calculation of
the local volumetric productivity ploc [nM h
21] based on
Eq. (4), a variation of the Luedeking-Piret equation:52
ploc5l 
ﬃﬃﬃ
X
p
 fr
|ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
Pfr
1l  X  frX
|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
PfrX
1X  fX
|ﬄﬄ{zﬄﬄ}
PfX
(4)
where fr, fX, and frX are growth- and/or biomass-related
model parameters, corresponding to terms for a strongly
growth-associated (fr [nM]) (primary), growth-associated (frX
[nmol g21]), and non-growth-associated (fX [nmol g
21 h21])
(secondary) product formation. The initial product concentra-
tion P0 [nM] was part of the parameter estimation. Product
arising from each model term was evaluated according to the
horizontal braces. Constraints for P0 and X0 [g L
21] were
chosen according to the Supporting Information, section S1.
Confidence intervals for the parameters were determined as
described in section S2. Two additional definitions of the
productivity were used for a more detailed analysis:
pspec5
ploc
Xloc
(5)
pSTY5
P2P0
t
(6)
where pspec [nmol g
21 h21] is the (local) specific productiv-
ity related to the local biomass concentration Xloc and pSTY
(space time yield) [nM h21] is the overall productivity for
the product concentration P at a given time point t. ploc and
pspec therefore served as parameters for a kinetic analysis,
whereas pSTY was used for the overall balance of the pro-
cess. For courses of pspec, the product concentration was
directly fit to Eq. (2) to minimize deviations. Additionally,
the process selectivity sP/X [nmol g
21] was considered for
the balance as defined in Eq. (7):
sP=X5
P
X
(7)
If not specified otherwise, all of these parameters refer to
extracellular tetrameric biotin-free streptavidin. Parameter
estimation and simulation based on the acquired parameters
was performed in Scilab 5.5.053 using the Levenberg-
Marquardt-algorithm (lsqrsolve-function). Plots were created
in Gnumeric 1.12.17.
Results and Discussion
Vector construction, transformation and screening
Construction of the GAP promoter-based vector
pPpT4_GAP_aS-cSAV and transformation into P. pastoris
X-33 yielded three producers. Microplate fed-batch charac-
terization of the clones in YPD medium (YPD medium with
glycerol instead of glucose) resulted in 2.526 0.01 mM of
streptavidin in 96 h, corresponding to a volumetric produc-
tivity p of 26 nM h21. As shake flask cultivation in YPD
and YPG medium indicated slightly superior production
kinetics for glucose instead of glycerol (Supporting Informa-
tion Figure S3), glucose was used for the following studies.
Bioreactor experiments
Synthetic media. First bioreactor experiments were based
on the synthetic BSM medium, commonly used for
methanol-based expression.54 The given bioreactor system
did not contain baffles or allow the application of head
pressure. Thus, glucose (500 g L21) was fed at a constant
rate of 2 mL h21 (5 mL L21 h21 relating to the initial culti-
vation volume of 400 mL) instead of exponentially to avoid
oxygen limitation of the culture, as oxygen supply was only
moderate (kLa  144 h21, dynamic measurement55). This
strategy of feeding was applied, e.g., by Gasser and
coworkers.56 It results in a steadily decreasing l over time.
The initial fermentation conditions resulted in the process
shown in Figure 1. The cultivation yielded 1.836 0.03 mM
of bioactive SAV in 90 h of cultivation, characterized by a
Figure 1. Fed-batch bioreactor cultivation of P. pastoris in BSM medium.
The standard biotin supplement, 40 g L-1 of glucose, and feeding of a 500 g L-1 glucose solution were applied. (A) Display of the productive proper-
ties. Product courses were directly fit to Eq. 2 to improve the accuracy of the local (ploc) and overall productivity (pSTY). The shaded area represents
the proportion of biotin-blocked SAV according to PHT and PRT, respectively (Eq. 1). (B) Feeding (fed volume Vfed) and consumption of substrate S,
and specific growth rate l. OD600 at inoculation: 0.2, lmax (X> 2 g L
-1): 0.17 h-1, end of the lag phase (l> 0.01 h-1): 3.7 h.
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proportion of biotin-blocked binding sites Qblocked of
0.266 0.06 (26%) due to the strong biotin supplement of the
medium.
Various strategies were tested in order to decrease
Qblocked. Cells neither grew in biotin-free BSM medium, nor
in a medium in which biotin was substituted by oleic acid
and aspartic acid as described for the production of avidin
by P. pastoris (data not shown).57 This may be the result of
the carbon source glucose, which seems to inhibit the posi-
tive effects of the substitutes.37 Replacement of biotin by
small concentrations of complex supplements (soy peptone
and yeast extract, 2 g L21 each) allowed the accumulation
of only small concentrations of both SAV and biomass.
However, reducing the concentration of biotin to 50%
resulted in improved bioactivity (1.516 0.02 mM after 78 h,
Qblocked5 0.176 0.01). A summary of characteristic process
parameters is given in Table 1.
Despite these improvements, the DCW concentration was
low (31.96 1.4 g L21 for 1x biotin and 25.86 0.4 g L21
for 0.5x biotin) compared to typical high cell density
cultivations of P. pastoris, which are usually in the range of
100 g L21 for BSM medium.54,58
Complex media. Shake flask studies (Supporting Infor-
mation, Figure S3) showed that SAV-producing clones of
P. pastoris are capable of growing in complex media without
biotin supplementation, potentially improving the bioactivity
of SAV. Thus, bioreactor studies in YPD and MGY medium
were performed, using either a glucose concentrate or con-
centrated cultivation media as feed solutions.
All of the experiments resulted in low proportions of
biotin-blocked binding sites (Qblocked< 0.1). YPD medium
with glucose feeding resulted in the highest DCW concentra-
tion of this study (45.66 1.2 g L21), but process selectivity
and maximal SAV concentration were superior when glucose
feeding was applied to MGY medium. Media concentrates
brought about worse results (see Table 1). Thus, MGY
medium and the glucose feed solution were chosen for the
following studies.
As shown in Figure 1, cultivation in BSM medium
resulted in a degradation of product towards the end of culti-
vation, which is potentially due to proteolysis. In methanol-
based processes, this effect is commonly avoided by lower-
ing pH or temperature for induction.59–61 To analyze if this
also applies to constitutive, PGAP-based protein production in
complex media, the producer strain was cultivated in YPD
medium at a temperature of 258C and a pH of 5.0. This led
to very small concentrations of DCW and SAV (see Table
1), but improved the selectivity of the process. To exploit
this property without harming the accumulation of biomass,
pH and T were shifted to lower values with a delay in the
Table 1. Process Parameters for the Constitutive Production of SAV by Pichia pastoris
Medium Carbon source/feed strategya T- and pH-profileb
pSAV
c
[nM h21]
Pmax
d [mM]
(t [h])
Xmax
e [g L21]
(t [h]) Qblocked
f [-]
sP/X
g
[nmol g21]
BSM Glc: 2 mL h21 from 42 h C: 308C, 5.0 20.3 (31.1) 1.836 0.03 (90) 31.96 1.4 (66) 0.266 0.06* 57.4
BSMh Glc: 2.5 mL h21 from 72 h C: 308C, 5.0 19.4 (21.2) 1.516 0.02 (78) 25.86 0.4 (54) 0.176 0.01* 58.5
BSMi Glc: no feeding C: 308C, 5.0 4.4 0.326 0.01 (72) 3.16 0.5 (48) 20.016 0.09* 103.2
YPD Glc: 2 mL h21
from 24 to 60 h
C: 308C, 6.0 10.7 0.776 0.02 (72) 45.66 1.2 (72) 0.036 0.04* 16.9
YPD 5x YPD: 2 mL h21
from 24 to 60 h
C: 308C, 6.0 10.3 0.746 0.03 (72) 23.06 0.2 (66) 0.076 0.10* 32.2
YPD Glc: no feeding C: 258C, 5.0 5.7 0.346 0.02 (60) 4.666 0.33 (36) 0.066 0.03* 73.0
MGY 5x MGY (2.5x YNB):
2 mL h21 from 24 to 60 h
C: 308C, 6.0 20.4 1.106 0.05 (54) 26.96 0.4 (60) 20.016 0.11* 40.9
MGYj Glc: 1.8 mL h21 from 20 h C: 308C, 6.0 25.8 1.246 0.02 (48) 36.36 2.4 (42) 0.056 0.02 34.2
BSMj Glc: 2.9 mL h21 from 44 h D: 308C/278C (40 h);
S: 5.0 ! 3.5
27.1 (29.8) 1.956 0.09 (72) 31.56 0.8 (66) 0.116 0.02 61.9
MGYj Glc: 2.2 mL h21 from 21 h D: 308C/278C;
D: 6.0 ! 5.0 (24 h)
37.4 2.696 0.03 (72) 31.86 0.2 (72) 0.036 0.02 84.6
MGYj Glc: 2.1 mL h21 from 20 h D: 308C/278C;
D: 6.0 ! 5.0 (36 h)
20.5 0.876 0.03 (42) 36.16 0.4 (42) 0.066 0.02 24.1
MGYj Glc: 1.8 mL h21 from 20 h D: 308C/278C
(24 h); S: 6.0 ! 3.0
42.9 2.326 0.07 (54) 22.36 0.3 (54) 20.036 0.03 104.0
MGYj Glc: 1.6 mL h21 from 20 h D: 308C/278C
(24 h); S: 6.0 ! 4.0
42.7 2.056 0.07 (48) 30.86 5.3 (42) 0.026 0.02 66.6
MGYj Glc: 2.1 mL h21 from 20 h S: 308C/248C;
S: 6.0 ! 4.0
57.8 4.166 0.11 (72) 29.86 1.2 (42) 0.006 0.02 140.0
Fed-batch cultivation was performed in BSM, YPD and MGY medium in the bioreactor. Benchmark values are printed in bold face.
aFeeding strategy and carbon source used. All feed concentrates except for the media concentrates contained the PTM1 trace salt solution in a con-
centration of 2 mL per 100 mL. The PTM1-solutions for the processes on complex media were biotin-free. The concentration of the glucose feed solu-
tion was 500 g L21).
bProfile of pH and T for the fermentation process. C: both parameters were kept constant at the given setpoint. D: direct shift of the parameter at the
indicated point of cultivation. S: successive shift of the parameter throughout the cultivation. If both parameters were directly shifted, the cultivation
time in brackets relates to the shift of both parameters.
cProductivity from cultivation start to Pmax. The productivity refers to bioavailable (biotin-free) SAV. If high proportions of SAV were biotin-
blocked, the second productivity (given in brackets) refers to the maximal total SAV concentration.
dMaximal product concentration and corresponding cultivation time, referring to the bioavailable SAV-binding sites.
eMaximal DCW concentration and corresponding cultivation time.
fProportion of biotin-blocked sites of the maximal SAV concentration according to Eq. (1). If PHT was not determined at Pmax, the value is an aver-
age of Qblocked of the neighboring values. If so, this is indicated by an asterisk (*).
gProcess selectivity: Maximal (bioactive) product concentration divided by maximal DCW concentration.
hBiotin concentration lowered to 50% of standard BSM medium. A biotin-free PTM1-solution was applied for the feed.
iBiotin-free BSM medium supplemented with 2 g L21 of yeast extract and soy peptone, respectively.
jFeeding was performed by the Sixfors pumps based on a step-wise adjustment of the mass flow of the feed solution. Average volumetric flow rates
were calculated after the fermentation and therefore vary slightly.
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following experiments. The pH shift was either performed
metabolically, i.e. without the addition of acid, or actively at
a certain time of cultivation (i.e., after 24 or 36 h). The
interval of variation for the pH value (3.0 to 6.0) was based
on the data of Siegel et al.59 To avoid the low DCW concen-
trations of the process at 258C and pH 5.0, T was directly
and moderately shifted from 30 to 278C after 24 h, i.e. dur-
ing early growth (high l), or 36 h, i.e. in the decelerating
growth phase of the culture.
A summary of the studies is given in Table 1. Only minor
improvements were achieved for BSM-based cultivation. For
MGY medium, lower maximal DCW concentrations were
achieved for lower final pH values (36.36 2.4 g L21 for pH
6.0, 22.36 0.3 g L21 for pH 3.0). However, the strategy
generally resulted in improved product concentrations, which
were in the range of 2.056 0.07 to 2.696 0.03 mM as
opposed to 1.246 0.02 mM in the reference culture at pH
6.0. The cultivation time for the shift of T proved to be criti-
cal: improved product concentrations were only achieved for
a shift after 24 h, whereas a shift after the initial growth
phase (at 36 h) showed no effect.
For the final process strategy, the pH was therefore moder-
ately shifted from 6.0 to 4.0 by metabolic acidification of the
medium, avoiding the necessity of acid supplementation and
allowing a successive adaptation of the culture to the new pH.
The relative dissolved oxygen saturation rDO was used for reg-
ulation of the temperature. Whenever this parameter dropped
below 20% the setpoint for T was lowered by 0.58C to 248C.
The result of this optimized strategy is shown in Figure 2.
This final process led to a concentration of 4.166 0.11 mM
of practically biotin-free SAV (Qblocked5 0.006 0.02) after
72 h of cultivation, corresponding to approx. 221 mg L21 of
SAV (assuming a theoretical MW of 53.1 kDa for the un-
glycosylated tetramer). The final space time yield pSTY of
57.8 nM h21 and the process selectivity of 140 nmol g21 sur-
passed all previous experiments. The concentration of ethanol
throughout this final process was below 5 g L21 for all time
points of sampling.
Comparison to literature. In comparison to literature, the
maximal concentration for the optimized process surpassed
titers for E. coli (typically 1-2.6 mM), but was achieved for a
lower productivity, as this parameter is usually in the range
of 65 to 340 nM h21 for this host.12–14,16,17 The productivity
was close to the pSTY of 67.9 nM h
21 achieved for P. pasto-
ris by Nogueira et al.25 The concentration of SAV was con-
siderably lower than the reference concentrations for the
methanol-based production processes for SAV by P. pastoris
reported by Casteluber et al. (71 mM)24 and Nogueira et al.
(11 mM),25 but was achieved in a shorter cultivation time
(72 vs. 167 h and 162 h, respectively). Generally, Castelub-
er’s process is difficult to compare or scale up, because it
was performed in spinner flasks aerated through a porous
stone at very high volumetric flow rates (4 vvm) and con-
tained a washing step between growth and induction phase,
bearing the risk of contamination. Due to this system, no
measurement or control of parameters like pH or rDO was
possible. In comparison to the study of Nogueira et al.,
which was performed in a standard bioreactor, the process
selectivity of this study was increased (140 vs. 46.8 nmol
g21), because Nogueira’s process led to a surprisingly high
DCW concentration of 235 g L21 (usually up to 160 g L21
for BSM-based processes).58 From the perspective of bioac-
tivity, Nogueira’s study led to 20% of biotin-blocked binding
sites, whereas this study resulted in a higher product quality
by yielding SAV free of biotin or biotinylated proteins,
which may offer advantages, e.g., for medical applications
necessitating a pure product or the production of high
capacity SAV columns for affinity chromatography.
Despite lower product concentrations and productivities,
the process offers advantages compared to cultivation of the
natural producer S. avidinii, since this organism is much
more sensitive towards environmental factors, shows a com-
plex morphology, slow growth and resulting long process
times in an un-optimized environment, and imposes higher
requirements for biochemical engineering.26
The new process strategy necessitates complex media
compounds, which may result in batch-to-batch variability
and the need for diafiltration during downstream processing.
However, it is methanol-independent, thus eliminating cen-
tral disadvantages of the application of PAOX (see Introduc-
tion). This results in different demands for the fermentation
Figure 2. Optimized fed-batch bioreactor cultivation of P. pastoris in MGY medium.
Glucose was fed in a concentration of 500 g L-1 and initially supplemented in 40 g L-1. T and pH were shifted to 248C and 4.0, respectively,
throughout the cultivation. (A) Consumption and feeding of substrate (fed volume Vfed) and production of biomass (X) and streptavidin (P). (B) Dis-
play of the volumetric streptavidin productivity (local ploc and overall pSTY) and the process parameters dissolved oxygen (rDO), pH and temperature
(T). OD600 at inoculation: 0.5, lmax (X> 2 g L
-1): 0.37 h-1, end of the lag phase (l> 0.01 h-1): 0.3 h.
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equipment: Nogueira et al. had to apply concentrated oxygen
due to the strong oxygen dependency during induction by
methanol,54 whereas conditions of low oxygen supply (ves-
sels without turbulence promoters, atmospheric pressure,
1.2 vvm) were sufficient for this study. Generally, the use of
concentrated oxygen poses the risk of explosion and
increases process cost. As opposed to this, it has been
reported that hypoxic conditions may actually increase the
productivity of PGAP-based processes.
62 With respect to pro-
cess design, only two (batch, glucose feeding) instead of
three (batch, glycerol feeding, methanol induction) process
phases have to be prepared. Moreover, no optimization of
the inducer concentration is necessary, which is critical for
the methanol-based induction of PAOX.
30,63
Model-based evaluation of the optimized cultivation condi-
tions. To characterize the optimized culture conditions,
selected fermentation courses were compared by parameter
estimation. Figure 3 visualizes the contribution of the model
terms of Eq. (4) to the overall product concentration of the
final process in comparison to the reference culture at pH
6.0 and 308C. The regions of the plot were highlighted
according to the three terms marked by the horizontal braces
of the equation.
Figure 3. Analysis of the contribution of the model parameters of Eq. 4 (horizontal braces) to the overall product concentration Ptot.
Both processes shown were based on MGY medium and glucose feeding. (A) Reference fed-batch at constant T (308C) and pH (6.0). Parameters
(confidence interval of the parameter causing a maximal increase of the sum of squared errors by 5 % given in brackets): P05 20.4 nM, fr5 0,
frX5 29.396 0.89 nM nmol g
-1, fX5 0 nmol g-1 h-1. (B) Optimized fed-batch with a successive shift of T to 248C and of the pH to 4.0 (Figure 3).
Parameters: P05 20.4 nM, fr5 (0. . .)41.57 nM, frX5 0(. . .20.62) nmol g
-1, fX5 2.736 0.25 nmol g
-1 h-1. PfrX and Pfr correspond to growth-related,
primary product formation, whereas PfX only depends on X (secondary product). P0 and Pexp refer to the initial (parameter estimation) and experi-
mental product concentration, respectively.
Figure 4. Results of the process optimization procedure.
Cultivations were based on glucose feeding and the media specified by the labels. YPD, shake flask refers to a shake flask batch cultivation (batch,
pH uncontrolled; Supporting Information, Figure S3). BSM labels contain the relative concentration of biotin towards standard BSM medium. YPD
and MGY correspond to fed-batches at constant T (308C) and pH (6.0). For MGY, T-shift (24 h) T was shifted to 278C after 24 h and the pH was
not controlled until it reached 4.0. MGY, steady shift refers to the final procedure shown in Figure 3 (continuous shift of pH and T, respectively).
(A) Productive properties: Pmax5maximal (bioactive) product concentration, pSTY5 productivity from 0 h to Pmax, Qblocked5 biotin-blocked binding
sites (if determined). (B) Display of the contribution of the model terms of Eq. 4 to the final product concentration Pmax (Pfr, PfrX5 growth-
associated, primary product formation, PfX5 secondary product). Color coding is identical to the areas shown in Figure 3. Where indicated (*),
parameter estimation was based on measurements of the overall binding sites (PHT).
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According to Figure 3, the optimized conditions led to an
increased accumulation of SAV in the late phase of the pro-
cess, characterized by diminishing growth rates (m 
D< 0.01 h21). In contrast, production of SAV was strongly
associated to biomass growth in the reference process, result-
ing in a stagnating product concentration towards the end of
cultivation. In optimized conditions 89.06 6.1% of SAV
accumulated due to the PfX-term of the model (secondary
product), whereas only 10.5 to 16.6% were due to the
growth-related Pfr- and PfrX-terms (primary product). In con-
trast, the PfrX-term was dominant in the reference culture,
contributing to the final product concentration by a propor-
tion of 98.36 0.1%.
To verify if the model accurately reflects the process, a
protease study was performed for which cell-free superna-
tants of the reference and optimized cultivation were incu-
bated at the final process pH and temperature in the presence
of growth inhibitors (sodium azide). There was no loss of
activity in 72 h of incubation for both processes (data not
shown). This may be an effect of the media compounds
yeast extract and peptone, which are known to reduce pro-
teolytic degradation of the product.64 Thus, the increased
accumulation of SAV seems to be the result of an increase
in production rather than a decrease in proteolysis.
Characteristic productive properties for selected steps of
the process development are summed up in Figure 4A. Fig-
ure 4B shows the contribution of the model terms of Eq. (4)
to the final product concentration Pmax for each of these
steps. A shift from growth-related (Pfr and PfrX) to growth-
independent (PfX) product formation can be observed
throughout the optimization procedure. This shift is also visi-
ble for the reference shake flask batch cultivation, for which
the pH was uncontrolled.
Conclusions
This study for the first time demonstrates that the protein
streptavidin, which is toxic to many heterologous hosts due
to the binding of biotin, can efficiently be produced in a con-
stitutive manner by the biotin-dependent yeast P. pastoris,
leading to 4.166 0.11 mM of highly bioactive, extracellular
tetrameric SAV in 72 h.
The production of SAV by P. pastoris was strongly
dependent on the cultivation parameters pH and temperature.
Commonly, PGAP-based processes are performed at constant
T and pH derived from preliminary screenings. Separation of
fermentations into stages with different setpoints for the
parameters is rarely applied.32 Jahic et al. reported a
temperature-limited fed-batch for PAOX-based processes.
60
However, to our best knowledge, a continuous shift of pH
and T throughout the cultivation has not been reported for
the PGAP-based expression of heterologous genes by P. pas-
toris. Despite causing lower DCW concentrations, the meta-
bolic acidification and slow cooling of the medium improved
the productivity by the factor 2.2 and the product concentra-
tion by the factor 3.4. The low l-dependency of the specific
productivity (Supporting Information, Figure S4) suggests
that an active control of l is not necessary for the optimized
conditions due to improved productivities at lower growth
rates. This simplifies processes based on constant instead of
exponential feeding and allows the extension of the produc-
tive period of the culture. The strong accumulation of prod-
uct in the final phase of the process (m  D) came as a
surprise, because processes based on the GAP promoter typi-
cally rely on growth-associated production, as the specific
product formation rate for this promoter is usually positively
correlated to the specific growth rate.40
On the genetic level, further experiments may focus on
stronger variants of the GAP promoter65 and multiple inte-
gration of the expression cassette into the host genome.64
From the perspective of medium optimization, further
decreasing process cost by eliminating the complex media
compounds via the development of a fine-tuned synthetic
medium may be worthwhile. However, proteolytic activity
has to be monitored carefully in this regard. Further
improvements for the complex medium may be achieved by
optimizing its C/N-ratio. In respect to bioengineering, the
new process strategy should be reproduced and evaluated in
larger scales. A comparison of the strategy applied here to
exponential fed-batch cultivation applying a constant setpoint
for l and an oxygen-rich environment is also desirable.
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Notation
AA = amino acid
BSM = basal salt medium
DCW = dry cell weight
GAP = glyceraldehyde-3-phosphate
SAV = streptavidin
Literature Cited
1. Chaiet L, Wolf FJ. The properties of streptavidin, a biotin-
binding protein produced by streptomycetes. Arch Biochem Bio-
phys. 1964;106:1–5.
2. Stapley EO, Mata JM, Miller IM, Demny TC, Woodruff HB.
Antibiotic MSD-235. I. Production by Streptomyces avidinii and
Streptomyces lavendulae. Antimicrob Agents Chemother
(Bethesda). 1963;161:20–27.
3. Bayer EA, Wilchek M. Application of avidin-biotin technology
to affinity-based separations. J Chromatogr A. 1990;510:3–11.
4. Katz BA. Binding of biotin to streptavidin stabilizes intersubunit
salt bridges between Asp61 and His87 at low pH. J Mol Biol.
1997;274:776–800.
5. Gonzalez M, Argarana CE, Fidelio GD. Extremely high thermal
stability of streptavidin and avidin upon biotin binding. Biomol
Eng. 1999;16:67–72.
6. Skerra A, Schmidt TGM. Applications of a peptide ligand for
streptavidin: the strep-tag. Biomol Eng. 1999;16:79–86.
7. Bayer EA, Kulik T, Adar R, Wilchek M. Close similarity
among streptavidin-like, biotin-binding proteins from Streptomy-
ces. Biochim Biophys Acta. 1995;1263:60–66.
8. Nordlund HR, Hyt€onen VP, Laitinen OH, Kulomaa MS. Novel
avidin-like protein from a root nodule symbiotic bacterium Bra-
dyrhizobium japonicum. J Biol Chem. 2005;280:13250–13255.
9. P€ahler A, Hendrickson WA, Kolks MA, Argarana CE, Cantor
CR. Characterization and crystallization of core streptavidin.
J Biol Chem. 1987;262:13933–13937.
10. Bayer EA, Ben-Hur H, Hiller Y, Wilchek M. Postsecretory
modifications of streptavidin. Biochem J. 1989;259:369–376.
11. Sano T, Pandori MW, Chen X, Smith CL, Cantor CR. Recombi-
nant core streptavidins. A minimum-sized core streptavidin has
enhanced structural stability and higher accessibility to biotinyl-
ated macromolecules. J Biol Chem. 1995;270:28204–28209.
862 Biotechnol. Prog., 2016, Vol. 32, No. 4
124 Jakob M. Müller
12. Sano T, Cantor CR. Expression of a cloned streptavidin gene in
Escherichia coli. Proc Natl Acad Sci USA. 1990;87:142–146.
13. Gallizia A, de Lalla C, Nardone E, Santambrogio P, Brandazza
A, Sidoli A, Arosio P. Production of a soluble and functional
recombinant streptavidin in Escherichia coli. Protein Expr Purif.
1998;14:192–196.
14. Wu S-C, Wong S-L. Intracellular production of a soluble and
functional monomeric streptavidin in Escherichia coli and its
application for affinity purification of biotinylated proteins. Pro-
tein Expr Purif. 2006;46:268–273.
15. Risse JM, Flaschel E, Friehs K, Zillmer J. Gewinnung von
Streptavidin mittels Streptomyces avidinii bzw. Escherichia coli.
Chemie Ingenieur Technik. 2006;78:1383.
16. Miksch G, Risse JM, Ryu S, Flaschel E. Factors that influence
the extracellular expression of streptavidin in Escherichia coli
using a bacteriocin release protein. Appl Microbiol Biotechnol.
2008;81:319–326.
17. M€uller JM, Wetzel D, Flaschel E, Friehs K, Risse JM. Constitu-
tive production and efficient secretion of soluble full-length
streptavidin by an Escherichia coli ‘leaky mutant’. J Biotechnol.
2016;221:91–100.
18. Nagarajan V, Ramaley R, Albertson H, Chen M. Secretion of
streptavidin from Bacillus subtilis. Appl Environ Microbiol.
1993;59:3894–3898.
19. Wu S-C, Wong S-L. Engineering of a Bacillus subtilis strain
with adjustable levels of intracellular biotin for secretory pro-
duction of functional streptavidin. Appl Environ Micobiol. 2002;
68:1102–1108.
20. Wu S-C, Qureshi MH, Wong S-L. Secretory production and
purification of functional full-length streptavidin from Bacillus
subtilis. Protein Expr Purif. 2002;24:348–356.
21. Lardy HA, Potter RL, Burris RH. Metabolic functions of biotin
I. The role of biotin in bicarbonate utilization by Lactobacillus
arabinosis studied with 14C. J Biol Chem. 1949;179.
22. Lynen F, Knappe J, Lorch EJ, Ringelmann E, Lachance JP. Zur
biochemischen Funktion des Biotins. 2. Reinigung und Wir-
kungsweise der beta-methyl-crotonyl-caboxylase. Biochem Z.
1961;335:123.
23. Zocchi A, Jobe AM, Neuhaus JM, Ward TR. Expression and
purification of recombinant avidin with a lowered isoelectric
point in Pichia pastoris. Protein Expr Purif. 2003;32:167–174.
24. Casteluber MC, Damasceno LM, da Silveira WB, Diniz RH,
Passos FJ, Passos FM. Cloning and expression of a functional
core streptavidin in Pichia pastoris: strategies to increase yield.
Biotechnol Prog. 2012;28:1419–1425.
25. Nogueira ES, Schleier T, D€urrenberger M, Ballmer-Hofer K,
Ward TR, Jaussi R. High-level secretion of recombinant full-
length streptavidin in Pichia pastoris and its application to enan-
tioselective catalysis. Protein Expr Purif. 2014;93:54–62.
26. M€uller JM, Risse JM, Jussen D, Flaschel E. Development of
fed-batch strategies for the production of streptavidin by Strep-
tomyces avidinii based on power input and oxygen supply stud-
ies. J Biotechnol. 2013;163:325–332.
27. Zhang A-L, Luo J-X, Zhang T-Y, Pan Y-W, Tan Y-H, Fu C-Y,
Tu F-Z. Recent advances on the GAP promoter derived expres-
sion system of Pichia pastoris. Mol Biol Rep. 2009;36:1611–
1619.
28. Bertrand GL, Millero FJ, Wu C-H, Hepler LG. Thermochemical
Investigations of the water-ethanol and water-methanol solvent
systems. I. Heats of mixing, heats of solution, and heats of ioni-
zation of water. J Phys Chem. 1966;70:699–705.
29. Niu H, Jost L, Pirlot N, Sassi H, Daukandt M, Rodriguez C,
Fickers P. A quantitative study of methanol/sorbitol co-feeding
process of a Pichia pastoris Mut1/pAOX1-lacZ strain. Microb
Cell Fact. 2013;12:33.
30. Khatri NK, Hoffmann F. Impact of methanol concentration on
secreted protein production in oxygen-limited cultures of
recombinant Pichia pastoris. Biotechnol Bioeng. 2006;93:871–
879.
31. Jungo C, Marison I, von Stockar U. Mixed feeds of glycerol
and methanol can improve the performance of Pichia pastoris
cultures: A quantitative study based on concentration gradients
in transient continuous cultures. J Biotechnol. 2007;128:824–
837.
32. Zhao W, Wang J, Deng R, Wang X. Scale-up fermentation of
recombinant Candida rugosa lipase expressed in Pichia pastoris
using the GAP promoter. J Ind Microbiol Biotechnol. 2008;35:
189–195.
33. Gasser B, Dragosits M, Mattanovich D. Engineering a biotin-
prototrophy in Pichia pastoris for robust production processes.
Metabol Eng. 2010;12:573–580.
34. Ahmad F, Rose AH, Garg NK. Effect of biotin deficiency on
the synthesis of nucleic acids and protein by Saccharomyces
cerevisiae. Microbiology. 1960;24:69–80.
35. Moat AG, Ahmad F, Alexander JK, Barnes IJ. Alteration in the
amino acid content of yeast during growth under various nutri-
tional conditions. J Bacteriol. 1969;98:573–578.
36. Ahmad F, Rose AH. Effect of biotin-sparing substances on
growth of biotin-deficient Saccharomyces cerevisiae and on the
synthesis of nucleic acids and protein. Microbiology. 1962;28:
147–160.
37. Adler JH, Gealt MA, Nes WD, Nes WR. Growth characteristics
of Saccharomyces cerevisiae and Aspergillus nidulans when bio-
tin is replaced by aspartic acid and fatty acids. Microbiology.
1981;122:101–107.
38. Waterham HR, Digan ME, Koutz PJ, Lair SV, Cregg JM. Isola-
tion of the Pichia pastoris glyceraldehyde-3-phosphate dehydro-
genase gene and regulation and use of its promoter. Gene. 1997;
186:37–44.
39. C¸alık P, Atab €O, G€unes¸a H, Massahib A, Boya E, Keskina A,
€Ozt€urk S, Zerzea GH, €Ozdamarc TH. Recombinant protein pro-
duction in Pichia pastoris under glyceraldehyde-3-phosphate
dehydrogenase promoter: From carbon source metabolism to
bioreactor operation parameters. Biochem Eng J. 2015;95:20–36.
40. Maurer M, K€uhleitner M, Gasser B, Mattanovich D. Versatile
modeling and optimization of fed batch processes for the pro-
duction of secreted heterologous proteins with Pichia pastoris.
Microb Cell Fact. 2006;5:37.
41. Wang X, Sun Y, Ke F, Zhao H, Liu T, Xu L, Liu Y, Yan Y.
Constitutive expression of Yarrowia lipolytica lipase LIP2 in
Pichia pastoris using GAP as promoter. Appl Biochem Biotech-
nol. 2012;166:1355–1367.
42. Potvin G, Zhang Z, Defela A, Lam H. Screening of alternative
carbon sources for recombinant protein production in Pichia
pastoris. Int J Chem React Eng. 2016;14:251–257.
43. Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in
Pichia pastoris: recent achievements and perspectives for heter-
ologous protein production. Appl Microbiol Biotechnol. 2014;
98:5301–5317.
44. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA,
Smith HO. Enzymatic assembly of DNA molecules up to sev-
eral hundred kilobases. Nat Methods. 2009;6:343–345.
45. Sambrook J, Russell DW. Molecular Cloning: A Laboratory
Manual, 3rd ed. New York: Cold Spring Harbor Laboratory
Press; 2000.
46. Lin-Cereghino J, Wong WW, Xiong S, Giang W, Luong LT,
Vu J, Johnson SD, Lin-Cereghino GP. Condensed protocol for
competent cell preparation and transformation of the methylotro-
phic yeast Pichia pastoris. BioTechniques. 2005;38:44. 46,48.
47. Cregg JM. Methods in Molecular Biology 389: Pichia Protocols,
2nd ed. Totowa: Humana Press; 2007.
48. Kad G, Falk H, Gruber HJ. Accurate measurement of avidin
and streptavidin in crude biofluids with a new, optimized biotin-
fluorescein conjugate. Biochim Biophys Acta. 1999;1417:33–43.
49. Kada G, Kaiser K, Falk H, Gruber HJ. Rapid estimation of avi-
din and streptavidin by fluorescence quenching or fluorescence
polarization. Biochim Biophys Acta. 1999;1427:44–48.
50. M€uller JM, Risse JM, Friehs K, Flaschel E. Model-based devel-
opment of an assay for the rapid detection of biotin-blocked
binding sites of streptavidin. Eng Life Sci. 2015;15:627–639.
51. Baud M. Methods of Immunological Analysis 1: Fundamentals,
1st ed. New York: VCH Publishers, Inc., 1993.
52. Luedeking R, Piret EL. A kinetic study of the lactic acid fer-
mentation. Batch process at controlled pH. J Biochem Micro-
biol. 1959;1:393–412.
53. Scilab Enterprises. Scilab: Free and open source software for
numerical computation (OS, version 5.5.0). Available at: www.
scilab.org. 2012.
Biotechnol. Prog., 2016, Vol. 32, No. 4 863
Jakob M. Müller 125
54. Invitrogen Co. Pichia fermentation process guidelines overview
(Version B. 053002). Invitrogen Co., San Diego, USA. Avail-
able at: http://www.invitrogen.com/content/sfs/manuals/pichia-
ferm_prot.pdf. May, 2002. Accessed December 14, 2015.
55. Bandyopadhyay B, Humphrey A, Taguchi H. Dynamic measure-
ment of the volumetric oxygen transfer coefficient in fermenta-
tion systems. Biotechnol Bioeng. 1967;9:533–544.
56. Gasser B, Maurer M, Gach J, Kunert R, Mattanovich D. Engi-
neering of Pichia pastoris for improved production of antibody
fragments. Biotechnol Bioeng. 2006;94:353–361.
57. Jungo C, Urfer J, Zocchi A, Marison I, von Stockar U. Optimi-
sation of culture conditions with respect to biotin requirement
for the production of recombinant avidin in Pichia pastoris.
J Biotechnol. 2007;127:703–715.
58. Jahic M, Rotticci-Mulder J, Martinelle M, Hult K, Enfors S-O.
Modeling of growth and energy metabolism of Pichia pastoris pro-
ducing a fusion protein. Bioprocess Biosyst Eng. 2002;24:385–393.
59. Siegel RS, Buckholz RG, Thill GP, Wondrack LM. Production
of epidermal growth factor in methylotrophic yeast cells. WO
Patent 1990010697 A1, 1990.
60. Jahic M, Wallberg F, Bollok M, Garcia P, Enfors S-O. Temper-
ature-limited fed-batch technique for control of proteolysis in
Pichia pastoris bioreactor cultures. Microb Cell Fact. 2003;2:6.
61. Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. Het-
erologous protein production using the Pichia pastoris expres-
sion system. Yeast. 2005;22:249–270.
62. Baumann K, Maurer M, Dragosits M, Cos O, Ferrer P,
Mattanovich D. Hypoxic fed-batch cultivation of Pichia pastoris
increases specific and volumetric productivity of recombinant
proteins. Biotechnol Bioeng .2008;100:177–183.
63. Zhang W, Bevins MA, Plantz BA, Smith LA, Meagher MM.
Modeling Pichia pastoris growth on methanol and optimizing
the production of a recombinant protein, the heavy-chain frag-
ment C of botulinum neurotoxin, serotype A. Biotechnol Bioeng.
2000;70:1–8.
64. Sreekrishna K, Brankamp RG, Kropp KE, Blankenship DT, Tsay
JT, Smith PL, Wierschke JD, Subramaniam A, Birkenberger LA.
Strategies for optimal synthesis and secretion of heterologous pro-
teins in the methylotrophic yeast Pichia pastoris. Gene. 1997;190:
55–62.
65. Qin X, Qian J, Yao G, Zhuang Y, Zhang S, Chu J. GAP pro-
moter library for fine-tuning of gene expression in Pichia pasto-
ris. Appl Environ Microbiol. 2011;77:3600–3608.
Manuscript received Dec. 17, 2015, and revision received Mar. 2,
2016.
864 Biotechnol. Prog., 2016, Vol. 32, No. 4
126 Jakob M. Müller
Müller et al.  1 
Biotechnology Progress 
 
Supporting information to 
 
GAP promoter-based fed-batch production of highly bioactive core 
streptavidin by Pichia pastoris 
Jakob Michael Müller *,a, Simon Bruhn a, Erwin Flaschel a, Karl Friehs a, and Joe Max Risse a 
 
[a]   Lehrstuhl für Fermentationstechnik, Technische Fakultät, Universität Bielefeld,  
PF 10 01 31, D-33501 Bielefeld, Germany 
[*] e-mail: jmu@fermtech.techfak.uni-bielefeld.de · phone: +49 521 106 5299 
fax: +49 521 106 6475 (secretary’s office) 
 
 
S1 – constraints for parameter estimation 
 
The parameters for modelling of the course of the product concentration P as well as the 
constraints used for the parameter estimation were chosen based on calculations and test-
wise fitting to exemplary fermentations. As all of the cultures were inoculated to a specific 
OD600 and in order to avoid errors of the maximal specific growth rate caused by deviations 
of the initial biomass concentration X0, this model parameter was calculated from the 
theoretical OD600 at the start of cultivation (0.5 or 0.2). A correlation factor of 0.228 g L
-1 per 
absorption unit OD600 for the conversion of OD600 to X acquired from a corresponding 
correlation (see Fig. S1) was used. Furthermore, the initial product concentration P0 was 
estimated applying an upper limit of 544 nM in the pre-culture. This concentration was 
measured in the YPD-based shake flask-cultivation of Fig. S3 A after 24 h of cultivation. A 
volume of up to 15 mL of this pre-culture was diluted by the initial fermentation volume of 
400 mL. This results in a typical initial product concentration P0 of up to 20 nM, which was 
therefore chosen as an upper limit for the estimation of this parameter. 
 
For the kinetic course of the product concentration several models were evaluated. Three 
model variants of equation (4) were applied in Fig. S2. The removal of the strongly primary 
product-correlated fr -term of the model (blue curve) resulted in a lack of fit in the initial 
growth period. When no upper limit for the initial product concentration P0 was used, this lack 
of fit was partly compensated by an increased value for this parameter (green curve). 
However, expected initial product concentrations in the bioreactor are in the range of <20 nM 
of SAV as discussed above, indicating a lack of fit for the unconstrained parameter 
estimation. Therefore, (i) the model term based on the square root of the biomass 
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concentration X was included in the estimation procedure and (ii) P0 was estimated in a 
constrained manner. 
 
Fig. S1 Correlation of OD600 and dry cell weight concentration X for Pichia pastoris used for the calculation of the 
model parameter X0 for the parameter estimations resulting in the biomass courses. The regression resulted in 
the correlation X = 0.22844 g L
-1
 * OD600. 
 
 
Fig. S2 Comparison of three parameter adjustments in respect to the outcome of parameter estimation for two 
fermentations. Parameters were either chosen according to equation (4) (+fr) or the square root-term for biomass 
in combination with µ and fr was removed (-fr). Furthermore, the initial product concentration was estimated either 
constrained (+P0) or unconstrained (-P0), i.e. with or without an upper limit. 
 
S2 – confidence intervals for the estimated parameters  
Confidence intervals for the parameters were estimated manually by manually introducing 
constraints on a single model parameter and observing the change of fit quality (sum of 
squared errors). Intervals are based on a maximal reduction of the fit quality by 5 % caused 
by the change of each parameter. Confidence intervals for the resulting proportions of the 
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contribution of each model parameter to the final product concentration were derived from 
the resulting altered parameter set. 
 
S3 – shake flask cultivation 
 
Shake flask characterization of the clones was performed in YPD and YPG medium 
supplemented with 40 g L-1 of glucose and glycerol, respectively, in 1 L baffled glass shake 
flasks (Schott Duran, DURAN Group GmbH, Wertheim/Main, Germany). The degree of filling 
of the flasks was 15 %. Cultivations were performed on a rotary shaker at 200 min-1 (shaking 
diameter: 20 mm) and 30 °C. The inoculum was taken from an overnight culture in 30 mL of 
YPD medium grown in a 300 mL shake flask, inoculated with 300 µL of a freshly thawed 
glycerol stock. Samples were automatically taken and cooled to 4 °C every 2 h by a fraction 
collector. Results for this characterization step are shown in Fig. S3. 
 
Fig. S3 Batch growth curves of Pichia pastoris X-33 clone B13 cultivated on YPD (A) and YPG (B) medium in 
baffled shake flasks (µmax for X > 2 g L
-1
: 0.18 and 0.14 h
-1
, respectively). Due to limited sampling volumes all 
measurements were performed onefold. Process selectivities (62-66 h): sP/X = 102.6±9.8 and 132.2±11.2 nmol g
-1
, 
respectively. 
Biomass was formed more rapidly in YPD medium, leading to maximal specific growth rates 
µ of 0.18 h-1 and 0.14 h-1 for glucose and glycerol, respectively (determination for X > 2 g L-1). 
Ethanol formation in both shake flasks indicates hypoxic conditions throughout the cultivation 
(Baumann et al. 2008). The phase of oxygen limitation can be expected to be more 
pronounced for glucose due to the faster substrate consumption and stronger ethanol 
formation. Despite the differences in growth, the resulting SAV concentrations after 66 h 
were comparable, reaching 1.36 µM on glucose vs. 1.47 µM on glycerol. However, the 
courses of the space-time-yield pSTY and the local productivity ploc peaked earlier in the 
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glucose-based cultivation. Therefore, glucose was chosen as carbon source for the following 
bioreactor experiments 
 
S4 – analysis of the specific productivity pspec 
 
An analysis of the biomass-related productivity pspec (equation (5)) may contribute to a better 
understanding of the production in different growth phases. Fig. S4 shows plots of this 
parameter for the initial process conditions on MGY medium (pH 6.0, 30 °C) and the final, 
optimized process on MGY medium (steady shift of pH and T throughout the cultivation, 
Fig. 2 in the main document). 
 
 
 
Fig. S4 Additional data for two fed-batch cultivations of P. pastoris X-33 clone B13 in the bioreactor on MGY 
medium with 40 g L
-1
 of glucose, glucose feeding and an initial OD600 of 0.5. The fermentations correspond to the 
plots in Fig. 3 in the main document. (A) Successive shift of the pH  to 4.0 and direct shift of T to 27 °C after 24 h. 
(B) Successive shift of pH and T towards 4.0 and 24 °C, respectively. Parameters were acquired by direct fitting 
of biomass and product concentration to the four-parameter logistic model of equation (2) to minimize the 
deviations of data and model. Subsequently, the specific productivity (productivity per biomass) was calculated 
from the biomass course and the local productivity ploc. 
The plot reveals a steep decrease of the specific productivity for low specific growth rates for 
the initial process conditions, whereas pspec remains nearly constant for the optimized 
process conditions in the same range of the growth rate. 
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5.3.5 Summary of additional experiments applying P. pastoris
Additional studies applying P. pastoris focused on multiple chromosomal integration of the GAP
promoter-based expression cassette used in Müller et al. (2016a) and expression of SAV gene variants
by use of the AOX1 promoter.
5.3.5.1 Methanol-based production of SAV by P. pastoris
In addition to the GAP promoter-based construct described in the publication, several expression
cassettes using the AOX1 promoter were studied. One of the corresponding constructs was used for
demonstration of the functionality of the assay for the detection of biotin-blocked binding sites as
illustrated in section 3.3 (p. 30ﬀ.; Fig. 5 in the corresponding article).
For the corresponding constructs, full-length as well as core SAV genes were applied. Furthermore,
a sequence of the α-mating factor secretion signal modiﬁed according to Xiong et al. (2004) was
used. Due to a relatively small number of clones no detailed conclusions can be drawn concerning
the ideal genetic conﬁguration of the expression cassette. However, microplate results (data not
shown) indicated that the optimized secretion signal peptide may be slightly advantageous towards the
unmodiﬁed peptide from Saccharomyces cerevisiae (factor in the range of 1.1 regarding the extracellular
concentration of SAV). Furthermore, the application of a full-length gene seemed to result in improved
production (factor 1.3 towards core SAV). These observations have to be conﬁrmed in more detailed
experiments. Moreover, scale-up to the bioreactor is essential for methanol-based induction due to the
high oxygen demand in corresponding studies. These experiments were not a part of this thesis due to
the high benchmark concentrations achieved for methanol-based production of SAV by P. pastoris by
Casteluber et al. (2012) and Nogueira et al. (2014).
5.3.5.2 Multiple chromosomal integration of the expression cassette into the
genome of P. pastoris
Multiple chromosomal integration of the gene of interest has been associated to increased production
of heterologous proteins by P. pastoris. Based on the protocol by Sunga et al. (2008), the chromosomal
expression cassette was ampliﬁed post-transformationally using the clone of the core SAV/GAP pro-
moter construct applied for the studies in Müller et al. (2016a) by the exposure to increased selection
pressure. Selection by increasing concentrations of Zeocin yielded clones resistant to up to 2 g L−1 of
the antibiotic instead of the typically applied concentration of 100mgL−1. The expression pattern for
the cultivation of clones resulting from this selection procedure in 96-well plates is shown in Fig. 5.3.
Fig. 5.3 shows that the procedure yielded clones surpassing the average concentration of SAV from
all wells by a factor of up to 2.4 (1.38 vs. 0.66±0.15 µM). Generally, the best results were achieved
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Fig. 5.3: Expression pattern of 192 clones of P. pastoris producing core SAV under control
of the GAP promoter acquired by post-transformational vector amplification (PTVA)
according to Sunga et al. (2008). Characterization was performed in 96-well plates. The
highlighted blocks indicate increasing concentrations of Zeocin™ used for the selection
procedure (from left to right: 200, 500, 1000 and 2000mgL−1).
for a concentration of 1 g L−1 of antibiotic (third section in the plot), which brought about 6 out of 7
clones accumulating more than 1µM of SAV in the supernatant.
However, a subsequent characterization of the best-performing clones in 24-well plates without
selection pressure resulted in concentrations of SAV resembling the productive properties of the original
clone. This indicates problems of genetic stability of the clones acquired by PTVA. Multiple streaking
of multi-copy integrants on plates supplemented by the increased concentration of Zeocin prior to the
production study did not solve the issue. Thus, further studies should focus on the stabilization of
multi-copy integrants.
If other strategies of stabilization are successful, the application of an optimized secretion signal
peptide may also be a useful tool for further experiments in the context of multiple chromosomal
integration, because the increased production may lead to a bottleneck in the secretory pathway of
P. pastoris. This could cause problems of host toxicity, which is one potential reason for the loss of
productive potential during the studies in the absence of the antibiotic.
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5.4 Production of SAV by Hansenula polymorpha
The promising results from the studies of Casteluber et al. (2012) and Nogueira et al. (2014) on
the production of SAV by P. pastoris suggested that yeast-based expression of the SAV gene may
be superior to competing prokaryotic heterologous expression systems. This led to considerations of
testing alternative yeasts for the expression of the gene.
Like P. pastoris (see section 5.3, p. 116), the methylotrophic yeast H. polymorpha is established in
heterologous protein production for more than 20 years (Hollenberg & Gellissen, 1997; Stöckmann et al.,
2009) and has led to protein concentrations in the multi-gram per liter-range
(Mayer et al., 1999). It therefore seemed a suitable host for the production of SAV. Like P. pastoris,
common production media for H. polymorpha contain a biotin supplement, indicating an auxotrophy
for the vitamin (Mayer et al., 1999).
5.4.1 Goals of this study
As H. polymorpha has not been used for a production of SAV before, this study focused on a variety
of aspects on diﬀerent levels of process development, including the evaluation of genetic factors,
optimization of culture conditions, and scale-up to the bioreactor.
5.4.2 Manuscript
The results were published in the Journal of Biotechnology (Wetzel et al., 2016) (with permission
from Elsevier, Copyright 2016), as shown on the following pages. The section contains the research
article and the corresponding supporting information.
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a  b  s  t  r  a  c  t
Streptavidin  –  a protein  secreted  by  the  ﬁlamentous  bacterium  Streptomyces  avidinii  –  is  applied  in  a
variety  of  methods,  leading  to numerous  studies  on  its  heterologous  production.  Development  and  char-
acterization  of  a novel  expression  system  for  streptavidin  genes  by  Hansenula  polymorpha  is described
utilizing  different  target  gene  variants  along  with  the  two methanol-inducible  promoters  PMOX and  PFMD.
Extracellular  product  concentrations  were  higher  for  cultivation  at 30  instead  of 37 ◦C. The  best  per-
forming  strain  carrying  the  full-length  streptavidin  gene  under  control  of PFMD was characterized  in  the
bioreactor  applying  a synthetic  medium  and  oxygen-controlled  feeding  of  glucose.  Derepression  resulted
in an  extracellular  concentration  of  1.31  ± 0.07  M of  tetrameric  streptavidin  after  48  h  (27.3  nM  h−1).
Feeding  of glycerol  improved  biomass  formation,  but  lowered  the  product  concentration.  By  combin-
ing  derepression  and  methanol  induction  the  ﬁnal  extracellular  streptavidin  concentration  increased
to  11.42  ±  0.22  M (approx.  751  mg  L−1),  yielding  a  productivity  of 52.5  nM  h−1. Despite  supplementing
biotin  the  proportion  of  biotin-blocked  binding  sites  in the supernatant  dropped  from  54.4 ± 5.0  %  after
18  h to  17.2  ±  6.5  %  towards  the  end  of  glucose  feeding  to a ﬁnal  value  of  1.1  ± 3.8  %, indicating  a highly
bioactive  product.  Thus,  H.  polymorpha  proved  to  be  a suitable  host  for  the  production  of streptavidin.
©  2016  Elsevier  B.V.  All  rights  reserved.
1. Introduction
The interaction of the homotetrameric protein streptavidin
(SAV) and its natural ligand biotin is characterized by one of the
smallest dissociation constants known in biological systems (Kd of
4 × 10−14 M;  Green, 1990). This property is fundamental for the var-
ious applications of the interaction, including – among numerous
others – the puriﬁcation of peptide-tagged (Skerra and Schmidt,
1990) or biotinylated (Rösli et al., 2008) proteins. These applications
are facilitated by the stability of SAV towards various environ-
mental factors like pH (Sano and Cantor, 1995) and temperature
(González et al., 1999).
Naturally occurring in the ﬁlamentous bacterium Streptomyces
avidinii (Chaiet and Wolf, 1964), the SAV gene has been subject
to many studies of heterologous expression since the 1980s. Vari-
Abbreviations: -MF, -mating factor; SAV, streptavidin; vvm, volume per vol-
ume  and minute.
∗ Corresponding author.
E-mail address: jmu@fermtech.techfak.uni-bielefeld.de (J.M. Müller).
1 Both authors contributed equally.
ous hosts were applied in the studies, ranging from Escherichia coli
(Sano and Cantor, 1990; Gallizia et al., 1998; Miksch et al., 2008;
Müller et al., 2016) to Bacillus subtilis (Wu  et al., 2002), Strepto-
myces lividans (Meade and Jeffrey, 1984), and, more recently, to
Pichia pastoris (Casteluber et al., 2012; Nogueira et al., 2014).
After cleavage of the native signal peptide, mature SAV
monomers naturally consist of 159 amino acids, but often occur
in shortened, bioactive forms in supernatants due to N- and C-
terminal cleavage of the protein by proteases (Bayer et al., 1989).
As only a core motif of 118–127 amino acids is necessary for the
binding of biotin (Pähler et al., 1987; Sano et al., 1995), expression
may  focus either on truncated forms of the SAV gene, resulting in
so-called “core streptavidins”, or on full-length SAV.
Due to the biotin-binding ability of SAV, the protein exhibits
toxic properties in heterologous expression, limiting the maxi-
mal  product concentration especially for intracellular production
of the protein. Nevertheless, studies with P. pastoris in methanol-
and secretion-based production processes resulted in remarkable
extracellular concentrations of 11 (full-length SAV, bioreactor culti-
http://dx.doi.org/10.1016/j.jbiotec.2016.03.017
0168-1656/© 2016 Elsevier B.V. All rights reserved.
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vation; Nogueira et al., 2014) and 71 M1 (core SAV, cultivation in
spinner ﬂasks at 4 vvm, washing between growth and induction;
Casteluber et al., 2012) of tetrameric SAV. Thus, despite typically
being biotin-auxotrophic, yeast-based expression systems seem to
be efﬁcient for the production and secretion of the protein.
1.1. Goals of this study
The yeast Hansenula polymorpha is industrially established for
heterologous protein production (Weydemann et al., 1995; Mayer
et al., 1999) and thus seemed a promising host for the secreted pro-
duction of SAV. Like P. pastoris, this yeast is accessible to methods of
gene technology, established in fermentation engineering, able to
secrete proteins to the supernatant in the grams per liter range and
grows to dry cell weights of more than 100 g L−1 in standard fed-
batch fermentations (Weydemann et al., 1995; Mayer et al., 1999).
In the past the yeast was renamed several times. The two  strains
used in this study were classiﬁed as Ogataea polymorpha (ATCC
34438) and Candida parapolymorpha (ATCC 26012, DL-1) recently
(Suh and Zhou, 2010). However, the designations H. polymorpha for
the genus and DL-1 and ATCC 34438 for the strains, respectively,
were used in this study, as they are still most widely employed in
literature. The promoters of the methanol oxidase (MOX) (Ledeboer
et al., 1985) and formiate dehydrogenase (FMD) (Hollenberg and
Janowicz, 1987) genes were chosen for overexpression of the SAV
gene. In addition to being strongly inducible by methanol both pro-
moters allow heterologous gene expression upon derepression in
the presence of growth limiting concentrations of carbon sources
like glucose and glycerol (Weydemann et al., 1995; Mayer et al.,
1999).
2. Materials and methods
2.1. Microbial strains and plasmids
The strain E. coli KRX (Promega, Fitchburg, Wisconsin, USA),
which is optimized for recombinant protein production and cloning
of DNA, was used for cloning work and vector ampliﬁcation. S.
avidinii (CBS 730.72) was ordered from CBS (Centraalbureau voor
Schimmelcultures, Utrecht, Netherlands) and used for the ampli-
ﬁcation of the SAV gene. The H. polymorpha strains ATCC 34438
(DSMZ, German Collection of Microorganisms and Cell Cultures,
Braunschweig, Germany) and DL-1 (ATCC 26012, ordered from CBS)
were used for the study.
2.2. Plasmid construction, transformation and veriﬁcation of
cloning steps
Plasmids used for this study were assembled isothermally at
50 ◦C for 1 h as described by Gibson et al. (2009) using a master mix
purchased from NEB (Ipswich, Massachusetts, USA). The plasmid
fragments were ampliﬁed by PCR using primers with overlaps of up
to 30 base pairs, followed by clean-up from agarose gels. E. coli was
transformed by electroporation using 3 L of the resulting solution
according to standard laboratory procedures (Sambrook, 1989). The
cloning steps were veriﬁed by sequencing at Bielefeld University
(IIT Biotech GmbH, Bielefeld, Germany). After clone selection by
Ampicillin and preparative plasmid isolation from positive clones,
approx. 10 g of linearized plasmid were used for the transforma-
tion of H. polymorpha by electroporation in general following the
protocol from Faber et al. (1994), but using 1,5 kV, 50 F and 100 .
Clone selection of was performed by ZeocinTM (Song et al., 2003).
1 Assuming a tetrameric molecular weight of the core SAV of 56 kDa.
Table 1
Variants of expression vectors for the production of streptavidin by Hansenula
polymorpha.
vector designation promoter streptavidin genea
FMD-cSAV FMD  core SAV
FMD-AP-cSAV FMD  ala-pro core SAV
FMD-AP-SAV FMD  ala-pro full-length SAV
MOX-cSAV MOX  core SAV
MOX-AP-cSAVb MOX  ala-pro core SAV
MOX-AP-SAV MOX  ala-pro full-length SAV
a Variant of the streptavidin gene: core SAV = shortened streptavidin gene (AA
13–139), full-length SAV = AA 1–159. Variants labelled ala-pro contain an N-terminal
alanine-proline-modiﬁcation as described by Eilert et al. (2013).
b Transformation of ATCC 34438 with this vector did not yield producers.
Glycerol stocks of H. polymorpha were prepared applying a ﬁnal
concentration of 15% (w/v) of glycerol, freezing in liquid nitrogen
and storage at −80 ◦C.
The expression vectors were constructed according to the
detailed description in Section S1 (supplementary material). In
brief, the pUC-based pAaZBgl vector backbone (Pichia Pool/TU Graz,
Graz, Austria; Ahmad et al., 2014), designed for the AOX1 (alcohol
oxidase) promoter-based expression of heterologous genes by P.
pastoris, was modiﬁed for its application in H. polymorpha. The mod-
iﬁed backbone allowed secretion of the target protein mediated
by the -mating factor (-MF) secretion signal from S. cerevisiae,
termination of transcription by the AOX1 terminator from P. pas-
toris, selection by a ZeocinTM-resistance cassette and integration
into the genome of H. polymorpha by a part of the 3′-UTR (untrans-
lated region) of the FMD  locus. The latter region was  cut by the
single cutter BglII prior to the transformation. The promoter region
for the gene of interest was  exchanged by the MOX  or FMD promot-
ers, which were ampliﬁed from a genome isolate of H. polymorpha
ATCC 34438.
The ﬁnal expression vectors (Table 1) contained different vari-
ants of the SAV gene. The gene variants were ampliﬁed from the
genome of S. avidinii CBS 730.72, covering either the complete
length of mature SAV (AA 1–159) or a core structure of the pro-
tein (AA 13–139). In some cases, the N-terminal amino acids were
exchanged by an alanine-proline motif as described by Eilert et al.
(2013) to improve processing of the -MF  signal sequence.-
2.3. Media and supplements for cultivation
HSG medium was  used as standard cultivation medium for E. coli
containing (per L) glycerol 14.9 g, soy peptone 13.5 g, yeast extract
7.0 g, NaCl 2.5 g, K2HPO4 2.3 g, KH2PO4 1.5 g, and MgSO4·7H2O
0.249 g. The pH was set to 7.4 using 6 N NaOH.
Microplate and shake-ﬂask cultivations were performed using
YPD or YPG medium (Cregg, 2007), containing (per L) 20 g soy pep-
tone, 10 g yeast extract and 20 g of carbon source (d-glucose for
YPD, glycerol for YPG), which was  adjusted to pH 7.0.
Bioreactor cultivation was  based on Mayer’s synthetic medium
(Mayer et al., 1999), consisting of (per L) 5 g KH2PO4, 10 g
NH4H2PO4, 5 g (NH4)2SO4, 2.3 g KCl, 0.5 g NaCl, 0.75 g CaCl2·2H2O,
0.1 g Na-EDTA, 0.1 g (NH4)2Fe(SO4)2·6H2O, and 4.5 g MgSO4·7H2O,
adjusted to a pH value of 4.6 and autoclaved in the fermenters.
d-Glucose (10 or 30 g L−1) was sterilized separately as a 10fold
concentrate. Additionally, sterile-ﬁltered thiamin and biotin were
added to a ﬁnal concentration of 100 and 0.3 mg  L−1, respec-
tively, using 1000- and 500fold concentrates. A volume of 10 mL
(1% (v/v)) of a 100fold trace salt solution was  added after ster-
ilization, consisting of (per L) 0.05 g H3BO3, 0.125 g CuSO4, 3 g
ZnSO4·7H2O, 4 g MnSO4·H2O, 0.1 NiSO4·6H2O, 0.1CoCl2·6H2O, and
0.1 Na2MoO4·2H2O, 0.1 g KI, acidiﬁed by the addition of 0.5 mL  of
85% (w/w) H2SO4 per L for an improved solubility. Inoculation was
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performed by an overnight culture applying a half-concentrated
medium of the same composition, using the full amount of glucose
(30 g L−1), thiamin, biotin, and trace salts. Feed solutions were an
aqueous glucose or glycerol solution (550 g L−1) for biomass gener-
ation and sterile-ﬁltered methanol (HPLC-grade, VWR, Darmstadt,
Germany) for induction.
2.4. Characterization in microplates and shake ﬂasks
Screening of transformants of H. polymorpha was performed in
96 well-deepwell plates (Deepwell Plate 96/2000 L, Eppendorf
AG, Hamburg, Deutschland) based on the methods for P. pastoris by
Weis et al. (2004) and Hartner et al. (2008). A cultivation volume of
500 L of YPD medium was inoculated by single colonies and sealed
by a gas-permeable, sterile sealing ﬁlm (BREATHsealTM, Greiner
Bio-One International GmbH, Kremsmuenster, Austria). After three
days of incubation at 28 ◦C and a shaking frequency of 350 min−1
(shaking diameter 2.5 cm), the plate was used for the creation of
glycerol stocks and 10 L of the culture were used for the inocula-
tion of a second 96 well plate (main culture) ﬁlled with 490 L of
YPG medium per well. After three additional days, the loss of water
was compensated by the addition of sterile demineralized water
(differential weighing) and induction was started by 1% (v/v) of
sterile methanol. Cultivation was terminated after three more days
and a ﬁnal compensation of evaporation by sterile water. Where
indicated, 24 squared well-deepwell-plates (Axygen® 24 Well Clear
V-Bottom, Corning Inc., New York, USA) were used. The cultivation
volume was increased to 3 mL  for these experiments. All further
steps were performed as described in the 96 well-protocol, but
scaled according to the increased volume.
Shake ﬂask cultivations were performed in YPG medium in baf-
ﬂed 500 mL-shake ﬂasks (DURAN® bafﬂed ﬂask with membrane
screw cap, Schott AG, Mainz, Germany) with a ﬁlling volume of
50 mL  at 30 ◦C and a shaking frequency of 200 min−1 (shaking diam-
eter: 2 cm). Upon sampling (every 24 h), methanol and glycerol
were added for induction and derepression in concentrations of
0.5% (v/v) and 5 g L−1, respectively. Flasks were inoculated to an
OD600 of 0.1 by an overnight culture.
2.5. Fermentation in the bioreactor
Bioreactor fermentation took place in the Sixfors fermentation
system by Infors HT (Infors AG, Bottmingen, Switzerland) with
glass vessels without turbulence promoters and a maximal ﬁlling
volume of 500 mL.  The working volume was 400 mL.  Three six-
bladed rushton turbines, one three-bladed propeller stirrer and
one mechanic foam disruptor were used as stirrers. Characteris-
tic dimensions of the reactor were 2.77:1 (bioreactor aspect ratio)
and 0.4 (ratio of stirrer to reactor diameter). Cultivations were per-
formed at 30 ◦C, an air ﬂow rate of 3 vvm (1.2 NL min−1), and a
stirring frequency of 1000 min−1. The volumetric oxygen transfer
coefﬁcient kLa of the system was determined by dynamic measure-
ment (Bandyopadhyay et al., 1967). Input air was  saturated with
water vapor. The pH value was metabolically shifted from 4.6 (ini-
tial pH) to 3.4 during the cultivation, followed by control at this
value by the automatic addition of 20 % (w/w)  H3PO4 and 25 %
(w/w) NH3. The initial fermentation volume of 400 mL  was adjusted
to an optical density OD600 of 1.0 at inoculation, using a shake ﬂask
overnight culture. A 550 g L−1 D-glucose or glycerol solution was
fed pulse-wise to reach a glucose concentration of 1 g L−1 when the
relative dissolved oxygen saturation rDO surpassed 50 %. After glu-
cose feeding (48 h), the culture was induced by methanol based on
the rDO in a similar manner, resulting in a methanol concentration
of 0.5 % (v/v) per pulse.
Samples were automatically taken in intervals of 6 or 8 h, cooled
to 4 ◦C and processed in intervals of 24 h. Media were supplemented
with 1 drop of antifoam agent (Pluronic® PE 8100, BASF SE, Lud-
wigshafen, Germany) per 50 mL  of medium (≈0.7 g L−1).
2.6. Analysis of substrate (S) and biomass (X, OD600)
Glucose concentrations were determined by HPLC as described
previously (Müller et al., 2013). For measurement of the optical
density at 600 nm OD600 (BioPhotometer plus, Eppendorf AG, Ham-
burg, Germany) samples of cultures were diluted by a solution of
NaCl (9 g L−1) if required, i.e. if the optical density was higher than
0.8. The dry cell weight concentration X was determined by differ-
ential weighing after drying at 50 ◦C to constancy of weight. Cell
pellets were acquired from 1 mL  of culture broth washed twice in
an aqueous NaCl solution (9 g L−1).
2.7. Quantiﬁcation of product (P) and the proportion of
biotin-blocked binding sites (Qblocked)
The tetrameric concentration of soluble SAV was determined by
ﬂuorescence quenching of biotin-4-ﬂuorescein (Kada et al., 1999a,
1999b). The assay was  performed in ﬁnal volumes of 1 mL  as spec-
iﬁed elsewhere (Müller et al., 2013). The overall binding sites of
SAV were quantiﬁed via heat-based displacement of biotin by B4F
(Müller et al., 2015) by incubating the samples at 70 ◦C for 10 min
prior to the ﬂuorescence measurement. Samples were diluted to
overall SAV concentrations ≤300 nM of tetrameric SAV to allow full
detectability of the binding sites. The proportion of biotin-blocked
sites Qblocked was  calculated from the difference of the measure-
ments at room temperature (free binding sites) and after heat
incubation (overall binding sites) and scaled from 0 (biotin-free
SAV) to 1 (product completely inactive).
3. Results
3.1. Clone characterization in microplates
The different expression constructs described in Table 1 were
used for transformation of the two H. polymorpha-strains. Clones
were analyzed in 96 well-plates. Results are shown in Fig. 1.
Generally, transformation efﬁciency was more than 12fold
higher for H. polymorpha DL-1 than for ATCC 34438 (total number
of clones: 478 vs. 38) which is probably due to the more efﬁcient
homologous recombination in the strain DL-1 (Rhee et al., 1999).
According to the distribution of SAV concentrations, the expression
pattern of the clones was  rather inhomogeneous. This is particu-
larly true for the DL-1 constructs FMD-cSAV and MOX-AP-SAV, for
which the ﬁnal product concentration ranged from 0 to 1766 nM
(FMD-cSAV) and from 0 to 1287 nM (MOX-AP-SAV), respectively.
ATCC 34438 transformed with the FMD-AP-SAV-vector led to a very
narrow expression pattern and yielded by far (factor of >2.3 to all
other combinations) the highest median of product concentrations
(1601 nM). However, these results are only based on 5 clones due
to low transformation efﬁciency.
The results for H. polymorpha DL-1 suggest that the alanine-
proline-terminus fused to the core SAV gene (AP-cSAV) had a
negative impact on the SAV concentration (median AP-cSAV = 41
and 121 nM for FMD  and MOX; median cSAV = 541 and 224 for FMD
and MOX). Thus, it would be desirable to analyze if removal of the
AP-motif leads to improved SAV production for the full-length con-
struct as well (not tested). No clear conclusions are possible for the
choice of promoter and length of the SAV gene. However, the ATCC
34438 FMD  AP-SAV construct showed the best overall performance
of the combinations tested.
Three best-performing clones were taken to the next step of
characterization in shake ﬂasks. To provide comparable conditions,
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only FMD-based constructs were evaluated, namely one clone of
ATCC 34438 FMD-AP-SAV, DL-1 FMD-cSAV, and DL-1 FMD-AP-SAV,
respectively.
3.2. Comparison of selected clones in shake ﬂasks
The courses of product and biomass of the three clones were
evaluated in shake ﬂasks under conditions of induction and dere-
pression. Results are shown in Fig. 2.
Generally, ﬁnal product concentrations were 1.6- to 2.6fold
improved by induction towards pure derepression of the same
construct. Derepression was most effective for ATCC 34438 FMD-
AP-SAV, yielding 523 nM of SAV after the initial growth phase
(24 h). Remarkably, derepression of the corresponding clone led to
a concentration of SAV surpassing or in one case (induction of DL-1
FMD-AP-SAV) matching the concentrations achieved by induction
or derepression of all further constructs, implying a suitable genetic
conﬁguration for the heterologous production of SAV for subse-
quent studies. In comparison to the previous results, cultivation
in microplates (Fig. 1) yielded higher concentrations of SAV than
in shake ﬂasks for H. polymorpha DL-1, whereas cultivation of the
clone of ATCC 34438 led to comparable concentrations in both cul-
tivation systems (microplate: 1601 nM,  induction in shake ﬂasks:
1782 nM). Upon induction, ATCC 34438 FMD-AP-SAV accumulated
a maximal concentration of 1782 nM of SAV in the supernatant, sur-
passing the SAV concentration in all other cultures by a factor of at
least 2.4.
Due to the favorable properties upon derepression and the
higher overall product concentration, the corresponding clone
(ATCC 34438 FMD-AP-SAV) was used for a more detailed charac-
terization.
3.3. Impact of the cultivation temperature on SAV production
The cultivation temperature was varied in a microplate study,
as this factor was of central importance in the optimization of SAV
production by E. coli (Müller et al., 2016). Results are shown in Fig. 3.
A cultivation temperature of 30 ◦C was favorable for the accumula-
tion of SAV. The ﬁnal OD600 and product concentration achieved at
this temperature were 1.2 and 1.9fold increased towards cultiva-
tion at 37 ◦C, respectively. Thus, the temperature was  adjusted to
30 ◦C for all following experiments.
Fig. 1. Box plot for the effect of different host strains (ATCC 34438 and ATCC
26012 = DL-1) and combinations of promoter (MOX or FMD) and streptavidin gene
(SAV = full-length, cSAV = core SAV (AA 13–139), AP-SAV/cSAV = alanine-proline-
motif at N-terminus) on the extracellular concentration of streptavidin P. Outliers are
shown as open circles. Expression was performed in 96 well-plates (YPG medium,
induction by methanol). The number of clones analyzed is shown in brackets. Where
indicated (*), cultivations were performed in 24 well-plates due to the small number
of  clones.
3.4. Effect of the carbon source on biomass and SAV production
Derepression of the promoter in fed-batch studies in
microplates led to lower concentrations of biomass (factor
1.7 on average) and SAV (factor 1.6) for the carbon source glucose
compared to pure glycerol (data not shown).
Moreover, as a byproduct of the continuously growing biodiesel
industry glycerol may  contribute to a more sustainable process.
Quality and composition of crude glycerol vary depending on the
manufacturer and the process established (Yang et al., 2012). In this
study crude glycerol from Cargill GmbH (Krefeld, Germany) and
Campa AG (Ochsenfurt, Germany) was used as carbon source for
different batch and fed-batch cultivations instead of pure glycerol
for laboratory use. The studies led to comparable results regarding
ﬁnal product concentration and productivity (data not shown). A
process based on pure derepression applying crude glycerol may
therefore be an ideal choice regarding sustainability.
Fig. 2. Comparison of different producer strains of H. polymorpha in shake ﬂasks as described in Section 2.4. Where indicated (once per gray area), cultures were either
induced by 0.5% (v/v) of methanol (induction) or fed with 5 g L−1 of glycerol (derepression). (A) Optical density at 600 nm. (B) Product concentration P.
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Fig. 3. Impact of the cultivation temperature on the concentration of streptavidin P
and  the optical density at 600 nM OD600 of Hansenula polymorpha ATCC 34438 FMD-
AP-SAV grown in YPG medium in microplates in duplicates according to Section 2.4.
Methanol was supplemented to the wells in a ﬁnal concentration of 1.0 % (v/v) after
sampling.
3.5. Production of SAV in the bioreactor
To ensure up-scalability of the system, the best-performing
clone of ATCC 34438 based on the FMD  promoter-based AP-SAV
expression cassette was cultivated in the bioreactor. Dynamic
measurement (Bandyopadhyay et al., 1967) yielded a volumetric
oxygen transfer coefﬁcient kLa of 129 ± 19 h−1 for the condi-
tions applied (3 vvm, 1000 min−1). Fermentation was performed
as described in Section 2.5 applying a synthetic medium suitable
for the production of dry cell weight concentrations larger than
100 g L−1 (Mayer et al., 1999). Glucose and glycerol were tested as
carbon source. All of the substrates were fed pulse-wise based on
the relative dissolved oxygen saturation rDO. The pH was  shifted
metabolically to 3.4 from an initial value of 4.6. The process was
divided in three phases: batch phase on glucose, limiting feeding
of glucose (derepression), and induction by methanol. Results are
shown in Fig. 4. Regression curves of biomass and SAV (Fig. 4A) were
acquired by ﬁts to logistic models, resulting in courses of the local
(ploc) and overall (space time yield, pSTY ) productivity as shown in
Fig. 4B.
Biomass was  formed primarily in the batch and glucose feed
phase (derepression, 77.1%), whereas the majority of product
(88.7%) accumulated upon induction by methanol. This is con-
sistent with previous fed-batch experiments in microplates (data
not shown). Derepression of the construct led to a concentration
of SAV of 1.31 ± 0.07 M (48 h, pSTY = 27.3 nM h−1). This concen-
tration further increased upon induction by methanol, reaching a
maximum of 11.42 ± 0.22 M (≈751 mg  L−1, assuming a theoreti-
cal MW of 65.8 kDa per un-glycosylated tetramer) of biotin-free,
tetrameric SAV in 216 h (pSTY = 52.5 nM h−1). The proportion of
biotin-blocked binding sites (Fig. 4 B) dropped from 54.4 ± 5.0 %
after 18 h to 17.2 ± 6.5% towards the end of the glucose feed phase
(48 h), further decreasing to a diminishingly small proportion of
1.1 ± 3.8% in the end of the process (216 h), thus leading to a highly
bioactive product. The ﬁnal selectivity of the process (product per
biomass) and speciﬁc productivity (productivity per biomass) were
244.5 nmol g−1 and 1.13 nmol g−1 h−1, respectively.
A corresponding process applying glycerol instead of glucose in
the batch- and ﬁrst fed-batch phase yielded a 1.3fold higher con-
centration of biomass (60.1 ± 1.2 vs. 46.3 ± 1.3 g L−1 after 216 h),
resembling the microplate results (section 3.4). However, due
to a lower extracellular concentration of product (0.31 ± 0.02
vs. 1.31 ± 0.07 M after 48 h upon derepression, 9.22 ± 0.26 vs.
11.42 ± 0.22 M after 216 h upon induction) the strategy yielded
a reduced process selectivity (153.3 nmol g−1) and speciﬁc produc-
tivity (0.71 nmol g−1 h−1).
Several additional fermentations were performed (data not
shown). Further studies based on glucose feeding in pulses of 3 g L−1
brought about similar results for the derepression phase. Cultiva-
tion applying a constant pH of 4.6 without the metabolic shift from
pH 4.6–3.4 resulted in a reduced overall product concentration.
Optimization of the induction procedure by methanol was tested by
step-wise reduction of the cultivation temperature or the feed vol-
ume  per pulse to avoid relative dissolved oxygen saturations <10%
(oxygen limitation). However, both of these strategies resulted in
decreased product concentrations.
Fig. 4. Fed-batch bioreactor cultivation of H. polymorpha ATCC 34438 producing AP-SAV under control of the FMD  promoter in a synthetic medium. The cultivation volume
was  400 mL.  Feeding was  performed pulse-wise based on the dissolved oxygen signal, divided in a phase of glucose (14–48 h) and methanol feeding (48–216 h), respectively.
The  ﬁnal volumes of the feed solutions were 32 mL  of 550 g L−1 glucose and 173 mL  of pure methanol, respectively. (A) Glucose (cGlc) consumption, feeding (Vfed), and
concentrations of dry cell weight (X) and SAV (P). (B) pH,  proportion of biotin-blocked binding sites Qblocked , and local (ploc) and overall (pSTY ) productivity. Vfed corresponds
to  the proportion of the ﬁnal feed volume of both feed solutions (Glc = glucose, MeOH = methanol). The methanol concentration was <3 g L−1 for all sampling points (data not
shown).
138 Jakob M. Müller
8 D. Wetzel et al. / Journal of Biotechnology 225 (2016) 3–9
4. Discussion
The production of SAV by the yeast H. polymorpha was  sucess-
fully established. According to the clone characterization in shake
ﬂasks, H. polymorpha ATCC 34438 is a more suitable host for the
expression of the SAV gene than DL-1. A cultivation temperature
of 30 ◦C improves SAV production towards 37 ◦C like previously
observed for E. coli (Müller et al., 2016).
Cultivation was successfully scaled up from microplates via
shake ﬂasks to the bioreactor, showing suitable properties for
industrial processes. As reported by Mayer et al. (1999), who  pro-
duced a phytase under control of the FMD  promoter, derepression
using glucose instead of glycerol led to improved product forma-
tion. However, it remains unclear why methanol induction also
resulted in lower product concentrations for the glycerol-based
process, since this strategy was more efﬁcient for biomass genera-
tion. This may  be an effect of the pulse-wise feeding of methanol,
potentially limiting the productive potential of the biomass. Experi-
ments based on optimized induction by the use of methanol sensors
and a constant concentration of methanol are therefore in prepa-
ration.
The ﬁnal product concentration of 11.42 ± 0.22 M for glucose-
based cultivation is among the highest reported for the heterol-
ogous expression of a full-length SAV gene, surpassing maximal
concentrations for secretion-based E. coli processes (2.60 ± 0.17 M
in bioreactor cultivations; Müller et al., 2016) by a factor of 4.4.
In contrast to the bioreactor study of Nogueira et al. (2014) using
P. pastoris, the parameters for methanol induction were chosen
to allow expression of the SAV gene under conditions of reduced
oxygen supply for improved process scalability, i.e. without the
application of concentrated oxygen. Nevertheless, the ﬁnal prod-
uct concentration was in the same range (11.42 ± 0.22 M,  this
study vs. 11 M of Nogueira and coworkers), although productiv-
ities were lower (52.5 vs. 67 nM h−1). However, the concentration
was reached for a much lower DCW concentration (46.3 ± 1.2 g L−1
vs. 235 g L−1), leading to a drastically improved process selectivity
(244.5 vs. 46.8 nmol g−1). The proportion of biotin-blocked binding
sites was reduced from 20% (Nogueira et al., 2014) to 1.1 ± 3.8%
(this study). Furthermore, the derepression stage of the process
shows that the construct allows the accumulation of SAV in the
absence of methanol, which may  be exploited to circumvent prob-
lems like high oxygen demand, ﬂammability, and solvent toxicity
accompanying the use of the organic solvent.
In summary, the properties indicate that H. polymorpha is a
highly suitable host for the production of SAV. On the genetic level,
multiple integration of the SAV expression cassette into the host
genome may  further improve SAV production (Sohn et al., 1996).
The latter strategy may  be useful in combination with derepression
of the host to achieve higher concentrations of SAV without the use
of methanol (Mayer et al., 1999). Furthermore, regarding the results
for the core SAV gene a construct expressing a full-length gene of
SAV without the AP-modiﬁcation may  futher improve SAV produc-
tion. Finally, selected DL-1 clones should also be cultivated in the
bioreactor to check, whether the production behavior in this culti-
vation system resembles the promising microplate results (Fig. 1)
or brings about decreased concentrations of SAV like observed in
shake ﬂasks (Fig. 2).
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S1 - detailed description of the cloning strategy 
The plasmid pAaZBgl (Ahamad et al. 2014) was used as backbone for the cloning work 
described here. For the purpose of recombinant protein production with H. polymorpha the 
P. pastoris derived promoter and 3` UTR of the AOX1 locus were substituted by 
H. polymorpha- derived sequences. Other functional parts of pAaZBgl like the S. cerevisiae 
α-MF signal sequence, the AOX1 transcription terminator, the Zeocin expression cassette, 
the Ampicillin resistance cassette and the pUC origin of replication were kept. 
 
With primers 1 to 4 two fragments of pAaZBgl were amplified by PCR. One of them 
contained the E. coli – specific part including the pUC ori and the ampicillin resistance gene. 
The second fragment covered the yeast-specific elements i.e. the Zeocin resistance 
cassette, the MF-alpha secretion signal and the AOX1 transcription terminator. For 
heterologous gene expression in H. polymorpha the promoter sequences of both the FMD 
(formate dehydrogenase) and the MOX (methanol oxidase) gene were used. For 
recombination purpose the transcription terminator of the FMD gene was cloned. All three 
regulatory elements were amplified from the genome of the H. polymorpha strain ATCC 
34438 by PCR using primers 5 to 10. 
 
The two fragments of the pAaZBgl vector were assembled with the regions of the FMD or 
MOX promoter and the FMD terminator by Gibson Assembly. 
Jakob M. Müller 141
2 
 
Thereafter, different SAV coding genes were inserted into the newly designed expression 
vector for H. polymorpha. For this purpose, the vector was linearized using primers 11 and 
12. The different SAV-coding genes were amplified using primers 13 to 16. For optimization 
of Kex2 cleavage during secretion of recombinant streptavidin in some constructs alanine 
and proline were chosen as the products` N-terminal amino acids i.e. AP-SAV and AP-
coreSAV. Eilert et al. (2013) observed improved processing for this amino acid combination 
following the S. cerevisiae α-MF signal sequence. Accordingly, primers 17 and 18 were used 
to change genes coding for a coreSAV into AP-coreSAV. 
 
During construction of the different plasmids the BglII site upstream of FMD or MOX 
promoter was deleted by PCR (primers 1 and 19). Using constructs with only one single BglII 
site led to improved transformation efficiencies after BglII digest compared to constructs with 
two BglII sites (data not shown). 
 
Tab. S1 Primers combinations used for the construction of the final expression vectors. 
Primer 
desig-
nation 
Sequence (orientation: 5`3`) remark 
primer 1 
(fwd) 
ATGAGATTTCCTTCAATTTTTACTGC
TGTTTTATTCGCAGCATCCTCCG 
Amplification of the E. coli – specific 
part of pAaZBgl 
primer 2 
(rev) 
ATGCGAGGATGCTGCTGGAGACGA
TTCAA 
primer 3 
(fwd) 
AGATCTTCACTGACTCGCTGCGCTC
GGTCG 
Amplification of the yeast-specific part 
or pAaZBgl without promoter and 3` 
UTR of AOX1 locus primer 4 
(rev) 
AGATCTGACGAAAGGGCCTCGTGAT
ACGCCTA 
primer 5 
(fwd) 
GGCGTATCACGAGGCCCTTTCGTCA
GATCTATCGCAGAAATGTATCTAAAC
GCAAACTCC 
Amplification of FMD promoter from H. 
polymorpha genome, introducing 
homologpus 3` extensions for 
introducing into pAaZBgl backbone primer 6 
(rev) 
AAACAGCAGTAAAAATTGAAGGAAA
TCTCATGATTTGATTGATGAAGGCA
GAGAGCGCAAGGAGGC 
primer 7 
(fwd) 
GAATCGTCTCCAGCAGCATCCTCGC
ATTGCGGTCTTGGAGGAGCTGATTG
GATCTAG 
Amplification of FMD terminator from 
H. polymorpha genome, introducing 
homologpus 3` extensions for 
introducing into pAaZBgl backbone primer 8 
(rev) 
GACCGAGCGCAGCGAGTCAGTGAA
GATCTCTTGACTTTCTGGGTGATGG
TCTTGGAGG 
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Tab. S1 (continued) Primers combinations used for the construction of the final expression 
vectors. 
primer 9 
(fwd) 
AGGCGTATCACGAGGCCCTTTCGTC
AGATCTGATGCACCAATTAATTGTTG
CCGCATGCATCCTTGC 
Amplification of MOX promoter from H. 
polymorpha genome, introducing 
homologpus 3` extensions for 
introducing into pAaZBgl backbone primer 
10 (rev) 
TAAAACAGCAGTAAAAATTGAAGGA
AATCTCATTTTGTTTTTGTACTTTAGA
TTGATGTC 
primer 
11 (fwd) 
GCGGCCGCAAACGGTTTTAGCCTTA
GAC 
Linearization of the H. polymorpha 
specific expression vector for 
introduction of different SAV genes primer 
12 (rev) 
TCTTTTCTCGAGAGATACCCCTTCTT
CTTTAGCAGCAATGC 
primer 
13 
(fwd) 
GAAGAAGGGGTATCTCTCGAGAAAA
GAGCCGAGGCCGGCATCACCGGCA
CCTG 
Amplification of native core-SAV coding 
gene from S. avidinii genome and 
introducing homologous 3`-extensions 
for integration into H. polymorpha 
expression plasmid backbone 
primer 
14 (rev) 
GTCTAAGGCTAAAACCGTTTGCGGC
CGCTTATTAGGATGCCGCGGACGG
CTTCAC 
primer 
15 (fwd) 
GAAGAAGGGGTATCTCTCGAGAAAA
GAGCCCCCTCCAAGGACTCGAAGG
CCCAGGTC 
Amplification of full-length AP-SAV 
coding gene from S. avidinii genome 
and introducing homologous 3`-
extensions for integration into H. 
polymorpha expression plasmid 
backbone 
primer 
16 (rev) 
GTCTAAGGCTAAAACCGTTTGCGGC
CGCTTATTACTGCTGAACGGCGTCG
AGCGGGTTGC 
primer 
17 (fwd) 
CCCGCCGGCATCACCGGCACCTG Linearization of coreSAV coding 
plasmids for introduction of alanine and 
proline as N-terminal amino acids (AP-
coreSAV) 
primer 
18 (rev) 
GGCTCTTTTCTCGAGAGATACCCCT
TCTTC 
primer 1 
(fwd, 
see 
above) 
ATGAGATTTCCTTCAATTTTTACTGC
TGTTTTATTCGCAGCATCCTCCG 
Linearization of expression plasmids in 
order to delete BglII site upstream the 
expression cassette 
primer 
19 (rev) 
GACGAAAGGGCCTCGTGATACGCC
TATTTTTATAGGTTAATGTC 
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6 Evaluation of alternative methods for
the purification of SAV
In addition to studies on the optimization of the production of SAV, puriﬁcation of the protein by a
variety of methods was analyzed.
6.1 Motivation
Due to expensive materials and loss of product during the puriﬁcation procedure, downstream
processing (DSP) often causes the majority of cost associated to protein production. SAV is no
exception to this rule: 2-iminobiotin agarose, which is used for aﬃnity chromatography of SAV, is
listed at a price of 307.50e per 5mL of gel material.[1] Moreover, the corresponding columns have
to be replaced after few cycles of puriﬁcation in the experience of the author, which is costly and
unsustainable.
6.1.1 Goals of this study
Due to these aspects, cheaper and more ecological methods for the puriﬁcation of the biotin-binding
protein were in the focus of interest. For this project, several methods were evaluated using the su-
pernatants of the homologous and heterologous producers studied in this thesis. The DSP procedures
included diaﬁltration, fractional precipitation by ammonium sulfate and centrifugation, thermal inacti-
vation of contaminants, and - targeting a novel method for the puriﬁcation of SAV - aqueous two phase
extraction (ATPE). All of these methods are based on inexpensive materials compared to puriﬁcation
by chromatography.
6.2 Host-dependent product purity
Generally, most supernatants analyzed in this study showed a low proportion of contaminating
proteins. This was, however, not the case for supernatants of E. coli for the ﬁnal process strategy
described in Müller et al. (2016c), as qualitatively illustrated in Fig. 6.1.
[1]Sigma-Aldrich, retrieved 14th of April, 2016
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(a) Supernatants of E. coli, partially denatured. (b) Supernatants of H. polymorpha, partially de-
natured.
(c) Supernatants of S. avidinii, completely dena-
tured.
Fig. 6.1: SDS-PAGE analysis of different supernatants used for DSP studies. Lane 1 in
subfigure (c) shows a 1µM solution of commercial SAV (Sigma), whereas all other
lanes show supernatants of different cultivations of the optimized strains of all hosts,
as described in the previous sections. Supernatants of P. pastoris resembled those of
H. polymorpha (data not shown). The gel bands in subfigures (a) and (b) indicate that
the samples were only partially denatured due to the presence of bands in the size of
tetrameric SAV. SAV bands were identified by B4F-staining according to Humbert &
Ward (2008) (data not shown). For the SDS-PAGE shown in subfigure (a), samples were
applied to the gel without (sublabel a) and with (sublabel b) dilution.[2]
As a consequence of the load of macromolecular contaminants, most of the studies focused on
supernatants of E. coli.
[2]The contrasts were adjusted using the image processing software GIMP (see Table 2.4, p. 24) to reduce
background noise.
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6.3 Summary of the results
The results of the corresponding studies are shown in the following sections. Detailed descriptions of
the methods used for this section are shown in section 8.1.3 (p. 176ﬀ.) in the supplementary material.
6.3.1 Aqueous two phase extraction
Aqueous two-phase extraction of SAV was tested in two diﬀerent polymer-salt systems. First stud-
ies were performed in a PEG/citrate system, whereas PEG/phosphate systems were applied for all
subsequent experiments due to the availability of detailed characteristics for the latter (Albertsson,
1986).
6.3.1.1 Preliminary studies in a PEG/citrate system
For preliminary studies, a PEG/citrate system was analyzed based on binodal curves of Kula &
Vernau (1990). The supernatant used for the studies was derived from the cultivation of S. avi-
dinii applying the optimized fed-batch process strategy developed in section 4 (p. 60ﬀ.). Results are
summarized in Fig. 6.2.
As can be concluded from the distribution of SAV in the screening, the majority of SAV was located
in the PEG-rich phase for most of the conditions tested. This behavior was intensiﬁed by alkaline
values of the pH. Generally, increased chain lengths of PEG caused a displacement of SAV from the
PEG-rich top- to the citrate-rich bottom phase. A maximal proportion of SAV of 99% was located in
the PEG-rich phase for all systems adjusted to pH 11, whereas the maximal proportion of 74.9% of
SAV in the citrate-rich phase was observed for the combination of two polymer chain lengths (PEG
1500 and PEG 3000). Based on these preliminary results, more detailed studies were performed using
a PEG/phosphate system.
6.3.1.2 Detailed screening in a PEG/phosphate system
In a DoE-approach, the aqueous two-phase extraction of SAV in a polymer/salt-system consisting
of PEG 4000 and potassium phosphate was analyzed. These experiments were based on supernatants
of E. coli grown in twofold concentrated HSG medium in the presence of Triton and Pluronic®, as
described in section 5.2 (p. 93ﬀ.). The change of systems was performed due to the better characteriza-
tion of PEG/phosphate-systems. This feature is demonstrated, e.g., by a broad availability of bionodal
curves and compositions of top- and bottom-phases (Albertsson, 1986). This more detailed screening
focused on one chain length of PEG, but contained systematic variations of the concentrations of salt
and polymer, the pH, and the supplementation of sodium chloride. Like in the preliminary screening
in the PEG/citrate system, SAV was successfully transferred to one speciﬁc phase by adjusting the
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Fig. 6.2: Analysis of the absolute distribution of SAV in PEG/citrate systems. Proportions
refer to the amount of SAV nSAV in the whole system. Labels indicate the molecular
weight of PEG used and the pH value to which it was adjusted. Phase ratios were
typically balanced, with a slightly larger top phase. Exact phase volumes and system
compositions are shown in Table 8.1 and 8.2 (p. 178 in the supplementary material).
The HPEG-system corresponds to a PEG-rich system (phase ratio: 70% top phase, 30%
bottom phase), whereas the 1500/3000-system contained both PEG 1500 and PEG 3000
in addition to citrate.
conditions. Table 6.1 sums up system compositions suitable for the extraction of SAV into either the
top or the bottom phase.
As can be concluded from Table 6.1, the presence of high concentrations of potassium phosphate
and either sour or alkaline pH values seemed to favor the transfer of SAV to the PEG-rich top phase
of the system. A shift to the bottom phase was achieved by adjusting the pH to values in the range
of the theoretical isoelectric point (pI) of the protein in a potassium phosphate-rich system with low
concentrations of PEG. The former eﬀect may be surprising regarding the charge of SAV, since the pI
of SAV is relatively neutral,[3] causing a positive or negative net charge of the protein for strongly sour
and alkaline pH values, respectively. Thus, contrary to the results, transfer to the salt-rich phase would
be expected. However, the simple in silico-analysis of the pI does not reveal surface-related eﬀects of
[3]Theoretical pI of 6.1 for full-length SAV according to the ProtParam-toolbox of the Swiss Institute of
Bioinformatics, http://web.expasy.org/protparam/.
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Tab. 6.1: Summary of ATPE compositions suitable for the aqueous two-phase
extraction of SAV based on a supernatant of E. coli. All of the listed extractions
resulted in a balanced ratio of top and bottom phase. The composition shown in
the shaded row was analyzed in detail in subsequent studies (see Fig. 6.3). The
major fraction of SAV for each extraction is printed in bold face.
cPEG4000 [% (w/w)] cKH2PO4/K2HPO4 cNaCl [% (w/w)] pH [-] xtop [%] a xbottom [%] a
[% (w/w)]
25.0 15.0 1.5 9.5 85.5 -
22.0 16.8 1.3 8.7 90.9 4.6
25.0 9.0 1.5 4.5 100.7 -
18.6 16.3 1.0 7.8 83.1 -
22.0 11.0 0.3 8.7 96.9 -
12.3 12.7 1.0 7.8 18.0 94.9
12.4 12.8 0.5 6.2 18.4 100.4
9.3 18.1 0.0 6.3 11.8 109.2
13.2 10.7 1.0 7.0 - 98.0
a Recovery of SAV in the top- and bottom phase of the extraction, respectively, related to
the initial quantity of SAV supplied to the system. The overall percentage may exceed
100% due to a varying activity of SAV in the phases.
the charge distribution, which may contribute to a diﬀerent distribution of the protein in the system.
Unfortunately, for the majority of system compositions contaminating proteins distributed in the
system in a manner comparable to SAV, resulting in poor improvements of product purity. The only
promising candidate was the composition described in line 4 of Table 6.1 (shaded row). This system
showed relatively suitable properties for the distribution of the total protein in each phase and in an
SDS-PAGE analysis, as illustrated in Fig. 6.3. The corresponding extraction procedure removed at
least a fraction of contaminating proteins by their extraction to the bottom phase of the two-phase
system. SAV, on the other hand, was almost exclusively located in the top phase.
In addition to this moderate puriﬁcation, the method may be useful for the concentration of SAV by
using the conditions described and altering the ratio of the phases without modiﬁcation of the relative
composition of each phase.[4] Altered phase ratios could also improve puriﬁcation by other system
compositions according to Table 6.1. To a certain extent, this step also potentially allows removal
of low molecular weight contaminants, which typically don't show a preference for one of the phases.
However, this comes at the cost of new, extraction-derived contaminants (salts, polymer). Upcoming
studies may furthermore combine the eﬀect of chain-length dependent transfer of SAV to the salt-rich
phase of the preliminary screening with the pH- and NaCl-based eﬀects observed in the PEG/phosphate
[4]This can be achieved by using different working points, i.e., initial concentrations of salt and polymer,
located on the same tie line in the binodal curve plot of the corresponding system, as shown in Fig. 2.10
in section 2.5.1 (p. 23).
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Fig. 6.3: SDS-PAGE analysis of the phases of an aqueous two-phase extraction applying a
supernatant of E. coli. The overall composition of the system is described in line 4 of
Table 6.1. The lanes show the supernatant used for the study in different dilutions (1:10
and 1:5, lanes 1 and 2) and composition of top (lanes 3, 5, 7) and bottom phases (lanes
4, 6), respectively, for three repetitions of the extraction. SAV bands were identified by
the supplementation of B4F and UV imaging as described by Humbert & Ward (2008).
The apparent molecular weight of SAV was in the range of 17 kDa.
system.
Furthermore, it may be interesting to analyze, whether aﬃnity derivatives of PEG (like PEG-coupled
HABA) would cause a more speciﬁc extraction of SAV in a system with one PEG-rich and one PEG-
deprived phase and thus cause separation of SAV and contaminants. For this purpose, an analysis of
the phase composition of each of the phases would be beneﬁcial.
In respect to the following steps of puriﬁcation, transfer of SAV to the phosphate-rich phase would
be advantageous, as salts can easily be removed from the samples by dialysis, whereas separation of
the product and PEG is more cumbersome. Alternatively, a two-step extraction could be performed in
which SAV is ﬁrst extracted to a PEG-rich top phase and afterwards extracted back to a phosphate-rich
bottom phase.
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6.3.2 Filtration
Diaﬁltration was successfully applied by hollow ﬁbre modules in cross-ﬂow operation to remove
residual peptides and low molecular weight contaminants from the supernatant after cultivation. This
procedure thus targeted the major contaminants of supernatants of H. polymorpha, P. pastoris, and
S. avidinii . Depending on the molecular weight cut-oﬀ (MWCO) of the membrane, the method may
also be used to selectively dispose of very small or very large contaminating proteins as well as chemical
impurities like salts. Fig. 6.4 shows a potential ﬂow chart for the combined removal of these compounds
based on a tetrameric weight of SAV in the range of 50-66 kDa (see section 2.2, p. 5).
Generally, for the purpose of concentration of supernatants, ultra- instead of diaﬁltration would
suﬃce.
Unfortunately, additional studies on the removal of biotin from biotin-blocked samples of SAV via
diaﬁltration at elevated temperatures (60 and 70 °C) did not result in the recovery of blocked binding
sites.
6.3.3 Ammonium sulfate precipitation
Based on the results of Suter et al. (1988), precipitation of SAV was studied by the addition of
ammonium sulfate. The majority of SAV precipitated in the presence of 45-60% of relative saturation,
where 100% saturation corresponds to a concentration of 767 g L−1 of the salt. The experiments thus
brought about results comparable to the study of Nogueira (2013) (precipitation at 50% saturation).
However, the majority of contaminating proteins of the E. coli -supernatant precipitated in the same
range of concentrations, preventing puriﬁcation of the target protein. Therefore, the method is only
suitable for alternative purposes like the concentration of SAV after fermentation.
6.3.4 Thermal inactivation of contaminating proteins
Based on the results of Gallizia et al. (1998) and the thermostability of SAV (González et al., 1997),
experiments on the thermal inactivation of contaminating proteins were performed. The experimental
setup was based on incubation at 60, 75 and 80 °C for an appropriate period of time according to
Fig. 3.3 (p. 56). Heat incubation was generally followed by centrifugation (4 °C, 10.000×g, 20min)
for the removal of resulting insoluble contaminants. An SDS-PAGE analysis based on central studies
is depicted in Fig. 6.5.
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Fig. 6.4: Flow chart for a diafiltration process for the combined removal of low molecular
weight (LMW) contaminants like salts, peptides, and small (30 kDa module) and large
contaminating proteins (100 kDa module). The trans-membrane pressure (retentate
pressure valve) for the second ultrafiltration (UF) module should be high enough to
prevent loss of product.[5]
Densitometric evaluation of the gel revealed a relative decrease of the intensity of contaminating
bands towards the SAV band by approximately 60% for an incubation at 80 °C for 5min. Based
on the Bradford method (Bradford, 1976), the total protein in the supernatants was analyzed via
the Roti®-Nanoquant system (Carl Roth GmbH + Co. KG, Karlsruhe, Germany). The evaluation
indicated that the overall protein content did not decrease in a similar manner. This may indicate
that contaminating proteins were degraded to peptides, which partially contribute to the signal in
the Bradford measurement, but are not visible in gel-based analysis. These peptides could easily be
removed by subsequent diaﬁltration.
For a preparative puriﬁcation of SAV, incubation at lower temperatures for longer periods of time may
be beneﬁcial due to the time necessary for heat transfer during heating and cooling of the ﬂuid prior to
and after heat incubation, respectively. However, as visible from Fig. 6.5, the eﬃciency of puriﬁcation
seems to increase upon rising temperatures, posing a challenge due to contradictory demands. Thus,
rapid heating and cooling for the thermal inactivation at high temperatures via eﬃcient heat exchangers
[5]The chart was created using the flow chart software Dia (see Table 2.4, p. 24).
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Fig. 6.5: SDS-PAGE analysis of the thermal inactivation of contaminating proteins in
supernatants containing SAV. Lanes: supernatant of E. coli, diluted 1:5 and 1:10 (lanes
1, 2), supernatant after heat incubation at 60 °C for 30min (1:5: lane 3, 1:10: lane 4),
at 75 °C for 10min (1:5: lane 5, 1:10: lane 6), and at 80 °C for 5min (1:5: lane 7, 1:10:
lane 8), respectively. SAV bands were identified by the supplementation of B4F and UV
imaging as described by Humbert & Ward (2008). The apparent molecular weight of
SAV was in the range of 17 kDa.
and large surface areas may be the method of choice. A ﬂow chart for a corresponding process is shown
in Fig. 6.6. This kind of puriﬁcation process could, e.g., be combined with continuous cultivation of
S. avidinii.
6.4 Suitability of different methods of purification
Fig. 6.7 sums up the suitability of the methods tested for diﬀerent purposes in the DSP of SAV.
In addition to the use of these methods as the sole puriﬁcation step, a variety of combined strategies
may be suitable for improved results:
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Fig. 6.6: Flow chart for an integrated process allowing the preparative removal of contami-
nants via thermal inactivation. The process consists of (a) fermentation, (b) biomass
removal, (c) thermal inactivation at a suitable temperature (e.g., 80 °C) and residence
time (e.g., 5min), and (d) diafiltration for the removal of resulting peptides. The transfer
from the bioreactor to the filtration device is performed once per batch or fed-batch
fermentation fermentation or continuously for chemostat cultivation. Washing buffer is
added several times for a step-wise dialysis of the sample.[6]
 Thermal inactivation may be integrated into diaﬁltration routines according to Fig. 6.4 to simul-
taneously denature and remove contaminating proteins, e.g., by tempering the feed vessel to
60 °C and applying a UF membrane permeable to peptides. Alternatively, when only less heat-
stable ﬁltration cassettes are available, heat-based inactivation could be performed batch-wise
followed by separation via ﬁltration at room temperature.
 Removal of residual peptides after thermal inactivation should also be possible by precipitation
or by ATPE applying a suitable phase ratio.
 The use of proteases may primarily result in the degradation of contaminating proteins due to the
stability of the core structure of SAV towards proteolysis (see section 2.2, p. 5). Thus, combined
[6]The chart was created using the flow chart software Dia (see Table 2.4, p. 24).
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Fig. 6.7: Suitability of selected alternative methods of downstream processing for the
purification of SAV. The ranking is alphabetical and does not reflect the suitability
of the methods. Brackets indicate limited performance or high experimental effort for
the corresponding method and the given purpose. Thermal inactivation is generally
combined with centrifugation. Abbreviations: ATPE = aqueous two-phase extraction,
LMW = low molecular weight.[7]
protease treatment, inactivation, e.g., by heat, and diaﬁltration via a membrane characterized
by a low MWCO could improve product purity. The removal of proteases may also be achieved
by ATPE.
 A two-step extraction may lead to increased purity, e.g. by extraction at pH 11 or pH 9 in a
PEG 1500/citrate-system (Fig. 6.2) followed by the addition of PEG 3000 and acidiﬁcation, or
by combining suitable extractions from Table 6.1 for a PEG/phosphate system. Here, phase
ratios altered in a suitable manner should improve the removal of contaminants.
 In respect to the continuous cultivation of S. avidinii (section 4.4.3, p. 86), diﬀerent ﬁltration
modules would allow direct processing of the outﬂow volume by either the removal or the
retention of biomass. Due to the large outﬂow volumes, both steps should be combined with
[7]Figure created in PowerPoint (see Table 2.4, p. 24).
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ultraﬁltration of the resulting supernatants to concentrate SAV. Operation in sterile conditions
may furthermore allow the recycling of media for high dilution rates, which lead to high residual
concentrations of substrate (see Fig. 4.9, p. 86).
In addition to these methods, precipitation by organic solvents like dimethyl ether as described by
Nogueira (2013) remains an option for the rapid puriﬁcation of SAV at low cost. However, correspond-
ing steps would require explosionproof devices.
Generally, due to the high speciﬁcity of the interaction of SAV and biotin, the simple and inexpensive
procedures shown in Fig. 6.7 may be suﬃcient for standard applications of SAV. For the supernatants of
S. avidinii, H. polymorpha, and P. pastoris, methods like diaﬁltration, ammonium sulfate precipitation,
and dialysis should already result in a relatively pure product by the removal of salts and residual pep-
tides from complex media compounds. Remarkably, even aliquots of a crude supernatant of S. avidinii
were successfully used for the quantitative detection of biotin and an immunological detection proce-
dure in additional studies (data not shown). However, further investigations are necessary to analyze,
whether the strategies described here are also suﬃcient for more complex applications, e.g., when the
avoidance of cross-reactions is critical.
Concerning the general applicability of the results it has to be taken into account that for a large
fraction of experiments the E. coli supernatant was used. This is not only relevant in respect to
the chain length of SAV, which may, e.g., alter the properties of extraction via ATPE towards core
SAV. As the impact of the media additives Triton and Pluronic®was not analyzed in a systematic
manner, studies based on supernatants of other host organisms may bring about slightly diﬀerent
results. Potential eﬀects of these compounds may, e.g., relate to phase separation behavior during
ATPE and solubilization of proteins during precipitation. However, the preliminary screening for ATPE
in a PEG/citrate system was based on a supernatant of S. avidinii. Nevertheless, the following studies
in the PEG/phosphate system applying the E. coli supernatant brought about comparable overall
tendencies for the distribution of SAV, suggesting a limited impact of the supplements. The same
accounts for the results of ammonium sulfate precipitation, which led to ﬁndings resembling the data
of Nogueira (2013).
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outlook
The challenges for the expression of the SAV gene by the hosts studied in this thesis were highly
diverse. While optimization of culture conditions for the natural producer S. avidinii mainly focused on
aspects of biochemical engineering and the complex morphology of the streptomycete, heterologous
expression shed light on various facets of host toxicity of SAV and resulting complications of process
design and strain maintenance. Moreover, the pH and temperature dependency of product accumu-
lation and the supplementation of detergents were identiﬁed as critical parameters for heterologous
production. A comparative analysis of SAV production by the various producers is given in this ﬁnal
chapter.
7.1 Comparative analysis of SAV production by four
different hosts
All of the hosts studied throughout this thesis produced extracellular, bioactive SAV in optimized
conditions. This may be supported by the absence of disulﬁde bonds and the relatively small size of
the target protein. Apparently, the high GC-content of the native SAV gene (69.2% for gene and
secretion signal sequence) did not pose a major problem to expression. Table 7.1 and Fig. 7.1 sum up
the results of central production processes for all hosts.
7.1.1 Comparison of the overall performance
The application of S. avidinii in a fed-batch process yielded an approximately twofold increased
volumetric productivity towards the best-performing systems of E. coli, P. pastoris and H. polymorpha.
Remarkably, the production of SAV by S. avidinii in a simple batch process in the bioreactor led to
productivities in the range of optimized conditions for the heterologous producers. Moreover, the
productivity by S. avidinii surpassed the accumulation of product in all heterologous hosts even in the
early stage of cultivation (see Fig. 7.1a), when advantages of heterologous producers may apply. When
referring, e.g., to literature values for the production of SAV by E. coli, product concentrations are
typically low, but during the short cultivation period the productivity often leads to superior results
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Tab. 7.1: Comparison of results for the different expression systems. Benchmark
values for homologous and heterologous expression of the SAV gene, respectively,
were highlighted by shading .
host/strain a expression Pmax pmax Qblocked sP/X process g remarks
cassette b [µM] c [nM h−1] d [%] e [nmol g−1] f
STA CBS 730.72 native, fSAV 6.9±0.1 48.1 n.d. h 1026 B, com i
STA CBS 730.72 native, fSAV 39.2 114 n.d. h 1600 FB, com
ECO JW1667-5 j Pbla, cst 1.6±0.1 43.6 8±4 % k 82 B, com l
(crc), fSAV
ECO JW1667-5 j Pbla, cst 2.6±0.2 65.2 8±4 % k 159 FB, com l
(crc), fSAV
HPO ATCC 34438 PFMD, ind 11.4±0.2 52.5 1±4 % 245 FB, syn m
(int), AP-fSAV
PPA X-33 PGAP , cst 2.0±0.1 27.1 11±2 % 62 FB, syn
(int), cSAV
PPA X-33 PGAP , cst 4.2±0.1 57.8 0±2 % 140 FB, com n
(int), cSAV
a host organism and strain used; STA = S. avidinii, ECO = E. coli, HPO = H. polymorpha, PPA = P. pastoris
b promoter: cst = constitutive, ind = inducible; type of vector: crc = circular, int = integration into genome;
SAV gene: fSAV = full-length SAV (AA 1-159), AP-fSAV = full-length SAV with N -terminal alanine-proline
modification, cSAV = core SAV (AA 13-139)
c maximal bioactive extracellular tetrameric concentration of SAV
d productivity to Pmax
e proportion of biotin-blocked binding sites
f process selectivity: Pmax / Xmax, where Xmax is the maximal concentration of DCW (see section 7.1.2)
g mode of operation: B = batch, FB = fed-batch; medium: com = complex, syn = synthetic
h not determined; nearly biotin-free according to the results from the development of the heat-based assay (see
section 3.3, p. 30ff.)
i for a rotary frequency of the stirrer between 400 and 700min−1
j periplasmic ’leaky mutant’
k average value of 3 cultivations
l upon supplementation of the cultivation medium with a surfactant
m methanol-based induction
n continuous shift of temperature and pH throughout the process
towards other hosts due to rapid growth and strong induction (see Table 7.4, p. 167).
The natural producer brought about even more pronounced advantages regarding the ﬁnal product
concentration, which exceeded the product titers of all other systems by a factor of at least 3.4. As the
cultivation of S. avidinii resulted in rather low concentrations of biomass (see Fig. 7.1), this brought
about a drastically superior process selectivity for this host (factor ≥ 6.5).
Although at the cost of a methanol-based process, H. polymorpha ranks best among the heterologous
hosts regarding product concentration, proportion of biotin-blocked binding sites and process selectivity,
whereas the application of E. coli yielded the highest productivity.
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(a) Concentration of SAV P. (b) Concentration of dry cell weight X.
Fig. 7.1: Graphical comparison of the final process strategies for the different hosts studied
for this thesis. Only data for the first 120 h of the corresponding processes is shown for
facilitated interpretation. The increase of the concentrations of product and biomass for
H. polymorpha and S. avidinii remain nearly constant after this time. For S. avidinii,
the courses refer to average values of three cultivations.
7.1.2 Discussion of the specific productivity
The optimized process strategies yielded maximal DCW concentrations of 24.5±1.0 g L−1 for
S. avidinii , 17.2±0.3 g L−1 for E. coli , 29.8±1.2 g L−1 for P. pastoris, and 46.3±1.3 g L−1 for H. poly-
morpha (summarized in Table 7.2, p. 164). Related to these concentrations, the speciﬁc productivities
pspec lead to a diﬀerent ranking of the organisms. These productivities were (ranked by performance)
4.65 nmol g−1 h−1 for S. avidinii, 3.79 nmol g−1 h−1 for E. coli, 1.94 nmol g−1 h−1 for P. pastoris, and
1.13 nmol g−1 h−1 for H. polymorpha.
This evaluation shows that the relatively high concentrations of product achieved for the yeast-based
expression systems were partly due to a higher concentration of DCW compared to the competitors.
Surprisingly, the increased concentration of biomass did not result in higher volumetric productivities
than the system based on E. coli. Like observed for the productivity and maximal product concentration,
the application of S. avidinii leads to the best performance regarding this parameter. In this context,
two factors are noteworthy. Firstly, since the induction protocol for H. polymorpha was coupled to
the dissolved oxygen signal as described in section 5.4 (p. 133ﬀ.), the productivity can most likely
be increased by providing a constant concentration of inducer and a constant oxygen saturation in
the medium. This may relativize the diﬀerences to the other systems by a more eﬃcient exploitation
of the biomass. Secondly, the results for the continuous cultivation of S. avidinii (see section 4.4.3,
p. 86) suggest that this host may be even more potent, reaching productivities of 221.3±32.0 nMh−1
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at a DCW concentration of only 4.0±0.5 g L−1 (D = 0.195 h−1). This would correspond to an
outstanding speciﬁc productivity of 55.6±10.6 nmol g−1 h−1, by far surpassing the results of all other
studies. Despite their preliminary nature and although values of pspec in this order of magnitude are
unlikely in other modes of operation, these parameters indicate that the organism oﬀers an even higher
potential than suggested by the optimized fed-batch process. Further fed-batch experiments will show
to which extent these values can be reproduced during exponential feeding at a corresponding setpoint
for µ. They may also elucidate at which point nutrients or other factors limit product formation for
the long-term operation in other modes of cultivation.
7.1.3 Analysis of process robustness
The courses of the product concentration for the production of SAV by E. coli and P. pastoris were
characterized either by deﬁned maxima or by an asymptotic behavior (see Fig. 7.1, p. 158). More-
over, the properties depicted in Table 7.1 were only achieved by an elaborate optimization of process
conditions, which in the case of P. pastoris [1] prolonged the period of SAV production. Therefore, at
least for the conditions applied, the productive potential of these expression systems can be considered
limited, which - among other factors - may be due to toxic eﬀects on the host. Especially for E. coli
this explanation seems plausible, since the dry cell weight concentration was very limited even for
optimized conditions. Vice versa, high concentrations of DCW were only achieved for P. pastoris and
E. coli when product concentrations were low.
As opposed to this, the accumulation of SAV by H. polymorpha and the natural producer S. avidinii
remained constant in optimized conditions. Prolonged processes can therefore be expected to lead
to higher concentrations of SAV. For H. polymorpha, constant product formation was achieved for
a rather simple, unoptimized process based on the induction by methanol. SAV production by this
host/promoter-combination thus seems to be an inherent, robust property. In contrast to this, process
optimization was necessary for the production of high concentrations of SAV by S. avidinii. Optimiza-
tion included the factors shear sensitivity, mycelial stability, and mode of feeding, suggesting that SAV
production by the ﬁlamentous bacterium relies on a ﬁne-tuned environment. This is supported by
a high sensitivity towards shifts of the cultivation temperature observed in shake ﬂask experiments,
in which ﬂuctuation to 33 instead of 30 °C led to marginal growth and product formation (data not
shown). Furthermore, the morphology was a key factor in shake ﬂasks, since pellet growth resulted
in diminishing concentrations of SAV, whereas ﬁlamentous growth provided suitable properties for
production. This sensitive behavior is typical for the production of antibiotics by streptomycetes, as
observed e.g., for the production of thiostrepton by S. laurentii (Suzuki et al., 1987). Finally, the
cultivation of S. avidinii is prone to contaminations due to relatively low growth rates in the beginning
[1]Successive shift of temperature and pH throughout the cultivation.
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of a cultivation and the absence of selective agents. In this context, Table 4.2 (p. 90) may provide the
basis for a reduction of these eﬀects by supplementing appropriate antibiotics. In conclusion, despite
showing a favorable overall performance regarding product formation, production processes based on
S. avidinii can be considered less robust.
7.1.4 Genetic stability of the SAV expression cassette
Expression of toxic genes commonly leads to a loss of plasmid or the expression cassette throughout
fermentation, as described, e.g., for E. coli (Dumon-Seignovert et al., 2004). However, problems of
genetic instability of the expression cassette were only a minor factor during production studies for
the constructs tested. The data of S. avidinii and H. polymorpha suggest suﬃcient stability in the
range of weeks of cultivation. For P. pastoris and E. coli production was stable for several days. This
indicates that the optimization of secretion eﬃciency and cultivation conditions for the Gram-negative
bacterium yielded suﬃcient plasmid stability, potentially by alleviating toxic eﬀects. However, slight
problems of stability emerged during the preparation of new glycerol stocks of the ﬁnal producer strain
of E. coli despite the addition of antibiotics (data not shown), which may be due to a relative instability
of the population. Nevertheless, once a glycerol stock with producers was acquired, production was
stable in expression studies. This is advantageous towards to the strategies of Sørensen et al. (2003b)
and other researchers, which were based on fresh transformation of the producer strains prior to every
study of induction.
Generally, production by the natural producer or by hosts based on integration of the expression
cassette into the genome seems beneﬁcial in respect to genetic stability. However, the results for
P. pastoris (section 5.3.5.2, p. 131) suggest deﬁciencies of genetic stability upon multiple chromosomal
integration of the SAV gene in the absence of antibiotics for yeast-based expression systems. This should
be considered for further experiments.
7.1.5 Effect of the cultivation temperature
Interestingly, cultivation of the two heterologous hosts E. coli and H. polymorpha at 30 instead of
37 °C improved product formation. The lower temperature resembles the conditions usually applied for
cultivation of the mesophile natural producer S. avidinii. Potential reasons for the increased product
formation by the heterologous hosts at 30 °C include reduced proteolysis, facilitated folding, improved
eﬃciency of secretion, and - closely related - decreased rates of protein synthesis, reducing the load
of the secretory machinery. For E. coli, a temperature downshift from 37 to 23 or 15 °C resulted
in improved production of a host-toxic TolAI-β-lactamase fusion construct (Mujacic et al., 1999).
For P. pastoris, lowering the cultivation temperature has been associated to reduced stress in the
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endoplasmic reticulum, a lower impact of the unfolded protein response (Zhong et al., 2014), higher
concentrations of molecular chaperones, reduced ﬂux in the TCA cycle, and reduced concentrations
of proteins involved in the oxidative stress response (Dragosits et al., 2009). These aspects were
accompanied by higher concentrations of heterologous proteins.
Protein solubility is another important temperature-dependent aspect (Schein & Noteborn, 1988).
Although this is improbable due to the relatively weak promoter used in the studies for E. coli , inclusion
bodies may have been formed during cultivation at 37 °C, which would not have been detected in the
ﬂuorescence assay. This should be conﬁrmed or disproved by additional experiments.
Generally, future experiments applying E. coli may focus on the application of inducible or temperature-
sensitive promoters in two-stage processes, allowing unimpaired, rapid growth at 37 °C followed by
induction at 30 °C or even lower temperatures. For the inducible construct based on H. polymorpha
corresponding two-stage processes can directly be implemented.
7.1.6 Effect of the secretory potential of the host
As indicated by the combined results of all heterologous expression systems and by various ﬁndings
in literature (Wang et al., 2005; Miksch et al., 2008), secretion seems to play an important role in
the production of SAV. P. pastoris and H. polymorpha are known to have eﬃcient secretory pathways
(Romanos, 1995; Gellissen et al., 1991), whereas the unfavorable surface structure of E. coli (see
Fig. 2.8a, 19) prevents similar results for the Gram-negative bacterium (Nossal & Heppel, 1966).
Therefore, it did not come as a surprise that secretion of SAV via the Sec pathway by E. coli targeting
the unfolded transport to the periplasm did not yield comparable concentrations of SAV for E. coli
than for the natural producer, who most likely uses the same secretory pathway.[2] This diﬀerence was
still present upon comprehensive optimization of the genetic conﬁguration and culture conditions.
However, expression of the SAV gene by the strain E. coli KRX - containing an intact outer membrane
structure - resulted in a large proportion of SAV in the cyto- (22%) and periplasm (43%) without a
impairing growth at low cell densities (see Fig. 1D in the corresponding research article; section 5.2.2,
p. 93). It is therefore unclear, to which extent the limitation of the DCW concentration of E. coli
JW1667-5 was due to the altered outer membrane rather than the production of SAV. Moreover, the
course of the optical density of a plasmid-free clone of JW1667-5 resembled that of the transformed
strain used for the expression of SAV (data not shown). In this context, the supplementation of
large concentrations of SAV to the medium to strains with an intact outer membrane and to a 'leaky
mutant' in the beginning of cultivation should lead to deeper insights. Furthermore, the use of stronger
promoters may contribute to clarify the interdependency of dry cell weight, product concentration, and
secretory eﬃciency. Corresponding studies seem worthwile, because - like mentioned in section 2.4.3
[2]Please refer to Fig. 8.1, p. 180 for an in silico-analysis of the native signal peptide.
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(p. 15) - a negative correlation of the concentrations of DCW and SAV for E. coli BL21(DE3) can be
deduced from the data of Miksch et al. (2008).
Regarding the results for E. coli KRX, soluble expression of SAV in the cytoplasm seems to be
possible at high levels, unlike suggested by Sørensen et al. (2003b). Thus, the formation of inclusion
bodies may be the result of ineﬃcient secretion or excessive translational activity rather than problems
of solubility of SAV.
Generally, vesicular transport by yeast seems to be more suitable for the secretion of SAV, allowing
higher extracellular concentrations of the protein. Optimization of the secretion signal peptide in
preliminary studies applying the methanol-inducible AOX1 promoter yielded only slight improvements
(see section 5.3.5.1, p. 131). However, secretion eﬃciency may be increasingly important for the use of
multi-copy integrants, suggesting detailed investigations on the application of optimized signal peptides
(Xiong et al., 2004; Lin-Cereghino et al., 2013) for diﬀerent levels of expression.
First estimates of the importance of secretory eﬃciency on SAV production by yeast may be achieved
by the application of diﬀerent concentrations of inducer for AOX1 promoter-based constructs. Accom-
panying experiments based on intracellular expression may also contribute to a better understanding
of secretion-dependent host toxicity. In this context, the cellular localization of biotinylated proteins
could be of importance, as discussed in section 2.4.3.3 (p. 18ﬀ.).
7.1.7 Suitability of yeast-based expression systems for the production
of SAV
The general potential of the yeast-based production of SAV is emphasized by previous reports on
the successful expression of avidin genes by P. pastoris (Zocchi et al., 2003; Jungo et al., 2007a). In
general, chromosomal integration of the expression cassette for the SAV gene may have contributed
to a more stable expression towards episomal expression as performed using E. coli , which is discussed
in section 7.1.4.
For P. pastoris, this thesis showed for the ﬁrst time that the advantageous properties for expression
of the SAV gene not only apply to methanol-based, but also to growth-coupled production processes
using the biotin auxotrophic yeast. Toxic eﬀects can partially be circumvented during induction-based
processes by separation of growth and production. This is, however, not the case for constitutive
production. Thus, the successful constitutive expression of the SAV gene is an indication for limited
toxic eﬀects.
Fortunately, glycosylation does not seem to be a problem for the activity of SAV derived from yeast-
based expression. N-glycosylation is usually performed on asparagine residues as part of the consensus
sequence Asn-Xaa-Ser/Thr, where Xaa is any AA except for proline (Marshall, 1972). A scan for
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N-glycosylation sites in the SAV AA sequence based on the PROSITE pattern PS00001[3] resulted in
no hits, supporting the beneﬁcial features of the host for the expression of the SAV gene.
7.1.8 Analysis of product purity
Three of the four hosts studied in this thesis led to a relatively pure product based on SDS-PAGE
analysis (see Fig. 6.1, p. 145). E. coli was the exception to this rule. The construct tested accumulated
a large number of unspeciﬁc proteins in the supernatant. As the native secretory potential of the host is
very limited (Nossal & Heppel, 1966), these contaminants are most likely the result of an uncontrolled
release of proteins from the periplasm to the medium due to the instability of the outer membrane
('leaky mutant'), supported by the addition of surfactants. These properties suggest the use of a
diﬀerent host, if a high purity of SAV is required. Alternatively, the knockout of additional genes
involved in the outer membrane formation may render the application of surfactants redundant. This
could in turn lead to a more speciﬁc release of the target protein to the medium and thus reduce the
load of contaminating proteins.
For P. pastoris, studies of cell viability accompanying bioreactor fermentations may contribute to a
better understanding of the host toxicity of SAV. Moreover, they may result in an improved product
purity by the optimization of culture conditions towards reduced cell lysis and improved protein secretion.
Comparable studies have already been performed for methanol-based processes applying this yeast
(Hohenblum et al., 2003). As H. polymorpha was induced by methanol in this study, corresponding
experiments may be beneﬁcial for this host, too.
7.1.9 Ecological assessment
All previous sections focused on aspects of production. However, the ecological balance of the
processes should also be considered. Since a complete life cycle assessment for all of the ﬁnal processes
would be too time-consuming, a more simple tool was employed for this purpose. A comparison of the
production processes using the E(nvironmental) factor (Sheldon, 1992), originally applied for chemical
reactions, allows a simple, qualitative assessment of the greenness, i.e., ecological performance, of a
given process. The dimensionless E − factor is deﬁned in equation 7.1.
E − factor = mwaste
mproduct
(7.1)
where mwaste is the mass of waste generated during the process, i.e., all substrates except from water,
and mproduct is the mass of product equivalents produced.
[3]Scan for common, non-mammalian N -glycosylation motifs, http://prosite.expasy.org/PDOC00001,
version last updated May 1991, accessed 11th of March, 2016.
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Thus, lower values of the E− factor correspond to beneﬁcial ecological properties. As emphasized
by Ni et al. (2014), the E−factor does neither take into account water, nor the electricity necessary for
the process. Moreover, it does not discriminate between toxic and harmless types of waste. However,
its calculation is by far less time-consuming than more complex approaches. It may therefore serve as
a compromise between signiﬁcance and eﬀort.
In addition to the E− factor-based evaluation, the ecological balance was analyzed in terms of the
eﬃciency of biomass and product formation via the yield coeﬃcients of biomass per substrate YX/S
and of product per substrate YX/P . Results of the assessment are shown in Table 7.2.
Tab. 7.2: Ecological assessment of the final processes. Positive and
negative benchmark concentrations were labelled in green and red ,
respectively. All specifications of masses and yield coefficients were
based on the assumption of volume constancy (sampling levels out
feeding of substrates and corrective agents) for reasons of simplicity.
organism/process a mwaste b mcarbon c Pmax d Xmax e YX/S f YP/S g E − factor h
[g] [g] [g L−1] [g L−1] [-] [-] [-]
STA B, com 45.6 27.6 0.44 7.0 0.25 0.016 103
STA FB, com 131.1 101.1 2.51 24.5 0.24 0.025 52
STA C, com i 28.0 j 10.0 k 0.16 5.5 0.55 k 0.016 179
STA C, com l 28.0 j 10.0 k 0.07 4.0 0.40 k 0.007 386
STA C, com m 28.0 j 10.0 k 0.03 2.8 0.28 k 0.003 931
ECO B, com 88.7 29.8 0.10 19.1 0.64 n 0.003 866
ECO FB, com 131.3 72.4 0.17 17.2 0.24 n 0.002 789
HPO FB, syn 445.0 416.5 0.75 46.3 0.11 0.002 593
PPA FB, syn 203.0 141.5 0.11 31.5 0.22 0.001 1911
PPA FB, com 220.0 176.6 0.22 29.8 0.17 0.001 987
a host organism, mode of operation and medium used for the process; organism: STA = S. avidinii,
ECO = E. coli, HPO = H. polymorpha, PPA = P. pastoris; mode of operation: B = batch, FB
= fed-batch, C = chemostat; type of medium: com = complex, syn = synthetic
b mass of waste generated (equation 7.1) per L of medium
c overall mass of carbon sources (methanol, glycerol, glucose) per L of medium
d maximal bioactive extracellular tetrameric concentration of SAV; conversion to mass concentra-
tions according to the molecular weight specifications of Table 7.4
e maximal dry cell weight concentration
f yield coefficient of biomass per carbon source
g yield coefficient of product per carbon source
h environmental factor according to equation 7.1; mass of waste related to liters
i dilution rate D = 0.058 h−1
j waste calculated for one complete exchange of the volume
k The actual concentration of glucose was lower (8.6 g L−1) due to the co-sterilization of glucose
and medium .(see 4.4.3, p. 86). The actual yield of biomass per substrate YX/S may therefore
be higher. Furthermore, the parameter estimation suggested a coefficient in the range of 0.71.
l dilution rate D = 0.195 h−1
m dilution rate D = 0.320 h−1
n These coefficients are influenced by insoluble aggregates caused by the addition of detergents and
antifoam agent to the cultivation (see 5.2.2, p. 93ff. ). The actual yield coefficients of biomass
per substrate are likely to be lower.
As can be concluded from the results, batch and fed-batch processes applying S. avidinii are not
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only superior to the heterologous production of SAV regarding product concentration and productivity,
but also reduce process waste by a factor of up to 36.5. Surprisingly, even chemostat processes for the
natural producer at dilution rates of up to 0.2 h−1 yielded lower E − factors than all heterologous
processes despite drastically lower concentrations of product compared to the batch or fed-batch
cultivation of S. avidinii. In regard to this parameter, the process for the cultivation of P. pastoris in
a synthetic medium resulted in the worst outcome.
The yield coeﬃcients YX/S were relatively low for most of the processes, suggesting that optimization
of the carbon-to-nitrogen ratio of the media may be worthwhile. Batch cultivation of E. coli resulted in
the highest yield of 0.64, followed by chemostat cultivation of S. avidinii at low dilution rates. Due to
diminishing growth on methanol, YX/S for the cultivation of H. polymorpha reached a minimal value
of 0.11. The yield coeﬃcients for SAV YP/S were even smaller and also show favorable properties for
processes based on the natural producer (improvements of a factor of up to 25).
7.1.10 Summary of the qualitative host-specific properties
Table 7.3 sums up qualitative properties of the diﬀerent hosts observed throughout the studies.
7.2 Comparison of the results to literature
Table 7.4 sums up reference values for the production of SAV reported in literature and benchmark
results of this study.
The table indicates that the strategies used for the expression of the SAV gene in this study were
successful, ranking well within the data reported in literature.
Productivities and product concentrations were lower than for methanol-based expression by
P. pastoris (Casteluber et al., 2012; Nogueira et al., 2014), who reached concentrations in the range
of 71 and 11µM, respectively. However, the process of Nogueira and coworkers was based on a sur-
prisingly high DCW concentration of 235 g L−1 despite the application of unoptimized conditions.[4]
This concentration decreases the process selectivity sP/X . Moreover, concentrated oxygen had to be
applied in the cultivation due to the high oxygen demand caused by the extraordinarily high DCW
concentration.
The cultivation system of Casteluber et al. (2012), namely a spinner ﬂask aerated through a porous
stone at very high volumetric ﬂow rates (4 vvm), is diﬃcult to compare or scale up. This is due
to insuﬃcient characterization from an engineer's point of view and its unavailability in larger scales.
[4]The synthetic medium applied (BSM medium, Invitrogen/Life Technologies, 2002) typically leads to dry
cell weight concentrations in the range of 100 gL−1, reaching maximal values of up to 160 gL−1 for
highly optimized conditions (Jahic et al., 2002).
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Tab. 7.3: Challenges of the hosts studied in this thesis in regard to their
potential to produce SAV. Effects of different aspects are compared
qualitatively (+++ very strong, ++ strong, + weak) or quantitatively.
aspect S. avidinii E. coli P. pastoris H. polymorpha
requirements of bioprocess engineering ++ + ++ ++
morphological effort +++ a + + +
robustness b + ++ ++ ++
effort for genetic engineering - c + +++ +++
product purity d +++ + +++ +++
duration of process setup e 24-48 h f <24 h <24 h <24 h
process duration g +++ + ++ +++
methanol-based h no no no yes i
no. of process stages g 2 2 2 3
genetic stability j +++ + k ++/+++ l +++
GMO m no yes yes yes
secretory potential n ++ o + ++ ++
necessity of antibiotics no yes yes/no p yes/no p
ecological balance q +++ + + ++
a necessity of filamentous growth for suitable productive properties; issues of reproducibility for
pellet growth
b summary process characteristics like risk of contamination and susceptibility towards shifting
environmental conditions according to section 7.1.3
c not necessary, natural producer
d estimated from SDS-PAGE data
e preparation of fermenter and duration of pre-cultivation
f depends strongly on age of glycerol stock and inoculation density; for a fresh glycerol stock and
a large inoculum size: approx. 24 h
g property of the final process strategies described in Table 7.1
h additional safety regulations and increased heat evolution and oxygen demand due to organic
solvent; property of the final process strategy
i not necessary for production; constitutive promoters or derepression-based production may
avoid this property
j considering the expression cassette: stability of product accumulation over time
k selection pressure necessary, risk of loss of plasmid
l stability may be lower for multi-copy integrants (see section 5.3.5.2, p. 131)
m genetically modified organism: potential additional regulations concerning treatment of leftover
biomass and process safety
n general property of the host without optimization
o based on the literature survey for S. lividans given in section 2.4.3.3 (p. 18ff.)
p AB only necessary for selection, not for the actual bioprocess
q based on the E − factor-evaluation (Table 7.2)
Moreover, the system does not allow measurement or control of process parameters like pH and
dissolved oxygen saturation, complicating cultivation in controlled conditions and interpretation of
the results. Finally, the washing step performed by Casteluber et al. between growth and induction
bears the risk of contamination. Therefore, a direct comparison to the bioreactor data of this study is
diﬃcult.
The novel expression system based on H. polymorpha seems to be one of the most eﬃcient studied for
the heterologous expression of a full-length SAV gene to date regarding the ﬁnal product concentration.
Despite these properties, expression of SAV by S. avidinii was much more eﬃcient than heterologous
production rated by the ﬁnal product concentration and productivity. Comparison to literature reveals
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Tab. 7.4: Literature survey on the production of SAV by various hosts (actualized and
modified version from Müller et al., 2013) ranked by host and year of publication.
Results from this thesis were labelled by shading of the corresponding rows.
organism MW [kDa] a Pmax [mg L−1] b Pmax [µM] b pmax [nM h−1] c reference
S. avidinii 72 53 0.74 10.3 Aldwin et al. (1990)
S. avidinii 70 145 2.07 8.6 Cazin Jr. et al. (1988)
and Suter et al. (1988)
S. avidinii 58 d 170 2.93 48.0 Kolomiets & Zdor (1998)
S. avidinii 52 160 3.1 18.3 Sumarningsih (2014)
S. avidinii 64 2509 39.2 114 this study
S. lavendulae - d 201 n.sp. n.sp. e Zhang et al. (2007)
S. lividans 54 d 250 4.63 n.sp. Meade & Jeffrey (1986)
S. lividans 66 56 0.9 6.4 Noda et al. (2015)
B. subtilis 68 50 0.74 61.3 Nagarajan et al. (1993)
B. subtilis 66 (88) d 50 0.79 37.0 Wu & Wong (2002)
B. subtilis 66 (88) d 94 1.42 109.2 Wu et al. (2002)
E. coli f 64 65 1.02 340.0 Sano & Cantor (1990b)
E. coli f 53 3 0.06 20 g Thompson & Weber (1993)
E. coli 65.7 70 1.07 267.5 Gallizia et al. (1998)
E. coli n.sp. n.sp. ∼0.26 h 36.4 i Sørensen et al. (2003b)
E. coli 16.6 j 70 1.05 843.0 j Wu & Wong (2006)
E. coli 60 96 1.6 k 200.0 k Miksch et al. (2008)
E. coli 14 l >50 l 0.89 l 44.5 l Demonte et al. (2014)
E. coli f 61.2 370 6.1 378 i Chen et al. (2014)
E. coli 64 167 2.6 65.2 this study
H. polymorpha 65.8 m 750 11.4 52.5 this study
P. pastoris 56 4000 n 71 n n.sp. Casteluber et al. (2012)
P. pastoris 63.5 650 o 11 o 67.9 o Nogueira et al. (2014)
P. pastoris 53.1 m 221 4.16 57.8 this study
S. cerevisiae - d - e 0.001-0.01 p - e Hong Lim et al. (2012)
a molecular weight
b maximal tetrameric product concentration
c volumetric productivity to Pmax
d MW not (clearly) given
e not specified
f insoluble expression as inclusion bodies; concentrations refer to bioactive SAV after refolding
g referring only to the cultivation time starting with induction (3 h); complete cultivation time not given
h cytoplasmic tetrameric SAV recalculated from the biotin-binding ability of an IF2-domain I-SAV fusion protein
i exact cultivation time not given; calculation based on an initial growth time of 4 h prior to induction
j monomeric SAV
k extracellular fraction
l expression of a maltose binding protein-monomeric SAV fusion protein; concentrations refer to tetrameric equiva-
lents of the SAV-fraction
m theoretical MW (calculated)
n cultivation in an uncontrolled environment in spinner flasks (see text)
o based on a surprisingly high DCW concentration of 235 gL−1
p estimated concentration of biotin equivalents; the concentration refers to a low OD600 of 4.0 of the culture
that - like discussed in the internal evaluation in section 7.1.1 and Fig. 7.1 - the productivity achieved for
the ﬁlamentous bacterium surpasses the majority of productivities achieved by heterologous producers.
Only a selection of systems based on E. coli (Sano & Cantor, 1990b; Gallizia et al., 1998; Wu & Wong,
2006; Miksch et al., 2008; Chen et al., 2014) yielded higher productivities for a short period of time,
but resulted in drastically lower maximal concentrations of SAV. The E. coli -based system studied in
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this thesis also resulted in lower productivities than these reference constructs, which is potentially due
to the relatively weak promoter.
New benchmark concentrations for the soluble production and secretion of SAV were achieved for
S. avidinii and E. coli. The improvements were particularly strong for the natural producer, for which
the product concentration was increased by a factor of 12.6 towards all reference studies using the
same host.
7.3 Conclusions and outlook
The following conclusive sections may serve as a guideline for future experiments based on the results
achieved in this thesis.
7.3.1 Conclusions
The host-vector-combinations and processes developed in this thesis may contribute to making SAV
more accessible for further applications. From the perspective of handling, the systems constructed
for P. pastoris and to a limited extent E. coli [5] should allow a simple production of SAV for laboratory
purposes in shake ﬂasks without deeper understanding of biochemical engineering or morphological as-
pects. However, regarding the overall productive potential of the hosts, the natural producer S. avidinii
can be considered the most suitable of the constructs tested. The complex morphology of this organism
can be compensated in shake ﬂasks (section 4.4.1, p. 80), whereas in the bioreactor shearing of the
mycelia quickly brought about ﬁlamentous growth without the addition of supplements or ﬁne-tuning
of conditions. The suitability of S. avidinii for the production of SAV is emphasized by extremely high
process selectivities, which surpassed all selectivities of the further heterologous hosts tested by a factor
of at least 6.5 in fed-batch operation (see Table 7.1).
However, the presumably most promising feature regarding the potential of S. avidinii for future
studies may be the speciﬁc productivity achieved in chemostat cultivations (see section 4.4.3, p. 86 and
section 7.1.2 in the ﬁnal discussion). Along with the results from medium optimization (section 4.4.2,
p. 85), they indicate that the ﬁndings presented here may just be one step towards more eﬃcient
production processes for the protein SAV by the ﬁlamentous bacterium.
Regarding simpliﬁed processes of puriﬁcation, the preliminary results for the puriﬁcation of SAV
by the alternative methods analyzed in section 6 (p. 144ﬀ.) suggest that for many purposes crude
supernatants may be suﬃcient, if the hosts S. avidinii, P. pastoris or H. polymorpha are applied.
[5]Due to the potential genetic instability.
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A crude supernatant of S. avidinii was successfully used for the detection of biotin and biotinylated
compounds, whereas diaﬁltration was suﬃcient for advanced applications like the immobilization of
SAV. In all of these cases, costly and time-consuming puriﬁcation by iminobiotin columns may therefore
be redundant. This is of particular importance regarding the laboratory-scale production of SAV for
straightforward applications by research groups with limited biotechnological experience.
7.3.2 Outlook
The results of this thesis can be used for a more rational design of upcoming experiments. This ﬁnal
section is meant to facilitate the choice of relevant parameters for the purpose of further optimization.
7.3.2.1 Homologous expression of the SAV gene
In respect to the productive properties, product purity and ecological performance, S. avidinii seems
to be the most promising host for upcoming studies. If the rather low biomass concentration can further
be increased without harming the selectivity, optimized processes may yield even higher concentrations
of product. For fed-batch processes, the results obtained during medium optimization (section 4.4.2,
p. 85) are a useful starting point in this context. Their use can be combined with alternative feeding
proﬁles like exponential feeding at suitable values of µset. However, eﬀects on the viscosity of the
culture broth can be expected here, which have to be carefully monitored (see section 2.4.1.1, p. 10).
As can be concluded from the theoretical considerations (section 4.3.5, p. 74), increased concentrations
of biomass potentially result in an only fractionally turbulent ﬂow regime, which may reduce mass and
energy transfer. For continuous cultivation, cell retention by membrane bioreactors or the use of
immobilized biomass is of interest. These strategies may allow higher concentrations of biomass than
in the previous studies even for high dilution rates (section 4.4.3, p. 86).
Further experiments may focus on genetic engineering of the natural producer (section 4.4.6, p. 88).
Generally, the insertion of additional expression cassettes into the genome of S. avidinii may increase
SAV production. Here, overexpression of signal peptidases is a potentially useful tool to avoid overload-
ing of the secretory machinery of S. avidinii (Anné et al., 2014). From the morphological perspective,
enhanced productive properties in the shake ﬂask could be achieved by overexpression of the ssgA-
morphogene (Kraal et al., 1999). This may lead to increased fragmentation and growth rates and thus
improve the viscous properties of the culture broth. Genome sequencing of the strain would facilitate
all of these experiments, which is currently in progress at the CeBiTec at Bielefeld University.
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7.3.2.2 Heterologous expression of the SAV gene
Of the heterologous hosts tested, H. polymorpha and P. pastoris seem the most promising regarding
the maximal product concentration. For both of these hosts, multiple insertion of the expression
cassette into the genome may lead to improvements of the production of SAV. Yet, in this context,
stabilization of the expression cassette could be a key factor, as indicated by the study based on
P. pastoris (section 5.3.5.2, p. 131f.). The Zeocin resistance gene used for expression vectors of both
hosts prevents stabilization of transformants by application of the antibiotic in production processes
due to high cost. However, Lin-Cereghino et al. (2008) demonstrated that a modiﬁed resistance gene
can be used for the selection of transformants of P. pastoris by kanamycin. This antibiotic is stable and
cheap enough to allow supplementation of bioreactor cultures for the purpose of genetic stabilization.
This strategy can be combined with optimization of the secretion signal sequence as performed by
Lin-Cereghino et al. (2013) to alleviate potential eﬀects of toxicity-induced problems of the genetic
stability of the construct.
A detailed characterization of the properties of H. polymorpha in conditions of derepression rather
than induction may be of interest targeting an improved process sustainability.
A recent study on the GAP-based expression of heterologous genes by P. pastoris (Güne³ & Çalik,
2016) showed that optimization of the concentration of dissolved oxygen leads to an improvement of
the production of a glucose isomerase by a factor of 2, when the setpoint for this process parameter
is adjusted to 15% of relative saturation rather than 20%. In this project, only a lower boundary of
the dissolved oxygen concentration of 20% was applied without control mechanisms like a cascade for
the stirrer for higher parameter values. Thus, ﬁne tuning of the environmental conditions may lead to
additional improvements for the production of SAV by this host.
Generally, the successful production of SAV by the yeasts P. pastoris and H. polymorpha suggests
the use of non-conventional yeast strains like the dimorphic Yarrowia lipolytica or the methylotrophic
Candida boidinii for upcoming projects, as both of them have already been used for the production of
heterologous proteins with great success (Madzak et al., 2004; Yurimoto & Sakai, 2009). Alternatively,
less established species like Arxula adeninivorans could be employed for this purpose (Stöckmann et al.,
2009).
If - despite the results presented in this thesis - additional studies using E. coli JW1667-5 are
performed, ﬁne-tuning of the expression level seems worthwhile. This may be achieved either by
exchange of the relatively weak promoter applied in this study or by modifying the plasmid copy number.
Furthermore, genetic optimization of the host, e.g., by the knockout of protease genes or additional
membrane-stabilizing structures could lead to reduced degradation of SAV and improved secretion,
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respectively. However, the eﬀect of corresponding modiﬁcations on growth should be analyzed carefully
for the latter strategy.
Alternatively, the lpp-knockout of E. coli JW1667-5 could be tested for established producer strains.
In the case of SAV, the 'Walker strains'[6] (Miroux & Walker, 1996), or other strains suited for the
production of toxic proteins seem to be reasonable targets for this strategy. In general, the results
for E. coli KRX (Fig. 1D in the research article) suggest that exchange of the strain may bring about
higher concentrations of total SAV. Finally, for optimization of the coexpression of inhibitors (see
section 5.2.5, p. 112ﬀ.), fusion constructs of peptide ligands of SAV and destabilizing amino acids like
PEST[7] regions (Rogers et al., 1986) may facilitate the recovery of binding sites after the production
process, if leakage of the inhibitor to the medium occurs.
7.3.2.3 Purification of SAV
Regarding alternative downstream processing approaches for the puriﬁcation of SAV, improved re-
sults for the aqueous two-phase extraction of SAV may be achieved by incorporating additional pa-
rameters like the chain length of PEG and the incubation temperature into additional DoE-based
experiments. These could be based on the systems showing a suitable distribution pattern in the
PEG/phosphate studies (Table 6.1, p. 148). Additionally, modiﬁcations of the polymer, e.g. by aﬃn-
ity tags or hydrophobic groups, are an option (Diamond & Hsu, 1992). As suggested in section 6.4
(p. 152), a two-step extraction with a transfer of SAV to the polymer-phase followed by transfer to the
salt-rich phase seems promising for improved performances of the strategy. Moreover, the application
of ionic liquids for aqueous two-phase extraction would oﬀer an even broader ﬁeld of potentially useful
parameters (Dreyer & Kragl, 2008). Alternatively, selective solubilization of SAV by inverse micelles
could be applied (Goklen & Hatton, 1987).
For the puriﬁcation of E. coli -derived SAV, fusion of the SAV gene to heat-responsive peptide tags
like ELP (elastin-like polypeptides) seems promising. These peptides undergo phase transition upon
heating, allowing the puriﬁcation of tagged proteins by inverse transition cycling (Meyer & Chilkoti,
1999). In this procedure, the insolubility of the target protein upon heating is used for the removal
of soluble contaminants, as illustrated in Fig. 8.6 (p. 185, supplementary material). The method is
particularly interesting due to the heat stability of SAV (Fig. 3.3, p. 56) and the thermal inactivation
of contaminating proteins (section 6.3.4, p. 150). It may therefore allow simultaneous inactivation
of contaminants and puriﬁcation of SAV by heat incubation and subsequent centrifugation at room
temperature for the removal of insoluble contaminants, followed by the usual procedure of inverse
[6]The E. coli BL21(DE3)-derivatives C41(DE3) and C43(DE3).
[7]Sequences rich in the amino acids proline, glutamic acid, serine, and threonine, leading to increased
degradation by the proteasome.
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transition cycling. Facilitated procedures based on alternative peptide tags like 18A and ELK16 have
been developed more recently (Xing et al., 2011).
Generally, further studies on the use of SAV puriﬁed by the methods discussed in section 6 (p. 144ﬀ.)
should lead to clear conclusions on which product purity is necessary for diﬀerent applications, facilitat-
ing the choice of the DSP strategy. In either case, the use of synthetic instead of complex production
media may simplify puriﬁcation in upcoming studies. Yet, in this context achieving ﬁlamentous growth
is essential for the expression by S. avidinii due to the interdependency of medium composition and
morphology (see section 4.4.1, p. 80).
7.3.2.4 Recovery of biotin-blocked binding sites
Finally, a comprehensive optimization of the methods for the removal of SAV-bound biotin (sec-
tion 3.5, p. 55ﬀ.) might result in a more eﬃcient recovery of biotin-blocked binding sites of the
protein. Many factors like incubation temperature, addition of urea, and adjustment of the pH value
were only varied in one factor at a time-experiments. Thus, a design of experiments-approach may
lead to synergistic eﬀects and yield a more holistic view of biotin degradation. Moreover, the applica-
tion of bandpass ﬁlters for the UV radiation-based treatment of SAV-bound biotin could partly protect
the protein of damaging eﬀects.
If these experiments are successful, this step may enable the recycling of SAV by recovering biotin-
blocked binding sites after the application of SAV. Furthermore, it could contribute to the recovery of
blocked sites on SAV columns used for the puriﬁcation of Strep-tagged proteins (Schmidt et al., 1996).
And ﬁnally, it would facilitate heterologous production of SAV, by allowing the supplementation of
larger concentrations of biotin to cultivation media without the necessity for methods of ﬁltration- or
dialysis-based de- and renaturing after cultivation.
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8.1 Additional methods
Additional methods are described in detail in the following sections.
8.1.1 Recovery of biotin-blocked binding sites
The recovery of biotin-blocked binding sites was tested by hydrogen peroxide treatment and UV
radiation.
Supernatants containing SAV were acquired from the cultivation of S. avidinii as described in sec-
tion 4 (p. 60ﬀ., ﬁnal process strategy). The supernatants were mixed with an aqueous solution of biotin
(100µM, Sigma-Aldrich Laborchemikalien GmbH, Seelze, Germany) to achieve full biotin-saturation
of the binding sites. The supernatants were then either subjected one of two diﬀerent methods of
treatment or to a combination of both of them.
For the chemical degradation of biotin, the supernatant was mixed with varying concentrations
of hydrogen peroxide (30% (w/w) stock solution, Sigma-Aldrich). If not indicated otherwise, heat
incubation was performed at 60 °C in 2mL reaction tubes in standard laboratory heat blocks with
water-ﬁlled wells. Samples of 150µL were taken in intervalls of 10min for 90min. The activity of SAV
was determined threefold by the standard ﬂuorescence assay by Kada et al. (1999a,b) (free binding
sites) and via heat-induced dissociation of biotin by the assay developed previously (overall binding
sites; section 3, pp. 28; incubation at 70 °C for 10min; cSAV ≤ 300 nM).
For UV treatment, samples were incubated on a transillumination device (TMW-20 Transilluminator,
Model White/UV, UVP, San Gabriel, CA, U.S.A.) in 50mL polypropylene tubes (Cellstar®, Greiner Bio-
One GmbH, Frickenhausen, Germany) prior to ﬂuorescence measurements according to the procedures
described above.
8.1.2 Homologous production of SAV by S. avidinii
The following section contains additional methods for the cultivation of S. avidinii and analysis of
the culture broth.
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8.1.2.1 Viscosity measurements
The dynamic viscosity η was measured applying a falling ball viscometer of the type 001-1926
(Haake GmbH, Karlsruhe, Deutschland) and a ball characterized by a diameter of 3mm. The density
of the ball was calculated by weighing, whereas for the corresponding culture broths this parameter
was determined by densitometry (DMA 48 density meter, chempro/PAAR, Graz, Austria).
Calculations were based on the force balance on the ball.[1] While falling, diﬀerent forces level out
after a short time, in which friction and buoyancy compensate the gravitational force, leading to a
constant terminal velocity of the ball. The latter can be used for the calculation of the viscosity of
Newtonian ﬂuids. The geometry of the ball and this force balance result in the general equation 8.1
for the dynamic viscosity:
η = 29 g (ρball − ρmedium)
r2 · t
s
(8.1)
where g is the gravitational acceleration (≈ 9.81m s−2), ρball and ρmedium are the densities of ball
and medium, respectively, r and t are the radius and falling time of the ball, respectively, and s is the
falling distance covered in the viscometer (2 cm).
Values of η were calculated in mPa s.[2] The term
K = 29
r2 · g
s
(8.2)
represents the ball constant deﬁned by the geometry of the system (ball diameter, diameter and length
of cylinder). K was determined tenfold for the 3mm ball and a reference ﬂuid characterized by known
properties (water at 30 °C; η ≈ 0.798mPa s; ρ ≈ 0.996 gmL−1) according to equation 8.3.
K = ηref(ρball − ρref ) t (8.3)
where ηref and ρref are the dynamic viscosity and the density of the reference ﬂuid, respectively.
The viscosity of a sample was then calculated by equation 8.4.
η = K (ρball − ρmedium) t (8.4)
[1]The theoretical considerations are roughly based on the online method “Measure-
ment of viscosity in a vertical falling ball viscometer" (Ping Yuan & Ben-Yuan
Lin, October 2008), http://www.americanlaboratory.com/913-Technical-Articles/
778-Measurement-of-Viscosity-in-a-Vertical-Falling-Ball-Viscometer/, last checked
5th of April 2016.
[2]1mPa s = 10−3 Nm2 s = 1
g
sm
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To compensate for potential time-dependent eﬀects (hysteresis of viscosity for small non-Newtonian
eﬀects, temperature dependency), the falling time was determined ﬁvefold after reaching a constant
value in a temperature-controlled environment (for the given purpose: the process temperature of
30 °C).
The values determined by this method should only be interpreted as an estimate of the rheological
behavior of the broth due to the non-Newtonian behavior of highly concentrated ﬁlamentous culture
broths (see 2.4.1.1, p. 10).
8.1.2.2 Pellet analysis by ImageJ
The area of pellets of S. avidinii was analyzed via a Digi Micro 1.3 USB microscope (1.3 MP, dnt,
Dietzenbach, Germany). For this purpose, a culture volume of approximately 0.5mL was adjusted to
10mL in a petri dish by the addition of twofold demineralized water. The dish was placed on black
cardboard. The sample was illuminated from above by soft, diﬀuse ambient light, which turned out to
be optimal for maximal illumination of pellets and minimal background noise.
Properties of the pellets were evaluated by the image analysis software ImageJ. For this purpose,
images were imported as image sequences and converted to 8-bit format. The threshold for the
detection of pellet edges was manually adjusted to cover a region from 0 to 200. An additional image
of a millimeter-scaled graph paper was used as a scale reference for the quantitative evaluation of the
microscopic images by the software.
8.1.2.3 Microplate cultivation
Microplate cultivation was based on a modiﬁed version of the protocol by Sohoni et al. (2012).
Cultivation was performed in squared 24 well -microplates (v-bottom, Axygen, Corning, USA). Glass
beads (6 per well, diameter: 3mm) were added to the wells prior to sterilization to avoid pellet
formation. The plates were shaken at a frequency of 200min−1 (shaking diameter: 20mm) at 30 °C.
All experiments were performed in 5 replicates. Medium optimization was based on a DoE approach
in the software MODDE. Randomized positions of the experiments in the wells were used for varying
compositions of the medium. For the preparation of cultivation media, 18mL of medium were mixed
with 1mL of 1M MOPS-buﬀer (pH 7.0, sterile ﬁltered). A volume of 200µL of freshly thawed glycerol
stock was used for inoculation of this mixture. Each of the wells was then ﬁlled with 3mL of the
resulting solution. After 48 and 96 h of cultivation, the loss of liquid volume was compensated by
the addition of sterile water (approx. 500 and 800µL per well, respectively, determined by diﬀerential
weighing).
During cultivation, microplates were sealed by a gas-permeable membrane (Breathseal, Greiner bio-
one, Frickenhausen, Germany).
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8.1.2.4 Continuous cultivation
Continuous cultivation was performed in the MBR bioreactor used for Müller et al. (2013). M3
medium, composed as described in the same article, was prepared in a vessel with a ﬁlling volume of
260 L without adjustment of the pH value. All compounds of the medium were sterilized simultaneously
for 45min, resulting in a loss of glucose due to Maillard reactions (glucose supplemented: 10 g L−1;
glucose measured after sterilization: 8.6 g L−1).
Flow in the MBR bioreactor was adjusted by a peristaltic pump. Outﬂow was based on a rising pipe
and a second peristaltic pump adjusted to a higher setpoint, ensuring the removal of liquid exceeding
the working volume of 3.16 L.
Cultivation parameters were a cultivation temperature of 30 °C, a setpoint for the pH of 7.0, a rotary
frequency of the stirrer of 500min−1, and a total air ﬂow rate of 6NLmin−1. The composition of the
inﬂow air was adjusted by the addition of oxygen from a medical oxygen concentrator (Topair 2, Kröber
Medizintechnik GmbH, Dieblich, Germany) depending on the dissolved oxygen signal (ratio aeration).
The relative dissolved oxygen concentration was kept constant at 80% of a maximal saturation of
100% gathered by calibration for a head pressure of 0.2 bar and aeration by regular air.
Cultivation at each dilution rate was performed until constant concentrations of SAV and DCW were
achieved, but for at least 5 residence times.
8.1.3 Purification of SAV
Several methods used for the puriﬁcation of SAV (section 6, p. 144ﬀ. in the main document) are
described in the following sections. As discussed in the main document, the methods were tested for
a supernatant of E. coli if not stated otherwise.
Generally, total protein was determined via the Roti®-Nanoquant system (Carl Roth GmbH + Co.
KG, Karlsruhe, Germany), whereas contaminating proteins were qualitatively analyzed via SDS-PAGE.
8.1.3.1 Thermal inactivation
Denaturing by thermal inactivation based on the results of Gallizia et al. (1998) was performed in
volumes of 200µL. Samples were incubated at 60, 75 or 80 °C. Three aliquots per temperature and
incubation time were used for triplicate determination of the concentration of SAV after the procedure.
Samples were incubated on ice directly after heat incubation. A reference sample was incubated at
4 °C for 60min without heat incubation.
After thermal inactivation, all samples were subjected to centrifugation at 10.000×g and 4 °C for
20min for the removal of denatured and precipitated proteins. The supernatant was used for the
determination of SAV according to the standard measurement procedure.
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8.1.3.2 Ammonium sulfate precipitation
Precipitation of SAV by ammonium sulfate was performed based on the general procedure by Green
& Hughes (1955) and the SAV-speciﬁc study of Suter et al. (1988). Precipitation was studied in 15mL
reaction tubes. A volume of 0.15mL of supernatant and 2.85mL of twofold demineralized water was
incubated at 25 °C prior to the addition of solid ammonium sulfate. For precipitation, samples were
incubated overnight at 4 °C after the addition of the salt. Subsequently, the samples were centrifuged at
40.000×g and 0 °C for 30min. Analysis of supernatant and precipitate was performed after separation,
resuspension of the precipitate in water, and tempering to 25 °C.
The amount of ammonium sulfate necessary for the precipitation at a deﬁned concentration was
calculated according to Green & Hughes (1955).
8.1.3.3 Aqueous two-phase extraction
For the preliminary screening using a PEG/citrate system, PEG of three polymer chain lengths was
used: PEG 1500 (Fluka, Buchs, Switzerland), PEG 3000 (Merck KGaA, Darmstadt, Germany), and
PEG 6000 (Carl Roth GmbH + Co. KG, Karlsruhe, Germany). The composition of the system was
based on Kula & Vernau (1990), yielding the initial system compositions shown in Table 8.1.
No phase separation was observed for the given concentrations at pH 5.2. Thus, the ﬁnal amounts
of both polymer and salt were increased to 2.5 and 1.6 g (PEG 1500 and citrate), 1.9 and 1.4 g (PEG
3000 and citrate), and 1.8 and 1.3 g (PEG 6000 and citrate), respectively, which resulted in an increase
of the overall volume. The exact phase volumes for all systems used are shown in Table 8.2.
The systems were vortexed and incubated at RT for 20min prior to the measurement of phase
volumes and SAV.
More detailed experiments on the aqueous two-phase extraction of SAV were based on a PEG/
phosphate system and binodal curves from Albertsson (1986).
PEG 4000 (AppliChem GmbH, Darmstadt, Germany) and diﬀerent potassium phosphate salts were
used (K2HPO4 and KH2PO4, both also purchased from AppliChem). These compounds were pre-
pared as aqueous stock solutions (20% potassium phosphate buﬀer at pH 7, 60 and 20% K2HPO4,
20% KH2PO4, and 40% PEG 4000; all concentrations referring to % (w/w)). The diﬀerent potas-
sium phosphate solutions were mixed in deﬁned ratios to adjust the pH to the given setpoint by the
Henderson-Hasselbalch equation as shown below. Additionally, NaCl was used as a supplement of the
systems, which was added directly to the extraction volume in solid form.
pH = pKA + log
cbase
cacid
(8.5)
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Tab. 8.1: Composition of PEG/citrate sys-
tems used for the preliminary screen-
ing for the aqueous two-phase extraction
of SAV. The amounts of PEG and cit-
rate were mixed with 1mL of a 720 nM
(tetrameric) supernatant of SAV from S.
avidinii, and adjusted to the target pH
(5.2, 7.0, 9.0, 11.0) and a final volume of
10mL.
MW PEG [Da] a mPEG [g] mcitrate [g]
1500 2.0 1.3
3000 1.5 1.1
6000 1.4 1.0
1500/3000 b 1.0/1.5 b 1.2
3000 HPEG c 3.0 0.5
a molecular weight of PEG used for the
study
b mixture of PEG 1500 (first amount) and
PEG 3000 (second amount)
c PEG-rich system, phase ratio not bal-
anced (see Table 8.2)
where pKA is the negative decadic logarithm of the dissociation constant of the acid KA, and cbase and
cacid are the (molar) concentrations of the conjugated base (deprotonated acid) and the acid present
in the solution, respectively, .
Extractions were prepared to reach an overall mass of 10 g. A volume of 350µL of the corresponding
SAV-containing supernatant was used for the extraction.
The extractions were mixed and incubated at 28 °C for 1 h. After determination of the phase volumes,
the phases were separated and used for the measurement of SAV. Prior to the quantiﬁcation of total
protein according to Bradford (1976), PEG was removed by dichlormethane extraction followed by the
removal of potassium phosphate via dialysis.
8.1.3.4 Dialysis
A 14 kDa cellulose bag (Visking type 8/32, Carl Roth GmbH + Co. KG, Karlsruhe, Germany) was
used for dialysis, characterized by a width of 10mm and a wall thickness of 0.05mm. The average
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Tab. 8.2: Phase volumes for the PEG/citrate-
based extraction of SAV. Volumes of the PEG-
rich top phase and the citrate-rich bottom
phase are shown.
system a Vtop [mL] Vbottom [mL]
1500, pH 11.0 5.5 4.5
1500, pH 9.0 5.6 4.4
1500, pH 7.0 5.6 4.4
1500, pH 5.2 6.5 4.5
3000, pH 11.0 5.6 4.4
3000, pH 9.0 5.6 4.4
3000, pH 7.0 5.5 4.5
3000, pH 5.2 6.5 4.5
6000, pH 11.0 5.6 4.4
6000, pH 9.0 5.5 4.5
6000, pH 7.0 5.6 4.4
6000, pH 5.2 6.5 4.5
1500/3000, pH 7.0 b 5.5 4.5
3000 HPEG, pH 7.0 c 7.0 3.0
a molecular weight of PEG and final pH value
used for the study
b mixture of PEG 1500 and PEG 3000 according
to Table 8.1
c PEG-rich system according to Table 8.1
length of the tubes used for dialysis was 10 cm. Filling volumes were in the range of 100µL to 2mL.
Incubation was performed in a volume of 5 L of demineralized water stirred by a magnetic stirrer at
4 °C for 24 h.
8.2 Supporting results
A selection of supporting results is presented in the following section.
8.2.1 Results of the in silico-analysis of the native signal peptide of
SAV from S. avidinii
The native secretion signal peptide of S. avidinii was analyzed in silico. Results are shown in Fig. 8.1.
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Fig. 8.1: Results of the in silico-analysis of the native secretion signal peptide of SAV from
S. avidinii by the prediction tool PRET-TAT described by Bagos et al. (2010). The
cleavage site of the signal peptide (AA 1-24) was predicted accurately.
8.2.2 Recovery of biotin-blocked binding sites of SAV
Fig. 8.2, 8.3, and 8.4 show additional results for the recovery of biotin-blocked binding sites of SAV.
Fig. 8.2: Course of the degradation constant for a first-order degradation of biotin over
the concentration of hydrogen peroxide at 60 °C derived from Fig. 3.4a (p. 58). The
constants only apply in the initial phase of degradation and for high degrees of biotin
saturation (Qbl → 1).
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Fig. 8.3: Analysis of the recovery of biotin-blocked binding sites of immobilized SAV by
hydrogen peroxide, displayed as the apparent amount of SAV detected in the fluorescence
assay. Abbreviations: imm = immobilized SAV, BS = biotin-saturated sample, HT =
sample incubated at 60 °C for 30 min. Furthermore, the concentration of H2O2 (in %
(w/w)) during incubation is shown where it was supplemented to the samples.
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(a) Hydrogen peroxide treatment: qualitative study. (b) Combined UV and hydrogen peroxide treatment: quantitative
study.
Fig. 8.4: Results of studies for the non-denaturing degradation of SAV-bound biotin by UV radiation and hydrogen
peroxide (concentrations in % (w/w)). (a) Qualitative study: Incubation of a biotin-saturated, SAV-containing
supernatant at 60 °C for 60min in the presence of varying concentrations of hydrogen peroxide. The apparent
concentration of SAV cSAV refers to a fluorescence measurement at room temperature. For the signal ratio RTHT−1,
the corresponding fluorescence was divided by the result of a measurement after 10min of incubation at 70 °C
(heat-based displacement of biotin) as a qualitative measure of the proportion of biotin-free binding sites (no dilution
to cSAV,HT ≤ 300 nM). (b) Quantitative study: normalized recovery Qrec of blocked binding sites and inactivation L
of overall binding sites in a supernatant containing 1.2µM of SAV incubated on a transillumination device for 5 h,
followed by treatment with varying concentrations of hydrogen peroxide at 60 °C for 30 or 60min.
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8.2.3 Course of the dynamic viscosity throughout a cultivation of
S. avidinii
Determination of the dynamic viscosity during bioreactor fermentation of S. avidinii allowed conclu-
sions on the state of growth of the culture, as depicted in the exemplary plot of Fig. 8.5.
Fig. 8.5: Course of the dynamic viscosity η over the cultivation time for a bioreactor
fermentation of S. avidinii. The course is compared to the courses of biomass and carbon
dioxide in the exhaust air. The second increase of biomass (from 50-100 h of cultivation)
was induced by the feeding of additional substrate.
8.2.4 Power input for the studies of S. avidinii
Table 8.3 shows the results of the calculations of Reynolds number and power input described in
section 4.3.5 (p. 74).
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Tab. 8.3: Theoretical power input for the given bioreactor.
Reynolds number Re [-] power input L [W] corr. L [W] a corr. Lspec [WL−1]
n [min−1] H2O b 2N c BS d H2O 2N BS H2O 2N BS H2O 2N BS
200 20384 18573 2280 0.31 0.32 0.32 0.56 0.57 0.57 0.11 0.11 0.11
300 30576 27859 3421 1.05 1.08 1.07 1.88 1.94 1.93 0.38 0.39 0.39
350 35671 32502 3991 1.66 1.71 1.70 2.99 3.07 3.06 0.60 0.61 0.61
400 40767 37146 4561 2.48 2.55 2.54 4.46 4.59 4.57 0.89 0.92 0.91
500 50959 46432 5701 4.84 4.98 4.96 8.72 8.96 8.92 1.74 1.79 1.78
700 71343 65005 7981 13.29 13.66 13.60 23.92 24.58 24.48 4.78 4.92 4.90
900 91727 83578 10262 28.24 29.03 28.91 50.83 52.25 52.03 10.17 10.45 10.41
1100 112110 102150 12542 51.56 52.99 52.78 92.80 95.39 95.00 18.56 19.08 19.00
1300 132494 120723 14823 85.10 87.47 87.12 153.18 157.45 156.81 30.64 31.49 31.36
1500 152878 139296 17103 130.73 134.38 133.83 235.32 241.88 240.89 47.06 48.38 48.18
a corrected values of power input; lower Newton number due to the d/D-ratio (p. 72) and doubled L because of the
number of stirrers (2).
b calculation for water (dynamic viscosity: 0.798mPa s, density at 30 °C: 995.64 kgm−3)
c calculation for 2N medium (basic medium in the linear fed-batch processes in Müller et al. (2013); experimental
dynamic viscosity: 0.9mPa s, exp. density at 30 °C: 1023.4 kgm−3)
d calculation for a biomass suspension (BS); exp. dynamic viscosity: 7.3mPa s, exp. density at 30 °C: 1019.2 kgm−3)
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8.3 Additional figures
8.3.1 Inverse transition cycling for the purification of proteins
Fig. 8.6 visualizes the method of inverse transition cycling.
Fig. 8.6: Visualization of the purification of proteins by inverse transition cycling (ITC)
according to Hassouneh et al. (2010). The target protein, which is fused to an elastin-like
polypeptide (ELP), is precipitated by heating or the addition of salts. The supernatant
is removed, the protein is redissolved in cold buffer, and again heated up for phase
transition. These steps are repeated until sufficient purity is achieved.
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beginnend mit der Bewerbung auf eine Promotionsförderung, einer unendlichen Zahl an experimentellen
Problemstellungen und nicht zuletzt der Diskussion, Verschriftlichung und Präsentation der Ergebnisse.
Seine sorfältigen, fundierten, geduldigen und stets äußerst scharfsinnigen Rückmeldungen war von
unschätzbarem Wert für die Qualität der dieser Dissertation zugrunde liegenden Publikationen. Den
enormen Freiraum, der mir für das Projekt eingeräumt wurde, habe ich zu jedem Zeitpunkt sehr
geschätzt. Seine Arbeitsweise hat mich darüber hinaus viel über die kritische Auseinandersetzung mit
der Fachliteratur gelehrt. Die Melange aus fachlichem feedback und einer allgegenwärtigen, feinen
Prise Humor hat zu ebenso zahllosen wie ertragreichen und unterhaltsamen meetings geführt, welche
leider auch gewaltige Mengen seiner wertvollen Zeit verschlungen haben. Tschuldigung! Vielen Dank,
es hat viel Spaß gemacht mit Dir!
Herr Dipl.-Ing. Thomas Schäﬀer, der Mann, der alles kann und deshalb auch alles machen muss
(O-Ton Prof. Flaschel), war der Schlüssel zum Erfolg der verfahrenstechnischen Aspekte dieser Arbeit.
Seine sisyphos-esken Anstrengungen aus einem sturen, undichten und unberechenbaren Schrotthaufen
namens Sixfors ein perfektes Fermentationssystem machen zu wollen, waren für den Verlauf der Arbeit
unverzichtbar. Zahllose Arbeitsstunden und seine engelsgleiche Geduld brachten letztlich einen leidlich
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der Prozessregelung und Netzwerk-Verwaltung. Ohne seine Ratschläge zu einem bunten Sammelsurium
technischer Probleme wäre zudem eine derart reibungsfreie Analytik nicht möglich gewesen. Deshalb:
Herzlichen Dank!
Dank meinen Mit-Doktoranden Dominik Cholewa,[3] Philipp Grimm, Ram Shankar, Gabriele
Kleiner, Jan Schwarzhans und Yingfei Shi und dem mittlerweile pensionierten Dauer-Masteran-
den Lars Wollenschläger waren die Arbeitsstunden und gelegentlichen Wartezeiten im Verlauf des
Projektes nicht trostlos und zermürbend, sondern oft höchst amüsant. Lustige Stunden zwischen Tür
und Angel, Kaﬀeeraum und Labor, sowie Büro und Westend waren das viel zitierte Sahnehäubchen
auf dieser Arbeit. Merci beaucoup, ich werde euch nicht vergessen!
David Wetzel, Julia Hassa und Simon Bruhn gilt mein Dank für die ebenso intelligente wie
sorgfältige Bearbeitung wichtiger Facetten dieses Promotionsprojektes im Rahmen von Abschlussar-
beiten, ohne die mehreren Teilbereichen viel Tiefgang abgehen würde.
Dem weiteren Laborinventar, bestehend aus Eberhard Wünsch, Galina Beck und Kirsten Lei-
wig, danke ich herzlich für die mannigfaltige Unterstützung im Laboralltag.
Meinem Zweitgutachter Prof. Dr. Jörn Kalinowski und Tetiana Gren von der AG Microbial
Genomics and Biotechnology am CeBiTec der Universität Bielefeld danke ich für die Kooperation zu
genetischen und gentechnischen Aspekten der Streptavidin-Produktion mit S. avidinii, welche die Arbeit
um eine wichtige Facette ergänzt haben und insbesondere im Blick auf künftige Studien von großem
Interesse sein dürften. Dr. Dirk Holtmann und Felicitas Vernen vom DECHEMA-Forschungsinstitut
(Arbeitsgruppe Bioverfahrenstechnik) bin ich für die fruchtbare Kooperation zur Morphologiekontrolle
an diesem Stamm verbunden.
Weiterhin bedanke ich mich herzlich bei den Sponsoren dieses Promotionsprojektes: der
Deutschen Bundesstiftung Umwelt (DBU) und insbesondere Herrn Dr. Schaefer gebührt Dank
für die Förderung im Rahmen des Promotionsstipendienprogramms, welche nicht nur aus ﬁnanzieller
Sicht die wichtigste Stütze des Projektes war, sondern mir durch die Stipendiatenseminare auch eine
große persönliche Bereicherung war und meinen Horizont erweitert hat. Dem Bielefelder Nachwuchs-
fonds danke ich für die Abschlussförderung während der letzten Schritte dieses Promotionsprojektes,
die die Grundlage für das sorgfältige Zusammenfassen der Ergebnisse in Form der Publikationen war.
Letztlich gilt hier wie überall sonst: Ohne Moos nix los.
Last but not least geht ein großer Dank an meine Freunde,[4] die für die nötige Auﬂockerung des
Promotionsalltags gesorgt haben, und meine Eltern, die mir während des Projektes - und in all den
Jahren zuvor - stets den Rücken gestärkt haben. Herzlichen Dank!
[3]Danke auch für die Korrektur dieser Arbeit, Doc!
[4]Übereinstimmungen mit dem Kollegenkreis können nicht ausgeschlossen werden.
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